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Abstract 
The membrane-bound enzyme, inositol phosphorylceramide synthase (IPC synthase), 
encoded by AURJ, has been identified in yeast and fungi. [PC synthase catalyses the 
phosphorylation of ceramide to form inositol phosphorylceramide, an essential step in 
sphingolipid biosynthesis. The selective inhibition of IPC synthase would prevent formation 
of complex sphingolipids and cause ceramide build up, which has been reported to cause 
apoptosis. Since [PC synthase is unique to fungi, there is an opportunity for development of 
a species-specific enzyme inhibitor that might have low toxicity to the host for use as a 
fungicide. 
It is most relevant to agrochemicals to study the effects on enzymes from fungi and yeasts. 
For this purpose, IPC synthase has been isolated from both wild type Saccharomyces 
cerevisiae and Botiytis cinerea. Initial studies on substrate tolerance and the inhibitor, 
Aureobasidin A, have been carried out using a working in vitro mixed micelle fluorescent 
assay of IPC synthase activity. Michaelis-Menten kinetic parameters have been determined 
for S. cerevisiae IPC synthase using Triton X- 100 solubilised microsomes 
(phosphatidylinositol km 360.tM and fluorescent ceramide, N-[6+7-nitro-2-1,3- 
benzoxadiazol-4-yl)amino]hexanoyl]-ceramide k m 5 .2pM). The fluorescent ceramide was 
found to exhibit substrate inhibition at high concentration (k 1 130pM). When the substrate 
inhibition parameter was considered the apparent km of N-[6-[(7-nitro-2- 1,3 -benzoxadiazol-
4-yl)amino]hexanoyl]-ceramide increased to 11 .4pM. 
Both B. cinerea and S. cerevisiae Aurl p have been cloned, recombinantly overexpressed and 
purified using affinity tags. B. cinerea Aurl p was overexpressed in E. coli Top 1 ØTM  cells in 
inclusion bodies as an N-terminal Glutathione-S-transferase fusion. However, IPC synthase 
activity was low and expression in P. pastoris was investigated. A large number of 
constructs were prepared and successful intracellular overexpression was achieved for both 
B. cinerea and S. cerevisiae Aurip in KM71H cells (MutS)  as C-terminal c-myc His 6 fusions. 
Although expression was achieved with both full length and N-terminally truncated forms, 
the full length proteins had greater activity. B. cinerea Aurip was far more active when 
expressed in P. pastoris rather than E. coli. Native S. cerevisiae IPC synthase was found to 
be functionally glycosylated with high mannose content and the increased activity is 
probably due to the correct processing and post translational modifications occurring in the 
eukaryotic system. Native IPC synthase activity was demonstrated in P. pa.storis and an 
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isolation method based on affinity chromatography has been identified for native P. pastoris 
and B. cinerea Aurip. 




°C Degrees centigrade 
10, 20, 30 Primary, secondary, tertiary 
3-KIH 3-ketodihyrosphingosine 
AbA Aureobasidin A 
ABC transporter ATP binding cassette transporter 
AE Sodium acetate, EDTA 
Af Aspergillusfumigatus 
An Aspergillus nidulans 
APS Ammonium persulfate 
aq Aqueous 
ATP Adenosine 5 '-triphosphate 
Aurip Protein encoded by the A URI gene, a similar notation is used for other 
proteins, e.g. Iptlp is a protein encoded by IPTJ 
Bc Botrytis cinerea 
Bis-Tris Bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane 
Bis-Tns-C1 Bis-Tns, pH obtained with hydrochloric acid. 
BLAST Basic Local Alignment Search Tool 
BMD Buffered minimal dextrose medium 
BMG Buffered minimal glycerol medium 
bp Base pair(s) 
BSA bovine serum albumin 
Bt Bacteroides thetaiotaomicron 
CI-3 Three conserved domains in the PAP2 superfamily and LPPs / C  domain of 
protein kinase C 
C18:O-CoA, C26:0-
CoA Co-enzyme A with an 18 or 26 carbon chain containing no double bonds 
C6--er C6-NBD-Ceramide, N-[6-[(7-nitro-2- 1 ,3-benzoxadiazol-4- 
yl)amino]hexanoylj-D-eythro-sphingosrne 
C6-NBD-IPC C6-NBD-Inositol phosphorylceramide, N-[6-[(7-nitro-2- I ,3-benzoxacliazol-4- 
yl)amlno]hexanoyll-Inositol phosphorylceramide 
Ca Candida albicans 
CaCl2 Calcium chloride 
Cg Candida glabrata 
CHAPS 3-[(3-Cholamidopropyl) -dimethylammonjo]- I -propanesulphonate 
CHAPSO 3-[(3-Cholamidopropyl) -dimethylammonio]- 2-hydroxy- 1 -propanesulphonate 
CMC Critical micelle concentration 
Cn Cryptococcus neoformans 
CoA Co-enzyme A 
ConA Concanavalin A 
c-region Amino acids immediately preceding the signal sequence cleavage site 
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Abreviation Description 
DAPA synthase 7,8-diaminopelargonate acid synthase 
DDM n-Dodecyl B-D-maltoside 
DEAE Diethylaminoethyl 
DHS Dihydrosphingosine, sphinganine 
DHS- 1-P Dihydrosphingosme- 1-phosphate 
DMSO Dimethyl sulfoxide 
DNA, cDNA Deoxyribonucleic acid, clone DNA derived from complementary DNA 
EDTA Ethylene diaminetetracetic acid 
ELISA Enzyme-Linked Immunosorbent Assay 
ER Endoplasmic reticulum 
E-value Expectation value of obtaining a sequence by random chance 
FBSM Fermentation basal salt medium 
FPLC Fast protein liquid chromatography 
g, mg, .tg g-force/ gram(s); mg, milligram(s); rig, microgram(s) 
GalCer(s) Galactosylceramide(s) 
GCS Glucosylceramide synthase 





GTP Guanosine 5 -triphosphate 
h Hour(s) 
HA Hemagglutinin 
His6 Six consecutive histidine residues 
HMM Hidden Markov models 
FIPLC High performance liquid chromatography 
h-region Hydrophobic region used for signal sequence prediction 
IC50 The concentration of the inhibitor that inhibits 50% activity of the enzyme 
Ig Immunoglobin 
IMAC Immobilised metal affmity chromatography 
IPC(s) Inositol phosphorylceramide(s) 
IPS-PLC Inositol phosphosphingolipid phospholipase C 
IPTG Isopropyl-,D-thiogalactopyranoside 
k Kilo 
k1 Dissociation constant of an inhibitor in enzyme kinetics 
km  Substrate concentration that permits half maximal rate of reaction (half VM) 
K-phos Potassium phosphate buffer containing both the monobasic and dibasic salts 
L, ml, .il Litre(s); ml, millilitre(s); j.ti, microlitre(s) 
LB Luria Bertani 
LCB(s) Long chain base(s) 
LCB-1-P Long chain base- i-phosphate 
LC-MS Liquid chromatography mass spectrometry 
LPP(s) Lipid phosphate phosphatase(s) 
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Abreviation Description 
M, mM, .tM, nM, pM Molar; mM, millimolar; p.M, inicromolar; nM, nanomolar; pM, picomolar 
mA Milliampere 
MALDI-ToF Matrix Assisted Laser Desorption Ionization Time-of-Flight 
MD Minimal dextrose medium 
MgCl2 Magnesium chloride 
MOY Minimal glycerol medium 
MIC Minimal inhibitory concentration, the lowest concentration of antimicrobial 




MM Minimal methanol medium 
MnC12 Manganese chloride 
MOPS 3-(N-morpholino)propanesulfonic acid 
MS Mass Spectrometry 
Muf Pichia pastoris methanol utilisation plus phenotype 
MutS Pichia pastoris methanol utilisation slow phenotype 
NaCl Sodium chloride 
NADPH Nicotinamide adenine dinucleotide phosphate, reduced 
NBD-X 6-(N-(7-nitrobenz-2-oxa- 1,3-diazol-4-yl)amino)hexanojc acid 
Nc Neurospora crassa 
mn, cm Nanomelre; cm, centimetre 
NMR Nuclear magnetic resonance 
NP40 Nomdet P40 
n-region Positively charged N-terminal amino acids, used in signal sequence prediction 
NTA Nitrilotriacetic acid 
OD Optical density 
ORF(s) Open reading frame(s) 
oxy-SAM S-adenosyl-2-oxo4-methyl-thiobutyric acid 
PAP2 Type 2 phosphatidic acid phosphates 
PBS Phosphate buffered saline 
PBST Phosphate buffered saline, Tween-20 
PBSTM Phosphate buffered saline, Tween-20, milk 
PCR Polymerase chain reaction 
pdb Protein data bank 
PEST PEST motifs are rich in proline (P), glutamic acid (E), serine (S) and 
threonine (T) 
PHS Phytosphingosine, 4-hydroxydihydrosphingosine, 4-hydroxysphinganine 
PHS- 1-P Phytosphingosine- 1-phosphate 
P1 Phosphatidylinositol 
PLP Pyridoxal-5 '-phosphate 
PMSF Phenyl methyl sulfonyl fluoride 
PPMP 1 -phenyl-2-palmitoylamino-3-morpholino- 1 -propanol 
PSI-BLAST Position specific iterated-BLAST 
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Abreviation 	Description 	 - 
Rf The retention factor, the distance travelled by the compound divided by the 
distance travelled by the solvent in TLC. 
RNA, mRNA Ribonucleic acid; messenger RNA 
rpm Rotations per minute 
RT Room temperature/ retention time 
S-i-P Sphingosine- 1 -phosphate 
SAM S-adenosyl-L-methionine 
SAM-OH S-adenosyl-2-hydroxy-4-methyl-thiobutyrjc acid 
Sc Saccharomyce.s cerevisiae 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SM Sphingomyelin 
SMS(s) Sphingomyelin synthase(s) 
Sp Schizosaccharomyces pombe 
spp. Species 
SPT Serine palmitoyl transferase 
TAE Tris acetate EDTA 
TAP Tandem affinity protein 
TCA Trichioroacetic acid 
TE Tris EDTA 
Temed N,N,N',N'-tetramethylethylenediamine 
TFA Tnfluoroacetic acid 
TLC Thin layer chromatography 
TMH(s) Trans membrane helix, Trans membrane helices 
Tris Tris (hydroxymethyl) aminomethane 
Tris-CI Tris (hydroxymethyl) aminomethane, pH obtained with hydrochloric acid 
Triton X- 100 Octylphenolpoly(ethyleneglycolether) 
U Unit(s) 
UDP Uridine diphosphate 
UV Ultraviolet 
v/v Volume to volume 
Vis Visible 
VLCFA(s) Very long chain fatty acid(s) 
VMAX Maximum initial velocity of an enzyme catalysed reaction 
wt Wild type 
w!v Weight to volume 
YNB Yeast nitrogen base 
YPD Yeast extract peptone dextrose medium 
YPDS Yeast extract peptone dextrose sorbitol medium 
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Chapter 1: Introduction 
"It is our conjecture that one cannot understand key areas of cell biology (including 
apoptosis, senescence, vesicle sorting and trafficking, membrane organization, and stress 
responses) and disease pathobiology (cancer, diabetes, aging, and inflammation) without 
understanding sphingolipid metabolism." [1] 
Sphingolipids are a complex and diverse lipid class present in essentially all eukaryotes as 
well as some prokaryotes [2]. The sphingolipid network is a rich source of bioactive 
molecules which can potentially be exploited for a variety of therapeutic and agrochemical 
uses. 
Sphingolipids are essential components of eukaryotic membranes and comprise a small but 
vital fraction of membrane lipids, typically 10-20% [3], the remainder consisting of 
glycerolipids and sterols (Figure 1.1). Sphingolipids are predominantly found in the plasma 
membrane outer leaflet, with their polar head groups pointing towards the cell wall [4]. In 
addition to acting as hydrophobic structural barriers, sphingolipids have been implicated in 
as diverse roles as calcium homeostasis and calcium mediated signalling pathways, the 
trafficking of secretory vesicles, signal transduction upon heat stress and cell cycle 
regulation functions including cell growth and proliferation, differentiation, angiogenesis, 
apoptosis and senescence [4-6]. 
Sphingolipids were originally discovered in 1884 in brain tissue by Thudichum [7]. He 
characterised three compounds; cerebroside, sphingomyelin (SM) and an aliphatic amino 
alcohol, sphingosin, named after the Greek mythological sphinx due to its enigmatic 
properties and elusive function. Carter et. al. were the first to correctly assign the structure 
of the sphingoid base in the 1940's and 1950's [8-11]. It was not until recently, however, in 
the past twenty years that there has been an explosion of literature regarding the functions of 
sphingolipids; over 5000 papers have been published on ceramide alone [1]. The increase in 
knowledge and understanding in the field of sphingolipids has also succeeded in highlighting 
the intricate detail involved in the complex regulation of sphingolipid metabolism and 
function and of the elegant manipulation required to achieve therapeutic results. 
There are numerous reviews on the subject of sphingolipids available. Studies of 
mammalian sphingolipids have been plentiful in recent years, partly due to their presence in 
vital organs and the discovery of sphingolipid storage diseases [12-17]. Studies on plant 
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sphingolipids have been limited to structural isolation and characterisation and the 
understanding of their biochemistry has only recently been initiated [2, 18]. 
Yeast and fungal sphingolipids have been the most widely studied and their sphingolipid 
metabolism is the most defined area of sphingolipid biology. Here most of the biosynthesis 
and degradation pathways have been determined [4-6, 19-23]. The majority of this work has 
been carried out using Saccharomyces cerevisiae due to the isolation of yeast mutants 
deficient in specific steps of the pathway and genetic manipulation. These enzymes have 
been shown to be the target of a number of antifungal agents, and inhibition studies have 
highlighted the importance of these in cell cycle regulation. 
Our understanding of sphingolipid metabolism has led to the recent development of 
mathematical modelling of the pathways, which has enabled evaluation of the effects of 
perturbations in sphingolipid levels [24, 25]. Sphingolipid metabolism is interconnected to a 
number of other metabolic pathways including fatty acid synthesis and elongation, 
phospholipid synthesis and breakdown, serine utilisation and sterol synthesis [23]. Cellular 
responses to stimuli can depend not only on sphingolipid perturbations but also on how they 
connect to other pathways. 
1.1 Sphingolipid Structure 
As is the case with all membrane lipids, sphingolipids are amphipathic in nature, consisting, 
to varying extents, of both hydrophobic and hydrophilic regions. Unlike the predominant 
glycerolipids which are based on a glycerol backbone linked to two acyl chains and a polar 
head group, sphingolipids are composed of a sphingoid base, which consists of an aliphatic 
chain typically possessing a 2-amino- 1,3 -diol functionality, usually with D— eiyfhro (2S,3R) 
stereochemistry, as shown in Figure 1.1 [15]. Various polar substituents are attached to the 
C  -hydroxyl group and a fatty acid is connected by an amide linkage at the C2-amino group. 
Due to the numerous head groups and the varying chain length, degree of saturation and 
hydroxylation of both the sphingoid hydrocarbon chain and fatty acid chain, the number of 
sphingolipids is extensive; over 300 were structurally characterised by 1996 [26]. The 
sphingolipid sub groups are characteristic of different organisms and in some multicellular 
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Figure 1.1: Examples of Common Sphingolipids, Glycerolipids and Sterols 
Head group A, hydrogen, phosphocholine, phosphate, carbohydrate residues such as glucose or 
galactose and fatty acid derived acyl chains; B, hydrogen or phosphate; D, hydrogen, 
phosphoinositol, phosphoinositol with singular or multiple mannose units, phosphoinositol-mannose-
phosphoinositol; E, glucose (but not in S. cerevisiae or Schizosaccharomyces pombe); F, as D, 
carbohydrate residues; G, hydrogen, phosphoinositol, phosphocholine, phosphoserine, 
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Sphingoid bases can vary from 14 to 22 carbon atoms in length. The principle mammalian 
sphingoid base is sphingosine 25 [(2S,3R-4E)-2-aminooctadec-4-ene-1,3-dioV, (E)-sphing-4-
enine] which has a C 18 chain and contains a 4,5 trans double bond. Its saturated analogue, 
dihydrosphingosine 8 [(2S,3R)-2-aminooctadecane-1,3-diol', sphinganine, (DHS)], is the 
second most abundant base and the hydroxylated version, phytosphingosine 10 [(2S,3S,4R)-
2-aminooctadecane- 1,3 ,4-triol 1 4-hydroxydihydrosphingosine, 4-hydroxysphinganine, 
(PHS)] is present in kidney and stomach sphingolipids. Both DHS 8 and PHS 10 are found 
in yeast and fungi, with PHS being the most predominant sphingoid base [3]. In addition to 
these yeast and fungi also have C 16 [27] and C 20-sphingoid bases. The C 20 base compounds 
increase in abundance when cells are grown at 37°C compared to 25°C [28, 29]. One or two 
hydroxyl groups on the base structure are common in yeast and fungal sphingolipids but this 
is rare in mammalian sphingolipids [30]. Bases that contain double bonds, hydroxyl and/or 
methyl groups are also common in fungi. Plant sphingolipids predominantly have 
unsaturated bases, either at C 8 , 9 or at both C 8 , 9 and C4 , 5 , the sphing-8-enines and sphing4,8-
dienes respectively, and also contain 4-hydroxy-8-sphingenine. The C 8 , 9 double bond can be 
either cis or trans, whereas the C 4 , 5 double bond is usually trans. Plant sphingolipids also 
contain DHS, PHS and trace amounts of sphingosine [2]. Sphingolipids in insects are based 
on a 14 carbon sphingoid base and nematode sphingolipids contain a C 16 base that is 
methylated at the C 15 position [3]. 
The sphingolipid fatty acyl chain is usually long and saturated. It can also be hydroxylated 
at the a-position [3]. Mammalian and plant sphingolipids contain fatty acid moieties which 
vary from 16 to 24 [31] and 16 to 26 [2] carbons in length, respectively. Yeast and fungal 
sphingolipids however, contain very long chain fatty acids (VLCFAs) which are typically 26 
carbons in length [30], both with and without a-hydroxylation, although C 24 chains have also 
been observed [32]. The precursor to all membrane sphingolipids is the N-acylated 
sphingoid base, ceramide. Exceptions to these generalisations do exist, for example, 
ceramides in mammalian skin have VLCFAs and unusual sphingoid base structures [14]. 
Sphingolipids are classified depending on the polar head group attached to the Ci-hydroxyl 
moiety of ceramide and are termed as either phosphosphingolipids or glycosphingolipids. 
Sphingomyelin (SM) 27, the mammalian [3] and nematode [33] phosphosphingolipid, has 
phosphocholine as its polar head group. The inositol phosphorylceramides (IPCs) in yeast, 
IUPAC names [14] 
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fungal, plant and protozoan phosphosphingolipids have phosphoinositol as their polar head 
group [30], similar to that found in the major glycerolipids phosphatidyicholine and 
phosphatidylinositol (P1) 28. Ethanolaminephosphorylceramide is the main 
phosphosphingolipid present in insects [34]. It is also present in small quantities in 
mammals [3]. 
Glycosphingolipids can be subdivided into neutral and acidic glycosphingolipids. Neutral 
glycosphingolipids contain uncharged monosaccharides, usually glucose or galactose, linked 
by a variety of glycosidic bonds. Glycosphingolipids which have one monosaccharide 
residue as the head group are termed cerebrosides. Acidic glycosphingolipids contain an 
ionisable functional group, such as phosphate (phosphoglycosphingolipids) or sulphate 
(sulfatoglycosphingolipids) and/or charged sugar residues, such as glucuronic acid, 
neuraminic acid and sialic acid [35]. If one or more charged sugar residue is sialic acid, the 
acidic glycosphingolipid is termed a ganglioside. Gangliosides are predominantly found in 
the central nervous system of higher organisms [26]. Phosphoglycosphingolipids are also 
known as glycosylinositolphosphorylceramides (GIPCs) and these are mainly found in fungi, 
plants and protozoa but not in mammals or other higher organisms [35]. 
The predominant complex sphingolipids in mammals are sphingomyelin and numerous 
neutral and acidic glycosphingolipids. Plants contain predominantly glucosylceramide, 
although, some GIPCs are also present [2]. Fungi, in contrast produce, as well as GJPCs, 
several neutral glycosphingolipids, the most common being glucosylceramide (GlcCer) [36]. 
S. cerevisiae produces only three classes of complex sphingolipids, 
inositolphosphorylceramide (IPC), mannosylinositolphosphorylcerannde (MIPC) and 
mannosyldiinositolphosphorylceramide (M(IP) 2C) (Scheme 1.1 and Scheme 1.2). 
Glycosphingolipids have been found to be essential for the development of complex 
multicellular organisms; but phosphosphingolipids appear to function at a more basic level 
being required for growth and survival of individual cells [2]. 
1.2 Sphingolipid Metabolism 
1.2.1 	De novo synthesis 
The initial steps of sphingolipid biosynthesis (Scheme 1.1) occur in the endoplasmic 
reticulum (ER) and are conserved throughout all eukaryotes. The first step is rate-limiting 
and involves the decarboxylative condensation of palmitoyl-CoA 5 and senne 6, catalysed 
by serine palmitoyl transferase (SN', 3-ketodihyrosphingosine synthase, a heterodimeric 
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enzyme encoded by the LBCJ and LBC2 genes) to yield 3-ketod1hyrosphingosine (3-KDH) 
7. SPT is the only heterodimeric membrane bound enzyme in the pyridoxal-5'-phosphate 
(PLP)-dependant a-oxamine synthase family. It is not understood why eukaryotic SPT 
consists of two subunits; however, the Lcb2 subunit which appears to contain the functional 
residues associated with catalysis appears to be unstable unless associated with Lcb Ip. 
Specific mutations in human LCBJ are known to reduce SPT activity and cause hereditary 
sensory neuropathy type 1 autosomal disease [37]. The bacteria Sphingomonas paucimobilis 
expresses a soluble homodimeric SPT that possesses 30% homology to both Lcblp and 
Lcb2p at the amino acid level [38, 39]. 
There are a number of natural and synthetic inhibitors of SPT that are thought to structurally 
mimic the intermediates of the multi step PLP reaction mechanism. The natural products 
sphingofiingins [40], lipoxamycin (neoenactin Ml) [41], myriocm (ISP-1, thermozymocidin) 
[42] and the recently discovered sulfamisterin [43] are highly potent inhibitors of both fungal 
and mammalian SPT with 10 50 's in the nanomolar range. The observed resistance of S. 
cerevisiae to myriocin (micromolar IC 50) [42, 44] is likely to be due to the inactivation of 
myriocin by the Ship protein [45]. Viridiofungins are potent inhibitors of mammalian SPT 
[46] and also inhibit squalene synthase [47]. Common synthetic PLP-dependant enzyme 
inhibitors, such as L-cycloserine and 13-chloro-L-alanine also inhibit SPT [48, 49]. 
Gable et. al. have shown that a third protein, Tsc3p, is required for optimal SPT activity in 
yeast [50]. They postulated that Tsc3p increases SPT activity by binding palmitoyl-CoA 5 
and delivering it to the LcblILcb2 protein complex. Tsc3p is a small 80 amino acid 
membrane protein that interacts with both Lcb subunits. However, Tsc3p has been shown to 
be essential only at elevated temperatures [50]. In addition, a mutation in Lcb2p outside the 
catalytic site increases Tsc3p independent SPT activity, removing the requirement for Tsc3p 
at high temperatures [51]. A mammalian homologue of Tsc3p has not been discovered to 
date. 
The C3 of 3-KDH 7 is reduced (by NADPH) to yield sphinganine (dihydrosphingosine, 
DHS) 8. The reaction is catalysed by 3-KDH reductase encoded by TSCJO. Tsc lOp has a 
single membrane spanning domain situated at the C-terminus and is part of the short chain 
dehydrogenase/reductase family of enzymes. In yeast TSCJO is essential for viability, 
however, a tsclOA mutant can grow in the presence of exogenous DHS or PHS [52]. 
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Scheme 1.1: Sphingolipid Biosynthesis: Main Steps in the Yeast and Fungal Pathways 
Structures depicted in this scheme are the most common in S. cerevisiae. For other variants refer to 
Scheme 1.2. Biosynthetic steps until DHS 8 formation are shared by all eukaryotes. For the 
mammalian sphingolipid pathway after DHS 8 formation refer to Scheme 1.3. 
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Scheme 1.2: Possible complex sphingotipids in S. cerevisiae 
* denotes the hydroxyl group added to the VLCFA by CCC2p 
# denotes possible steps that the CCC2p could hydroxylate the VLCFA. 
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Abbreviations: PC, phosphatidyicholine; PE, phosphatidylethanolamine 
After the formation of DHS 8, the fungal and mammalian pathways diverge. In the fungal 
pathway, hydroxylation of C4 of the C 18 chain of DHS is catalysed by a hydroxylase, 
encoded by non-essential SUR21SYR2 [53, 54]. This reaction yields the predominant yeast 
sphingoid base, PuS 10, which differs from the mammalian sphingosine 25 by the 
replacement of a C 4,5-double bond with C4-hydroxyl group. The C4-hydroxylation in yeast 
is inhibited by syringomycin E [53, 55]. Sur2p is a membrane bound hydroxylase and a 
member of the di-iron, eight histidine motif protein family [56]. Sur2p homologues have 
been found in plants [57] and Mus musculus (mouse) [58]. 
The N-acylation of DHS 8 or PHS 10 by VLCFA-CoA is catalysed by ceramide synthase, 
yielding dihydroceramide (ceramide-A) 9 or phytoceramide (ceramide-B) 11, respectively, 
typically with 26 carbons in the fatty acid chain. It is not known whether hydroxylation 
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occurs prior to or after fatty acid acylation in vivo as Sur2p can also utilise dihydroceramide 
9 as a substrate to yield phytoceramide 11 [53, 59]. However, it has been suggested that 
hydroxylation occurs first as PHS 10 does accumulate when ceramide synthase is inhibited 
[32, 60]. 
Two homologous genes, LACI and LAG], have been identified in both yeast and mammals 
as necessary for ceramide synthase activity [61-63]. Guillas et. al. have shown using a 
microsomal assay, there is a strong preference for C 26 VLCFA in yeast and for C 24 and 
shorter derivatives in human homologues, suggesting that the different enzymes are chain 
length specific [63]. It has been shown that C 24 and C 18 VLCFA do not compete with each 
other in rat microsomal ceramide synthase assays, and different ratio's are present in 
different cell types and tissues [64]. This suggests that mammals contain several ceramide 
synthases with different specificity. Both genes had previously been identified in S. 
cerevisiae as longevity assurance genes, with single deletion mutants living 50% longer, thus 
suggesting a role for ceramide in aging [65-67]. S. cerevisiae LACJ/LAG1 double deletion 
mutants are either non-viable or very sick, depending on their genetic background [63]. 
Recently Vallee et. al. have co-purified a third subunit of yeast ceramide synthase, Lipip, 
using tagged Lacip and Laglp. Liplp is a single spanning ER membrane protein and 
appears to be required for both in vitro and in vivo ceramide synthase activity [68]. 
Ceramide synthase has been identified as the target of two classes of natural product 
inhibitors, fumonisins [69] and auslralifungin [60]. The fumonisins are severely toxic to 
animals and humans due to the inhibition of mammalian ceramide synthase, which leads to 
loss of ceramide and complex sphingolipids, and accumulation of sphingoid bases [70]. 
However, the fumonisins possess poor antifungal activity, although fumonisin B  does 
inhibit Candida albicans ceramide synthase in vitro [71]. Australifungin is a potent broad 
spectrum antifungal but there is a lack of knowledge regarding its effects on mammals. 
Nagiec et. al. have shown that fumonisin B I and australifungin were marginally more potent 
against a S. cerevisiae sphingolipid bypass mutant than the wild type indicating that either 
the inhibitors are not specific for ceramide synthesis as previously thought, or that ceramide 
synthase has additional essential functions other than ceramide synthesis [72]. 
VLCFAs are critical for the sphingolipid pathway. Although only 4% of fatty acids in yeast 
are VLCFAs, almost all of this is found as C 26 VLCFA in ceramide and its products [22]. 
The elongation process occurs in an ER-associated complex. Elo2p and Elo3p are two 
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components of this complex and are thought to catalyse the condensation reaction required 
for elongation. These were identified due to their homology to ELOJ, which encodes a fatty 
acid elongation enzyme, Eloip, which elongates fatty acids from C 14 to C 16 [73]. Elo2p and 
Elo3p have slightly different substrate specificity; Elo2p elongates C 18 fatty acid chains to 
C224 and Elo3p elongates C 22124 fatty acid chains to C 26 . Double Elo2pA and Elo3p 
mutants are non-viable, although single mutants can survive. Elo3pA mutants contain no 
C26-VLCFA but in Elo2pA mutants, EIo3p can utilise C118  fatty acids although less 
efficiently than Elo2p [32]. 
Three other genes thought to be involved in fatty acid elongation have been identified; 
YBR159w [74], TSC13 [75], and ACB1 [76]. YBR159w and TSC13 are thought to be 
involved in the synthesis of the C 18-stearoyl-CoA 20. Ybr 1 59wp appears to reduce 3-
ketostearoyl-CoA 17 to the corresponding 3-hydroxy compound 18. The gene is not 
essential and in its absence the 3-hydroxy moiety can be generated later [74]. TSC13 is an 
essential gene and Tsc I 3 appears to catalyse the reduction of trans-2-stearoyl-CoA 19 to 
stearoyl-CoA 20. Tsc l3p is known to form a complex with Elo2p and Elo3p, but it is not 
known if the compex is required for activity [75]. A 50-70% reduction in sphingolipid 
production was observed in the absence of the acyl-CoA binding protein, Acblp, together 
with accumulation of C18:0-CoA and reduction in C26:0-CoA. Thus, it has been postulated 
that Acb 1 p  is required for delivery or transport of acyl-CoA (C 18 :0-CoA) to the Elo2p/Elo3p 
elongation system [76]. 
Further hydroxylation is carried out on the a-position of the fatty acid component of 
dihydroceramide (ceramide-A) 9 or phytoceramide (ceramide-B) 11, using a hydroxylase 
encoded (either partially or fully) by SCS7 to yield ceramide-B' 21 or ceramide-C 12 (also 
known as phytoceramide), respectively [53]. Like Sur2p, Scs7p is a non essential membrane 
bound hydroxylase and a member of the di-iron, eight histidine motif family [77]. 
1.2.1.1 Complex Sphingolipids 
1.2.1.1.1 Yeast, Fungal and Plant Complex Sphingolipids 
Yeast and ftingal complex sphingolipids are synthesised by the transfer of myo-inositol 
phosphate from P128 to the Cl-hydroxyl group on ceramide (e.g. ceramide-C 12) to yield 
1PC (e.g. IPC-C 13) and diacylglycerol (DAG) 29 (Scheme 1.4). This reaction is catalysed 
by membrane bound inositol phosphorylceramide synthase (phosphatidylinositol:ceramide 
phosphoinositol transferase, IPC synthase) [78]. Nagiec et. al. identified by 
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complementation studies (see section 1.7.2) that the essential gene, AUR], encodes IPC 
synthase (or an essential subunit) [79]. Homologues to AURI have been identified in a wide 
variety of fungi [79-84] and recently IPC synthase activity has been observed in plant 
tissues, although an AURJ homologue has yet to be identified [85]. Bioinformatic analysis 
of Aurip highlight four conserved domains that contain motifs present in the PAP2 (type 2 
phosphatidic acid phosphatase) superfamily of haloperoxidases [84]. Levine et. al. have 
shown that IPC synthase is located in the medial Golgi apparatus with the catalytic site 
situated in the Golgi lumen [86]. Aurip is the target of a number of antifungal natural 
products; aureobasidin A (AbA) 33, rustmicin or galbonolide A 34 and khafrefungin 41 [71, 
79-83, 87, 88], with 10 50 's in the nanomolar range. A number of single point mutations have 
been shown to render Aurlp resistant to AbA [80-83]. 
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Scheme 1.4: IPC Biosynthesis 
As previously noted, sphingolipids vary in chain length, saturation and hydroxylation. There 
are at least fifteen known complex sphingolipids in S. cerevisiae; five JPCs derived from two 
ceramides that utilise DHS as a precursor and three that utilise PHS, five MTPCs and five 
M(IP) 2Cs (Scheme 1.2). The major JPC species, synthesised from PHS-ceramide, are 
denoted as IPC-B, IPC-C 13 and IPC-D, containing 0,1 and 2 hydroxyl groups on C 26 
VLCFA, respectively [30, 89]. The predominant IPC found in wild type cells is [PC-C 13 
synthesised from ceramide-C 12. Hydroxylation of IPC-C 13 to IPC-D is catalysed by a 
copper (II) transporter encoded by CCC2 [90]. Whether this hydroxylation occurs on 
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VLCFA, ceramide or complex sphingolipids still remains poorly understood [90], although 
Ccc2p is thought to utilise complex sphingolipids as it is located in the late or post Golgi 
[91]. 
The second class of complex sphingolipids, MIPCs, are synthesised by the mannosylation of 
IPC (e.g. IPC-C 13) to yield MIPC (e.g. MIPC-C 14) (Scheme 1.2). Four genes have been 
implicated in the mannosyl transferase reaction; SURJ/CSGI [90], CSG2 [92], CSHJ [93] 
and VRG4 [94]. The VRG4 gene encodes a nucleotide sugar transporter that delivers GDP -
mannose from the cytosol to the Golgi lumen. As well as being essential for IPC 
mannosylation, VRG4 also assists in the modification of both N- and 0-linked glycoproteins 
[94]. The mannosyl transferase is probably encoded by SURJ/CSGJ as it contains a 93 
amino acid reading frame motif that is similar to two yeast a-i ,6-mannosyltransferases, 
Ochip [95] and Hoc ip [96]. Uemura et. al. discovered a second gene, CSHJ, which encodes 
a mannosyl transferase that also contains the 93 amino acid motif and catalyses MIPC 
formation [93]. The two MIPC mannosyl transferases, Surlp/Csglp and Cshlp are 
functionally homologous and both co-localise with Aurip in the medial Golgi [97]. Studies 
using single and double SURI/CSGJ and CSHI deletion mutants have provided evidence to 
suggest that Csglp and Cshlp function independently and possess specificity for different 
LPCs [93, 97]. Lisman et. al. have suggested that Surlp/Csglp catalyses the majority of IPC 
mannosylation, and Cshlp has minor [PC mannosyltransferase activity [97]. The function of 
Csg2p is unclear although it does contain an EF-Ca" binding domain and 9-10 putative 
transmembrane helices (TMHs) [98, 99]. It is thought that CSG2 may form a complex with 
SURI/CSGI or CSHI and act as a Ca 2,  mediated regulator [93]. CSGI or CSG2 mutants are 
viable but deletion reduces MIPC synthesis, causes [PC accumulation and calcium 
sensitivity [90, 98]. It has been postulated that the calcium sensitivity is due to [PC-C 13 
accumulation and/or mislocalisation rather than a lack of MIPC [90]. Csg2p is located in the 
ER [100] and has been suggested to play a role in calcium homeostasis [99] that is unrelated 
to its role in MIPC production in the Golgi [101]. 
The last step of M(EP)2C  synthesis is similar to that of IPC synthesis. Inositol phosphate is 
transferred from P1 28 to MIPC (e.g. MIPC-C 14) to yield M(EP)2C (e.g. M(EP)2C 15), the 
major sphingolipid found in fungal membranes. This reaction is catalysed by M(IP) 2C 
synthase (inositoiphosphotransferase), encoded by the non-essential gene, IPTJ [102]. The 
IPTI gene is the only gene homologous to A URJ in S. cerevisiae, sharing 27% identity over 
a 365 amino acid region. Iptlp contains the four conserved domains of Aurip and motifs of 
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the PAP2 family [102]. Two hydrophilic PEST motifs that are rich in proline (P), glutamic 
acid (E), serine (5) and threonine (T) have been identified in Iptip [23]. The PEST motifs 
are thought to be a target for rapid degradation [103]. Ipt Ip has seven or eight predicted 
TMHs, several of which correspond to Aur 1 p  predicted domains [23], however, the 
orientation of some domains is inverted. Thus, experimental analysis will be required to 
determine the correct topology. The homology of Iptip to Aurlp suggests that the active site 
of Ipt I resides in the Golgi lumen [22]. However, large scale yeast proteome analysis of sub 
cellular localisations indicate that Ipt I  may be present in the ER and cytoplasm [104]. 
M(IP)2C synthase activity is inhibited by AbA but is 2500-5000 times less sensitive than IPC 
synthase [102]. 
IPTM mutants have been shown to accumulate MIPC and apparently possess no 
dehabilitating phenotype. The phenotype may not be obvious because MIPC could 
compensate for M(IP) 2C function. The mutant is, however, slightly more resistant to Ca 2,  
growth inhibition [102]. A second mutant, termed mic2, has also been reported, which 
displays the same attributes as the IPTM mutant [105]. A decrease in the ratio of negatively 
charged to uncharged plasma membrane phospholipids was observed in the ,nic2 mutant 
(41%) compared to the wild type (55%). This decrease is attributed mainly to a reduction in 
plasma membrane phosphatidylserine and P1 28 and an increase in 
phosphatidylethanolamine, suggesting that S. cerevisiae compensates for elevated negatively 
charged sphingolipids, namely MIPC, in the mic2 mutant plasma membrane by decreasing 
the quantity of negatively charged phospholipids in order to maintain membrane fluidity 
[105]. 
The mic2 mutant has been shown to be resistant to the antibiotic nystatin [105]. 
Furthermore, Stock et. al. by the use of an S. cerevisiae IPTLA mutant as well as 
SURI/CSGIA and CSG2A mutants defective in MIPC formation have shown that M(EP)2C 
is required for the antifungal action of the lipodepsipeptide Syringomycin E [106]. 
Syringomycin E is thought to act by forming voltage dependent pores in the fungal plasma 
membrane [107]. 
IPTI has also been identified by genetic complementation as the gene that determines the 
sensitivity of S. cerevisiae to the plant defensin DmAMPI [108]. Plant defensins are small, 
basic, cysteine rich peptides (45-54 amino acids) stabilised by four disulfide bonds (reviewed 
in [109]). They are active against a broad range of yeast and fungal species at micromolar 
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concentrations and are thought to act like Syringomycin E by disrupting the plasma 
membrane [36]. Under limited nutrient conditions the IPTIA mutant was sensitive to 
DmAMP 1 and Syringomycin E indicating that the mutant still produces small amounts of 
M(1P)2C by an alternative biosynthetic pathway [107]. Hence, it is not the IPTJ gene but 
M(IP)2C that infers DmAMPI sensitivity. The relative susceptibility of different yeast 
strains to DmAMPI is thought to be attributed to the quantity of M(EP)2C in their membranes 
[107, 108]. The reason that M(EP)2C is a target may be due to its anionic nature possibly due 
to a strong ionic interaction with the cationic DmAMP1 and/or Syrmgomycin E [107]. 
Complex sphingolipids make up 7-8% of the mass of wild type S. cerevisiae plasma 
membrane, of which 75% is M(EP)2C and the remaining 25% is divided equally between IPC 
and MIPC [22]. IPC is principally located in the Golgi apparatus and vacuoles, although it 
has also been found in mitochondria [89]. Plants, fungi and protozoa all contain [PC and its 
more complex derivatives [30]. As yet no wild type fungus is known to exist without 
sphingolipids. In fungi a number of sugar residues can be added on to the head group of 
MIPC to yield complex GIPCs. There is broad variation in the glycosyl structure of GIPCs, 
which is species dependent and in some cases morphological phase dependent [36]. GIPCs 
can be classified depending on the nature of the second sugar residue attached to [PC. 
Cryptococcus neoformans [110], C. albicans [Ill] as well as S. cerevisiae are known to 
Contain M(1P)2C  [112] and Histoplasma capsulatum produces several mannosylated 
sphingolipids but not M(IP) 2C during growth in its yeast phase [113, 114]. Bennion et. al. 
structurally characterised di- and tri-mannosyl IPCs in Aspergillus nidulans by 1 D and 2D 
NMR and MS methods. These authors have also partially characterised a penta-mannosyl 
IPC [115]. C. albicans has been reported to possess a novel type of GIPC called 
phospholipomannan derived from MIPC by the addition of mannose phosphate [116]. The 
glycan moiety of phospholipomannan contains up to 19 unbranched linear mannose residues 
and due to its hydrophilic properties it can diffuse into the fungal cell wall. The biological 
significance in the variation of G[PC glycan chains is unknown. Levery et. at. have 
proposed that complex glycan GIPCs may be characteristic of fungi exhibiting dimorphism 
between mycelial and unicellular forms [117]. As yet very little is known about the 
glycotransferases presumed to be involved in the synthesis of these complex GIPCs. Plants 
do not seem to have MIPCs and related compounds, instead they possess GIPCs that have 
glucuronic acid attached to the inositol followed by N-acetylated or non-acetylated 
glucosamine [118-120]. A major lipid of Neurospora crassa has been identified that 
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contains (IP) 2-ceramide [111]. So far no fungal GIPCs have been found to contain 
glucuronic acid. 
The pathogenic protozoan parasite Typanosoma cruzi expresses an unusual family of GIPCs 
on its surface that are closely related to glycosyiphosphatidylinositol (GPI) anchors [121]. In 
GPI-anchored proteins the initial lipid anchor, P1, is remodelled in the ER and Golgi by the 
replacement of the DAG moiety with ceramide to yield a mature GPI-anchored protein that 
contains an IPC anchor [122, 123]. S. cerevisiae is unusual as two different lipid moieties, 
DAG and ceramide, either containing C 26 or hydroxylated C 26 VLCFA can be found on GPI-
anchored proteins [124]. By utilising metabolic labelling of [3H]-DHS and AbA inhibition 
of IPC synthase, Reggiori et. al. have shown that newly synthesised ceramide, not the 
ceramide breakdown product of JPC, is the substrate for ceramide containing GPI-anchors. 
They have also reported that IPC synthesis and GPI-anchor remodelling are catalysed by 
different enzymes. In addition, they report that for remodelling to occur in the Golgi the 
newly synthesised ceramide must be transported from the ER to the Golgi by COPH vesicles 
[125]. 
1.2.1.1.2 Sphingomyelin (Scheme 1.3) 
In mammals, DHS 8 is N-acylated with a C 124 fatty acid (predominantly C 18) to yield 
dihydroceramide 23 and this is followed by rapid desaturation of the sphingoid base to yield 
mammalian ceramide 24 containing the 4,5 trans double bond [126]. Complex sphingolipids 
are synthesised by the addition of various functional groups to the C  -hydroxyl group of 
ceramide 24 to yield SM 27 and glycolipids, as shown in Scheme 1.3. 
SM 27 is the major mammalian, nematode and protozoan counterpart of the yeast and fungal 
complex sphingolipid, IPC. Thus, SM synthase (SMS) is equivalent to [PC synthase. 
Phosphocholine, instead of myo-phosphoinositol, is transferred from phosphatidylcholine to 
the C  -hydroxyl group on ceramide 24 to yield SM 27 and DAG 29. 
By searching bioinformatic databases for motifs present in A UR] and lipid phosphate 
phosphatases (LPPs) and using a functional cloning strategy in yeast, which lacks SMS, 
Huitema et. al. identified a family of integral membrane proteins exhibiting the properties of 
SMS [127]. Two of these SMSs, SMSJ and SMS2, have been identified in human and mouse 
genomes, and evidence has been found for up to three homologues in the nematode 
Caenorhabditis elegans [127]. Two orthologous SMSs have also been identified in the 
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human malaria parasite Plasmodiumfalciparum [127, 128] and a soluble bacterial SMS has 
been found in Pseudomonas aeruginosa [129]. 
Human SMSI is located in the Golgi, the active site presenting itself in the lumen [127], 
whereas SMS2 is mainly found in the plasma membrane [127, 130]. Both enzymes have also 
been localised to the perinuclear space [127] and SMS activity has been observed in 
mitochondria [21]. Whether the two SMSs are isoforms is not yet known. 
1.2.1.1.3 Glycosphingolipids 
Glycosylation of ceramide with glucose yields the cerebroside, glucosylceramide (GlcCer). 
The reaction is catalysed by UDP-glucose:ceramide glucosyl transferase (glucosylceranude 
synthase, GCS) on the cytosolic face of early Golgi apparatus [131-134]. GCS is encoded by 
one gene in mammals, GCS, however, three analogues have been identified in C. elegans 
[135-138]. Homologues have also been identified in C. albicans, Pichiapastoris, 
Magnaporthe grisea and Gossypium arboreum (cotton) [137]. GicCer is translocated across 
the Golgi membrane into the Golgi lumen by an unknown mechanism. However, it has been 
proposed that the drug efflux pump, p-glycoprotein, which is also present in the Golgi as 
well as the plasma membrane, may be involved [139]. Once in the Golgi lumen, galactose is 
added to yield lactosylceramide (Ga11-4GlcCer) [135, 140, 141] and the compound is 
modified further to yield more complex glycosphingolipids and gangliosides. Nucleotide 
sugars must be imported to the Golgi in order for synthesis to occur [140-142]. 
GIcCer is one of the major lipids found in the plasma membrane [143] although it has also 
been observed in the inner membrane of rat liver mitochondria [144], in cytoplasmic droplets 
[145] and in the trans Golgi network-like structures [21]. Yeast and mammalian SPT 
mutants that lack sphingolipid synthesis require the addition of exogenous sphingoid base for 
survival [146, 147]. A mammalian SPT mutant could be rescued by SM but not GlcCer 
[147, 148] suggesting that SM, but not GlcCer, fulfils an essential role in mammalian cells. 
S. cerevisiae and S. pombe do not synthesise GlcCer; however, glycosphingolipids are 
essential components of some fimgal membranes [5, 19] and GicCer has been found in fungi, 
such as P. pastoris [149] C. albicans [150], C. neoformans [151, 152] A. Jumigatus [153, 
154], Pseudallescheria boydii [155] and Sporothrix schenckii [156]. There is growing 
evidence that fungi have two separate pools of ceramide that are used in the synthesis of 
different sphingolipids [36]. The ceramide in fungal GleCer is primarily 9-methyl-4,8- 
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sphingadiene linked to a C 16 or C 18 hydroxy fatty acid [149-151, 155] whereas the ceramide 
in complex sphingolipids like IPCs and GJPCs is phytoceramide predominantly containing 
C26  VLCFA. Although, some GicCer species containing VLCFAs have been identified 
[137]. The main difference so far between fungal and plant GicCers appears to be that 
fungal GicCers have a branching 9-methyl group [36]. Some results suggest that GCS in 
plants utilises UDP-glucose as the sugar donor [157] while others provide evidence that the 
donor is a novel steryl glucoside [158]. 
As well as M(IP)2C, fungal GicCer biosynthesis has also been shown to be a target of plant 
defensins. Thevissen et. al. have identified the GCS gene in P. pastoris as the plant defensin 
RsAFP-2 sensitive gene. Using an ELISA they have shown that RsAFP-2 only interacts with 
fungal GicCer and not human or soyabean GicCer. These observations have been attributed 
to structural differences in the GicCer species produced [143]. Furthermore, Ferket et. al. 
have shown that N crassa mutants resistant to antifungal plant defensins exhibit novel 
glycosphingolipids [159]. 
Mammals can also synthesise galactosylceramides (GalCer) [160-163], which are the 
precursors to sulfatide lipids (HSO 4-3GalCers) [164-166], and 1-O-acylceramide [167-170]. 
GalCer is not present in most mammalian cell types including GicCer negative cells [1711. 
It is synthesised in the luminal ER of specialised cells [172]. Knock out mice without 
functional GalCer synthase have been produced. The mice survived but males could not 
reproduce, indicating a role for GalCer or its products in spermatogenesis [173]. The mice 
also experienced compromised nerve function [174, 175]. 
1.2.2. Sphingolipid Degradation 
1.2.2.1. Complex Sphingolipid Degradation 
Complex sphingolipids can be degraded by the removal of the head group followed by 
hydrolysis of ceramide to yield the sphingoid base and fatty acid chain. The resulting 
products are reused or metabolised further. Glycosphingolipids are degraded by glycosidase 
or lysosomal saposin cascades and any defects in this process causes lysosomal storage 
diseases [176, 177]. 
Catabolism of SM by sphingomyelinase is thought to be one of the main sources of ceramide 
involved in signal lransduction in mammals (reviewed in [178, 179]). There are three main 
types of sphingomyelinase classified by their optimal PH; acidic (optimum pH 4.5-5.0), 
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neutral (optimum pH 7.4) and alkaline (optimum pH 8.5). These are further sub-divided 
based on cation dependency and cellular location [21, 179]. 
To date, there is no data on the in vivo turnover of IPC, MIPC or M(IP) 2C in S. cerevisiae. 
However, it would be extremely difficult to detect the degradation of a small percentage of 
complex sphingolipids [5]. The potential for turnover is indicated by the observation of 
sphingomyelinase activity in S. cerevisiae [180] and phospholipase C activity in cell free 
extracts, both of which catalysed the hydrolysis of complex sphingolipids to yield ceramide 
[181]. Sawai et. al. have identified an inositol phosphosphingolipid phospholipase C (IFS-
PLC) gene, ISCJ, which exhibits homology to neutral sphingomyelmases [182]. Iscip 
displays in vitro activity towards SM but its natural substrates are [PC, MIPC and M(IP) 2C. 
It has lower km and higher VMAX values for MIPC and M(IP) 2C compared to IPC indicating 
that mannosylated IPCs are the preferred substrates. Sawai et. al. have demonstrated that 
Iscip does not hydrolyse P1, phosphatidylcholine or lyso phosphatidyicholine but requires 
phosphatidylsenne or other acidic phospholipids and Mg 2+ for activity. The reaction was 
inhibited by Mn2 [182]. De Avlos et. al. have recently shown that Isc ip localises to the 
mitochondria, is activated in a growth dependent manner and that ISCJ deletion causes a 
growth defect [183]. Recent studies have led them to propose that the mitochondrial 
phospholipids, phosphatidylglycerol and cardiolipin, activate Isc I  in vivo [184]. The 
enzyme has two putative TMT{s and belongs to the magnesium dependent exonuclease ffi-
apurinic endonuclease nuclease family [185]. It also contains a 'p-loop-like' motif that is 
identified by an ATP-GTP binding domain, thought to play a role in either substrate 
recognition and/or catalysis [186]. 
An ISCJ homologue, CSSJ+ that encodes hydrolysis of IPC and MIPC to yield ceramide has 
been identified in S. pombe. This is an essential gene and a temperature sensitive CSSI+ 
mutant exhibits growth arrest at low temperature. In the mutant, glucan wall precursors 
accumulated in the periplasmic space indicating a role for sphingolipase activity in the 
incorporation of glucan precursors into the cell wall [187]. 
1.2.2.2. Ceramidases 
Ceramide is hydrolysed to a sphingoid base and fatty acid chain by ceramidases, which like 
sphingomyelinases, can be categorised as acidic, neutral and alkali ceramidases. Each class 
appears to show specificity towards different ceramide structures. Acid and neutral 
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ceramidases have been identified in a variety of eukaryotic species at various locations 
within the cell [3, 21, 188-191]. 
Mao et. al. identified two homologous yeast alkaline ceramidase genes, YDC] and YPCJ 
[192, 193]. Both encode integral ER proteins that contain several putative TMHs and 
function optimally at pH 9 or higher. The two proteins exhibit different substrate 
specificities; Ydclp hydrolyses dihydroceramides (e.g. ceramide-A 9 and ceramide-B' 21) 
[192] and Ypclp hydrolyses phytoceramides (e.g. ceramide-B 11, ceramide-C 12 and 
ceramide-D 22) [193]. Neither is able to hydrolyse unsaturated mammalian ceramide 24. 
Deletion of either one or both genes result in no apparent growth defects; but, deletion of 
YDCJ and not of YPCI reduces thermotolerance, indicating that hydrolysis of 
dihydroceramides, but not of phytoceramides is involved in heat stress response [6]. In the 
absence of VLCFA-CoA , LAC] and LAG] ceramide synthase genes in a double deletion 
mutant or in the presence of the ceramide synthase inhibitor, fumonisin B 1, Ydc I  and 
Ypc I  exhibit reverse activity and produce small amounts of ceramide [62, 192, 193]. 
Ypc ip has a higher level of reverse activity and is able to utilise both PHS and DHS 
compared to Ydc lp, which can only utilise DHS in small quantities in vitro. This suggests 
Ypclp and Ydclp do not play exactly the same role, despite their 52% homology. The 
quadruple mutant lacking LAG], LAC], YDC1 and YPCJ is viable in the W303 background 
strain and has no detectable ceramide or complex sphingolipids. There are, however, two 
unknown lipids that are alkali stable and are also present in LA GI LA C1 A mutants [62]. 
Homologues of the yeast alkali ceramidases have been identified in human and murine 
species [194]. 
1.2.3. Phosphorylated Ceramide and Sphingoid Bases 
Ceramide can be phosphorylated to yield ceramide- 1-phosphate, primarily found in 
mammalian neutrophil plasma membrane [195]. In humans, the reaction is catalysed by a 
calcium and ATP dependent ceramide kinase, encoded by JICERK [196]. Little is known 
about ceramide- 1-phosphate and ceramide- 1-phosphate kinase, although putative 
homologues to hCERK have been identified in a wide variety of multicellular organisms 
[196]. 
The alternative, and more studied route, of mammal ceramide 24 metabolism is catabolism 
to yield sphingosine 25, which is subsequently phosphorylated to yield sphingosine-1-
phosphate (S-l-P) 26. The majority of S-l-P is thought to be produced by the almost 
Rachel Breen 	 Chapter 1: Introduction 	 Page 21 
stoichiometrjc conversion of SM to sphingosine via the action of sphingomyelinase and 
ceramidase, followed by phosphorylation by sphingosme kinase [197]. 
S-i-P is a bioactive lipid and a second messenger believed to be involved in cell proliferation 
and survival (reviewed in [198, 199]). It is the main phosphorylated sphingoid base in 
mammals and is present in most eukaryotes. In higher organisms (boney fish to mammals) it 
acts as a cell function regulator by binding to extracellular G-protein coupled receptors. 
Two sphmgosine kinases have been cloned and characterised in humans and mice, SPHKJ 
and SPHK2 [200-202]. They share high amino acid identity and contain five conserved 
domains; however, SPHKIp is much smaller and is expressed in the cytosol. Although 
SPHK2p has several predicted TMHs [198], the activity of both kinases has been observed 
both in the cytosol and the membrane [200, 201]. Liu et. al. have observed that SPH1K1p is 
predominantly expressed in the lungs, spleen and liver; whereas SPIIK2p is predominantly 
expressed in the heart, kidney and testis. Both are expressed in the liver, although SPHX2p 
is predominant. They exhibit different substrate specifity; SPHK ip prefers D-erythro-
sphingosine 25 while SPH1K2p prefers D-erythro-DHS 8. In addition, unnatural D,L-threo-
DHS and D,L-threo-PHS can be utilised by SPHK2p but not SPHK1p. It has been 
postulated that SPHK 1 p  might be related to the survival properties associated with S-i-P and 
SPIIK2p might be related to S-i-P effects involved in angiogenesis and allergic responses in 
view of its unique expression pattern in embryos and adults [203]. 
Another study has suggested that there are three mammalian sphingosine kinases; one 
localised to the cytoplasm and two membrane bound sphingosine kinases localised to the ER 
and plasma membrane [204]. Sphingosine kinases have also been identified in S. cerevisiae 
[205], A. thaliana [206], S. pombe, C. elegans [21] and Drosophila melanogaster [198]. An 
ER bound S-i-P lyase [207, 208] and a specific phosphatase [209, 210] have also been 
reported, both of which presumably facilitate S-l-P degradation. 
Two genes, LCB4 and LCB5, have been identified in S. cerevisiae. These encode 
sphingosine kinases and are referred to as long chain base (LCB) kinases [205]. They share 
53% amino acid identity and have similar substrate specificity including DHS and PIIS. 
Like mammalian LCB kinases, 66% Lcb4p and 33% Lcp5p are localised to membranes, 
although neither appears to contain a membrane localisation motif. The remainder resides in 
the cytoplasm [205]. Lcb4p is thought to exhibit tight membrane association with the ER 
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However, it has also been observed in the trans Golgi network and late endosomes 
 
LCB4A LCB5L\ mutants were found not to synthesise dihydrosphingosine-1 -phosphate 
(DHS- 1 -P) indicating that these enzymes are the only LCB kinases in yeast [211]. Although 
lacking in DHS- 1 -P, the double deletion mutant has no detectable phenotype, exhibiting wild 
type growth [205]. 97% of the total cellular LCB kinase is Lcb4p, with Lcb5p comprising 
the remaining 3% [205]. Thus, it appears that the two kinases have different functions, 
membrane association and location. Lcb4p is thought to play a role in apoptosis and growth 
inhibition [213, 214], whereas Lcb5p is involved in heat stress resistance [27]. Funato et. al. 
have reported that membrane Lcb4p, not cytosol Lcb4p, is required for ceramide synthesis. 
This may be due to two overlapping Lcb4p functions; cytosol Lcb4p may be involved in 
signal generation and the membrane isoform involved in biosynthesis [211]. Both Lcb4p 
and Lcb5p contain a putative DAG kinase catalytic domain [23]. 
S. cerevisiae LCB phosphatases encoded by LCB31YSR2 and YSR3 were identified 
independently by three different research groups [215-217]. Although both LCB31YSR2 and 
YSR3 are homologous, with over 50% amino acid identity, encode dephosphorylation of long 
chain base- i-phosphate (LCB- 1 -P) and are localised to the ER, they have different 
physiological roles. They both possess three domains containing the PAP2 motif and four to 
eight TMIHs [23, 218]. Neither LCB31YSR2 nor YSR3 are essential but null and 
hyperexpression mutants exhibit different phenotypes. Lcb3p and not Yrs3p is required for 
exogenous DHS incorporation [215]. Single deletion mutants accumulate DHS-1-P and 
double mutants do so to a higher level [219]. In addition, LCB3 has four fold higher mRNA 
transcription levels than YRS3, the YRS3 mRNA levels being barely detectable [219]. 
Funato et. al. have suggested that in order for exogenous LCBs to be efficiently incorporated 
into S. cerevisiae sphingolipid biosynthesis they must be processed via a membrane localised 
phosphorylation-dephosphorylation cycle. In order for this to occur, Lcb4p and Lcb3p but 
not Lcb5p is required. If exogenous DHS cannot be phosphorylated then the cycle can be 
bypassed, although the incorporation is less efficient. There is evidence that the intracellular 
location of LCB phosphorylation is critical for determining its function in ceramide 
biosynthesis, phospholipid biosynthesis or signalling. The Lcb4p function cannot be 
bypassed by the addition of DHS- 1-P. On the basis of these results it has been suggested 
that DHS-i-P cannot be incorporated into ceramide synthesis if formed in the cytosol [211]. 
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S. cerevisiae also contains a sphingolipid-1-phosphate lyase. The gene was originally 
identified by Saba et. al. and termed BSTI. BSTI is now referred to as DPLJ and encodes a 
DHS- 1-P lyase [220]. The C 23 bond of LCB- I-P is cleaved to yield phosphoethanolamine 
and palmitaldehyde by a PLP dependent mechanism. The preferred substrate is C 16 DHS-l-P 
rather than the C 18 or C20 homologues [214] and both breakdown products are reutilised in 
glycerolipid synthesis [220]. The enzyme is located both in the ER and cytoplasm [104] and 
contains one predicted TM}I [22]. The null mutant is viable but sensitive to exogenous LCB. 
Over expression of Rsblp, a flippase or putative transporter, so named for its exhibited 
resistance to sphingoid LCBs [221], suppresses this sensitivity [23]. DPLJ is not essential in 
the log phase as cells lacking Dpllp grow normally [5], however, a DPLJ and LCB3 double 
deletion mutation is lethal. The lethality is suppressed by a LCB4 mutant, which highlights 
the importance of DHS- 1-P and phytosphingosine- 1-phosphate (PHS- 1 -P) 
dephosphorylation [213, 214]. It is possible that Dpllp 'senses' phosphosphingolipid levels 
and coordinates phosphosphingolipid catabolism and glycerolipid synthesis [5]. 
1.3. Sphingolipid Trafficking 
Initial sphingolipid biosynthesis occurs in the ER where it proceeds until the formation of 
ceramides. As ceramides are synthesised in the ER lumen and more complex sphingolipids 
are synthesised in the Golgi, the rate of ceramide translocation affects the synthesis of more 
complex sphingolipids [222]. However, intracellular transport is fast, taking minutes, 
compared to sphingolipid turnover, which can take hours [3] (for trafficking reviews see [3, 
22, 222-224]). 
Lipid transport can occur by one or more of the following mechanisms; secretory vesicles 
bud from donor membranes and fuse to acceptor membranes, lipid monomers transfer 
through the cytosol or transfer occurs through contacting membranes [223-228]. A number 
of lipid transfer proteins and mutants defective in lipid transport have been identified, 
although the precise role of proteins in lipid sorting and net transport is not yet known [223, 
227,229-231]. It has been suggested that the protein Arvip is involved in the trafficking of 
sterols in yeast [232]. Swain et. al. have shown that S. cerevisiae mutants deficient in Arvip 
accumulate phytoceramide, suggesting that Avrlp is also involved in the transport of 
ceramide from the ER to the Golgi for use by IPC synthase [233]. Hanada et. al. have 
recently identified an ER to Golgi transport protein, CERT, required for SM synthesis. 
CERT extracts ceramide from membranes and delivers it to the Golgi for use by SMS. It has 
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also been found to contain a pleckstrin homology domain that targets it to the Golgi [234, 
235]. 
Yeast and mammalian ceramide has been shown to be delivered from the ER to the Golgi by 
both vesicular and non-vesicular pathways [236-238]. In yeast the non-vesicular pathway is 
ATP independent, and requires ER-Golgi membrane contact and a cytosolic factor [236]. 
These conclusions have been drawn from the observations that in vivo IPC synthesis 
continues, albeit to a lesser extent, when ER to Golgi vesicle transport is blocked in 
temperature sensitive secretion mutants (secl2, -16, -17, -18 and -23) at restrictive 
temperature [101, 125, 236] and even under conditions of blocked protein synthesis and ATP 
depletion in sec 18 [236]. In contrast, the biosynthesis of IPC-D, MIPC and M(1P)2C  does 
require vesicle transport and metabolic energy [22]. 
It has been suggested that ceramide in yeast is delivered by vesicle transport to the cis Golgi 
[22, 239]. However, the ceramide predominantly utilised by Aurlp, which resides in the 
medial Golgi [86], is delivered by ER-medial Golgi membrane contact [236]. This is also 
thought to occur in mammals whereby GCS in the cis Golgi receives ceramide by vesicular 
transport, and GCS and SMS in the trans Golgi [240] appear to receive ceramide by 
contacting membranes [241]. Contact has also been observed between the ER and 
mitochondrial membranes [242], between the ER and the plasma membrane [243] and at the 
interface of nuclear and vacuolar membranes in yeast [75]. 
Due to the putative topology of the active site of Aur lp [86], ceramide must be translocated 
across the Golgi membrane to the Golgi lumen [22]. An energy independent translocation 
process has also been suggested for ceramide delivery to SMS [244] and for GIcCer delivery 
to the Golgi lumen in mammals [222]. Complex glycosphingolipids, SM and IPCs cannot 
translocate across the Golgi membrane from the lumen to the cytosol [140, 245] instead they 
are transported on the lumenal surface of vesicles [224, 246, 247]. 
1.4 Sphingolipid Functions 
A striking feature of sphingolipids in S. cerevisiae is that they can be bypassed. If the LCBI 
deletion (lcb- 100) is accompanied by a mutation in the sphingolipid compensatory gene, 
SLC1, which is thought to encode a fatty acyl transferase, cells are viable [248, 249]. SLC1p 
facilitates synthesis of novel glycerolipids based on PT, mannosyl-PI and inositol-P-
mannosyl-PI and contain C 26 VLCFAs rather than the usual C 16 or C 18 chains [250]. These 
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structurally and biophysically mimic S. cerevisiae sphingolipids suggesting that the primary 
role of sphingolipids is structural and their VLCFAs are required to provide thickness to the 
plasma membrane bilayer [4, 5, 250-252]. However, the putative signalling functions of 
sphingolipids appear to be dispensable for growth and survival only under non-stressed 
conditions. When under heat, pH or salt stress the mutants can only grow if in the presence 
of exogenous PHS, indicating a role for sphingolipids in stress response [251]. 
Sphingolipids are thought to contribute to stress response and cellular signalling in at least 
three ways (reviewed in [21]). They can be released by activated cells, such as platelets, and 
act as classical mediators by binding to G-coupled protein receptors [253]. They can 
function as second messengers [21] and are also thought to reside in rafts, which have been 
implicated in signalling cascades [254, 255]. 
Within the sphingolipid population there is a huge range of bioactive molecules (ceramide, 
sphingosine, PHS, S-I -P, GlcCer, DAG and other lipids) all with individual actions. When 
the actions of these species are combined it gives rise to vast variation in the overall 
bioactive lipid response [1]. The majority of responses are thought to be correlated to the 
concept of the sphingolipid rheostat [198, 256]. This has been evolutionary conserved 
throughout eukaryotes [198] and is based on the notion that a balance exists between 
ceramide (pro-apoptotic and anti-proliferative) and its metabolite LCB-1 -P that exerts 
opposing effects. The ceramide/LCB- 1-P rheostat has also been referred to as the 
ceramide/S- 1-P rheostat or the sphingosine/S- 1-P rheostat. There are numerous enzymes 
that can influence this balance including SMS, IPC synthase, sphingomyelinase, ceramide 
synthase, ceramide kinase, ceramidase, LCB kinases, LCB lyases, LCB phosphatases and 
GCS [257]. Consequently, predicting the actions of specific enzymes is difficult as the 
activation of sphingomyelinase to yield ceramide can be coupled with the action of 
ceramidase followed by sphingosine kinase to yield sphingosine then S-1-P, subsequently 
resulting in growth stimulation instead of growth inhibition [258]. In extreme cases one 
metabolite will dominate the cell response (e.g. substantial changes in ceramide or S-i-P 
levels). However, it is more probable that any agonist(s) would alter several metabolite 
levels and thus, the final outcome would be dependent on the overall balance [21]. 
1.4.1 Apoptosis and Stress Response 
Cowart et. al. have studied S. cerevisiae sphingolipid heat stress response by analysing the 
mRNAs from heat stressed wild type and lcb-100 cultures using a hybridising microarray 
Rachel Breen 	 Chapter 1: Introduction 	 Page 26 
[259]. During the first 15 minutes of heat stress the lcb-100 strain displayed differential 
regulation of approximately 70 genes compared to the wild type, indicating that de novo 
sphingolipid biosynthesis is required for the correct regulation of these genes during heat 
stress. The study highlighted new roles for sphingolipids in amino acid metabolism, protein 
synthesis, tRNA regulation and cell wall organisation and, as the study utilised a mutant 
deficient in de novo sphingolipid biosynthesis, the information obtained encompassed all 
sphingolipid dependent transcriptional events although those originating from individual 
sphingolipid species could not be distinguished. 
Ceramides and sphingoid bases have been shown to be involved in heat stress responses and 
programmed cell death in both mammals and fungi [1, 6, 29, 179, 181, 260-264]. The up-
regulation of a heat shock protein, a B crystalline, induced by mammalian ceramide has been 
observed [265]. Plant sphingolipids have also been implicated in drought stress and cold 
hardiness acclimatisation in addition to membrane stabilisation (reviewed in [2, 18]). Liang 
et. al. have presented evidence that ceramide is involved in the mediation of cell death in A. 
thaliana and that ceramide levels are modulated by ceramide kinase [266]. 
1.4.1.1 Ceramide 
Ceramide accumulation is stimulated by a plethora of factors including cytokines (e.g. 
tumour necrosis factor a, interleukin I 3, nerve growth factor and FAS ligands), cytotoxic 
agents (e.g. chemotherapeutics and multi drug resistance modulators), environmental stresses 
(e.g. heat shock and ionising IJV radiation), infections (e.g. HIV and bacterial infections), 
injury and vitamin D3 [261, 267, 268]. Once accumulated by the cell ceramide initiates a 
number of stress responses that can result in apoptosis, cell cycle arrest, cell senescence and 
cellular differentiation [67, 261, 264, 268]. Ceramide appears to modulate these responses 
by several modes of action, which include phosphatase and kinase activation [267, 269]. 
Ceramide activated protein phosphatases can in turn either dephosphorylate and activate the 
retinoblastoma gene product and cause cell cycle arrest or activate effector caspases and 
cause programmed cell death [261, 270]. In S. cerevisiae ceramide has been shown to 
induce G 1 cell cycle arrest via a ceranude activated protein phosphatase [271] and ceramide 
accumulation has been shown to promote cell death in an IPC synthase mutant upon the 
addition of exogenous PHS [79]. There also appears to be number of ceramide activated 
kinases that can initiate stress responses and signalling cascades. Proline-directed kinase 
phosphorylate c-Raf and activate the mitogen activated protein kinase pathway [272]. Jun 
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kinases [273] and death associated protein kinase [274] are also ceramide kinase targets and 
are often involved in ceramide induced apoptosis. 
Studies of ceramide induced stress response have generally used exogenous cell permeable 
ceramide, such as C 2, C6 and C8 ceramides. The shorter chain ceramide analogues mimic 
most of the apoptotic and cell cycle arrest effects induced by cytokines, including DNA 
fragmentation [267, 275], cytochrome C release [276] and protein kinase C inhibition [277] 
as well as those discussed above. However, it has been shown that these ceramide analogues 
act as stress inducers resulting in endogenous SM derived ceramide accumulation [278]. 
Kroesen el. al. have reported that C 16 ceramide is specifically generated during apoptotic 
responses [279]. A number of publications have reported that only initial ceramide 
accumulation and not delayed ceramide generation is related to apoptotic signalling [278, 
280-282]. Ceramide and phytoceramide but not dihydroceramide appear to be involved in 
programmed cell death and growth inhibition [267, 270, 271]. 
The site at which the bioactive lipid is generated may be crucial to the role it plays [86, 195]. 
There is evidence to suggest that ceramide synthases located in the mitochondria are 
activated in response to the stimulating factors discussed above such as cytokines, 
chemotherapeutics and environmental stresses [197, 283-286]. Ceramide [144] and a novel 
ceramidase [189] have been detected in mitochondria. Furthermore, apoptosis was only 
observed in breast cancer cells when recombinantly expressed bacterial sphingomyelinase 
was targeted to the mitochondria [287]. This suggests a role for mitochondrial ceramide in 
regulating apoptosis (reviewed in [261]). The release of cytochrome C from mitochondrial 
membranes is now regarded as a major apoptosis initiation mechanism [288]. Studies using 
synthetic unilamellar vesicles have demonstrated that ceramide can form pores large enough 
to allow efflux of molecules 20 to 60 kDa in size [289-291] indicating that ceramide may 
also play a role in apoptosis at a structural level. 
Mammalian ceramide used to mediate apoptosis is thought to be derived from both 
catabolism of SM [178, 179] and de novo synthesis [283, 292-296]. Dolgachev et. al. have 
recently reported that in photosensitised cells ceramide accumulation occurs due to SMS 
inactivation [297]. In S. cerevisiae, Wells et. al. have shown that ceramide accumulation 
appears to be due de novo synthesis rather than phospholipase C type catabolism of more 
complex sphingolipids [181]. They demonstrated this by the absence of ]PC, MIPC and 
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M(1P)2C sphingolipid head group accumulation and that the increase in ceramide levels is 
sensitive to the ceramide synthase inhibitor, australifungin, during heat stress. 
Controversy exists as to whether ceramide is actually the species involved in apoptosis, as it 
is not always observed [180]. Tserng et. al. have proposed that it is in actual fact a ceramide 
metabolite, possibly octadecane-1,2-diol, which acts as a signalling molecule in the initiation 
of apoptosis rather than intact ceramide itself [298]. Grazide et. al. have prosposed that SM 
derived ceramide may not be a second messenger but a precursor for a pro-apoptotic second 
messenger, GD3 and an apoptotic protector, GalCer [280]. 
1.4.1.2 LCBs 
1.4.1.2.1 Sphingosine 
Sphingosine was first identified as a possible signalling molecule when it was discovered 
that it was a potent protein kinase C inhibitor [299, 300]. Activation of protein kinase C is 
known to protect against cell death and promote survival [301]. It has been postulated that 
sphingosine could induce apoptosis via protein kinase C inhibition [302]. Prostate cancer 
cells treated with exogenous sphingosine or the sphingosine kinase inhibitor, N,N-
dimethylsphingosine, have been shown to initiate apoptosis [303]. In addition, Cuvillier et. 
al. have shown that the mitochondrial cytochrome c release, caspase activation and apoptosis 
that occur in breast cancer cells treated with doxorubicin are preceded by an increase in 
sphingosine [304]. 
Unlike ceramide, which is confined to membranes, sphingosine can diffuse through them 
enabling it to affect various cellular compartments. In addition to protein kinase C 
inhibition, sphingosine is also an inhibitor of phosphatidic acid phosphohydrolase as well as 
an activator of phospholipase D, DAG kinase [305-308], casein kinase 2, p2  1-activated 
kinase [309, 310] and sphingosine dependent kinases that phosphorylate 14-3-3 proteins, 
which subsequently act as adapter proteins in signalling pathways [311]. 
There is much conflicting data regarding the function of sphingosine [312] and evidence has 
been provided suggesting that as well as being pro-apoptotic, it also displays anti-apoptotic 
behaviour. At high concentrations sphingosine is cytotoxic but at low concentrations it can 
stimulate growth [2]. It is possible that rapid interconversion of ceramide, sphingosine and 
S-i-P is responsible for the different effects. 
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1.4.1.2.2 PHS and DHS 
PHS is the most common LCB in yeast and is an important signalling molecule in heat stress 
response, endocytosis and regulation of the actin cytoskeleton [262, 313, 314]. Like 
sphingosine, PHS and DHS can diffuse through membranes and as mentioned above can 
complement SPT activity [146, 147, 251]. 
During heat stress in S. cerevisiae, SPT is activated causing sphingoid bases, their 
phosphates and ceramide to accumulate over 10-120 minutes [315]. The LCBs, DHS and 
PHS, increase several fold during the first 10-20 minutes, followed by an increase in 
ceramide levels over 1-2h [29]. Moreover, GI cell cycle arrest caused by heat stress has 
been shown to be initiated by DHS and PHS, not ceramide [316]. However, in A. nidulans 
ceramide accumulation appears to cause GI cell cycle arrest [262]. 
PHS has been shown to be a potent inhibitor of S. cerevisiae growth. It does this by 
regulating ubiquitin dependent proteolysis and inhibiting nutrient uptake and transport [317-
319]. However, in A. nidulans PHS does not seem to inhibit nutrient uptake but instead 
induces metacaspase independent apoptosis without involving ceramide [263]. The 
antifungal activity of exogenous DHS and PHS is related to their specific structure and 
stereochemistry as only the naturally occurring LCBs can induce apoptosis [263]. The reason 
PHS induces apoptosis in A. nidulans and not in S. cerevisiae may be due to the fact that S. 
cerevisiae does not have a homologue of the mitochondrial membrane protein, apoptosis 
inducing factor, which is conserved in nearly all eukaryotes and prokaryotes except S. 
cerevisiae [263]. Apoptosis inducing factor has been shown to be a key regulator of caspase 
independent apoptosis in mammals [320]. It is normally localised to the mitochondria but 
upon the induction of apoptosis it is rapidly translocated to the nucleus. As well as causing 
mitochondrial membrane disruption, the apoptosis inducing factor translocation coincides 
with the caspase independent activation of chromatin condensation and DNA fragmentation 
[321, 322]. It is conceivable that PHS promotes apoptosis inducing factor translocation. 
This theory also explains why the mitochondrial role is essential in PHS induced 
metacaspase independent apoptosis [263]. In A. nidulans a metacaspase dependent apoptosis 
pathway also exists [263]. 
Reactive oxygen species in S. cerevisiae have been shown to be essential for apoptosis-like 
cell death and accumulate during it [323-325]. Although reactive oxygen species have been 
observed in both A. nidulans [263] and mammalian [326] apoptosis, they are only associated 
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with it and not required for it. In S. cerevisiae apoptosis-like cell death is mediated through 
the metacaspase YCA1 [327] and reactive oxygen species in S. cerevisiae may be required 
for activation of YCA1. 
1.4.1.3 Gangliosides 
As yet, how gangliosides, specifically GM2 and GD3, are involved in apoptosis is not 
understood. However, there is accumulating evidence that indicate gangliosides may be 
genuine sphingolipid second messengers involved in the regulation of neuronal growth and 
development [16], [280, 328-330]. 
1.4.2 Proliferation and Heat Tolerance 
LCB-1-Ps, particularly the main mammalian LCB-l-P S-l-P, have been shown to promote 
cell proliferation, apoptosis protection [301] and growth stimulation [331]. A number of 
external stimuli that activate ceramide accumulation can also activate sphingosine kinases, 
including tumour necrosis factor a [332], nerve growth factor [333, 334] and vitamin D3 
[335]. The list of activators is rapidly growing and also includes platelet derived growth 
factor [336-340], muscarinic acetylcholine agonists [341] and cross-linked product of the 
immunoglobulin receptors FceR 1 [342] and FcgR 1 [343]. 
S-I-P can either act extracellularly or intracellularly. As an extracellular mediator S-l-P 
binds to G-protein coupled receptors, originally known as EDG-1,3,5,6 and 8, and now 
termed s-i-P 1-5 [344]. In turn, the receptors couple to G-proteins initiating intracellular 
signalling pathways [199] involved in cell migration, cAMP synthesis inhibition, 
intracellular calcium release and activation of kinases that regulate actin cytoskeletal 
dynamics [198]. As an intracellular second messenger S-I-P is involved in calcium 
homeostasis and signalling pathways, which lead to proliferation [345, 346] and suppression 
of apoptosis [301, 333, 346-348]. The physiological roles of S-l-P in multiple organ 
systems are still not fully elucidated but effects on heart development regulation, vascular 
system formation, maturation and angiogenesis, oocyte survival as well as immune cell 
trafficking inflammatory responses have recently been reported [199, 349]. 
Even though lower organisms, such as plants and yeast, are responsive to LCB- 1-Ps and are 
able to regulate survival and stress responses in a similar manner to mammalian S-1 -P, they 
do not seem to possess S-i-P receptors/G-protein coupled receptors [198]. However, 
Suharsono et. al. have demonstrated that S-I -P and G-protein interactions may be involved 
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in defence signalling in rice [350]. s-i-P in plants is also thought to playa role in guard cell 
signalling and stomatal closure [351-353]. Deletion of S. cerevisiae genes phosphatase 
YSR21LCB3 [209, 219, 354] or lyase DPLJ [250, 354] cause accumulation of LCB-1-Ps 
(DHS-1-P or PHS-1-P) and result in increased heat shock tolerance. In contrast, 
hyperexpression of YSR21LCB3 made yeast cells super sensitive to heat stress [6] and during 
heat stress LCB- 1-Ps have been shown to increase 5-fold within 5 minutes [354]. These 
observations and others collectively indicate that in S. cerevisiae DHS- i-P and PH S-i-P are 
required for heat resistance and heat stress protection [213, 217, 219, 355]. Even though 
LCB- 1-Ps in S. cerevisiae are thought to be involved in survival mechanisms, recent 
analyses indicate that DH S- 1-P accumulation can be toxic to yeast cells, more so than PHS-
1-P and that the removal of these excess intermediates is carried out by the Lcb3 phosphate 
phosphatase rather than the Dpll lyase [214]. 
1.4.3 Calcium Homeostasis 
S. cerevisiae spbingolipids have been implicated in calcium homeostasis and calcium 
regulated processes by a number of observations including the fact that ceramide synthase 
CSG2 mutants do not grow in 100mM Ca" and only produce one, as yet uncharacterised, 
type of IPC [98]. IPC accumulation increases calcium sensitivity and this sensitivity is 
suppressed by mutants with decreased IPC levels [6, 92]. Also, sphingosine and S-i-P 
causes intracellular Ca 2' release in various mammalian cell types [356] and there is evidence 
implicating S-i-P in calcium mobilisation and signalling in mammals [343, 357, 358], yeast 
[359] and higher plants [351]. It has been suggested that sphingolipid metabolism in S. 
cerevisiae could be regulated by Ca 2+  [92]. 
1.4.4 Fungal Pathogenicity 
Sphingolipids in C. neoformans are thought to be crucial to the survival of the pathogen in a 
hostile macrophage environment. This is based on the observation that when sphingolipid 
biosynthesis is down regulated, growth is impaired in vitro at low pH and in vivo within the 
macrophage [360]. However, sphingolipid synthesis was down regulated by inactivating 
IPC synthase rather than SPT. This would allow the toxic intermediate, ceramide, to 
accumulate. Hence, it is unclear whether ceramide accumulation or the down regulation of 
sphingolipid biosynthesis impaired growth. 
Two independent studies have shown that the SPT subunit LCB2 is down regulated in 
pathogenic forms of Leishmania major indicating that de novo sphingolipid biosynthesis is 
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not required for Leishmania pathogenicity and survival in host macrophages [361, 362]. 
Both groups also demonstrated that Leishmania LCB2L mutants lacking complex 
sphingolipids (e.g. [PC), although viable, exhibit abnormal expression of glycoconjugates, 
are defective in membrane trafficking and are unable to differentiate into infective 
extracellular parasitic forms. It has been postulated that this may be related to IPC being 
required for plasma membrane raft formation and the stable association of glycoconjugates 
with these rafts (reviewed in [363]). These results suggest that Leishmania uses alternative 
strategies for survival compared to C. neoformans. 
A number of studies have shown that pathogens sequester sphingolipids from their hosts 
[364, 365] and/or can utilise precursors from alternative sources for complex sphingolipid 
biosynthesis [366]. Zhang et. al. have recently shown that Leishmania mutants can salvage 
sphingolipids from their host (mouse) and remodel the head groups to yield parasite specific 
IPCs. After a delay rapidly progressive lesions in the mouse model were observed [367, 
368]. 
Sphingolipids have also been implicated in plant pathogen interactions [18]. Cerebrosides 
isolated from fungi [369-37 1] and plants [372] have been shown to stimulate the formation 
of the fruiting body of Schizophyllum commune, a fungus involved in wood degradation. 
Also, SPT is up regulated during the hypersensitive response of a potato resistant to late 
blight infected with Phylophihora infesians [373]. More recent studies have shown that 
fungal cerebrosides cause hypersensitive cell death, phytoalexin accumulation and increased 
resistance to compatible pathogen infections in plants [374-376]. The importance of the 
structure of LCBs in plant-pathogen interactions is demonstrated by the C 8 , 9 double bond 
requirement in fruiting body induction and the C 4 , 5 double bond and C9-methyl group 
requirement for hypersensitive responses to phytopathogens [18]. 
1.45 Additional Sphingolipid Functions 
Sphingolipids have been implicated in both endocytosis and exocytosis [5, 377, 378]. They 
are thought to be the main, if not only, sink for VLCFAs (C 24 and C26) in yeast and fungi 
[87]. When elongation genes are disrupted sphingolipid levels are reduced, plasma 
membrane Hi -ATP levels are altered, resistance towards sterol synthesis inhibitors is gained 
and bud site localisation defects are observed [3, 32]. It has been suggested that VLCFAs 
facilitate membrane budding and fusion by physically stabilising highly curved membranes 
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[379]. VLCFAs have also been found in the nucleus and have been demonstrated to be 
important in nuclear pore formation [380]. 
The range of known sphingolipid functions is still appreciating. In addition to those 
discussed above, sphingolipids have also been implicated in Golgi sorting and trafficking 
[3], raft formation [3, 286, 381, 382], multidrug resistance (section 1.6.2) and the 
establishment and maintenance of cell polarity [5, 2621. Also, ceramide-1-phosphate is 
thought to facilitate vesicle transport, regulate aspects of synaptic vesicle function [383-385], 
stimulate fibroblast cell division [386, 387] and be involved inflammatory responses [388, 
389] in humans. 
1.5 Sphingolipid Regulation 
The regulation of sphingolipid metabolism is extremely complex and still remains to be fully 
elucidated. Regulation appears to occur at multiple levels, including by enzyme expression 
control, post translational enzyme modifications and allostenc mechanisms. Regulation is 
cell type specific controlling either which sphingolipids are synthesised at different stages in 
cell development or in response to specific signals [17]. Due to the interconnectivity of 
sphingolipid metabolism many of the enzymes in this pathway act as regulators or switches, 
for example in the ceramide/LCB- 1-P rheostat [1]. There also appears to be coordinated 
regulation between sphingolipid and sterol metabolism [233, 390-393]. 
1.6 Therapeutic and Agrochemical Interest 
Sphingolipids have been implicated in a number of diseases. Molecular or pharmacological 
manipulation of the enzymes involved in regulating the sphingolipid rheostat should able to 
alter the ceramide/LCB-1 -P equilibrium, changing cellular responses, and ultimately the 
overall effect (reviewed in [257]). 
1.6.1 Mammalian Diseases 
It was once thought that the role of sphingolipids in neuronal diseases was restricted to 
lysosomal sphingolipid and glycosphingolipid storage (reviewed in [176]). Sphingolipids 
have now been implicated in degenerative neuronal diseases (reviewed in [16, 177]). Studies 
have also implicated elevated ceramide levels in diabetes [394, 395]. 
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The involvement of sphingolipids in the human immune system has been reviewed by 
Cinque et. al. [195], and a LCB analogue, FTY720 30, is currently undergoing clinical trials 
as an immunosuppressant for transplant graft maintenance [396]. As the level of FTY720-
phosphate in the blood accumulates to high (nanomolar) concentrations, it has been 
postulated that the pharmacologically active isoform of FTY720 is phosphorylated and its 
mode of action is similar to that of S-i-P [397, 398]. 
Sphingolipids have been implicated as a target of cancer treatment (reviewed in [197, 302, 
399]). Malignant mammalian cells seem to be hypersensitive to ceramide perturbation and 
generate endogenous ceramide in response to chemotherapeutic agents [197, 400, 401]. 
Exogenous ceramide and sphingoid base derivatives have been shown to enhance the effects 
of chemotherapeutic agents, such as paclitaxel [402], tamoxifen [403] and doxorubicin 
[404]. Indeed some sphingoid base derivatives are already under evaluation as 
chemotherapeutic agents [302, 404-407]. 
Metabolism of ceramide to less toxic forms can occur by glycosylation, acylation or by 
catabolism to sphingosine, followed by phosphorylation to yield S-I -P. Combination 
therapies that promote ceramide generation and inhibit ceramide metabolism should provide 
an effective approach to cancer treatment. Currently, formulations of L-threo-sphinganine 
(safingol) 31 and PPMP (1 -phenyl-2-palmitoylamino-3 -morpholmo- I -propanol) 32, a GCS 
inhibitor, in combination with 4-HRP are in clinical trials [197]. Also, the combination of S-
i-P treatment and radiation therapy has been shown to prevent adult wild type female mice 
from radiation induced oocyte loss, the event that causes female cancer patients to 
experience premature ovarian failure and infertility [408, 409]. 
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Figure 1.5: Examples of LCB Analogues (30,31) and a GCS Inhibitor (32) in Clinical 
Trials 
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1.6.2 Multi Drug Resistance 
Cancer cells and fungi frequently acquire drug resistance, which once obtained usually 
develops into multi drug resistance. Multi drug resistance is caused by multiple mechanisms 
that can be loosely categorised as drug removal or drug toxicity reduction. The sphingolipid 
pathway has been implicated in multi drug resistance [139, 401, 410-412] and Sietsma et. al. 
postulate four mechanisms in which sphingolipids may be involved [139]. Firstly, SM acts 
as a multi drug ATP binding cassette (ABC) transporter substrate and could be translocated 
out of the cell preventing SM catabolism to ceramide. Secondly, ceramide can be 
metabolised to less toxic forms, such as GIcCer. The third mechanism., in contrast to the 
others, involves an increase in sensitivity. They suggest that natural lipids compete with 
drugs as ABC transporter substrates. The last mechanism they suggest is that sphingolipid 
metabolites are directly involved in the regulation of the drug efflux pumps. Whether all 
these mechanisms act in an independent, opposing or synergistic manner and to what degree 
they are involved is not understood. 
1.6.3 Fungal Infections 
1.6.3.1 Fungal Infections in Humans 
Fungal infections in human health have not historically been given a high priority, as only 
5% of these are considered to be pathogenic [413]. However, these are a rapidly growing 
problem as the number of life threatening infections in immuno-suppressed individuals 
caused by pathogenic fungi such as C. neoformans, Candida spp., Aspergillus spp. and 
Mucor spp. are on the increase [84, 360, 414]. For example, C. neoformans causes most of 
the fungal meningitis infections in AIDS patients worldwide [360, 415, 416]. 
There are two main classes of fungicidal agent currently used for treatment, azoles and 
polyenes [417,418]. Azoles (such as fluconazole and intaconazole) interfere with ergosterol 
biosynthesis causing abnormal sterols to accumulate, thus impairing fungal membrane 
functions [419]. Polyenes (e.g. amphotericin B) bind to ergosterol, disrupt the plasma 
membrane and cause cytoplasmic leakage and hence cell death [420]. Azoles are fungistatic 
and susceptible to resistance development [421, 422] whereas polyenes are fungicidal but 
demonstrate severe host toxicity [418]. 
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1.6.3.2 Fungal Infections in Plants 
The control of fungal infections in agriculture is of great importance. Fungal plant diseases 
are estimated to destroy approximately 20% of major food and cash crops worldwide [423]. 
Botrytis cinerea (section 1.8) is an example of a plant pathogenic fungus that causes serious 
pre and post harvest diseases in economically important crops, and is regarded as a good 
model for studying infectious mechanisms present in phytopathogenic fungi [424]. 
Over the past fifteen years, three types of compounds, which exhibit both excellent activity 
against B. cinerea and possess different modes of action (which are beyond the scope of this 
review) have reached the market; the anilinopyrimidines (e.g. cyprodinil, pyrimethanil and 
mepanipyrim), the phenylpyrroles (e.g. fludioxonil) and the hydroxyanilide (e.g. 
fenhexamid) [425]. Even though management strategies of current fungicides [426] have 
contributed to keeping resistance under control, it still remains problematic and is 
endangered by the adaptability of B. cinerea to develop tolerant or resistant strains [425]. 
Thus, the development of new fungicides is paramount. 
1.6.3.3 Novel Antifungal Targets 
Four areas that could act as targets for new antifungal agents have been highlighted by Fostel 
et. al. [417] and Groll et. al. [427]. The first includes DNA, amino acid and protein 
synthesis (e.g. a unique ribosomal factor that is essential for protein synthesis in fungi [428]). 
The plasma membrane has been identified as the second (e.g. sterol or sphingolipid 
biosynthesis, or treatment with antimicrobial peptides). The third is the specific inhibition of 
electron transport (e.g. mitochondrial electron transport) and the fourth, inhibition of fungal 
cell wall biosynthesis. 
A number of publications suggest that the sphingolipid pathway is potentially a viable target 
for fungicide development [84, 417, 427]. Bacterial and fungal fermentation extracts have 
proven to be a rich source of inhibitors for enzymes of the sphingolipid pathway and fatty 
acid elongation pathway [40-42, 46, 60, 69, 71, 79, 87, 429-432]. Most of these naturally 
occurring inhibitors possess broad spectrum antifungal activity [432]; however, enzymes 
early in the sphingolipid pathway, such as SPT and ceramide synthase, have mammalian 
counterparts and thus, are less attractive as antifungal targets. IPC synthase is a prime 
candidate as it is essential to yeast and fungi but absent in mammals [433]. 
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As previously stated, a notable feature of sphingolipid biosynthesis is that ceramide 
accumulation activates apoptosis and cell cycle arrest at GI [1, 21, 261, 267, 271, 434] 
(section 1.4.1.1). IPC synthase is involved in mediating cellular ceramide levels. It has been 
demonstrated that cells defective in JPC synthase or treated with the IPC synthase inhibitor, 
AbA, have eight fold increased ceramide levels prior to apoptosis [79] and that cells 
defective in ceramide generation can survive a blockage in IPC synthesis [62, 79]. As well 
as causing ceramide accumulation, IPC synthase inhibition would prevent complex 
sphingolipid formation. Even though TPC [79], not MJPC [90] is required for vegetative 
growth in S. cerevisiae, there may be essential roles for MIPC, M(IP) 2C and further GIPCs 
in higher fungi [115]. For example treatment with AbA prevents differentiation in the 
parasite T cruzi [435]. These observations demonstrate that selective inhibition of IPC 
production could be exploited to initiate fungal cell death without affecting the mammalian 
pathway. Although IPC synthase activity has been discovered in plants [85], the difference 
in uptake rates, sensitivity and pharmacokinetics between plants and fungi could still make 
JPC synthase a viable fungicidal target. 
1.7 Aurl p and IPC Synthase Activity 
1.7.1 AURI 
The S. cerevisiae AURJ gene (1203 base pairs (bp), 401 amino acids, open reading frame 
(ORF) YKLO04W (EMBL/GenBankl DDBJ accession number Z28004)[81] was first 
identified by two independent groups as an aureobasidin resistance gene, and was initially 
called ABRJ [80, 81, 436-439]. Random mutagenesis afforded mutant strains exhibiting 
resistance to the natural product AbA (section 1.7.4.1). Genomic libraries of the mutant 
strains were prepared in shuttle vectors and complementation studies with AbA sensitive S. 
cerevisiae strains were carried out [80, 81]. Endonuclease restriction digests with )thal [80] 
and Hindffl [81] allowed identification of three ORFs, identifying the AUR] ORF by nested 
deletions, and one ORF, AURJ, respectively. When wild type strains were crossed with 
mutant haploids they became resistant, suggesting the mutations are dominant [80, 81]. 
Tetrad analysis indicated the mutants resided in one locus on chromosome XI [80, 81]. The 
mutations conferring resistance where found to be A URI single bp mutations, resulting in 
amino acid mutations at leucine 137 to phenylalanine, histidine 157 to tyrosine [80] and 
phenylalanine 158 to tyrosine [81] (denoted by * in Figure 2.1). 
In addition, both groups demonstrated A UR] to be an essential gene. Hashida-Okado et. al. 
engineered A URI gene disruption [81] and Heilder et. al. carried out partial deletion studies 
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[80]. In both cases cells were able to germinate but were restricted by an inability  to divide 
past a few rounds, indicating that A URJ is essential for growth. Furthermore, a high 
throughput systematic deletion study of the S. cerevisiae genome by Winzeler et. al. found 
the AUR1 null mutant to be non viable [440]. 
At the time of its identification no function for A UR] had been determined, although 
observations by Hashida-Okado et. al. had suggested a role in microtubule organisation and 
stabilisation [81]. 
1.7.2 Regulation of IPC synthase Activity 
In 1972 Angus and Lester demonstrated that P1 acts as a precursor for inositol containing 
sphingolipids [441]. However, it was not until 1980 that Becker and Lester identified [PC 
synthase in crude S. cerevisiae membranes. IPC synthase catalyses the transfer of myo-
phosphoinositol from P1 28 to ceramide (e.g. ceramide-C 12) to yield IPC (e.g. IPC-C 13) 
and DAG 29 [78] (Scheme 1.4). 
Ko et. al. have shown that IPC synthase is maximally expressed in the presence of inositol 
during the logarithmic growth phase indicating that [PC synthase expression is cell cycle 
regulated [442]. However, no further information regarding the regulation of IPC synthase 
was available until Nagiec et. al. genetically manipulated the S. cerevisiae genome and 
showed that A URJ encodes [PC synthase (or at least an essential subunit) [79]. Using a 
sphingolipid bypass mutant Nagiec et. al. were able to isolate a mutant strain defective in 
[PC synthase activity, which was sensitive to exogenous PHS. As the defective mutant 
proved to poorly transform plasmid DNA, a diploid version was transformed with a 
recombinant DNA library. Strains transformed with the complementary gene were isolated 
on plates containing 10 to 20mM PHS. Plasmids from surviving colonies contained the 
same EcoRI digest pattern. The AURI ORF was identified by comparison of the sequence to 
the S. cerevisiae genomic database. Furthermore, Nagiec et. al. were able to inhibit [PC 
formation by treatment with AbA, providing additional support for [PC synthase being 
encoded byAURJ [79]. 
Although A URI does restore the [PC synthase defect and enzyme activity, as yet the protein 
has not been purified so it remains unclear whether A URJ fully encodes [PC synthase or is 
an essential sub unit. Using microarray hybridisation Spellman et. al. have shown that 
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messenger RNA for AURI peaks at the G2 stage of the cell cycle, providing further evidence 
that A URJ is cell cycle regulated [443]. 
1.7.3 Location of Aurl p and IPC Synthase Activity 
The location of Aurip and IPC synthase activity has been studied in an extensive series of 
experiments by Levine et. al. [86]. They employed immunofluorescence and membrane 
fractionation techniques to localise Aurlp to the Golgi with the active site in the Golgi 
lumen. Aurlp was tagged at the C-terminus with either three copies of the hemagglutinin 
(HA) epitope tag or with protein A. The HA tag did not effect growth but enabled the 
location of Aurip to be detected by organelle fractionation. Fractions were then probed with 
rabbit, rat or mouse anti-HA antibody. Aurlp-HA presence was indicated by a 45kDa band 
on protein blots. To ensure the HA tag did not distort results, membrane fractions from wild 
type cells were treated with fluorescently tagged ceramide, C 6-NBD-ceramide 44, in order to 
determine the locus of [PC synthase activity. These results are in agreement with previous 
findings, that [PC synthase is localised in the Golgi apparatus [86]. 
They also tagged one allele of a diploid at the C-terminus with a myc epitope. The 
remainder of the genes were wild type or mutated at histidine 294 to alanine (denoted by A  in 
Figure 2.1). Myc protein blotting determined that the levels of Aurip were the same in the 
two strains but when sporulated only the wild type produced viable haploids. Stability of the 
mutated protein was not affected but the enzymatic activity was too low to sustain growth. 
This suggests that His 294 is part of the active site (see section 2.1). As there is one TMIH C-
terminal to the mutant, the active site and C-terminus have to reside on opposing sides of the 
membrane. An Aurip-protein A fusion was employed to determine which side of the 
membrane the C-terminus is located. It was found that cleavage of protein A at the TEV site 
occurred in the absence of detergent. When protein A was attached to a lumenal C-terminus 
of type H Golgi enzyme Van lp, detergent was required to cleave the tag. Thus, the C-
terminus of IPC synthase must reside in the cytoplasm with the active site in the Golgi 
lumen. This is consistent with the fact that when yeast cells are incubated with C 6-NBD-
ceramide the product remains in the Golgi instead of the cytosol, where it can be transferred 
to other organelles. 
In addition, Levine et. al. used a sec 23 mutant at 37°C, which allows recycling from the 
Golgi to the ER but is defective in ER to Golgi transport and accumulates recycled proteins 
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in the ER. This was not observed with Aurip thus, if it is recycled it behaves like a medial 
protein and recycles to earlier Golgi cisternae and not the ER. 
1.7.4 Natural Product Inhibitors 
1.7.4.1 Aureobasidin A 
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Figure 1.3: Aureobasidin A 
Abbreviations; D-Hmp, 2(R)-hydroxy.3(R)-methylpentanoic acid; MeVal, N-methyl-L-valine; Phe, L-
phenylalanine; MePhe, N-methyl-L-phenylalarnne, Pro, L-proline; Leu, L-leucine; alle, L-allo-
isoleucine; HOMeVa1, 3-hydroxy-N-methyl-L-valine. 
The natural product, AbA 33 is the major aureobasidin isolated from Aureobasidium 
pullulans R106 [444] (Figure 1.3). It is a cyclic depsipeptide (1100 Da) containing eight 
amino acid residues, of which four are N-methylated, and a hydroxyacid. The structure and 
absolute configuration was elucidated by spectroscopic and degradative studies [445]. It is a 
potent broad spectrum antifungal agent, which targets IPC synthase and has potent activity 
against S. cerevisiae (IC50 0.2nM) [79] and pathogenic fungi, such as Candida spp. (C. 
albicans, C. glabrata, C. tropicalis, C. parapsilosis, and C. krusei) [88, 4461, C. neoformans 
[446] and Aspergillus spp. (A. fumigatus, A. flavus, A. niger and A. terreus) [88]. 1050 's for 
these organisms are in the range of 2-5 nM. 
It has been shown that S. cerevisiae cells are killed in the log phase but not in the stationary 
phase [447], again suggesting Aurip is cell cycle regulated. Both A URI -depleted cells and 
AbA treated cells exhibited morphological changes such as microtubule disappearance, 
tubulin degradation and abnormal chitin deposition in both S.cerevisiae and S. pombe [81, 
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82, 447]. Cell elongation deficiency in S. pombe was also observed [82] as were polarised 
growth defects in A. nidulans [262], indicating a role for A UR] in these phenotypes. 
However, in S. cerevisiae only AbA treated cells displayed abnormal actin distribution, 
including actin filament disappearance which suggests that AbA may cause changes in S. 
cerevisiae by an alternative mechanism [81, 447]. 
A limitation of AbA as an anti fungal agent is that the pathogen, A. fumigatus, is resistant in 
vivo [448]. In the presence of mammalian multidrug modulators (e.g. verapamil, 
chlorpromazine and trifluoperazine) the MIC of AbA for A. fumigatus is lowered from 
>50mg/mi to 2-3 mg/ml [88]. Also, the previously resistant T. cruzi becomes sensitised to 
AbA when incubated with verapamil [121]. Both these observations indicate that some 
transporter(s) are present, presumably involved in the efflux of AbA. 
AbA has been implicated as an ABC transporter multi drug resistance inhibitor following 
reports that AbA, and clycosporin A, which has a similar structure, act as substrates for 
human p-glycoprotein (AbA IC 50 2.27±0.55p.M) [449]. AbA has also been shown to inhibit 
p-glycoprotein catalysed efflux of vincristine in multi drug resistant cancer cells [450]. 
When investigating fungal cell resistance to AbA, Owgawa et. al. [450] identified a S. 
cerevisiae mutant strain, aur3, which has a recessive mutation in the pleiotropic drug 
resistance gene, PDRJ. PDRI is a transcriptional regulator of two ABC transporter genes, 
the oligomycin, reveromycin and organic anion resistance gene, YORJ, and the pleiotropic 
drug resistance gene, PDR5. YORJ is a member of the cystic fibrosis transmembrane 
conductance regulator subgroup and PDR5 is a member of the multi drug resistance 
subgroup. These results indicate that AbA may interact with and be a substrate for fungal 
ABC transporters and that YORI is the more important ABC transporter gene in conferring 
AbA resistance. Both functional YOR] and mutated PDRI are required for AbA resistant 
phenotypes. It is thought that mutation in PDRJ induces abnormal hyper expression of 
YORI [450]. 
AbA has high efficacy in the murine model of candidiasis and has very low animal toxicity 
[446]. This indicates potential clinical utility but the resistance to AbA by filamentous fungi 
needs to be addressed. A number of AbA analogues have been prepared [45 1] but most 
analogues display reduced antifungal activity, although there are a few exceptions [451, 
452]. Tiberghien el. al. have demonstrated that there is no correlation between the structure 
activity relationship of AbA as an ABC transporter substrate and as an antifungal agent 
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[452]. The N-methylated amides appear to restrict AbA to biologically useful conformations 
[453] and for p-glycoprotein inhibition AbA must be polarised to one domain of the 
molecule [454]. The hydroxyl moiety of [3-HOMe Val is essential for antifungal activity 
[454, 455]. Thus, it may be possible to engineer an AbA derivative that lacks multi drug 
resistance activity but retains potent antifungal activity. 
Although AbA is thought of as a broad spectrum antifungal, fungal zygomycetes such as 
Mucor and Rhizopus species are completely resistant to AbA [413]. This is probably due to 
the fact that zygomycetes do not contain GIPCs and hence no IPC synthase equivalent. 
Instead they have novel neutral glycosphingolipids consisting of multi-galactose sugar 
residues or mono-glucose attached to two different types of ceramide [413]. 
In AbA sensitive yeast and fungi there are a number of reported cases where single amino 
acid mutations have rendered Aurip resistant to AbA (denoted by * in Figure 2.1). In S. 
cerevisiae resistant mutants are characterised by single base alterations at Leu 137 to Phe, 
His 157 to Tyr [80] and Phe 158 to Tyr [81]. It must be noted that the mutants were not 
generated spontaneously, but required treatment with mutagenesis inducing agents such as 
ethyl methane sulfonate [80, 81]. As these mutations occur within close proximation, this 
region must be important for AbA binding and it has been argued that either the mutations 
cause a change in the binding site of IPC synthase or that AbA still binds but the protein 
maintains its function. Overexpression of S. cerevisiae wild type Aurip also results in AbA 
resistance, although to a lesser extent than in mutants [81]. It is probably due to AbA being 
trapped in excess Aurip, leaving no free AbA to inhibit further IPC synthase. 
A mutation in S. pombe Aurip at glycine 240 (to cysteine) confers resistance to AbA. As 
with S. cerevisiae, wild type overexpression is AbA resistant [82]. A single point mutation 
at glycine 275 (to valine) in A. nidulans, which corresponds to glycine 240 in S. pombe, also 
confers resistance [83]. Hashida-Okado et. al. have carried out a three base pair mutation in 
the S. cerevisiae AURI gene where alanine 240 is mutated to cysteine, also conferring AbA 
resistance. They have utilised this mutant A URJ-C, as a selection marker for use in 
combination with AbA in a new transformation system for industrial strains of S. cerevisiae 
as well as other yeast strains such as C. glabrata, Kluyveromyces lactis and K. marxianus. 
They have also inserted a unique StuI site into the A URI-C coding region to facilitate 
homologous recombination into the genome and found that the copy number of the 
integrated A URI -C exhibits a dosage effect, increasing with AbA concentration [456]. 
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Hansen et. al. have further modified the AURI-C transformation system by constructing a 
pYC series that contains a LacZ reporter gene and also allows for the insertion of various 
promoters as well as alternative selection markers for use with other antibiotics [457]. 
AURJ-C has also been employed in mass-mating spore suspension methods in order to select 
hybrids from industrial yeasts [458-460]. 
1.7.4.2 Rustmicin 
e 
R = H, Rustmicin (Galbonolide A) 34 
	
R = H, Galbonolide B (Neorustmicin?) 36 
R = OH, 21-Hydroxyrustmcin 35 
	
R = OH, 21-Hydroxygalbonolide B 37 
Figure 1.4: Rustmicin and Analogues 
There are a further two classes of natural product AURI inhibitors; rustmicin 34 and 
khafrefungin 41, neither of which is structurally related to AbA. Rustmicin is a 14-
membered macrolide isolated from Micromonospora chalcea [461, 462]. It is also known as 
galbonolide A 34, since it was isolated at the same time from Streptomyces ga/bus [463]. 
Like AbA it is especially potent towards C. neoforinans JPC synthase (IC 50 -70pM) [71]. It 
is a reversible inhibitor [71] and does not inhibit DNA, RNA or chitin synthesis, or 
destabilise the membrane [71, 464]. It has been found to be non toxic in animal studies; 
however, its limitation to use is its stability (see Figure 1.5) and transport out of the target 
cell [71]. Under acidic conditions the enol ether is hydrolysed to an inactive C6-ketone 
analogue 38. Under basic to neutral conditions, and especially in serum, it is known to 
rapidly epimerise at the C2 to give 39 and this subsequently rearranges to the corresponding 
inactive y-lactone 40 [71, 465]. Even at its optimal pH (5.5) it still degrades relatively 
rapidly in aqueous media [71, 464, 465] although it is stable in methanol at -20°C [432]. 
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Rustmicin C6 ketone analogue 38 L-760,262 39 
(Rustmicin C2 epimer) 
L-770,715 40 
(Rustmicin y-lactone) 
Figure 1.5: Rustmicin Degradation Products 
Galbonolide B 36 and its 21-hydroxylated analogues 35, 37 were also isolated from M. 
chalcea as minor components [431]. The Merck microbial biotransformation program also 
isolated and characterised the 21-hydroxy analogues 35, 37, thought to be produced via 
cytochrome P450 oxidation [466]. The absolute stereochemistries of galbonolide A 34 and 
B 36 were determined by total synthesis [467, 468] and in the case of galbonolide B, also by 
its crystal structure [468]. Although a number of papers do state that galbonolide B and 
neorustmicin are the same compound, this has been questioned [464]. 
A number of rustmicin derivatives have been synthesised but they possess lower activity 
than the parent compound [431, 465, 469, 470]. The order of potency for IPC synthase 
inhibition by rustmicin derivatives is rustmicin, galbonolide B, 21 -hydroxyrustmicin 35 and 
2 1 -hydroxygalbonolide B 37. This trend, however, is not truly representative of antifungal 
activity due to differences in chemical instability and drug transport [417]. The difference in 
potency of rustmicin between C. neoformans (IC 50 70pM), C. albicans (IC50 3.8nM) and S. 
cerevisiae (IC 50  19.8nM) can also be attributed to chemical stability and efflux properties. 
C. albicans and S. cerevisiae have membrane bound ATP synthases, which can rapidly 
acidify the media [471]. Buffering at pH 5.5 has been shown to increase potency [71]. C. 
albicans and S. cerevisiae are known to have several multidrug efflux pumps and 
fluconazole resistance in C. albi cans can be partially attributed to drug efflux efficiency 
[472-474]. PDR5 disruption has been shown to dramatically increase the sensitivity of S. 
cerevisiae to rustmicin [71]. 







OOH H  
Lactone Derivative 42 
Figure 1.6: Khafrefungin and its Lactone Derivative 
Khafrefungin 41 is a linear C 22-polyketide acid that is esterified with an aldonic acid. It was 
isolated from an endophytic fungus. Like AbA and rustmicin, khafrefungin is active against 
C. albicans, C. neoformans and S. cerevisiae, and is an [PC synthase inhibitor with 10 50 's in 
the nanomolar range [87]. The absolute stereochemical configuration of khafrefungin was 
elucidated by Wakabayashi et. al. [475]. The same laboratory group have also published a 
convergent synthesis [476], a large scale synthesis [477] and structure activity relationship 
data [477]. Unfortunately all the synthetic derivatives, except for a lactone type derivative 
42, exhibited little or no antifungal activity. They have shown that the aldonic acid moiety is 
essential for antifungal activity and, as the lactone possesses almost equivalent activity to 
khafrefungin suggested that the two compounds may exist in equilibrium. The presence and 
stereochemistry of the hydroxyl groups on the aldonic acid are extremely important for 
activity. Their results have suggested that the mode of inhibition is mediated by its polar 
head group, which may mimic phosphoinositol. 
As yet no khafrefungin resistant mutants have been reported. Nagiec el. al. have shown that 
although khafrefungin specifically inhibits [PC synthase, in sphingolipid bypass mutant 
assays it does have a lower specifity than AbA or rustmicin [72]. A limitation for 
commercial use is the fact that khafrefungin is lytic to red blood cells at concentrations of 
12.5 to 25 p.g/ml, which may be a consequence of its detergent like properties [432]. 
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1.7.5 IPC synthase: A Molecular Switch 
The sphingolipid and glycerolipid pathways interconnect at IPC synthase and M(IP) 2 C 
synthase in yeast and fungi and at SMS in mammals. In addition to cataysing [PC formation, 
[PC synthase may regulate both ceramide and DAG levels. DAG activates certain isoforms 
of protein kinase C and this activation has been implicated in the stimulation of melanin 
production [478-480]. Melanin is thought to protect pathogenic cells from reactive oxygen 
and nitrogen species produced by the host [481]. Luberto et. al. have provided evidence to 
suggest that melanin production may be modulated through [PC synthase regulated DAG 
[360, 482]. By putting C. neoformans IPCI under the control of a leaky galactose promoter 
(GAL 7:: IPCJ) they have shown that melanin production increases by 80% under galactose 
inducing conditions but reduces by 60% when repressed. Down regulation of IPCJ also 
impaired growth at low pH in a murine macrophage model and reduced pathogenicity in a 
rabbit model [360]. The impaired growth may be due to a lack of complex sphingolipids 
since the plasma membrane is deficient in sphingolipids, which makes it more permeable to 
Na and H ions involved in pH and osmotic stress responses [360]. 
Schneiter et. al. have shown that P1 in fungal cells is heterogeneously distributed with 
different subspecies localised to different compartments [483]. Ipclp may just use P1 
subspecies distinct to the Golgi and as such only regulate a small subset of DAG species. 
This hypothesis is strengthened by the observation that protein kinase C is differentially 
activated by different DAG subspecies [482]. The C  domain of C. neoformans protein 
kinase C is a typical DAG binding domain; however, C  domains in S. cerevisiae and C. 
albi cans protein kinase Cs are insensitive to DAG. The DAG-protein kinase C activation 
mechanism in C. neoformans may specifically be used for melanin production, which does 
not occur in S. cerevisiae or C. albicans [482]. 
As ceramide accumulates upon down regulation of IPCJ and inhibits protein kinase C 
activity, [PC synthase may act as a molecular switch for protein kinase C activation (DAG) 
and inhibition (ceramide) [482]. DAG has also been implicated in vesicle budding from the 
Golgi apparatus [484]. Thus, vesicle budding may be controlled by ]PC synthase and 
M(IP)2C synthase activity. 
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1.7.6 JPC synthase Activity in Plants 
IPC synthase activity has recently been demonstrated in plants [85]. Using both 
radiolabelled P1 ([ 3H]PI) and fluorescently tagged ceramide (C 6-NBD-ceramide) Bromley et. 
al. have monitored UPC formation in wax bean microsomes by thin layer chromatography 
(TLC). Activity was observed with both C 6-NBD-ceraniide and ceramide containing 
hydroxylated and non-hydroxylated fatty acid chains as substrates. The TPC synthase 
activity has been shown to be inhibited by AbA and rustniicin with IC 50 values of 0.4-0.8 and 
16-2OnM, respectively [85]. It was also demonstrated in this study that the IPC synthase 
activity is closely but not exclusively associated with the Golgi. 
Although enzyme activity has been observed, BLAST searches of the A. thaliana genome or 
other plant genomes such as rice, wheat, barley and oat have revealed no apparent AURJ 
homologues [18]. Furthermore, [PC specific phospholipase C activity has not been observed 
in plants nor has an ISCI homologue been found [2, 182, 485]. 
1.8 Botrytis cinerea 
The Botrytis genus of pathogenic fungi has been known for a long time and was first named 
in 1729 after the Greek term for a bunch of grapes, berriesa [425]. Many botrytis variants are 
specialised, infecting only one type of plant. In the majority of cases these specialised 
variants can be regarded as distinct species [486], for example, B. elliptica infects only lillies 
[487]. The first known literature describing and naming Botrytis cinerea is an account in the 
'Synopsis Methodica Fungoruma' in Zurich by Von Hailer in 1771 [425]. B. cinerea is now 
commonly known as grey mould or botrytis blight and is one of the most important of the 22 
botrytis species. Unlike some of its more specialised relatives, B. cinerea is indiscriminate 
in its phytopathogenicity, infecting most plants and plant parts. The economic impact is 
even greater when you consider that it infects cash crops not only in the field but in storage 
and transport [425]. The disease favours cool, moist conditions with little or no wind [488]. 
It is a weak parasite and so is found on delicate, ripe, injured or senescent plant tissues [489] 
and infects fruit and vegetables as well as trees, shrubs, flowers and weeds [488]. 
However, as well as being a problem, under certain conditions, B. cinerea can be beneficiary 
being the cause of 'noble rot' which dries berries and causes the sugar and flavour to 
concentrate without affecting the acidity. These benefits of late B. cinerea infection in white 
wine production were discovered in 1775 in Germany and infection with 'noble rot' is now 
an essential part of the process of production of dessert wines such as Trockenbeerenauslese 
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from Germany, Sauternes from France, Tokay from Hungary and the late wines from 
California [425, 490]. Paradoxically however, the modem consumer trend leans towards 
clean, noble rot free wines [425]. 
The plants that B. cinerea can infect vary greatly in their biochemical defences [491]. The 
fungus infects tissues by coordinating the expression of pathogenic enzymes, thus degrading 
their chemical defences and protective cell coatings (reviewed in [4921). Van Baarlen et. al. 
have demonstrated that B. elliptica induced lily cell death requires protease and phosphatase 
activity as well as sphingolipid metabolism [487]. 
Ippolito et. al. have shown that the yeast like fungus Aureobasidium pullulans controlled 
apple wound decay caused by B. cinerea (grey mould) and P. expansum (blue mould) and 
reduced the decay by 89% and 67% respectively, compared to a water treated control [493]. 
They had previously shown that A. pullulans isolated from the surface of grape berries can 
also control the decay of grape, sweet cherry, strawberry and kiwifruit [493-495]. A. 
pullulans has also been shown to protect onion leaf surfaces [496] and suppress B. cinerea 
sporulation on dead leaves [497]. A. pullulans is thought to weaken pathogen cells by out 
competing them for space and nutrients, thus increasing their vulnerability to host chitinases 
and 3-1,3-glucanease as well as A. pullulans secreted lytic enzymes and antibiotics [493]. 
As the ][PC synthase inhibitor, AbA, was isolated from A. pullulans fermentation broth, it is 
possible that A. pullulans suppresses B. cinerea infection by the action of AbA on 1PC 
synthase activity. Moreover, the IPC synthase inhibitor galbonolide A, isolated from 
Streptomyces galbus culture broth, possesses potent activity against B. cinerea and numerous 
other pathogens [463, 498]. The above studies indicate that B. cinerea would be a good 
model for further study of IPC synthase as a potential fungicidal target. 
1.9 Aims 
The regulation and control of the complex sphingolipid matrix is not fully understood and 
none of the enzymes involved have been characterised to any great extent. Thus, there is an 
opportunity to exploit enzymes in the sphingolipid pathway(s) in terms of species specific 
enzyme inhibition. 
The membrane bound enzyme, IPC synthase encoded by the essential A URJ gene has been 
identified in yeast and fungi [79, 84]. Deletion has been shown to be lethal in yeast [80, 81, 
440] and selective inhibition of IPC synthase by natural products (AbA, rustmicin and 
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khafrefungin) leads to a lack of complex sphingolipids, ceramide accumulation and 
apoptosis in fungi [71, 79-83, 87, 88]. Since JPC synthase does not exist in mammals 
(although IPC synthase activity has been observed in plants [85]) there is an opportunity here 
for development of a species specific IPC synthase inhibitor as a fungicide, that might have 
low toxicity to the host. 
[PC synthase, like other enzymes in the sphingolipid pathway is still poorly characterised 
and further studies ofAurip and TPC synthase activity need to be carried out. It would be 
most relevant to agrochemical research to study the effects on enzymes from 
phytopathogenic fungi. Thus, one aim of this program was to isolate wild type IPC synthase 
from both S. cerevisiae and B. cinerea, and to carry out initial substrate and inhibitor studies 
(Chapter 3). This should allow for future structure based design of a fluorescent substrate 
for use in a high throughput assay, which would allow screening of selective inhibitors. 
Little work has previously been carried out on IPC synthase expression and purification, and 
the reported procedures are rather tortuous and inefficient [442, 499-501]. In April 2002 an 
AURJ gene construct from B. cinerea was made available to us by Syngenta. So the second 
aim of this study was to develop robust protein purification protocols to enable cloned and 
overexpressed IPC synthase to be obtained in an active form. I intended to achieve this 
through heterologous recombinant expression of B. cinerea AURJ constructs in Escherichia 
coli and P. pastoris. For comparison, it was planned to recombinantly express the S. 
cerevisiae A URI gene (Chapter 4). 
In order for both of these aims to be fulfilled, bioinformatic analysis of B. cinerea A URJ was 
required. Although some analysis has previously been carried out on the S. cerevisiae AURI 
sequence [84], further study was required in order for comparison to the B. cinerea 
homologue (Chapter 2). 
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Chapter 2: Bioinformatic Analysis 
2.1 Aurl p Sequence Analysis 
In order to identify conserved residues in both S. cerevisiae and B. cinerea Aur I  that may 
be important for structural stability and/or catalytic activity, a sequence alignment analysis 
was carried out (Figure 2.1). The Basic Local Alignment Search Tool, BLASTp [502, 503], 

















AURI AbA R S. cerevisiae P36107 807 0 387/401 96 
KLLAOBJ3387g Chrom B K. lactis Q6CVB2 560 1x10' 58 267/384 69 
IPCJ IPCS C. glabrata Q9Y797 521 1x10' 248/377 65 
ABRO04C ABR0004Cp Ashbyagossypii Q75DL4 520 1x10' 247/385 64 
AURI AbAR C. albicans 013332 443 IX 10-123 209/355 58 
IPCI IPCS C. parapsilosis Q9Y799 442 lxlO 123 216/357 60 
DEl-IA 0EI3442g Chrom E Debaryomyces Q6BPK5 432 lxlO 120 201/360 55 hansenzi 
IPCI IPCS C. tropicalis Q9Y7AO 417 lxi 0' 15 188/341 55 
IPCI IPCS C. krusei Q9Y798 355 7x10 9 ' 184/384 47 
YALIOEI6434g ChromE C. lipolytica Q6C5P1 332 1x10 89 159/327 48 
AURJ AbAR S. pombe Q10142 319 6x10 86 157/328 47 
AURA AbA R A. nidulans Q9Y744 309 8x10 83 148/326 45 
AURJ AbA R A.fumigatus Q9Y745 308 2x10 82 149/326 45 
AURJ AbA R put Pneumocystis Q6AHVI 306 4x10 82 146/304 48 carinu 
NCU02282.1 Hypo N. crassa Q7S586 294 2x10 78 148/325 45 
IPCI IPCS C. neoformans Q9Y7A1 286 4x10 76 139/292 47 
IPTI Hypo albicans Q5APJ5 123 6x10 27 66/168 39 
DEHAOF27O6Og Chrom F hansenii Q6BK22 113 6x10 24 69/176 39 
IPTI M(IP)2C S S. cerevisiae P38954 103 6x10 21 52/128 40 
CAGLOG05313g Chrom G C. glabrata Q6FT53 102 1x10 20 52/135 38 
KLLAOEJ0I64g ChromE K. lactis Q6CNTO 95 3x10 18 47/126 37 
Bacteroides 
BT1552 AbA R put thetaiotaomicron Q8A7K2 86 1x10' 5 62/258 25 
- 	 Hypo 	Cynomolgus 	Q9BGU6 	36 	1.6 	20/73 27 
monkey 
C9orf67 	Hypo 	Homo sapiens Q9BRC3 	36 	1.6 	20/73 27 
AMT2 Am trans 2 A. thaliana 	Q9M6N7 34 6.3 29/115 25 
Table 2.1: BLASTp Similarity Search Against S.cerevisiae Aurip (P36107) 
BLASTp 1 .5.4-Paracel [502, 503] was carried out against the ExPASy/UniprotKB database [504]. 
Low complexity regions were replaced by X in the S. cerevisiae Aurlp (P36107) query sequence. 
Sequences with an E-value 2  above lxi 0 have been included except when a gene and corresponding 
chromosomal ORF were obtained, only the gene is included. The sequences are grouped into three 
sections based on similar E-values 2 . In the Swiss-Prot/TrEMBL database the proteins are annotated 
as: AbA R, AbA resistance protein; AbA R put, putative AbA resistance protein; IPCS, IPC synthase; 
M(IP) 2C S, M(IO2C synthase; Hypo, hypothetical protein; Chrom X, ORF on chromosome X; Am 
trans 2, Ammonium transporter 2. The Primary accession numbers were obtained from the Swiss-Prot 
database. 
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The first sixteen entries in Table 2. 1, grouped in the first section (E-values 2 0 - 4x10 76), have 
extremely low E-values 2  indicating they are all yeast or fungal homologues of S. cerevisiae 
Aur ip. The only other homologous gene to A UR] in the S. cerevisiae genome, IPT], 
exhibits a relatively good E-value and as such is centrally located in the second section (E-
values 6x 10-21 - lxi 0' 5)  Sequence alignment of proteins within this section suggests that 
with exception to the bacterial entry, B. thetaiotaomicron, they are Ipt 1 p  homologues. 
Furthermore, the same sequences gave rise to the best hits in a BLASTp search against S. 
cerevisiae Iptlp. Although they are still identified as chromosomal regions and not as 
legitimate genes, these results suggest IPTJ, like A URJ, exists in a broad variety of yeast and 
fungi. Of particular interest is the B. thetaiotaomicron entry [505]; although annotated as a 
putative AbA resistance protein, if confirmed it would be the first Aurip homologue to be 
identified in bacteria. 
Entries in section three (E-values 1.6-6.3) exhibit very poor similarity to S. cerevisiae Aurip. 
They are the closest mammalian and plant sequences to Aurip currently in the 
ExPASyfUniprotKB database [504]. Alignment of the human and monkey translated brain 
cDNA sequences reveal that their central sections are almost identical to each other but 
neither is closely related to SMS or Aurip sequences. The closest related plant gene is an A. 
thaliana ammonium transporter, which has very poor alignment with Aurip. The same 
sequence was returned as the closest related protein with an E-value of 0.24 and 0.56 when 
S. cerevisiae Aurip was blasted against the UniprotKB A. thaliana database and the 
Syngenta plant database, respectively. 
B. cinerea and S. cerevisiae Aur I  were aligned with seven other amino acid sequences 
selected from section one over a range of E-values. The putative Aurip from B. 
thetaiotaomicron and Ipti p from S. cerevisiae were also aligned (Figure 2.1). A second 
alignment was prepared in which S. cerevisiae Iptlp was removed due to IPTI being a 
putative paralog to S. cerevisiae A URI. The alignment of the remaining putative 
orthologous Aur ip 's was used to generate a phylogenetic tree (Figure 2.2) representative of 
the presumed evolutionary relationship of the AURJ genes. The sequence distance method 
was utilised and the Neighbor Joining algorithm [506] was used to reconstruct the tree. This 
method utilises a matrix of distances that corresponds to the divergence observed between 
2 
The E-value is the Expectation value of obtaining a sequence by random chance; the closer to zero 
the value is, the closer the sequence is to the query. Only values less than 10 -5 are classed as good E-
values. 
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pairs of sequences. Gaps in the alignment were ignored to ensure sequences were compared 
over the same number of residues and as the observed distances can underestimate the 
evolutionary distance, Kimura's correction [507] was employed in order to factor for 
multiple substitutions. 
Although the phylogenetic tree constructed using Vector NTI does give an indication of 
evolutionary distance, no value to indicate robustness is provided. Bootstrapping was 
employed in order to determine whether every portion of the alignment supports the tree. 
Bootstrapping is the term used to describe the generation of an alignment that is equal in 
length to the original but is composed of randomly selected columns from the original. One 
hundred bootstrap cycles were carried out using the Phylip:protdist program [508, 509], from 
which 100 matrices were generated. The Neighbor distance method in conjunction with the 
JJPGMA reconstruction algorithm generated a corresponding 100 trees and a consensus. 
The tree in Figure 2.2 is representative of the consensus tree obtained by this method. The 
values on the branches which annotate Figure 2.2 give an indication of how many branches 
in the individual trees support the consensus. In this case, the phylogenetic tree appears to 
be robust, enabling conclusions to be drawn. 
The divergence and clustering observed in the phylogram is reflective of the grouping of the 
E-values in Table 2.1. The yeast Aurip's consisting of Candida spp. and S. cerevisiae are 
clustered together as are the fungal Aurlp's such as the Aspergillus spp., B. cinerea and N. 
crassa. Although the fission yeast, S. pombe is closer to the fungal Aurlp's it is the closest 
of that group to the yeast proteins, as occurs in the BLASTp results. Both methods 
automatically rooted the tree and as expected, the bacterial putative Aurip appears to be the 
most evolutionary divergent of the analysed proteins and the major out group of the dataset. 
However, C. neoformans also appears to be an out group to the dataset indicating 
evolutionary divergence from both the fungal and yeast Aurip's. This divergence is 
reflected in the alignment in Figure 2.1. The common Aurlp ancestor would lie between the 
B. thetaiotaomicron Aurlp sequence and the C. neoformans Aurlp sequence for this 
phylogram. 
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Figure 2.1: Amino Acid Sequence Alignment of Aurip and Related Proteins 
Areas of high homology are highlighted by coloured text and blocks of colour: red text on yellow, identical residues conserved in all sequences; blue text on turquoise, 
consensus derived from identical residues in at least 50% of sequences; black text on green, consensus derived from similar residues; green text on white, residue 
weakly similar to consensus; black text on white, residues dissimilar. The conserved domains (D1-4) are underlined in black, the amino acids are in bold and the yeast 
and fungal motifs are written underneath. The symbols for the motifs are: x, any amino acid; n, small neutral amino acid; 4), aromatic amino acid; h, hydrophobic 
amino acid; b, branched amino acid. The LLP domains are lipid phosphate phosphatase domains, C2 and C3 with 70% amino acid conservation. Putative catalytic 
triad residues are in orange text. Residues that possibly stabilise the phosphate transition state via hydrogen bonding are in pink text. The C neoformans Aurip 
sequence predicted to bean ABC transporter domain is underlined in blue. Amino acid mutations which render AURI with increased resistance to AbA, are denoted 
by * . The histidine mutation in [86] is denoted by ^. The conserved putative N-glycosylation site is denoted by +4-F.  124 amino acids in a hydrophilic loop are 
omitted from the S. cerevisiae Iptlp sequence (residues 313-433) denoted by A. B. cinerea and S. cerevisiae A URI were truncated for expression studies in P.pastoris 
(Chapter 4.2) corresponding to Ser75 and A1a4 Ion the respective Aurlp sequences, denoted by V. Abbreviations: Sc, S. cerevisiae; Bc, B. cinerea; An, A. nidulans; 
Af, A. fumigatus; Nc, N. crassa; Sp, S. po,nbe; ('a, C. albicans; ('g, C. glabrata; Ch, C. neofor'nans; Bt,. B. theiaiotao,nicron. Primary Accession Numbers from 
Swiss-Prot: Aurlp Sc, P36107; Aurlp Bc, sequence available from Syngenta; AurAp An, Q9Y744; Aurlp AJ Q9Y745; Aurip? Nc, Q7S586, sequence also available 
from Syngenta; Aurlp Sp, Q10142; Aurip Ca, 013332; lpclp Cg, Q9Y797; Ipclp Cn, Q9Y7AI; Aurlp? Bt, Q8A7K2; Iptlp Sc, P38954. Aurlp? Nc is still a 
hypothetical protein; its gene name is NCU02282.1. Aurlp? Bt is still only a putative AbA resistance protein; its gene name is BT1552. 
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971 1 
99 	
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I 98 
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Figure 2.2: Phylogenetic Tree of Putative Orthologous Aurip Sequences 
Aurlp sequences in Figure 2.1 were re-aligned without S. cerevisiae Iptlp. The phylogenetic tree was built using the sequence distance method and the Neighbor 
Joining tree reconstruction algorithm [506], and displayed using Align X available in Vector NT! suite 8. Correction for multiple substitutions was carried out using 
Kimura's correction [507] and positions containing gaps were ignored. The calculated distances (time units) are displayed in parenthesis. Abbreviations and primary 
accession numbers are as described in Figure 2.1. The values in blue indicate the robustness of the branches out of 100 trees generated using 100 bootstrapping cycles 
obtained with the Phylip:protdist [508, 509] Neighbor distance method and the UPGMA algorithm. 
Rachel Breen 	 Chapter 2: Bioinformatic Analysis 	 Page 57 
Domain searching, using both InterProScan [510-512] and the NCBI CD server [513], on the 
Aurlp sequences in Figure 2.1 revealed PAP2 super family, acid phosphatase homologue 
and acid phosphatase/vanadium-dependent haloperoxidase domains. Stukey and Carman 
first proposed the existence of a phosphatase super family in 1997 [514]. The family, 
defined by three conserved domains (C 1-3), has since expanded [84, 515-517] to encompass 
both globular and membrane proteins including acid phosphatase homologues, such as lipid 
phosphate phosphatases (LPPs) [518], sphingoid base phosphate phosphatases [216, 217], 
glucose-6-phosphatases [519-521], diacylglycerol pyrophosphatases [522, 523], bacterial 
acid phosphatases [524] and the Drosophila developmental protein, Wunun [525], as well as 
haloperoxidases [516, 526]. It is not surprising that vanadium-dependent haloperoxidases 
are included in this family as vanadate adopts a penta-configuration similar to the phosphate 
transition state structure [527, 528]. Vanadate has also been shown to inhibit phosphate 
metabolising enzymes such as acid phosphatases and glucose-6-phospatase [529] although it 
has not been tested as an inhibitor of JPC synthase. 
2.1.1 Central Section 
The sequence alignment in Figure 2.1 shows the conserved Aurip (and Iptip) regions lie 
within the central section (approximately 250 amino acids) and as reported by Heidler et. al. 
there is 53-73% homology at the nucleic level and 56-94% similarity at the amino acid level 
[84]. Within the central section four conserved domains (D1-4) have been identified, of 
which two, D3 (FGAxPLSH) and D4 (YxxxxxWxTMYLx}fflYxxDLxJ(Gxxxn), are similar 
to two of the three conserved domains that define the super family, C2 (nxxSGHn) and C3 
(hocnxnRbxxxxfl4xxDbxxnxxxn), respectively. Furthermore, the spacing between the 
domains is of similar distance [84, 530]. 
LPPs hydrolyse phosphatidic acid 43 releasing DAG 29 (Scheme 2.1). The mechanism 
(Scheme 2.2) is believed to proceed via nucleophilic attack on the phosphate by the 
imidazole nitrogen of the conserved histidine residue in C3. The adjacent aspartate promotes 
the nucleophilic attack by electron donation to the imidazole. DAG release occurs following 
proton donation from the histidine in C2. The same histidine is then able to promote 
hydrolysis of the phospho-histidine intermediate by increasing the nucleophilicity of the 
water through hydrogen bonding. A similar catalytic mechanism can be suggested for IPC 
and M(EP)2C  synthases. P1 28 could form a unique inositol phosphoryl histidine 
intermediate with one of the conserved histidines in D4. The Ci-hydroxyl group of 
ceramide (e.g. ceramide-C 12), or the mannose-OH of MIPC (e.g. MIPC-C 14), could 
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hydrolyse the intermediate to yield IPC (e.g. IPC-C 13), or M(IP)2C (e.g. M(EP)2C 15), 
respectively. The histidine in D3 could increase the nucleophilicity of ceramide or MIPC via 
hydrogen bonding. Unwanted hydrolysis would be prevented by the hydrophobicity of the 
catalytic site (see section 2.4). This hypothesis is reinforced by the study conducted by 
Levine et. al. [86]. They have demonstrated that mutating the second conserved histidine in 
D4 (His294) to alanine in S. cerevisiae Aurlp (denoted by A  in Figure 2. 1), which 
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Scheme 2.2: Putative Catalytic Triad Reaction Mechanism of LPPs, Aurip and Iptip 
The conserved catalytic residues in 2 1)4 are in red. The conserved histidine in C2/D3 is in blue. 
Species in the first step of the reaction: R"PO 4-R' is phosphatidic acid 43 (LPPs) or P1 28 
(Aurlp/Iptlp); R"OH is DAG 29. Species in the second step of the reaction: R ... OH is H 20 (LPPs), 
ceramide (Aurip) or MIPC (Iptip); R ... PO 4-R' is HP042 (LPPs), LPC (Aurip) or M(IP) 2C (Iptip). 
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Further information on the role of residues in the Aurip active site can be gleaned from 
Chloroperoxidase (Ec 1.11.1.10, P49053), a soluble vanadium-dependent haloperoxidase, 
which has had its structure determined to 2.1A (protein data bank (pdb):1VNC [531, 532]). 
In addition to the conserved residues in the putative catalytic triad (C2, His404; C3, His496, 
Asp500), a number of residues have been highlighted that stabilise the vanadate ion via 
hydrogen bonding (C 1, Lys353, Arg360; C2, Ser402, Gly403 backbone nitrogen; C3, 
Arg490) [516]. Due to the similar penta-configuration of the vanadate and phosphate 
transition state, and that these residues are conserved in PAP2 alignments, three of the 
phosphate oxygen's could be subject to similar hydrogen bond stabilisation [516]. With the 
exception of Lys353, this could be extended to similar residues in Aur 1 p  and Ipt I  (pink text 
in Figure 2.1): Arg360 (C 1) could correspond to the conserved arginine in 132; Ser402 (C2) 
is conserved in D3; the backbone nitrogen of the conserved leucine in D3 could function as 
the G1y403 (C2) backbone nitrogen; with the exception of bacterial Aurip, the conserved 
threonine in D4 could function as Arg490 (C3). The exclusion of a corresponding Lys353 in 
Aurlp and Iptip sequences could possibly be attributed to the position of myo-inositol. 
The first two domains, Dl (DhhAWxxYxxxHxxxp) and D2 (YxxxGxxxoLxRxD), are 
unique to Aurlp and Iptip. SMS shares a similar domain profile to Aurip and exhibits four 
conserved domains. As with Aurip, SMS D3 and D4 are similar to LPP C2 and C3 but Dl 
and D2 are unique [127]. Heidler et. al. have suggested that there could be possible 
alignment between Aurlp/Iptlp Dl, D2 and the first LPP domain, Cl (KxxhxxxRP), due to 
similar hydropathy profiles [84]. C  is predicted to reside in a hydrophilic turn bounded by 
two hydrophobic structural elements, in this case alpha helices [517]. Secondary structure 
prediction indicates D2 resides in a hydrophilic loop suggesting a possible surface 
environment; however, Dl is predicted to reside at the beginning of a TME (see section 2.4). 
Furthermore, D2 contains a conserved arginine that may correspond to the arginine in C  
and facilitate phosphate transition state stabilisation via hydrogen bonding. Both the 
hydropathy profile and conserved arginine suggest that in fact it may just be D2 that could be 
aligned to Cl, indicating that the putative function of D2 would be to bind and stabilise PT. 
The putative role of Aurip and Iptip Dl could be to bind and stabilise ceramide or MIPC so 
that the C  -hydroxyl or the mannose-OH lies at the membrane surface of the catalytic core in 
order for the transfer to occur. However, comparisons of Aurlp, Iptlp and Sur ip carried out 
by Dickson et. al. have found no shared ceramide recognition domain suggesting that large 
sequence conservation is unnecessary for TMHs to exhibit similar functions [19]. Dl must 
be structurally important for transferase activity due to the high level of conservation. In 
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addition, two mutations in S. cerevisiae Aurip at residues 157 [80] and 158 [81] lie within 
Dl. 
In addition to the domains previously discussed, C. neoformans Aurip was also found to 
contain an ABC transporter domain using both ScanProsite [533-535] and InterProScan 
[510-512] (sequence 200-214, LAFGWMNLLGVVCQL, underlined in blue in Figure 2.1). 
The sequence is situated in a conserved Aurip region midway between Dl and D2. 
Although very similar in this region, other Aurip sequences were not selected as exhibiting 
ABC transporter domains. Prosite has previously recorded 115 false hits [536] thus, it is 
possible that the C. neoformans sequence is too. However, ABC transporter substrates are 
polarised to one domain of the molecule and ceramide has been implicated as a putative 
ABC transporter substrate (see section 1.6.2). Furthermore, AbA 33 is an ABC transporter 
substrate (see section 1.7.4.1) and this sequence is centrally located within the region thought 
to be an AbA binding domain, indicated by the number of AbA resistant mutants generated 
herein. This region encompassing Dl and D2 could bind and stabilise ceramide and possibly 
P1 in a manner similar to ABC transporters. This would also explain why AbA is a potent 
Aur lp inhibitor. The reason for the differing structure activity relationship of AbA towards 
antifungal activity (Aurip inhibition) and multi drug resistance modulation (ABC transporter 
substrate) may be due to the fact that Aurip sequences in this region differ slightly to an 
ABC transporter domain sequence. 
2.1.2 N- and C- Termini 
In contrast to the central region of Aur I  sequences, the N-termini (70-100 amino acids) and 
the C-termini (90-150 amino acids) differ both in sequence and in length. However, Aurlp 
activity is impaired when the C-terminus is deleted by a frame shift mutation in S. cerevisiae 
and S. poinbe [79]. Furthermore, two temperature sensitive mutations in the S. pombe A URJ 
gene [82] have been localised to the C-terminus [83]. This evidence conflicts with the poor 
homology found in this region indicating that these regions may be important in species 
specific expression, processing or transport of the proteins [83]. Analysis of post 
translational modification patterns has found both the N- and C-termini to be rich sources 
(see Figure 2.3). Although the sequence similarity is poor, certain post translational 
modification patterns, such as phosphorylation sites, are conserved and may be involved in 
Aurip activation. 
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2.2 Post Translational Modification Prediction 
Post translational modification analysis of Aurip and Iptip was conducted by searching for 
post translational modification patterns using ScanProsite [533-535], PredictProtein [537] 
and searches that target specific modifications [538]. Due to the short length of the patterns 
many of the sequences occur by chance [539] and, although a large range of modification 
patterns were observed (Figure 2.3 and Table 2.2), not all are biologically relevant to Aurip 
and Iptip. 
2.2.1 N-Glycosylation 
The presence of an N-glycosylation site (denoted by a yellow block in Figure 2.3) is 
predicted by the consensus pattern N-x-S/T-x, where x is any amino acid other than proline 
[540]. This sequence alone is not sufficient to confer the glycosylation of the asparagine 
residue as protein folding is an important regulating factor [541]. 
Some of the Aurip sequences have multiple N-glycosylation patterns and could be multiply 
glycosylated. Upstream of Dl, but still in the central region is the consensus sequence, MS 
or NLS (denoted by ±-H- in Figure 2.1 and Figure 2.3), which due to its conserved nature has 
a greater probability of being a genuine N-glycosylation site. That B. thetaiotaomicron does 
not contain an N-glycosylation pattern within its Aurip sequence is not surprising as 
Bacteroides are gram negative bacteria that live in the human intestine [542, 543]. In 
support of Aurip N-glycosylation, LPPs also contain a conserved N-glycosylation site, 
thought to be localised to a lumenal hydrophilic loop [530]. Experimental evidence suggests 
that LPP-1 [544], LPP-3 [545] and Dri42 [546] are functionally glycosylated. 
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Aurlo Bc (86) I IAI FSLS I SQAPGPLMKTGAATLLMLALLMPVTRQFFLPVLPIFTWLVFFFNARFIP- - -AEYRP}IIWVKVLPALENI FYGAN------ 
AurAp An (87) IVGIFS! 	iPGPLGKTAIFSMLLFSLLIPMTRQFFLPFLPIAGWLLFFYACQFIP --- SDWRPAIWVRVLPALENI LYGAN------ 
Aurip Af (87) IVGIPST SPGPLAKTAAFTLLLVSLLLPITRQFFLPFLPIAGWLIFFYAC.FIP---SDWRPAIWVRVLPALENILYGAN------ 
Aurlp? Nc (84) GFILFSLFILPS-APIIKTAVLLALGGLLLMPITQQFFLPSLPIWTYLLYFFASRFIA---PEYRPHIWVKVLPALENVLyGAN------
Aurip Sp (52) GNLIFACIVIESPGFWGKFGIACLLALkLTVPLTRQIFFPAIVIITWAILFYSCRFIP --- ERWRPPIWvRvLPTLENILYGSN ------ 
Aurip Ca (65) VSILFFVFWFPASFFIKLPIILAFATCFLIPLTSQFFLPALPVFTWLALYFTCAKIP --- QEWKPAITVKVLPAI1ETILYGt)N ------
Ipclp Cg (53) SMIL1YSYF/NPLPFIVKTLIAI1ILMTLF'VVPMTSQFFFNALPILTWLILYFTSSHIP---NSHRPSISVEV1PAIETILYGN------
Ipclp Ch (70) LCASYSLYIMTiPPFPLKLGIPIAYIAAVIFPITSQFVWPATPIFAWLITFFSARFIP --- SGRRpEIHVALLpALEsvLyGAN ------ 
Aurip? Bt (15) ALFLi,LTAACILRSEHLLMAALYLVLFFAGLPRKLAVALLPFAIFGISYDWMR1I CP--- NYEVNPIDVAGI,YNLEKSLFGVMDNGVLV  
Iptlp Sc (87) TSKLPFWS 1SSSAFLLVFLICiPi'.\IWYYIYYIKHVNYNLLEWFANIFHYPCKRKQRPIQKFFRIFIPFALpLFTFvILI HF---- 
Consensus (91) 	LFSL II S GFLIK Al L LL LLIPITRQFFIJPALPI TWLI FF RFIP 	JJWRP I VKVLPALE ILYGAN 
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++ * 	190 	Dl ** 210 	220 	230 	240 	250 	260 	D2 
Aurip Sc (133) -LSDILA'lSTN ILAWLPYGLFHFGAPFVVAAILFVFGPPTVLQGYAFAFGYMNLFGVIMQNVFPAAPPWYFI Y LQS --- 1qYDM 
Aurlp Bc (167) - ISNILSAI-IQYVVLDVLAWLPYGILHFGGPFVWAALMFLFGPPGTVPVFARTFGYLNI IGVAIQLIFPCSPPWYEN! { LAP- - - ANYSM  
AurAp An (168) - ISNILSAHQNVVLDVLAWLPYGICHYGAPFVCSLIMFIFGPPGTVPLFAR1FGYISMTAVTIQLFFPCSPPWYENRY LAP- - - ADYS 1 
Aurip At (168) - ISNILSAHQNVVLDVLAWLPYGICHYGAPFVCSAIMFIFGPPGTVPLFARTFGYIsMAAvTIQLF'FPCSPPWYEN! Y LAP- - -ADYSM 
Aurlp? Nc (164) -LSNILSAJ-ISHPVLDLLAWFPYGIGHFALPAICSAILFLFAAPGSTPVFARAFGYMCMLAVTIQLIFPCTPPWYEKAH LEP --- ABY M 
Aurlp Sp (133) -LSSLLSKTTH ILAWVPYGVMHYSAPFIISFILFIFAPPGTLPVWARTFGYMNLFGVLIQMAFPCSPPwYENr1z LEP --- ATYAV 
Aurip Ca (146) -LSNVLAIITTGVL.TLWLPYGIIHFSFPFVLAAIIFLFGPPTALRSFGFAFGYMNLLGVLIQMAFPAAP YHNLH LEP --- ANYSM 
Ipclp Cg (134) - LSEILAAWQN ILAWIPYGLFHFGAPFVVAIVLFIFGPPTVLQGYAFAFGYVNLFGVLFQNIFPAAA Y THY LQV --- ANYSI 
Ipclp Cn (151) - ISDLQ!'RYTNAFL VW\WLPYGVLHFTLPFVVAVILWSLGPRGAVQFWGLAFGWMNLLGVVCQLLFPAAA YET 1H LU  --- UYSM 
Aurip? Bt (102) 	YAHHWAVA VF:GIFY-LCWVPVPILFGLCLYFKKERKTYLRFALFLFVNLIGFAGYYIHPAAP. YAINY EP ---- ILtJT 
Iptlp Sc (173) AYQSI ANFTKTK LLWI- VILHLTAP1LTAVYLYVFQPPGTLKCFSFALGLQNIAGVLTHLLVPMASPWFTHLY IDDTEHYNYTQ 
Consensus (181) LS ILSAH VLDVLAWLPYGI HFGAPFV A ILFIFGPPGTL FA AFGYMNL GVLIQLIFP APPWYE LYGL P A YSM 
Domains 	 DhhAWxxYxxxHxxxP 	 YXX 
271 D2 	280 	 * 	300 D3 	310 	320 	330 	340 D4 ^ 350 	360 
Aurip Sc (219) H SPG' ARIDKLLGINNYTTAFSNSVT G F iSGCATMEALFFCYCFPKL--KPLFIAYVCWLWWSTMYLTHHYFVDLMA SVLS 
Aurip Bc (253) E SPA AIDLLFGFDMYTTNFTASPL,V G F 	SGNAVLEALFMSHCFPKL--RPFVIGYAMWMWWATMYLSHHYAVDLVA GFILA 
AurAp An (254) Q PA AIDKLFGIDLYTSVFHQSPVV G F AADSTLAALFMSHVFPRM--KPVFVTYTLWMWWATMYLSHHYAVDLVA GLLA 
Aurip Af (254) P NPA AIDELFGIDLYTSGFRQSPVV G F 	AADSTLAALFMSQVFPRL--KPLFVIYTLWMWWATMYLSHHYAVDLVC GLJLA 
Aurlp? Nc (250) E SPA AIDKLFGVDMYTTFTTAPLP G F GANAVLEALFMQYYFPKF--KYPFIFYVGWIWWATMYLNHHYAVDLV GLJMA 
Aurip Sp (219) R SPG A IDALFGTSIYTDGFSNSPVV G F 	AGWAMLEALFLSHVFPRY--RFCFYGYVLWLCWCTMYLTHHYFVDLV MCLA 
Aurlp Ca (232) H SPG GIDKLLGVDMYTTGFSNSSII G F SGCCIMEVLFLCWLFPRF--KFVWVTYSWLWWSTMYLTHHYFVDLJC; lUlLS 
Ipclp Cg (220) K MPG 	rJL[,GVNLYSSGFKNSAVV G F 	SACATMEALFFSYCFPSL--TPLFIFYVWWLWWSTMYLTHHYFVDLrJ\ L;VLA 
Ipclp Cn (237) A SPG M I RVFHSSGYTNAFGAPLV G F SGCAVMEALFLSHFFPSL--KGLYWGYVGVLWWATMYLSHHYLIDLV ACLS 
Aurip? Bt (187) p NVA 	EIFGV 	SIYGRNANVA V 	iAAYMVVALVYAIIGKCRWYVIALFSVIMAGIWGTATYSCHHYIIDVLL ISCA 
Iptlp Sc (262) E FAA I ViSH1GTHLNTKGFHMSPIVVGAVPSLHSAIAFQCFLFLVSRDGFIP-KFWAILYIILQWWATMLDHft'RFDLFVGVLYA 
A 
Consensus (271) GSPAGLARID LFGV LYTSGF NSPVVFGAFPSLHSA AVLEALFLSH FPRL K LFI YV WLWWATMYLSHHY VDLVGGGLrJA 
Domains 	xGxxxGLxxD 	 FGAxP. 	 YxxxxxWxI MYLxH -Yxx LxxGxxxn 
LLP Domains 
	
C2 :nxP5U:in C3 : hxxnxnPbxxxxh4xx bxxnxxxn 
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361 	370 	380 	390 	400 	410 	420 	430 	440 450 
Aurlp Sc (307) YVIFQYTKYTHLPIVDTSLFCRWY 	KYDI PLA-----ADSNDIES------------------------------------- 
Aurip Bc  AIAFYIISKTNFLPRIQADKMFRWDYDYVERGDAP ----------------------------------------------------- TGI 
AurAp An  AIAFYFAKTRFLPRVQLDKw1"fvGE------------------------------------------------------- 
Aurlp Af (342) TVAFYFAKTRFMPRVQNDMFRWDYDYV4GDU---------------------------------------------------- 
Aurlp? Nc (338) *IAYYISRVRWLPRPQLEKRftR%YEY EFGDRIP- --------------------------------------------- 
Aurlp Sp  IJCFVFAQKLRLPQLQTGKIL 	IHGGLSEKTSN ----------------------------------------------- -SLA 
Aurlp Ca (320) T 	FTKYKYLPKNKEGLFCPV____ EKIDIQEIDPLSYNYIPVNSNDNESRLYTRVYQESQVSPPQRAETpEAFEMSNFSRSRQssK 
Ipclp Cg  Y IFQYTKYTHLPIVDPNLLFRW YSS1EFYDVKNNpLS ----- I 	IES -------------------------------------- 
Ipclp Cn (325) VLVFYLCMPEGPKDVDQIOW[EAVEGDGYEMIGGPRJTIDLDEEIRKLEE ---------------------------------- QGE 
Aurlp? Bt (277) ILGWLFFEYGLMKIRGFjJJFFDRYYYIL ------------------------------------------------------------- 
Iptip Sc (472) $ITSFIIINWFVLQPKVLKKWIHIPLCDKVD 
Consensus (361) 
541 
Aurip Sc (355) 
Aurip Bc (378) 
AurAp An (378) 
Aurip? Af (378) 
Aurip Nc (382) 
Aurip Sp (350) 
Aurip Ca (410) 
Ipclp Cg (356) 
Ipclp Ch (381) 
Aurip? Bt (306) 
Iptlp Sc (505) 
I F F K LP V K RWDYDYVE D 
451 	460 	470 	480 	490 	500 	510 	520 	530 
--VPT ____TDFDLNMTDEP-----------SVSP 	G-STSVSRSSATSITSLGVKRA----------------------------- 
YEYGLAVLDQDFRHD 	WTMGSSSSFSSGSR ENG- 	GDTLASQA 	LSEVIVR-------------------------- 
YGYGAAGYDGDFNLDS-DEWTVGSSSSVSSGSFT 	DH--YswEITsPH SGRHTFSP------------------------- 
CYGPASFEGEFNLDS-DEWTVGSSSSISSGSLJ I)H--Y'W 	SPSGRHF---------------------------- 
LSAGLGLLER 	-IEWTLGSS 	ST 	TVCG- - SSSSTPD I LSPTDFKHVVLGLTPQGDIWNGGRL8ARESELSDVVVLS 
RTGSPYLL RDSFTQ'PNAVAFMSGLNNMELANWSV- GPLPSPA DLIDRPASTTS 	kSHLP---------------- 
TQVPLSNTQVS:.INEEDEELEGDEISSSTP 	D-EQGSTYAASSA 	LDSKRN -------------------------- 
--IPLNTIELDTEEVFNIEREK --------- SRTPELSHA-VSSSSLANGRSQTYPNTGNTFKSKTRLSKLVI ----------------- 
ALFEQVIGDEE 	 GNSGAGGNLSGNjSSDSADSGRG GKGKGKGKQTAKKPKAKEQRS 	TKVMGEGAQVASENSS----- 
---FRTEMkVFCG 	FFDILA---------------------------------------------------------------- 
Consensus (451) 	 LE D 	S E 	S 	S SP 	S 	AS T 
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Figure 2.3: Amino Acid Sequence Alignment of Aurip and Related Proteins: Possible Post Translational Modification Patterns, Signal 
Sequence Predictions and Putative PEST Sequences 
Unless stated post translation modification patterns were found using ScanProsite [533-535] and PredictProtem [537]. Due to overlapping post translational 
modification patterns, various highlighting methods are employed: blocks of colour, boxes and underlining. Blocks of colour: yellow, N-glycosylation pattern, the 
conserved putative N-glycosylation site is denoted by +++; orange, myristoylation pattern; pink, protein kinase C phosphorylation pattern; green, casein kinase II 
phosphorylation pattern; turquoise, cAMP and cGMP phosphorylation pattern; red, tyrosine kinase phosphorylation pattern; grey, prokaryotic membrane lipoprotein 
attachment site. Boxes: green, casein kinase II phosphorylation pattern; turquoise, cAMP and cGMP phosphorylation pattern; orange, cell attachment sequence (RGD); 
dark green, tyrosine sulfonation pattern; blue, residues that could possibly be acetylated [538]; purple, patterns discussed by Aeed et. al. [501] thought to be frequently 
involved in protein-protein interactions; yellow, patterns similar to those discussed by Aeed et. al. [501]. Underlined: orange, myristoylation pattern; pink, protein 
kinase C phosphorylation pattern; grey, amidation site; red, possible PEST sequences, thought to be a target for rapid proteolytic degradation, predicted using 
PESTfind [103, 547] with a score above zero, both the first and second putative PEST sequences in S. cerevisiae Ipt ip are localised in the 124 amino acid hydrophilic 
loop that is omitted from the S. cerevisiae Ipt Ip sequence (residues 313-433) denoted by A; dark brown, hydrophobic region of the signal peptide or signal anchor 
with a score above 0.2 predicted by SignalP 3.0 [548-550] when the cut off is 70 amino acids; light brown, hydrophobic region of the signal anchor with a score above 
0.2 predicted by SignalP 3.0 when the cut off is 125 amino acids, hydrophobic regions denoted by dark brown underlining also feature in the 125 amino acid cut off 
prediction; dark brown double underlined, signal peptide cleavage site predicted by SignalP3.0 resides between the two underlined residues. 
Note: Almost all cited patterns occur frequently and not all patterns are biologically relevant to Aurip and Iptip. It is highly probable that the myristoylation patterns, 
cell attachment sequences, amidation site and tyrosine sulfonation patterns occur by chance and are not post translationally modified. 
Sequence similarity is denoted by coloured text: red text, identical residues conserved in all sequences; blue text, consensus derived from identical residues in at least 
50% of sequences; green text, consensus derived from similar residues; grey text, residue weakly similar to consensus; black text, residues dissimilar. The remaining 
annotations and abbreviations are as described in Figure 2.1. 
SignaiP 3.0 Signal sequence prediction 
















Protein 	Species 	Accession 
Number 
NetAceti .0 
Acetylation prediction 	PESTfind Score 
(probability) 
Rachel Breen 	 Chapter 2: Bioinformatic Analysis 	 Page 66 
Aurlp S. cerevisiae P36107 0.000 0.808 0.000 0.673 
Aurlp B. cinerea - 0.000 0.000 0.000 0.993 
AurAp A. nidulans Q9Y744 0.001 0.016 0.000 0.992 
Aurip A.fumigatus Q9Y745 0.000 0.004 0.000 0.899 
Aurlp? N. crassa Q7S586 0.000 0.000 0.000 0.968 
Aurlp S. pombe Q10142 0.002 0.805 0.001 0.929 
Aurip 	C. albicans 	013332 	0.001 	0.000 	0.000 	0.743 
I-A (0.476) No +6.13 (341-387) Yes 
3-T (0.489) No +5.28 (1-17) Yes, 
+6.39 (410440) Yes 
3-T (0.504) Yes +1.11 (363415) No 
2-T (0.482) No, 3-T (0.495) No +2.87 (363415) No 
- +9.03 (413438) Yes 
1-S (0.503) Yes, 2-A (0.487) No +4.96 (385407) No 
1-A (0.478) No, 2-S (0.507) Yes, 
+12.87 (409-469) Yes 3-S (0.508) Yes 
lpclp C. glabrata Q9Y797 0.068 0.720 	0.017 	0.899 3-G (0.465) No 	+1.25 (341-373) No 
Ipclp C. neoformans Q9Y7AI 0. 839 
(0.184;33-34) 0.001 	 0.938 
0.048 
(0.010;33-34) 1-S (0.517) Yes, 2-A, (0.475) No +5.06 (359-373) Yes 
Aurlp'? B. theiaioiaomicron Q8A7K2 0. 906 
(0.591;23-24) - 	
0.846 	
- (0.554;23-24)  
3-G (0.457) No 	-16.35 (167-195) No 
Iptlp S.cerevisiae P38954 0.003 0.003 	0.000 	0.739 1-13.21 (337-377) Yes - 
+8.40 (377-392) Yes 
Table 2.2: Possibility of Signal Sequences, N-Acetylation Modification and PEST Sequences Occurring in Aurip and Related Proteins 
Signal Sequence prediction using the hidden Markov model [548-550]: (x; y-z), x probability that the signal peptide cleavage site occurs between residue y and residue 
z. Acetylation prediction [538]: x-y (z), z probability that amino acid residue y at position x is acetylated; position x is based on methionine cleavage; -, No S, T, A or 
G residues at positions 1-3. As B. theiaiotaomicron Aurip has a predicted signal peptide, the mature protein after cleavage was used as the input sequence. Only those 
with a probability above 0.500 are thought to be biologically relevant, denoted by Yes. PEST sequence prediction: x(y-z), PESTfind [103, 547] score x for sequence 
between residue y and residue z. Scores x range from -50 to +50. PESTfind scores above zero denote possible PEST sequences but only scores above +5 are thought 
to be biologically relevant, denoted by Yes. Primary accession numbers were obtained from the Swiss-Prot database. 
Rachel Breen 	 Chapter 2: Bioinformatic Analysis 	 Page 67 
2.2.2 Phosphorylation 
Aurip and Iptip sequences contain a number of patterns that correspond to either serine or 
threonine phosphorylation sites [Protein kinase C phosphorylation sites (S/T-x-R/K where x 
is any amino acid [551], denoted by a pink block of colour or pink underlining in Figure 
2.3); Casein kinase H phosphorylation sites (SiT-x2-D/E [552], denoted by a green block of 
colour or a green box in Figure 2.3); cAMP and cGMP protein kinase phosphorylation sites 
(R/K(2)-x-SIT [553], denoted by a turquoise block of colour or a turquoise box in Figure 
2.3)] or tyrosine phosphorylation sites [Tyrosine kinase phosphorylation sites (RIK-x2-D/E-
x3-Y or RJK-x3-D/E-x2-Y [554], denoted by a red block of colour in Figure 2.3)]. As the 
patterns are short, there is a significant possibility that they occur by chance. The presence 
of phosphorylation patterns can only really strengthen experimental evidence rather than 
predict protein phosphorylation [539]. However, the fact that the majority of the Aur ip 
phosphorylation patterns are clustered on the N- or C-termini and that a number of the 
patterns are conserved suggests they could be genuine phosphorylation sites. LPPs also have 
several predicted phosphorylation sites on their cytosolic N- and C-termini [530]. Although 
no direct evidence is available to demonstrate Aurip or LPPs are regulated by 
phosphorylation, evidence has been provided by Waggoner et. al. that indicates LPPs are 
phosphoproteins [555]. 
2.2.3 	Covalent lipid modification 
Three covalent lipid modifications, prenylation, myristoylation and palmitoylation, are 
known to anchor proteins to the cytosolic face of membranes [556]. Prenylation describes 
the addition of isoprenoid compounds, derived from the sterol biosynthetic pathway, to a C-
terminal cysteine. Patterns that indicate potential prenylation sites [557] do not exist in 
Aurlp and Iptip sequences. 
Myristoylation describes the attachment of myristate, a C 14 saturated fatty acid, to an N-
terminal glycine via an amide linkage [558, 559]. The myristoylation pattern [560] (denoted 
by an orange block of colour or orange underlining in Figure 2.3) is present and conserved in 
all Aurip sequences. However, all predicted myristoylation sites are internal. Internal sites 
could be covalently modified if proteolytic processing and signal sequence cleavage exposed 
the glycine as N-terminal in the mature protein [560]. Aurl p and Ipt lp are predicted to have 
signal anchors rather than signal peptides containing cleavage sites (see section 2.3). 
Furthermore, the conserved patterns are situated within conserved domains D2, D3 and D4, 
as well as just upstream of D2 and the putative N-glycosylation site. Myristoylation is 
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unique to eukaryotes [539] and some of the conserved patterns are also present in the B. 
thetaiotaomicron Aurip sequence. These observations indicate that the myristoylation 
patterns in Aurip and Iptip are not genuine. 
Palmitoylation, also known as S-acylation and thioacylation, is the only reversible covalent 
lipid modification and the least understood of the three. It occurs in a wide range of protein 
sequences preventing a consensus sequence from being established [556]. Despite this, a 
few common motifs have emerged: integral membrane proteins are frequently modified at 
cysteine residues located next to membrane domains, G-protein subunits are modified at 
cysteine residues close to the N-terminus and dual lipid modification can also occur (e.g. 
palmitoylation at a cysteine adjacent to an N-myristoylated glycine or just upstream of a 
prenylation site) [557]. As Aurip is predicted to have no disulfide bonds [561-563], the free 
cysteine resides could be palmitoylated. 
2.2.4 Additional Modifications 
2.2.4.1 	Acetylation 
N-methionine cleavage and N-acetylation are two of the most abundant post translational 
modifications in eukaryotic proteins [538], although these modifications are known to occur, 
albeit with much lower frequency, in both prokaryotes and archaea [564]. Acetylation of N-
terminal amino acid residues neutralises the N-terminal positive charge and can alter the 
behaviour of the protein with respect to further modifications, stability, interactions and 
function [564]. The Yeast Protein Database [565] states that sequence based methods [566] 
predicted possible N-acetylation modification of S. cerevisiae Aurip. Thus, Aurip 
sequences were analysed for possible N-acetylation using NetAcet 1.0 server [538]. The 
server uses a neural network based method to predict acetyltransferase A mediated 
acetylation. It was developed using a yeast data set and is applicable to both yeast and 
mammalian proteins. A number of the Aurip sequences analysed have the consensus 
residues (S, I, A or G) at positions 1-3, based on methionine cleavage (Table 2.2, denoted by 
blue boxes in Figure 2.3). However, the presence of these residues does not necessarily 
mean the protein is N-acetylated as structure recognition by the acetyltransferase A is also 
thought to play a role. Not all Aurip sequences have a probability above 0.500, the 
threshold for potential modification. In fact of the sequences analysed only A. nidulans, S. 
pombe, C. albicans and C. neoformans Aurlp have a probability above 0.500. 
Rachel Breen 	 Chapter 2: Bioinformaric Analysis 	 Page 69 
	
2.2.4.2 	Amidation 
C-terminal aniidation, in which COOH is replaced with CONH 2, has not yet been observed 
in plants and unicellular organisms. The consensus pattern [567], in this case SGRR (denoted 
by grey underlining in Figure 2.3) only occurs in C. neoformans Aurip. As the species is 
unicellular and the pattern is not C-terminal, the pattern is not genuine. 
2.2.4.3 	Sulfonation 
Like other post translatuhal modifications, tyrosine sulfonation is required for the correct 
processing and biological activity of many proteins [568]. The sulfonation of 
macromolecules, such as glycosaminoglycans and secretory proteins, is catalysed by 
membrane associated tyrosine sulfontransferases, which reside in the trans Golgi [568, 569]. 
Therefore, tyrosine sulfonation is only biologically relevant to proteins that have passed 
through or are localised to the Golgi lumen [570]. The consensus pattern [571-573] (denoted 
by dark green boxes in Figure 2.3) is present in six of the Aurip sequences analysed. 
However, as Aur I  is localised to the medial Golgi [86] and that the patterns reside in the 
putative cytosolic C-termini (see section 2.4), it is highly improbable that Aurip is 
sulfonated. Furthermore, no tyrosine sulfated proteins or enzyme activity that performs such 
modifications has been identified in yeast or prokaryotes [574]. 
2.3 Signal Sequence Prediction 
Aurip sequences were analysed for signal peptides using SignalP 3.0 [548-550] (Table 2.2). 
Although there are a large number of different secretory signals, SignaiP 3.0 has focused on 
the prediction of classical signal peptides, which are cleaved by signal peptidase I. The 
classical structure of signal peptides consists of positively charged N-terminal amino acids 
(n-region) followed by a hydrophobic region (h-region) and a down stream signal peptidase 
cleavage site [575]. Amino acids immediately preceding the cleavage site are referred to as 
the c-region. In eukaryotes signal sequences are thought to target proteins initially to the ER 
for later transport to the secretory pathway [576], whereas prokaryotic signal peptides 
directly target proteins to the cell membrane. 
Both neural networks and hidden Markov models (11MM) [550] were used for the 
predictions. When the input cut off was set to 70 amino acids only C. neoformans and B. 
thetaiotaomicron Aur 1 p  sequences (Figure 2.4) were predicted to have a cleavage site and a 
signal peptide with probabilities of 0.839 and 0.906, respectively (see Table 2.2). The 
Rachel Breen 	 Chapter 2: Bioinformatic Analysis 	 Page 70 
predicted cleavage site for C. neoformans has a low probability (0.184 probability of 
cleavage between residues 33 and 34, denoted by dark brown double underlining in Figure 
2.3) compared to B. thetaiotaomicron (0.591 probability of cleavage between residues 23 
and 24, denoted by dark brown double underlining in Figure 2.3). This indicates that the 
predicted signal peptide in B. thetaiotaomicron is more likely to be genuine. Furthermore, 
the predicted B. thetaiotaomicron Aurip signal peptide sequence coincides with the 
prokaryotic membrane lipoprotein attachment site (denoted by a grey block of colour in 
Figure 2.3) predicted by ScanProsite [533-535]. Prokaryotic membrane lipoproteins are 
expressed with a signal peptidase that is cleaved by signal peptidase II, a specific lipoprotein 
peptidase. The peptidase cleaves upstream of a cysteine residue, which has been modified 
with a glyceride fatty acyl lipid, and is localised to the C-terminal end of the consensus 
pattern [577, 578]. Both SignalP 3.0 and the membrane lipoprotein attachment site predict 











PtPSKKTLTV I VIMLFLLLTAACIGLRSEHLLMAALYLVLFFAGLPTRKLAVALLPFAIFGISY3WMRJ 
0 	 10 	 20 	 30 	 40 	 58 	 60 	 70 
Position 
Figure 2.4: SignaiP 3.0 1548, 5 491 Prediction Plot of B.thetaiotaomicron Aurip 
Hidden Markov Models [550] trained on gram negative bacterial models were used with an input 
threshold of 70 amino acid residues. The first 70 amino acid residues of B. thetaiotaornicron Aurip 
are displayed above the x-axis. The score values represent the probability that the sequence is an n-
region ( 	), an h-region ( 	), a c-region ( 	) or a cleavage site ( 	). Only B. 
thetaiotaomicron Aurlp was predicted to contain a classical signal peptide. All other Aurip 
sequences analysed were predicted to contain signal anchors. They were trained on eukaryotic models 
with input thresholds of both 70 and 125 amino acid residues. 
S. cerevisiae, S. pombe and C. glabrata Aurlp sequences were predicted to contain a peptide 
anchor using 11MM prediction, with probabilities of 0.808, 0.805 and 0.720, respectively 
(Table 2.2). When the input cut off was extended to 125 amino acids all Aurlp sequences 
except B. thetaiotaomicron Aurip were predicted to contain a peptide anchor. It is also 
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worth noting that the probability that C. neoformans Aurip signal peptide has a cleavage site 
was reduced to 0.010. Signal anchors do not contain a cleavage site and thus, remain 
uncleaved. The h-region of the signal or anchor peptide (denoted in Figure 2.3 by dark or 
light brown underlining if predicted with the 70 or 125 amino acid cut off, respectively) 
corresponds to the predicted TMHs (see section 2.4). Whether an anchor sequence was 
predicted within the initial 70 amino acid cut off threshold depended upon whether the first 
predicted TMH had started and finished within the first 70 amino acids. This suggests that 
the signal anchor prediction selects any hydrophobic regions (e.g. TMHs) that occur within 
the amino acid cut off limit and cannot determine if the signalling anchors are genuine. 
Further similarities between Aurip and other phosphatases are indicated by reports that LPPs 
[530] (membrane proteins), chloroperoxidase [526] (a secretory protein) and glucose-6-
phosphatase [520] (an ER protein) contain no obvious traditional or classical pre-protein 
leader sequence and targeting mechanisms remain unknown. This could be explained by 
proposals put forward by Kelly [579] and Rothman [580]. Both have proposed that proteins 
destined for secretion or the plasma membrane move passively with lipid bulk flow while 
those that require regulated secretion or intracellular membrane retention contain signal 
sequences that remove them from the bulk flow. It is possible that the anchor peptides in 
Aurlp sequences act as membrane retention sequences instructing the organelle, in this case 
the Golgi, to retain the protein in its membrane preventing further passage along the 
secretory pathway. This hypothesis is supported by results provided by Machamer and Rose 
[581]. They have shown that the first TMH of the membranous glycoprotein, Coronavirus 
El, contains a Golgi retention signal. This signal, like a putative Aur 1 p  anchor signal, could 
either be an active signalling peptide sequence, where the sequence is recognised by other 
proteins or lipids that are retained in the Golgi or the retention could be passive. Passive 
retention would result from steric hindrance in that the structural properties of the protein 
would prevent incorporation into bulk flow mechanisms, such as transport vesicles. 
Furthermore, proteins that have multiple TMIHs, such as Aurip, have been shown by site 
directed mutagenesis and in vitro membrane insertion studies to Contain more than one signal 
peptide anchor [582, 583]. As the first two TMHs in Aurlp (see section 2.4) do not contain 
any of the four conserved domains (Dl -4) thought to be involved in the catalytic function of 
Aurlp, it is possible that one or both of these TMHs act as or contain an active or passive 
anchor that would retain Aurip in the medial Golgi membrane. 
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2.4 Structure Prediction 
Hydrophobicity profiling and secondary structure prediction of Aurip sequences were 
conducted using TMHMM versions one and two [584, 585] (Figure 2.5). TMHMIM uses a 
hidden Markov model and is thought to be one of the best methods for predicting TM}Is 
[539, 5861. The most common inaccuracy with TMHMM is the reversal of orientation with 
TMH. Experiments conducted by Levine et. al. have identified that S. cerevisiae Aurip has 
a cytoplasmic C-terminus, with the active site localised to the Golgi lumen [86]. Hence, at 
least one TMIH must reside between D4 and the C-terminus. For Aurip to be glycosylated 
(see Chapter 3.2) the membrane topology must be restricted so that the glycosylation pattern 
resides in the Golgi lumen [530]. Thus, the TMHMM prediction profiles in Figure 2.5 were 
analysed for correlation to experimental data (Table 2.3). 
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Figure 2.5: Hydrophobicity Profiles of Aurip and Related Proteins Predicted by 
TMHMM Versions 1 and 2 1584, 5851 
# Amino acid sequence alignment residues (x-axis values) have been adjusted by removing gaps in the 
central conserved section (see Figure 2.1) caused by Aurip Bt or Iptip Sc. 
Predicted TMHs are depicted by thick lines; TMH predicted by both Versions 1 and 2 ( 	), 
Version 1 only ( 	) or Version 2 only ( 	). Predicted hydrophilic loops are depicted by thin 
lines: loops predicted to reside inside ( 	) or outside ( 	) the cytoplasm with a probability ~t 
0.7; loops that may possibly reside inside ( ) or outside ( ) the cytoplasm with a 
probability < 0.7; either Versions 1 and 2 disagree or the probability that the loop resides inside or 
outside the cytoplasm is approximately 0.5 ( 	). As S. cerevisiae Aurlp has been localised to the 
Golgi apparatus [86], outside the cytoplasm would correspond to inside the Golgi lumen for all Aurlp 
except B. thetaiotaomicron Aurip, which would correspond to inside the periplasmic space. 124 
amino acids predicted to reside in a hydrophilic loop inside the cytoplasm are omitted from the S. 
cerevisiae Iptlp sequence (residues 313-436) denoted by A. The conserved domains (Dl-4) are 
highlighted ( 	). Potentially important amino acid residues are depicted by diamonds: putative 
catalytic triad residues Histidine ( ) and Aspartate (+); putative N-glycosylation site (+); one amino 
acid mutations, which render A UR 1 resistant to AbA (•). Abbreviations and Primary Accession 
Numbers are as described in Figure 2.1. 
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Number Consensus Active site in the Golgi lumen C-terminus 
Protein and Species of N-glycosylation or lumenal end of TM}I in the 
TM}Is motif m the Dl D2 D3 D4 cytoplasm Golgi lumen 
Aurip S. cerevisiae 6 V V V V 9 ? 
Aurip B. cinerea 7/8 TMH V V V 
Aurip A. nidulans 7 TM1HJV V V V 
AurlpA.fimigazus 7/8 TMH/V V V V V V 
Aur 1 p N. crassa 7 V V V V V V 
Aurip S. pombe 6/7 x x V V V V 
Aurip C. albicans 6/7 TMH/V ? V V ? x 
Aur 1 p C. glabrara 6 x x x x V V 
Aurip C. neoformans 6 x x x x V V 
Aurip B. thetaiotaomicron* 7 V V V V V V 
Ipti p S. cerevisiae 8 V V V V V V 
Table 2.3: Correlation of TMHMM Predictions of Aurip and Iptip in Figure 2.5 to 
Experimental Data 
* In the case of B. thetaiotaomicron Aurip, the Golgi lumen would correspond to outside the 
cytoplasm, in the periplasmic space. 
The TMHMIM predictions can be loosely categorised into two groups: those that have three 
putative TMIHs over the 133-134 region and those which have two. The consequence of three 
TMHs within this region is that D4 is localised over two TMHs. When the topology of other 
domains is considered, this prediction better supports current experimental data [86]. It 
appears that the predictions for B. thetaiotaomicron Aur I  and S. cerevisiae Ipt I  are highly 
probable. Although the orientation of the N-terminus is uncertain, the prediction for N. 
crassa Aurip is also highly probable. B. cinerea Aurip (see Figure 2.6 for the TMHMIM 
Version 1 prediction plot) and A. fumigatus Aurip exhibit very similar profiles. In both 
cases, separate TMHs localised to the D4 region predicted by version 1 or 2 overlap giving 
the appearance of one elongated TMH in Figure 2.5. If this is considered, both B. cinerea 
Aurip and A.fumigatus Aurip predictions correlate to experimental data. As the A. nidulans 
Aurl p sequence is so closely related to A. fumigatus Aur Ip, although not predicted by 
TMHMM, it is likely that A. nidulans Aurip also has three TMIHs over the 133-134 region. 
The secondary structure prediction would then support the experimental evidence. With 
respect to the S. pombe Aurip secondary structure prediction, it is only the N-terminal region 
which does not correlate to experimental data. The predicted Th4H close to Dl appears 
elongated due to versions 1 and 2 giving different predictions. if this TMH was in fact two 
TMHs, the prediction would support experimental evidence. 
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The predictions with two TMHs over the D3-D4 region exhibit two main problems: S. 
cerevisiae Aurip (see Figure 2.8 for the TMHMM Version 1 prediction plot) and C. albicans 
Aur I  do not have a TMH between D4 and the C-terminus; the orientation of C. glabrata 
and C. neoformans Aurip sequences between the N-terminus and D4 do not correlate with 
experimental data. In order to gain predictions with increased accuracy, B. cinerea and S. 
cerevisiae Aur I  sequences were analysed further using a number of prediction methods 
(Figure 2.7 and Figure 2.9, respectively). In addition to TMHMM [584, 585], TopPred [587, 
588], TMpred [589], SOSUT [590-593], MEMSTAT2 [594, 595], PHDhtm [596-598] and 
PSIPRED [599] analysis was carried out. Each program conducts predictions by a slightly 
different method: as previously stated, TMHMM uses a hidden Markov model; TopPred 
[587, 588] uses a G. Von Heijne algorithm based on a Goldman-Engelman-Steiz 
hydrophobicity scale [600]; TMpred [589] uses an algorithm based on the statistical analysis 
of TMbase, a database of naturally occurring transmembrane proteins; SOSUI [590-593] 
indexes amino acids with regards to Kyte and Dolittle hydrophobicity [601] and charge 
[592]; MEMSTAT2 [594, 595] accessed through the PSIPRED server [602] uses a novel 
algorithm based on the statistical analysis of well characterised membrane proteins; PHDhtm 
[596-598] is based on neural networks, the input is collated either through the PredictProtein 
server [537] by BLASTP [502, 503] and Maxilom multiple sequence alignment [603] or 
through the Network Protein Sequence Analysis server [604] by BLASTP [502, 503] and 
ClustaIW multiple sequence alignment [605]; PSIPRED [599] uses the average output from 
four neural networks using Position Specific Iterated-BLAST (PSI-BLAST) [503] as input. 
PSIPRED differs from the other methods in that it predicts secondary structure such as 
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Figure 2.6: TM}IMM Version 11584,  5851 Prediction Plot of B. cinerea Aurip 
Orientation: Inside, cytoplasm; Outside, Golgi lumen 
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Figure 2.7: Hydrophobicity Profile and Secondary Structure Prediction of B. cinerea 
Aurip using Various Methods 
Predicted TMHs are depicted by thick lines; Methods predict TMH is certain ( 	) or putative 
( 	). Predicted hydrophilic loops are depicted by thin lines; either no prediction of locality is 
made (. 	) or loops are predicted to reside inside ( 	) or outside ( 	) the cytoplasm. The 
TMHMM method indicates probability of loop locality; in this case all predictions have a probability 
>0.7. As S. cerevisiae Aurip has been localised to the Golgi apparatus [86], outside the cytoplasm 
would correspond to inside the Golgi lumen. The PSIPRED methods predicts secondary structure; 
helix ( 	), strand  ( 	) or coil ( 	). The conserved domains (131-4) are highlighted 
( 	). Potentially important amino acid residues are depicted by diamonds: putative catalytic triad 
residues Histidine ( ) and Aspartate (•); putative N-glycosylation site (•); one amino acid mutations, 
which render AURJ resistant to AbA (•). Methods: TM}IMM Versions 1 and 2 [584, 585]; TopPred 
[587, 588] predicts two possible structures, prediction 1 and 2; TMpred [589] predicts a strongly 
preferred model, prediction 1, and an alternative model, prediction 2, core TM}I residues are also 
indicated for each model, Core 1 and 2, respectively; SOSUI Version 1.0 [590-593]; MEMSAT2 
[594, 595]; PHDhtm Version 8.94_69 [596-598] accessed through both the NPS@ server [604] and 
the ProteinPredict server [537]; PSIPRED V2.3 [599]. 
Number Consensus Active site in the Golgi lumen C-temiinus 
Prediction Method of N-glycosylation 
or lumenal end of TMH in the 
TMHs pattern in the Dl D2 D3 D4 cytoplasm Golgi lumen 
TMHMM Version 1 8 TMH  
TMHMM Version 2 8 TMH / / V V / 
TopPred 6 V V x / x 
TMpred prediction 1 V v 
TMpred prediction 2 6 X x / V V V 
MEMSTAT2 8 / / V V V / 
PHDhtm (NPS) 7 V / V V / / 
PHDhtm (PredictProtem) 8 TMHI/ / / x / / 
Table 2.4: Correlation of B. cinerea Aurip Secondary Structure Prediction in Figure 
2.6 to Experimental Data 
SOSUI and PSIPRED were excluded as the experimental evidence is based on locality and both 
methods do not give any indication of membrane topology. 
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The topology of the TMHs does not correlate with experimental data when only six B. 
cinerea Aurip TMHs have been predicted (TopPred and TMpred prediction 2). The 
remaining methods have predicted structures that agree with experimental evidence except 
for the PHDhtm (PredictProtein) method, in which the position of helix f (see Figure 2.6 and 
Figure 2.7) is predicted to be slightly upstream and thus, affects the topology of D3. The 
consensus prediction, which agrees, with both the TMHMM predictions and the literature 
[86] is that the C-terminus resides in the cytoplasm and the active site is in the Golgi lumen. 
The predictions also indicate that B. cinerea Aurip has either seven or eight helices with 
helix c being in question. The orientation of helices d-h is agreed between the main models. 
It is the orientation of helices a-c, and in fact whether c exists at all, that remains uncertain. 
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Figure 2.8: TMHMM Version 11584, 5851 Prediction Plot of S. cerevisiae Aurip 
Orientation: Inside, cytoplasm Outside, Golgi lumen 
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Figure 2.9: Hydrophobicity Profile and Secondary Structure Prediction of S. cerevisiae 
Aurip using Various Methods 
Refer to Figure 2.7 for a description of the annotations. The TopPred method predicts two possible 
structures for S. cerevisiae Aurlp. The TMHMM method indicates probability of loop locality: Loops 
predicted to reside inside ( 	) or outside ( 	) the cytoplasm with a probability —>0.7; loops 
that may possibly reside inside ( 	) the cytoplasm with a probability < 0.7; the probability that 








pattern in the 
Golgi lumen 
Active site in the Golgi lumen 
or lumenal end of TMH 




TMHMM Version 1 6 / / 
TMHMM Version 2 6 / / V V ? ? 
TopPred prediction 1 5 x x / x / x 
TopPred prediction 2 6 X X X / X V 
TMpred prediction 1 5 X X / V V x 
TMpred prediction 2 4 X x / V V x 
MEMSTAT2 8 V / V V V V 
PHDhtm (NPS) 7 V V 
PHDhtm 
7 V / V 
(PredictProtein) 
Table 2.5: Correlation of S. cerevisiae Aurip Secondary Structure Prediction in Figure 
2.9 to Experimental Data 
SOSIJI and PSIPRED were excluded as the experimental evidence is based on locality and both 
methods do not give any indication of membrane topology. 
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The TopPred and TMpred prediction methods are in agreement with TMHMM for S. 
cerevisiae Aurlp, predicting the presence of only two TMHs over the 133-134 region. This 
prediction does not correlate well with experimental data as D4 and the C-terminus appear to 
reside on the same side of the membrane. However, as can be seen in the TMBTvIM version 
1 prediction plot of S. cerevisiae Aurlp (Figure 2.8), TMH prediction in the D3-D4 region is 
difficult due to the relatively steady hydrophobicity profile of the sequence. Based on 
experimental evidence that the active site is localised to the Golgi lumen and the C-terminus 
to the cytoplasm [86], the last three prediction methods appear to offer more accurate 
profiles. As is the case with the PHDhtm (PredictProtein) B. cinerea Aurip prediction, the 
last three TMHs predicted in S. cerevisiae Aurip are slightly upstream and thus, affect the 
topology of D3. Although S. cerevisiae Aurip has previously been predicted to have five 
TMHs [102], these results indicate seven possibly eight TMHs, with a very similar profile to 
B. cinerea, A.fumigatus, N crassa, S. pombe and B. thetaiotaomicron Aurip. Based on 
these results and that C. albicans, C. glabrata and C. neoformans Aurip TM}IMM 
prediction profiles closely resemble the profile predicted by TMHIvDvI for S. cerevisiae 
Aurip, it is highly likely that C. albicans, C. glabrata and C. neoformans Aurip also have 
seven or eight TMHs. The consensus Aurip secondary structure prediction is summarised in 
Figure 2.10. 
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Figure 2.10: Schematic Helical Wheel Diagram Displaying the Consensus Aurip 
Secondary Structure Prediction Profile 
The number of predicted amino acid residues per TMH ranged between 17 and 25, with 19 and 23 
being the most common. As Aurip is localised to the medial Golgi and not the plasma membrane, the 
consensus profile is based on 19 amino acid residues per TMH. The residues are denoted by lines 
when they are predicted to reside in lengthy hydrophilic loops. Key conserved residues in Dl -134 and 
the consensus N-glycosylation site are shown. Putative catalytic triad residues are in red. Residues 
that possibly stabilise the phosphate transition state via hydrogen bonding are in blue. The conserved 
putative N-glycosylation site is in green. The additional predicted TMH, which may be present in 
some Aurip sequences, is in grey. If it is present the topology from the N-terminus to this TMH 
would be reversed. In the case of B. thetaiotaomicron Aurip, the Golgi lumen would correspond to 
outside the cytoplasm, in the periplasmic space. 
3-D modelling of B. cinerea and S. cerevisiae Aurip was attempted using Swiss-Model 
version 36.0003 [606-608]. The closest related protein to the target sequences, with a crystal 
structure entered in the pdb, was an Acid phosphatase from E. Blattae (Ec 3.1.3.2, 
pdb: 1 D2T, resolution 1 .9A, [6091). C. Inaequalis chloroperoxidase (Ec 1.11.1.10; native 
isoform, pdb: 1 VNC, resolution 2.1 A [531]; recombinant mutant isoform, pdb: 1VNS, 
resolution 1.66 A [610]) was also used as a template. Unfortunately, due to a lack of 
sequence similarity between the pdb structure sequences and the B. cinerea and S. cerevisiae 
Aurlp sequences (Figure 2.11), tertiary structure prediction was not possible. 
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B. cinerea Aurip Target Sequence: 
	
Templates: ld2tA.pdb 	- 	 22% identity 
lvnc_.pdb I 	 - 	35.7% identity over 38 amino acid residues 
lvns_.pdb 	 - 35.7% identity over 38 amino acid residues 
S. cerevisiae Aurip Target Sequence: 
Templates: ld2tA.pdb 	1 - 	 38.1% identity over 22 amino acid residues 
lvnc_.pdb - 	18.9% identity 
Ivns_.pdb 	 - 18.9% identity 
Figure 2.11: Swiss-Model Version 36.0003 1606-6081 Sequence Alignment of Target 
Aurip Sequences and Homology Modelling Templates using AlignMaster 
Target sequences were rejected for either too low similarity to the templates or similarity occurs over 
too short a length to give meaningful results. 
As LPP sequences exhibit an increased sequence similarity with C. Inaequalis 
chioroperoxidase, Waggoner et. al. were able to conduct 3-D homology modelling [530]. 
LPPs have six putative TMHs with the conserved catalytic domains (C 1, C2 and C3) 
localised to the upper right of the structure [530]. This model also correlates with the 
consensus Aurip secondary structure prediction (Figure 2.10), where the conserved domain 
C2, corresponding to D3, is on the fourth TM}I and C3, corresponding to D4, is on the fifth 
TMH. Furthermore, Cl, possibly corresponding to D2, and the putative glycosylated 
asparagine reside within an extracellular hydrophilic loop after the third TMIH. Both the N-
and C-terminus are predicted to be extracellular. 
As shown in the consensus Aurip secondary structure prediction model (Figure 2.10), if 
seven TMHs are present the N-terminus would reside in the Golgi Lumen and the C-
terminus in the cytoplasm; however, if there is an extra TMH (denoted in grey in Figure 
2.10) the topology of the N-terminal TMHs and hydrophilic loops would be reversed, with 
the N-terminus residing in the cytoplasm. The fact that LPP has six putative TMHs and 
Aur lp has seven or eight would also correlate to the signal sequence hypothesis, where LPP 
is passive and is transported with bulk flow to the plasma membrane and the extra TMIH(s) 
in Aur lp could act as a signal anchor(s) retaining Aurip in the medial Golgi membrane. 
This would also explain the difference in the locality of S. cerevisiae Iptip and Aurip N-
terminal TIvI}ls; as Iptip is not localised to the medial Golgi an alternative signalling 
TMH(s) would be required. 
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This consensus Aurlp secondary structure prediction also corresponds to fmdings by 
Huitema et. al. that human SMS I D4 is localised to the Golgi lumen at the start of the last 
TM}l [127] suggesting IPC synthase and SMS may have evolved from a common ancestor. 
Unlike the putative bacterial [PC synthase, B. thetaiotaoinicron Aurip, which appears to 
have retained some of the main Aurip features and is a putative transmembrane protein, 
bacterial SMS identified in P. aeruginosa [129] lacks key mammalian SMS motifs and is 
soluble. This indicates that [PC synthase and SMS have arisen at least twice during 
evolution. 
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Chapter 3: Wild Type IPC Synthase 
3.1 Expression and Purification 
Little work has been carried out on JPC synthase expression and purification. S. cerevisiae 
[PC synthase expression has been studied at both 28°C [442, 500] and 30°C [79, 81], with 
maximal expression occurring during the mid to late exponential phase and in the presence 
of 5mM D-myo inositol [442]. The reported purification procedures are rather tortuous and 
inefficient. Typically, the cells were lysed by homogenisation using a bead beater and the 
microsomal membrane fraction obtained by centrifugation. The enzyme was solubilised 
with 1% Triton X-100 and purified to four bands by SDS-PAGE using six chromatography 
steps, which include anion exchange (DEAE Cellulose, Q-Sepharose and 2 x Mono Q) and 
hydrophobic chromatography (Octyl Sepharose and Phenyl Resource). A 3425-fold 
purification from the cell free extract was obtained, but with a 77% loss in protein [500]. 
Mandala et. al. have investigated the effect of three detergents; cholate, diheptanoyl 
phosphatidylcholine and Triton-X 100 on the isolation of C. neoformans [PC synthase. Both 
cholate (1%) and diheptanoyl phosphatidylcholine (1%) solubilised over 50% of the protein 
but the majority of the enzyme activity remained in the pellet. Triton X-100 (1%) appeared 
to solubilise the enzyme although very little activity was recovered from either phase. 
However, the addition of 1mM P1 during solubilisation dramatically improved results 
leading to almost quantitative recovery of [PC synthase activity in the supernatant [71]. 
Aeed et. al. reported similar findings with C. albi cans [PC synthase. Of the twenty six 
membrane-perturbing agents investigated, only octyiglucoside and Triton X-100 solubilised 
[PC synthase, and extracts required the presence of 5mM P1 to partially restore activity. By 
SDS-PAGE, density gradient separation and size exclusion chromatography they 
demonstrated that Triton X-100 solubilised C. albicans [PC synthase existed in protein and/ 
or lipid complexes (1.5x I 06-20x 106  Da) whereas octylglucoside solubilised [PC synthase 
was not truly in solution with the activity co-fractionating with intact membranes [501]. 
3.1.1 Wild Type S. cerevisiae IPC Synthase 
In order to obtain wild type S. cerevisiae [PC synthase for protein characterisation, S. 
cerevisiae cells were grown at 30°C 3 . To obtain maximal expression of [PC synthase D-myo 
inositol (3g/5L, 3.33mM) was added to the fermentation media and cells were harvested 
Dr. Laurie Cooper and Dr. Andy Herbert assisted with the fennentation studies. 
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(767g cell pellet/5L) during the mid to late exponential phase. The cells were disrupted 
using a French Press and microsomal membranes were obtained by differential 
centrifugation. The method described by Fischl et. al. [500] was used to solubilise [PC 
synthase. The microsomal membranes were diluted with Bis-Tris-CI (50mM, pH 6.0) 
containing Triton X- 100 (1 %v/v), glycerol (1 0%v/v), 3-mercaptoethanol (5mM), MnC12 
(1mM) and protease inhibitors. As reported by both Ko et. al. [611] and Fischl et. al. [500], 
activity was recovered in the supernatant with a three fold increase in specific enzyme 
activity when the microsomal membrane concentration was lOmg/ml. A reduction in the 
recovered activity was observed upon increasing the membrane concentration. The increase 
in specific activity can be attributed to enrichment of the active enzyme due to the removal 
of Triton X-100 insoluble proteins. Although [PC synthase solubilisation is attributed to 
Triton X- 100, it appears that the presence of the other additives in the solubilisation buffer 
ensures stability of the enzyme upon storage at -80°C. 
One difference between IPC synthase from S. cerevisiae to that from other organisms [71, 
5 0 1 ] is the fact that additional P1 is not required for the recovery of [PC synthase activity in 
the supernatant. Mandala et. al. have suggested that C. neoformans [PC synthase is 
stabilised by either binding P1 as a substrate and/or by the formation of 
detergentlphospholipid mixed micelles that mimic the membrane environment. They have 
attributed the different requirements to a five fold increase in S. cerevisiae membrane 
concentration during incubation with Triton X-100, which could lead to increased solubilised 
endogenous P1 [71]. Approximately 20% of phospholipid in the S. cerevisiae Golgi 
membrane has been shown to be P1 [612]. Furthermore, yeast cells grown in the presence of 
exogenous inositol have been shown to have elevated P1 levels in their membranes [613]. 
Thus, the exogenous inositol in the fermentation media may have stimulated in vivo P1 
production, negating the requirement for additional P1 in the solubilisation buffer. 
S. cerevisiae IPC synthase has previously been purified to four bands by SDS-PAGE (97, 66, 
50, 46 kDa). Any further purification resulted in total loss of activity [500]. In an attempt to 
optimise this procedure the six chromatography steps were reduced to three; Q-Sepharose 
(Figure 3.1B), Resource Phe (Figure 3.1C) and Mono Q (Figure 3.1D). [PC synthase was 
purified to five bands by SDS -PAGE (97, 66, 46, 40, 30 kDa, Figure 3.1E). Comparison of 
the published mass of the SDS-PAGE bands [500] and those obtained in Figure 3.IE 
indicates that S. cerevisiae [PC synthase could give rise to one or both of the bands at 46 and 
66 kDa, which will be discussed further in Chapter 4. Although 405-fold purification from 
NaCI (M) 
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microsomal membranes was achieved, the activity yield was rather low (see Table 3.1) 
requiring further purification. 
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Figure 3.1: Wild Type S.cerevisiae IPC synthase Purification 
SDS-PAGE of Triton X-100 solubilised microsomes (A), where M is the marker and S is the 
sample. Elution Profiles of Q-Sepharose (B), Resource Phe (C) and MonoQ (D) Chromatography. 
The red line under each x-axis represents eluted [PC synthase activity. SDS-PAGE of the purified 
and concentrated sample (E) after the treatment described above. 
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Microsomes 2000 360000 180 1 100 
Triton X-100 extract 680 367000 540 3 102 
Q-Sepharose 35 103000 2930 16 29 
Resource Phe 5.4 29000 5410 30 8 
Mono  
0.06 4300 71800 399 1 (fraction 0.l-0.2M NaCl) 
Mono  
0.03 2000 67800 377 1 (fraction 0.2-0.3M NaCI) 
Table 3.1: Purification of Wild Type S. cerevisiae IPC synthase 
Starting with 31.25g of S. cerevisiae cell pellet. The assay is discussed in further detail in section 3.3. 
The Triton X-100 solubilised microsomes were initially subjected to purification on a Q-
Sepharose 26/10 column and bound proteins were eluted over a 0-IM sodium chloride 
gradient in buffer containing 0.05% Triton X-100. IPC synthase activity eluted over 0.07-
0.3M NaCl (Figure 3.1B), a similar concentration to that previously reported by Fischl et. al. 
[500]. The specific activity increased by 16 fold but the total recovered activity was reduced 
to 29%. Although all protein mass was accounted for there was an overall reduction in IPC 
synthase activity to 61%, with only half in the elution buffer. The lack of binding is not due 
to column overloading as conducting the purification in multiple batches did not increase the 
yield, nor did altering the pH of the buffer system. S. cerevisiae IPC synthase has a reported 
isoelectric point of 5.66 and the solubilisation and Q-Sepharose purification steps were 
carried out at pH 6.0. As the quaternary ammonium resin is a strong anion exchanger an 
increase in pH should improve binding. However, even with an increase to pH 7.5 using 
Tris-Cl buffer a similar loss in overall activity was observed. Fischl et. al. employed the use 
of DEAE cellulose, a weak anion exchanger, in their purification procedure. S. cerevisiae 
IPC synthase, with a charge of -6.51, does not bind at pH 7.0, which they utilised by 
collecting unbound protein as input for the Q-Sepharose purification step [500]. 
The IPC synthase activity eluted from the Q-Sepharose was dialysed against Tris-Cl (50mM, 
pH 7.0), glycerol (lO%v/v), MgCl 2 (5mM), MnC12 (1mM), 13-mercaptoethanol (5mM), NaCl 
(1.5M) and protease inhibitors to facilitate binding to the Resource Phe resin. Bound protein 
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was eluted over a 0-1% Triton X-100 gradient. IPC synthase activity was eluted between 
0.2-0.6% Triton X-100 (Figure 3.IC) with a 29% activity yield and 1.8-fold purification. As 
a consequence the overall yield was reduced to 8% but with 31-fold purification. Since 
Triton X-100 absorbs at OD 280nm, a control column was ran in order to obtain a blank for 
the elution profile. All protein concentrations were determined by Bradford assay [614] 
against blank samples that contained equivalent detergent concentrations. 
The eluted active fractions were pooled and purified further using a high resolution Mono Q 
anion exchange column. JPC synthase activity eluted over 0.1-0.3M NaCl (Figure 3.1D), as 
previously observed, in Bis-Tris-CI (50mM, pH 6.0), glycerol (10%v/v), MgC1 2 (5mM), 
MnCl2 (1mM), 3-mercaptoethanol (5mM), Triton X-100 (0.05%v/v) and protease inhibitors. 
An activity yield of 22% for the purification step was achieved with 13-fold purification, 
resulting in an overall total activity yield of 2% and 405-fold purification in three 
chromatography steps. The fractions that eluted over 0.1 -0.2M NaCl were combined, 
concentrated 10-fold and analysed by SDS-PAGE (Figure 3.1E). Further concentration 
resulted in protein precipitation and loss of activity. The negative readings in the elution 
profile can be attributed to variance in the concentration of Triton X-100 in fractions 
compared to the blank. 
Both LC-MS and MALDI-ToF spectrometry 4 were attempted with Mono Q purified 
samples. No spectra of the intact proteins were obtained under the conditions tried. 
Although fragment peaks were obtained using trypsin digest and MALDI-ToF, peptide 
fingerprinting using the Mascot search engine (www.matnxscience.com ) did not reveal any 
significant matches to proteins held on the database, which indicated that they had 
previously not been characterised by mass spectrometry. Unfortunately they could not be 
correlated with the predicted mass peaks for S. cerevisiae Aurip either. Further purification 
development was obviously required. 
Above its critical micelle concentration (CMC) at 0.24mM (0.0 15%) Triton X-100 exists in 
micelles with an average weight greater than 90 kDa [615], preventing the removal of Triton 
X-100 by dialysis. The detergent level could not be reduced to below its CMC as protein 
precipitation occurred. The membrane-like environment created by the detergent may 
restrict access of IPC synthase to the resin in all three chromatography steps and reduce 
binding. Another factor possibly contributing to the reduction in IPC synthase activity in the 
Mass spectrometry and its analysis was carried out with the assistance of Nick Tomczyk 
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Q-Sepharose and Mono Q purification steps is the large decrease in Triton X-100 from 1% 
and 0.4%, respectively, to 0.05% in the elution buffer. Funato et. al. have reported that 
conversion of ceramide to IPC is reliant on cytosol. Cytosol treated by heat inactivation or 
trypsin digest resulted in loss of IPC synthase activity, but the presence of Triton X- 100 was 
able to abolish the cytosol requirement whilst maintaining activity [236]. This suggests that 
a cytosol protein(s) is required for ceramide transport (see Section 1.3). Although 5mM 
Triton X-100 is routinely used in the assay buffer there would be a reduction in the overall 
Triton X-100 concentration that originates from the added protein sample, possibly reducing 
the amount of ceramide reaching the active site. This would result in a lower increase in 
specific activity upon purification and thus lower total activity and protein yield. 
It is worthy of note here that one major factor affecting the recovered activity calculations is 
the high specific activity in the initial crude membrane and solubilised microsome fractions. 
Fischl et. al. reported initial specific activities in the low nanomolar region; however, in their 
preparation D-myo inositol was not added to the culture media upon cell growth. This would 
reduce the overall [PC synthase content and specific activity. Furthermore, Fischl et. al. 
reported two assays, one using radio labelled P1 ([ 3H]PI) and one using fluorescent ceramide 
(C6-NBD-Cer) without indicating which was used for their calculations. Both their 
radioactive and fluorescent assays were carried out under non-optimum catalytic conditions 
with regards to PT concentration. They used 0.5mM P1 [500], a concentration close to the 
km [78, 4481 (see section 3.3.1). Also, as C 6-NBD-Cer has been shown to be a substrate 
inhibitor at high concentration, JPC synthase activity would be inhibited by the lOOp.M C 6-
NBD-Cer present in the reaction mixture. There is a possibility that natural ceramide may 
also be a substrate inhibitor at high concentration and this was used at 2001.tM in the 
radioactive assay [500]. 
Although S. cerevisiae IPC synthase was purified to the point achieved by Fischl et. al. [500] 
the procedure could not be easily refined to give better results. It was decided to investigate 
wild type IPC synthase isolation from B. cinerea. 
3.1.2 Wild Type B. cinerea IPC Synthase 
The fungal pathogen B. cinerea can grow on a wide range of plant types, which can vary 
considerably in surface pH and biochemical defences [491]. Even though cultures of B. 
cinerea do grow in media buffered between pH 2.0-7.0, the optimum p11 for growth is pH 
4.0-5.0 [491]. B. cinerea was cultured in media buffered at pH 4.5 and agitated slowly 
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(120rpm) at 21'C. In order to achieve maximum JPC synthase expression 5mM D-myo 
inositol was added to the culture media with an initial moculum of I .x10 5 conidialml and the 
cells were harvested at mid to late exponential phase after eight days. 
Cells were lysed using a bead beater and the addition of various detergents, including Triton 
X-100, octylgiucoside and n-dodecyl B-D-maltoside (DDM), was investigated to maximise 
the recovered IPC synthase activity. However, detergent addition alone did not result in 
active fractions and, as reported for C. neoformans [71] and C. albicans [501], P1 (1mM) 
was required in conjunction with Triton X-100 (1%) to recover B. cinerea IPC synthase 
activity in the supernatant. Unlike S. cerevisiae microsomes in which activity was 
solubilised from the 100k g pellet, B. cinerea IPC synthase was solubilised from the 27k g 
pellet. This is reasonable since B. cinerea is multicellular and contains stacked Golgi 
cistemae whereas the Golgi apparatus in unicellular S. cerevisiae is dispersed. IPC synthase 
with a specific activity of 70nMJmin/mg (Table 3.2) was solubilised from the 27k g 
microsomal membrane fraction in the same buffer used for S. cerevisiae with the addition of 
P1(1mM). 
The quantity of protein solubilised from B. cinerea microsomes was low (8.5mg!5 .95g 
microsomal pellet) compared to protein solubilised from S. cerevisiae microsomes (680mg! 
2.00g microsomal pellet). This may be due to the microsomal membrane concentration 
utilised for B. cinerea (1 .2g!ml), which is much higher than that required for maximum 
recovery of solubilised S. cerevisiae [PC synthase (1 Omg!ml). Lower microsomal 
concentrations were tried for B. cinerea IPC synthase solubilisation; however, it proved very 
difficult to measure any activity in larger volumes, probably due to enzyme dilution and 
centrifugal concentration led to protein precipitation. 
Since the activity and protein yields were so low only limited attempts to concentrate activity 
were attempted. One finding of note was that a 4-fold purification of wild type solubilised 
B. cinerea [PC synthase was achieved in conjunction with a 25% activity yield when extracts 
were subjected to nickel based immobilised metal affmity chromatography (IMAC) (section 
4.2). This could be attributed to the two adjacent histidine residues in D4 predicted to reside 
at the membrane surface (see Figure 2. 10, section 2.4). The results of these findings are 
discussed further in Chapter 4. 





Protein (mg)Total Activity 	Specific Activity Concentration 
(nMlmin) (nM/mm/mg) 
1.7 	 5.00 	 8.5 	 600 	 70 
Table 3.2: Solubiised B. cinerea IPC synthase Activity 
B. cinerea IPC synthase activity was solubilised from the 27k g microsomal pellet (5.95g) with Triton 
X-100 (1% +1mM P1). Mass of the cell pellet was 61.48g. 
Compared to S. cerevisiae, [PC synthase extracts from B. cinerea exhibited much lower 
specific activity. Cheng et. al. have observed this with A. nidulans [PC synthase, reporting 
that little [PC synthase activity was observed in A. nidulans cells compared to S. cerevisiae 
cells [262]. As can be seen from the sequence alignment and phylogenetic tree in section 
2. 1, B. cinerea and A. nidulans IPC synthase are closer in amino acid sequence than either B. 
cinerea and S. cerevisiae or A. nidulans and S. cerevisiae. It is possible that fungal [PC 
synthases require additional unknown factors for optimum activity or that the assay 
conditions described in section 3.3 are not suitable for measuring fungal [PC synthase 
activity. 
In order to identify possible differences between S. cerevisiae and B. cinerea [PC synthase, 
and to optimise the activity assay for B. cinerea [PC synthase more enzyme was required. 
As isolation from native source did not give adequate yields, recombinant expression was 
investigated (Chapter 4). 
3.2 Functional Glycosylation of S. cerevisiae IPC Synthase 
Aur ip exhibits several N-glycosylation patterns in its amino acid sequence, one of which is 
conserved, with the exception of B. thetaiotaomicron, throughout the species analysed in 
Chapter 2. In order to determine if the patterns are actually modified wild type [PC synthase 
solubilised from crude S. cerevisiae microsomal membranes was used as an investigative 
tool. 
Initial experiments revealed that S. cerevisiae [PC synthase is functionally glycosylated as it 
bound to Concanavalin A (ConA), a lectin known to bind glucosyl and mannosyl residues of 
glycoproteins and polysaccharides [616]. The glycosylation properties were further 
characterised by treatment with the gylcosidases EndoHf and PNGaseF. EndoHf, a 
recombinant fusion of endoglycosidaseH and maltose binding protein, cleaves at the core of 
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high mannose N-linked glycoproteins [617]. PNGaseF, peptide:N-glycosidaseF, hydrolyses 
almost all N-glycan chains between the asparagine and the first N-acetylglucosamine 
residue, with the exception of glycans containing a a 1-3 fructose core [618]. Both enzymes 
are optimally active at 37°C when the glycoprotein substrate is denatured, as 2° and 3° 
proteins structures can often restrict endoglycosidase access. If the substrate must remain in 
its native form both longer incubation times and increased endoglycosidase concentrations 
are required. In order to determine if N-glycosylation affected IPC synthase activity and to 
provide an additional means of detection incubations were carried out with both native and 
denatured protein samples. The solubilised microsomes were dialysed prior to incubation to 
remove low molecular weight inhibitors and proteases. 
In control experiments RNaseB, a high mannose glycoprotein, exhibited full deglycosylation 
under denatured conditions but only partial cleavage occurred with PNGaseF when in its 
native form. SDS-PAGE with glyco-staining was a useful detection tool for RNaseB 
although a high concentration of pure protein was required for staining to be effective. 
Incubations of the crude microsomal preparations were analysed by this method but it proved 
an ineffective detection method as only a small quantity of IPC synthase was present in the 
crude solubilised microsomes. In contrast, subjecting the incubated samples to ConA 
sepharose 4B chromatography and IPC synthase activity assays proved successful. The 
results are summarised graphically in Figure 3.2 and in Table 3.3. Additional controls were 
carried out where native S. cerevisiae solubilised microsomes were subjected to equivalent 
incubation conditions but without the presence of endoglycosidases. Wild type solubilised S. 
cerevisiae microsomes were also subjected to ConA sepharose 4B chromatography without 
prior incubation at 37°C. 








o ConA Bound 




Figure 3.2: Total S. cerevisiae IPC Synthase Activity Distribution after Incubation with 
Endoglycosidase and ConA-Sepharose Chromatography 
The S. cerevisiae IPC synthase source was dialysed Triton X- 100 solubilised microsomes. The wild 
type sample was not incubated at 37°C prior to ConA sepharose chromatography. The EndoHf 
control and PNGaseF control were incubated at 37°C prior to chromatography, under equivalent 
conditions to EndoHf and PNGaseF treated samples, respectively, but without the addition of 
endoglycosidases. 
Prior to ConA ConA Unbound 	 ConA Bound 
Chromatography 
Tran trnnt 
nM nMimin nM nM/mm nM nMimin 
mg /min /mg 
mg /min /mg 
mg /mm /mg 
Wild type 0.9 300 340 0.8 25 30 0.5 245 490 
EndoHf control 0.2 60 290 0.2 6 30 0.2 80 380 
EndoHf 0.2 26 130 0.4 20 52 0.05 20 350 
PNGaseF control 1.4 50 35 2.0 65 32 0.02 5 230 
PNGaseF 1.2 20 16 1.9 30 14 0.04 0 0 
Table 3.3: Wild Type S. cerevisiae IPC synthase Incubated with Endoglycosidase, 
followed by ConA-Sepharose Chromatography 
For each stage in the ConA Sepharose Chromatography, the amount of protein (mg), the total activity 
(nM/mm) and the specific activity (nM/mm/mg) is given. For a description of the treatments refer to 
Figure 3.2. 
Under native incubation conditions at 37 °C a large percentage of protein precipitated and 
degraded giving both lower specific activity and total activity. When EndoHf and PNGaseF 
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are present there appears to be approximately 2-fold reduction in activity compared to their 
respective controls. This suggests that when IPC synthase is glycosylated it exhibits a higher 
level of activity by promoting either increased protein stability or activation. The 
endoglycosidases could also be bound to some of the uncleaved substrate reducing IPC 
synthase activity by blocking the active site with enzyme bulk. 
It appears that an additive(s) under PNGaseF digestion inhibits IPC synthase activity 
compared to EndoHf digestion. This can be explained by the incubation conditions. The 
EndoHf buffer is 50mM sodium citrate pH 5.5 whereas the PNGaseF buffer is 50mM 
sodium phosphate pH 7.5. The non-ionic detergent NP-40 (1% final concentration) is 
routinely added to the PNGaseF reaction mixture as it counteracts inhibition of the enzyme 
by SDS, which is present in the denaturing buffer. NP-40 is structurally very similar to 
Triton X- 100 with a CMC of 0.29mM, 0.0179%. Ko et. al. have reported that high Triton X-
100 concentrations inhibit S. cerevisiae IPC synthase, presumably due to substrate dilution in 
the detergent mixed micelles. Thus, the presence of Triton X-100 (1%) and NP-40 (1%) 
would increase the micelle concentration 2-fold diluting the lipid substrates and substantially 
reducing IPC synthase activity. 
For each sample subjected to ConA sepharose chromatography an increase in the protein 
concentration of the bound and unbound material compared to the column input was 
observed. This is due to ConA being washed off the resin, and this was identified by 
MALDI-ToF spectrometry. The eluted specific activity is greater than the initial activity. 
Some removal of impurities that inhibit IPC synthase activity by the chromatography step 
may occur and this presumably increases the activity observed. 
Both wild type S. cerevisiae Triton X- 100 solubilised microsomes and those under Endollf 
control conditions have higher specific activity and total activity in the ConA bound fraction 
compared to the unbound fraction (Figure 3.2) reconfirming that S. cerevisiae [PC synthase 
is glycosylated and that it binds to ConA. Although an activity yield of 70% is achieved, 
much higher than other chromatography procedures attempted (Chapter 3.1.1) there is only a 
1.4-fold purification. 56% of EndoHf treated S. cerevisiae [PC synthase activity is unbound 
compared to 8% unbound in the control (Figure 3.2) indicating that Endollf does 
deglycosylate S. cerevisiae [PC synthase and that the glycan has high mannose content. 
However, not all of EndoHf treated S. cerevisiae [PC synthase is unbound. This is probably 
due to the native 2° and 3° structure of [PC synthase obstructing access for EndoHf. 
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Although all RNaseB glycosylation appeared to be cleaved by EndoHf under native 
conditions, RNaseB is highly soluble. 
The majority of the S. cerevisiae IPC synthase activity does not bind to ConA in both the 
PNGaseF control and PNGaseF treated sample (Figure 3.2). As there is no endoglycosidase 
present in the control this is not due to glycan cleavage. Although there are reports of 
successful binding of glycoproteins to ConA sepharose in the presence of Triton X-100 (1%) 
[619] and SDS (0.05%) [620], the cumulative effect of Triton X-100 (1%) and NP40 (1%) 
both above their CMC may obstruct and shield the glycan from ConA preventing binding. 
That no IPC synthase activity is present in the ConA bound fraction of PNGaseF treated 
solubilised microsomes suggests that PNGaseF also deglycosylates IPC synthase although to 
what extent cannot be confirmed due to the high percentage (93%) of unbound glycosylated 
[PC synthase activity. However, the fact that there is no activity after PNGaseF treatment 
suggests that glycosylation is required for functional IPC synthase. In conclusion, the 
experimental evidence suggests that S. cerevisiae [PC synthase is functionally glycosylated 
with high mannose content. 
3.3 Assay Development 
There are two cell based growth assays reported in the literature [72, 8 1 ] both similar to 
those in use by Syngenta for Aurlp/IPC synthase inhibitor screening. The first, reported by 
Nagiec et. al. [72], uses a yeast sphingolipid bypass mutant which has a mutation in the 
sphingolipid compensatory gene (SLC-1) and can compensate for a lack in sphingolipid 
biosynthesis caused by deletion of the LCBJ gene (Lcb-100) by facilitating synthesis of 
novel glycerolipids with C 26 VLCFAs. However, in the presence of PHS the sphingolipid 
bypass mutant can synthesise complex sphingolipids. In the modification of this assay 
developed at Syngenta the sphingolipid bypass mutant is grown on media both with and 
without PHS to identify compounds that target complex sphingolipids, in particular [PC 
synthase. A second cell based assay (also in use by Syngenta) utilises GAL] promoted 
AURJ [81, 360] grown under both galactose inducing and glucose repressing conditions 
enabling Aurlp inhibitor sensitivity to be determined. 
Although the whole cell assays are useful, an in vitro assay would be more specific and 
sensitive in detecting [PC synthase inhibitors. It would also allow for tracking of IPC 
synthase activity when the enzyme is isolated and purified, assisting further protein 
characterisation. There are a number of in vitro [PC synthase activity assays reported in the 
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literature. The majority are based on incubation of either fluorescent [85, 86, 88, 448, 500, 
50 11 or radioactive [71, 79, 85, 87, 500, 611] substrates with microsomal membranes as the 
IPC synthase source. 
The fluorescent IPC synthase activity assay uses N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]-hexanoyl]-D-erythro-sphingosine (C 6-NBD-ceramide, C 6-NBD-Cer) 44 as the 
fluorescent substrate (Scheme 3.1). Thong et. al. have described a fluorescent HPLC assay 
in which yeast microsomal membranes, C 6-NBD-Cer and P1 were incubated at 30°C in 
varying quantities. The reaction was quenched with 10% acetic acid, centrifuged and the 
supernatant separated on a C 18 reverse phase HPLC column using a 50-90% acetonitrile 
gradient (flow rate imi/min). Two peaks were observed at RT 5.2 minutes and RT 12.2 
minutes. LC-MS and MS/MS have shown these to be the substrate, C 6-NBD-Cer (RT 12.2 
minutes, m/z 576) and the product C 6-NBD-IPC 45 (RT 5.2 minutes, m/z 818). The kinetic 
data they obtained using this assay fits the Michaelis-Menten equation with C 6-NBD-Cer 
having an apparent k m of 9.8±0.1tM and VmAx of 0.5±0.02 nMlminlmg of protein' [4481. 
OH 
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Scheme 3.1: Fluorescent IPC synthase Activity Assay Using C 6-NBD-Cer as a Substrate 
The assay described by Fischl et. al. uses thin-layer chromatography (TLC), instead of 
HPLC. A solvent system of chloroform/methanol/water (65/25/4) has been employed giving 
was calculated per milligram of crude microsomal membrane 
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R1 values of 0.77 and 0.13 for C 6-NBD-Cer and C 6-NBD-JPC, respectively [500]. Levine et. 
al. have also used the fluorescent TLC method, to measure both in vitro and in vivo IPC 
synthase activity [86]. 
Aeed et. al. have utilised the fluorescent incubation method with CHAPS washed C. 
albicans microsomal membranes as the enriched ]PC synthase source [501]. They have used 
an alternative detection method based on anion exchange chromatography described by 
Mandala et. al. [87]. The AG4-X4 resin binds C6-NBD-IPC, which is eluted with 1M 
potassium formate in 96% methanol, into a 96 well plate via the use of a vacuum manifold 
for quantification using a fluorescent plate reader (excitation X466nm, emission X536nm) 
[501]. Using Michaelis-Menten kinetics they determined C 6-NBD-Cer to have an apparent 
km and VMAX5 of 3.3j.tM and 0.884 nMlmin/mg of C. albicans protein, respectively. They 
also suggest that P1 exhibits substrate inhibition at high concentration with an apparent km, 
VMAX5 and k1 of 1381i.M, 1.864 nM/minImg and 588.2tM, respectively. 
Radioactive IPC synthase activity assays have utilised both radiolabelled [3H] P1 [85, 442, 
500, 611] and radiolabelled [3H] C2-ceramide [71, 79, 87]. The majority of the radioactive 
activity assays separate reactants and products by solvent extraction followed by scintillation 
counting [79, 442, 500, 611]. The estimated kinetic parameters for [3H] C2-ceramide (km 
30p.M and VMAJ5  0.26 nM/minlmg) [448] obtained using this method compare favourably 
with those obtained using the fluorescent based HPLC assay [448]. In the case of [ 3H] P1 
based assays [442, 500, 611] the solvent extraction occurs after mild alkaline hydrolysis, 
which causes P1 to degrade to water soluble glycerophosphoinositol [432]. Alternative 
detection methods for the radioactive assays reported include TLC ([ 3H] P1 as the radioactive 
substrate) [85] and anion exchange chromatography ([3  H] C2-ceramide as the radioactive 
substrate) [71, 87]. 
All of the above discussed in vitro assays, with three exceptions [71, 500, 611], use 
microsomal membranes as the IPC synthase source. Both of the assays described by Ko et. 
al. and Fisch] et. at. utilise 1% Triton X-100 S. cerevisiae solubilised microsomes as the IPC 
synthase source [500, 611]. As one of the aims was to develop purification protocols for IPC 
synthase, the assay used had to be optimised for soluble IPC synthase. For safety reasons a 
fluorescent assay was chosen over a radioactive one. 
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In preliminary experiments the assay using crude S. cerevisiae Triton X-100 solubilised 
microsomes was carried out under the fluorescent incubation conditions described by Fischl 
et. al. (Bis-Tris-CI (50mM, pH 6.5), MgCl, (5mM), MnC12 (1mM), Triton X-100 (5mM) and 
C6-NBD-Cer (100pM)) [500]. However, the P1 concentration was increased from 0.5mM to 
2mM since P1 is reported to have an apparent k m of 0.5mM [78, 448]. 
The solubilised enzyme was also assayed under the buffer conditions described by Zhong et. 
al. (Tris-Ci (50mM, pH 7.0), EDTA (10mM), CHAPS (2mM), NaCl (150mM) and 
glycerol( 10%)) [448]. As IPC synthase is insoluble in CHAPS and CHAPSO [501] it could 
not be solubilised from the crude microsomes directly into this buffer. Thus, the Triton X-
100 solubilised microsomes were dialysed against it to ensure removal of additives present 
during solubilisation. As Triton X-100 is present above its CMC it was not removed from 
the buffer, ensuring that the IPC synthase remained in solution. However, a poor turnover to 
C6-NBD-IPC was obtained with a specific activity of 7.5nM/minlmg compared to 
440nM/minlmg obtained with the control that was dialysed against normal assay buffer. 
This is consistent with the report by Bromley et. al. [85] who describe a 40% reduction in 
wax bean microsomal membrane IPC synthase activity under the conditions utilised by 
Nagiec et. al. in the presence of K-Phos (20mM, pH 7.0) and CHAPS (2mM) [79]. Ko et. 
al. also report that CHAPS is strongly inhibitory to [PC synthase activity [611]. 
As well as CHAPS inhibition the reduction in the solubilised S. cerevisiae [PC synthase 
activity may be due in part to the loss of MgCl2  and MnCl2, which are known to stimulate 
solubilised [PC synthase activity [611]. As previously mentioned, the presence of Triton X-
100 was shown to negate the requirement for cytosol, thought to contain a ceramide transport 
protein, in S. cerevisiae [PC synthase activity [236]. Under the normal conditions utilised 
C6-NBD-Cer would be transported to the [PC synthase active site in Triton X- 100 mixed 
micelles. As the CMC of CHAPS is 6-10mM, the assay under 2mM CHAPS buffer 
conditions would only contain the Triton X- 100 mixed micelles present from the 
solubilisation step but not the additional micelles from the assay buffer system thus reducing 
ceramide transport to the active site and as such activity. A 4-fold increase in S. cerevisiae 
[PC synthase activity was observed when Triton X-100 crude solubilised microsomes were 
dialysed against assay buffer prior to conducting the assay. This is probably due to the 
removal of low molecular weight inhibitors and proteases upon dialysis. 
Rachel Breen 	 Chapter 3: Wild Type IPC Synthase 	 Page 98 
Under our conditions a dependence upon exogenous PT was observed. This is consistent 
with other mixed micelle assays [500, 611] but differs from the results obtained by Becker 
and Lester [78], who found that exogenous ceramide did not stimulate crude microsomal 
membrane [PC synthase activity in the presence of Triton X-100. But results also differ 
from those described by Aeed et. al. [501], who observed a significant amount of product 
formation with C. albicans unwashed membranes without adding P1. Bromley et. al. also 
report that 30% of wax bean microsome IPC synthase activity occurred without the addition 
of P1 [85]. These differences can be attributed to endogenous substrate dilution in the Triton 
X-100 mixed micelles resulting in a dependence upon added substrates. 
3.3.1 Analysis of Assay Parameters 
The kinetic parameters of C 6-NBD-Cer and soy PT were determined for the mixed micelle 
assay using Triton X-100 solubilised S. cerevisiae microsomal membranes and the buffer 
system described by Fischl et. al. [500]. C5-NBD-Cer turnover to C 6-NBD-IPC was detected 
using a fluorescent HPLC method modified from that described by Thong et. al. [448]. A 
typical trace is presented in Figure 3.3. The incubation was terminated at various time points 
and initial rates were calculated. An initial time lag up to 2.5 minutes, also noted by Aeed et. 
al. [501], was observed under all substrate concentrations suggesting that there is a rate 
limiting event that occurs prior to the enzymatic reaction. This could be the deliverance of 




Figure 3.3: A Typical Fluorescent HPLC Trace of Solubilised Wild Type S. cerevisiae 
IPC synthase Activity Assay 
Incubation conditions were as described in section 5.18.3.1. Separation was achieved using a C 18 
reverse phase column with a 50-90% acetonithie gradient over 20 minutes (flow rate I ml/min) 
(section 5.18.3.4). Fluorescence detection was conducted at excitation X480nm and emission X 
535mm C6-NBD-Cer eluted at 13.4 minutes and C 6-NBD-IPC eluted at 5.0 minutes. 
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In order to calculate the kinetic parameters of the donor substrate PT, the acceptor substrate 
C6-NBD-Cer was present in excess at 20p.M and the P1 concentration was varied. Michaelis-
Menten treatment of the data is presented in Figure 3.4. As Aeed et. al. observed poor curve 
fit of their data for C. albicans IPC synthase (and as a result suggested substrate inhibition 
[501 ]) the data was also analysed with consideration for substrate inhibition. Both 
treatments gave rise to the same curve and lines in all three plots (Figure 3.4 A,B,C), with 
equivalent km and VMAX6 values of 360 ± 1 lOp.M and 300 ± 60 nM/minlmg, respectively, 
albeit with increased error margins when substrate inhibition was considered. A k 1 of 60M 
was also obtained for PT. These data suggest that under the assay conditions used P1 does 
not act as a substrate inhibitor for the yeast enzyme contrary to the result reported by Aeed 
et. al. [501 ] for C. albicans IPC synthase. It should be noted that the maximum P1 
concentration used by Aeed et. al. was 0.4mM, below the apparent kM of 0.5mM previously 
obtained for S. cerevisiae IPC synthase [78, 448]. In this study concentrations up to 2.5mM 
P1 were studied. 
6 VMJ( was calculated per milligram of Triton X- 100 solubilised crude microsomal membrane 
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Figure 3.4: Michaelis-Menten Kinetic Analysis of P1 (A) using a Double Reciprocal 
(Lineweaver-Burk) Plot (B) and a Hanes-Woolf Plot (C) 
Data treated with substrate inhibition kinetics gave rise to equivalent plots. Mean data points were 
obtained from rates calculated from duplicated assays. Calculated values, k m and VM,, are given ± 
standard error. The standard error incorporates both experimental and statistical errors. 
In order to calculate the kinetic parameters of the acceptor substrate C 6-NBD-Cer, the P1 
concentration used was six times its apparent k m and the C 6 -NBD-Cer concentration was 
varied. Michaelis-Menten treatment of the data (Figure 3.5 A,B,C) led to poor curve fit 
(Figure 3.5A) as well as poor line fit in the double reciprocal (Lineweaver-Burk) plot (Figure 
3.513) and the Hanes-Woolf plot (Figure 3.5C). The poor fit appears to be due to a reduction 
in velocity at high C 6-NBD-Cer concentrations, indicative of substrate inhibition. Thus, the 
data was also treated using the substrate inhibition algorithm (Figure 3.5 D,E,F). 
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Figure 3.5: C6-NBD-Cer Kinetic Analysis 
Michaelis-Menten Kinetics: (A) using a Double Reciprocal (Lineweaver-Burk) Plot (B) and a 
Hanes-Woolf Plot (C). 
Substrate Inhibition Kinetics: (D) using a Double Reciprocal Lineweaver-Burk Plot (E) and a 
Hanes-Woolf Plot (F). 
Mean data points were obtained from rates calculated from duplicated assays. Calculated values, k m  
and VMAX, are given ± standard error. The standard error incorporates both experimental and 
statistical errors. 
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Much better fits were obtained when the substrate inhibition parameter was considered. 
Under Michaelis-Menten kinetics an apparent k m of 5.2 ± 1.6 .M was obtained. When 
substrate inhibition was considered the apparent km increased to 11.4± 3.5  ~M.  The 
calculated VMAX6 was 300 ± 50 nM/mm/mg and 450 ± 1 lOnM/min/mg under Michaelis-
Menten kinetics and substrate inhibition kinetics, respectively. Using the substrate inhibition 
algorithm an apparent k 1 of 130 ± 50iM was obtained for C 6-NBD-Cer. 
Substrate inhibition by C6-NBD-Cer has not previously been reported. The highest C 6-NBD-
Cer concentration used during kinetic analysis by Aeed et. al. for C. albi cans IPC synthase 
was 20iM [501]. If the error margins are considered in the plotting of the data presented by 
Thong et. al. for S. cerevisiae IPC synthase, it may fit substrate inhibition kinetics [448]. 
Furthermore, Bromley et. al. did not study IPC synthase at high concentrations of C 6-NBD-
Cer for wax bean microsomal IPC synthase as a concentration of 70.tM appeared to be 
saturating[85]. This could indicate possible substrate inhibition for this enzyme. 
That C6-NBD-Cer is inhibitory at high concentration and Pus not is consistent with the 
predicted enzyme mechanism discussed in section 2.1. Although the kinetic data alone are 
hardly proof of the mechanism, if a substituted enzyme mechanism is valid P1 would bind to 
1PC synthase, transfer phosphoinositol forming an enzyme complex and release DAG, 
followed by binding of ceramide (Scheme 2.2). Formation of a ternary complex would be 
impossible as the two substrates would share one site or have overlapping binding sites. As 
Aurip has an additional unique domain, Dl, thought to be involved in ceramide binding 
compared to LPPs that bind phosphatidic acid containing DAG (Chapter 2) it is possible that 
the binding sites of ceramide and P1 are overlapping rather than are exactly the same. In this 
mechanism both substrates could potentially act as a substrate inhibitor at high 
concentration. However, steric hindrance caused by the phosphoryl-histidine intermediate 
would probably prevent P1 and IPC binding incorrectly, leading to the substrate and product 
lacking the transferred phosphoinositol group (e.g. ceraniide and DAG) being able to bind to 
the wrong binding site when present in high concentration. 
C6-NBD-Cer substrate inhibition would be most effective when the P1 concentration is low, 
resembling competitive inhibition. This coincides with the fact that intact S. cerevisiae 
Golgi membranes have been reported to contain high levels of P1 [612]. Results from this 
study and others [78, 448, 501] show that the kM for P1 is substantially higher than that for 
C6-NBD-Cer. If natural ceramide behaves in a similar manner to C 6-NBD-Cer the higher P1 
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concentration required for optimum IPC synthase activity would prevent substrate inhibition 
by ceramide in vivo. It has already been established that the rate limiting substrate in the in 
vivo [PC synthase reaction is ceramide [4, 501]. 
Although the km values obtained in this study are comparable to reported values, the VMAJ 
parameters are 300 - 900 fold higher, in line with the higher specific activities discussed in 
Chapter 3.1. 1. There are a number of factors that could contribute to the increase in activity 
and VMAX observed in this study. The assays with reported VM parameters [79, 448, 501] 
were all conducted in 2mM chaps or less, below its CMC. As previously discussed, under 
the initial incubation conditions in the presence of CHAPS buffer [PC synthase specific 
activity was reduced 59-fold from 439 to 7.46nM/minlmg compared to the Triton X-100 
mixed micelle assay used in this study. The value obtained under the CHAPS conditions is 
more in line with reported Vm Ax values, probably due to both the reported inhibitory effects 
of CHAPS [85, 611] and the lack of Triton X-100 mixed micelles thought to be involved in 
substrate delivery to the active site [236]. Furthermore, of all reported [PC synthase activity 
assays only Nagiec et. al. [79] grew their cells in the presence of D-myo inositol, reported to 
stimulate [PC synthase expression [442]. Even then the final concentration they used was 
0.28mM (50mg/L) compared to 3.33mM used in this study. Moreover, all the assays with 
reported VMAX values were carried out with microsomal membranes compared to the Triton 
X- 100 solubilised microsomal membranes used here. These two factors would cumulatively 
provide an enriched [PC synthase source yielding higher [PC synthase specific activity per 
milligram of microsomal membrane. A further consideration that is applicable to results 
obtained by Nagiec el. al. is that [3  H]C2-ceramide was used instead of C 6-NBD-Cer. 
Additional experiments discussed in section 3.3.3 show that C 8-ceramide 47 has 5.5-6-fold 
less affinity for ][PC synthase yielding a lower specific activity compared to when C 6-NBD-
Cer is utilised as the ceramide source. 
The assay conditions described above were optimised prior to analysis with respect to 
substrate inhibition parameters. Thus, the apparent k m values obtained under Michaelis-
Menten kinetics were used to calculate the steady-state assay conditions of 2mM P1 
(approximately 5xkM) and 16.5 p.M C 6-NBD-Cer (approximately 3xkM). Product formation 
over time is initially linear but does taper off after approximately 90-100 minutes (Figure 
3.6). So a time point of 80 minutes was selected for the termination of all future assays used 
in both inhibitor studies and specific activity calculations for [PC synthase expression and 
purification. Possible reasons for activity saturation are product inhibition, which is more 
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likely to be due to DAG than IPC due to the steric hindrance implications of the enzyme 
phosphoinositol intermediate complex discussed above, and build up of product in the mixed 
micelles containing IPC synthase. Product formation appeared to be proportional to the 
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Figure 3.6: Wild Type S. cerevisiae LPC synthase Activity over Time 
Incubation conditions were as described in section 5.18.3.2. Dialysed Triton X-100 solubilised 
microsomes were used as the IPC synthase source. 
For practical reasons IPC synthase activity assays carried out later in this study were carried 
out using the fluorescent TLC detection method described by Fischl et. al. [500]. Activity 
was quantified by phosphorimaging (excitation X488nm, emission X520 ± 40nm) and 
ImageQuant software. Rf values for C 6-NBD-Cer and C 6-NBD-IPC were as described by 
Fischl et. al. [500] at 0.77 and 0. 13, respectively. Typical TLC plates are presented in Figure 
3.7. 
C6-NBD-Cer proved unstable under storage conditions at -20°C. A major degradation 
product of C 6-NBD-Cer was identified as 6-(N-(7-nitrobenz-2-oxa- 1,3-diazol-4-
yl)amino)hexanoic acid (NBD-X, 46) by co-migration with a standard by TLC (R f 0.63). 
Chemical hydrolysis of C 6-NBD-Cer under acidic conditions (treatment with excess H2SO4) 
resulted in an increase of the degradation product by TLC, and inactivation of enzymatic 
samples by boiling identified the degradation to be a result of chemical rather than enzymatic 
hydrolysis. Mass spectrometry yielded no conclusive results. Disturbingly one of the other 
breakdown products had the same R f as C6-NBD-IPC. Moreover, the specific activity of 
freshly prepared samples from an original stock of cells was unstable to prolonged storage at 
-80°C. Inhibition of IPC synthase activity by C 6-NBD-Cer degradation products could have 
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contributed to the lower [PC turnover, Vm Ax and specific activities reported in the literature, 
compared to the higher values obtained in the kinetic parameter and inhibition studies 
discussed herein as well as wild type S. cerevisiae [PC synthase purification, which were all 
conducted with fresh cell preparations and with C 6-NBD-Cer stored at -80°C. 
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Figure 3.7: Typical Fluorescent TLCs of Solubilised Wild Type S. cerevisiae IPC 
synthase Activity Assay 
The IPC synthase source was treated in the same way, the difference is the quality and age of C 6-
NBD-Cer: TLC A, C6-NBD-Cer was freshly solubilised in DMSO from fresh powdered C 6-NBD-Cer 
stored at -80°C; TLC B, C 6-NBD-Cer was freshly solubilised in DMSO from powdered C 6-NBD-Cer 
after approximately 4 months storage at -20°C. Incubation conditions were as described in section 
5.18.3.1. TLC's were prepared and imaged as described in section 5.18.3.3. Fluorescence detection 
was conducted at excitation X 488nm and emission X 520d40nm. Product Y was reported by Levine 
et. al. to be AbA insensitive and thought to be released from C 6-NBD-Cer during the acidic lipid 
extraction prior to TLC [86]. 
3.3.2 Aureobasidin A Inhibition Studies 
Under the assay conditions described above a concentration response curve was obtained for 
AbA against IPC synthase from S. cerevisiae Triton X-100 solubilised microsomes (Figure 
3.8). Various concentrations of AbA were incubated with the [PC synthase source for five 
minutes prior to initiating the assay with the addition of substrate. This pre-incubation phase 
allowed for any slow binding of [PC synthase to be completed. The data presented in Figure 
3.8 demonstrates 50% inhibition of IPC synthase (IC 50) occurs at 175 ± 22nM. 10 50 's of 
similar values were consistently reproduced under these assay conditions. 
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This IC50 value is 875 times higher than that obtained by Nagiec et. at. [79]. Thong et. al. 
have reported an apparent k 1 in the low nanomolar region resulting from tight binding non 
competitive inhibition by AbA [448]. Both the reported literature values were calculated 
from crude microsomal membrane assays under non-micelle conditions. To date there has 
been no report of an AbA inhibition parameter calculated from a detergent mixed micelle 
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Figure 3.8: Concentration Response Curve of Wild Type S. cerevisiae IPC synthase 
Activity Treated with AbA 
The data points are the average of at least two values less than 5% in error. 
The presence of Triton X-100 mixed micelles in this study could reduce the concentration of 
available AbA resulting in an increase in the AbA concentration required for inhibition. This 
is not observed with the lipid substrates, probably due to the presence of endogenous 
ceramide and PT already diluted in the mixed micelles. Furthermore, there is a high 
possibility that (at least) part of the AbA binding site is hydrophobic [448]. This is 
supported by the fact that there are two AbA resistant mutants that have single base pair 
alterations at the end of Dl [80, 811, which is predicted to be localised to a TMIH (section 
2.4). The Triton X- 100 present in both the solubilisation and assay buffer could either 
compete with AbA for this binding site or mask it. Levine et. al. have reported that a 
reduction in Aurlp-ZZ cleavage was observed in the presence of Triton X-100 possibly due 
to partial masking of the cleavage site by Triton X-100 micelles [86]. Although the cleavage 
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site involved here is C-terminal it is possible that Triton X- 100 micelles could also mask 
amino acid residues involved in AbA binding. 
It is also worth noting that the 875-fold increase obtained in the IC 50 compared to literature 
values [79, 448] is comparable to the 300-900 fold increase observed in VMAX'S and specific 
activities. Cells overexpressing Aurip under the control of the GAL! promoter have been 
shown to exhibit resistance to AbA [81]. The [PC synthase content was higher in my study 
than that used by Thong et. al. [88, 448] and Nagiec et. al. [79] due to the effect of 3.33mM 
D-myo inositol in the fermentation media and that the [PC synthase source is solubilised 
microsomes. 
3.3.3 Alternative Assay Development 
Unfortunately fluorescent detection of [PC synthase activity assays by a continuous method 
such as fluorescent plate detection is not applicable as no differences in the assay 
fluorescence (excitation X485nm, emission X535nm) were observed between active [PC 
synthase, inhibited IPC synthase (in the presence of 0.1mg/mi, 91tM AbA) and controls 
(replacement of the [PC synthase source with distilled water). When the assays were diluted 
and the excitation and emission wavelengths were scanned using a fluorimeter at a fixed 
emission X535nm and various fixed excitation wavelengths, respectively, no shift in Xmax or 
change in the Xmax intensity was observed. Fluorescence polarisation is also not applicable 
as it requires a large change in mass of the fluorescent molecule and C 6-NBD-Cer (590.77) 
to C6-NBD-IPC (831.89) is not enough. FRET analysis, which requires the interaction of 
two fluorescent tags that are close in space, would be difficult to achieve as fluorescently 
tagging the inositol moiety would require lengthy synthesis. 
Although still discontinuous, methods which separate the fluorescent substrate and product 
and can be conducted as a plate based assay would increase the assay efficiency yielding it 
more applicable to high throughput or selective inhibitor screening. One such method was 
investigated with the use of the lectin ConA. Although generally known to bind glucosyl 
and mannosyl residues, ConA has also been reported to bind D-myo inositol and P1 in mixed 
liposomes [621-623]. Thus, ConA was employed to separate the fluorescent substrate (C 6-
NBD-Cer) from the inositol containing product (C 6-NBD-[PC). After the assay incubation 
phase the protein was precipitated with acetic acid to remove glycosylated proteins that 
would compete with inositol for binding. The acid was removed by gel filtration and 
numerous ConA binding and elution conditions were investigated including pH, buffer 
concentration and type, temperature, time periods, ratio of ConA sepharose resin to substrate 
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and product concentration as well as type and concentration of eluent. Maximum binding of 
C6-NBD-IPC, as assayed by TLC, was achieved in Bis-Tns-C1 (50mM, pH 6.5), NaCl 
(100mM), MgCl2 (5mM), MnCl2 (5mM) and CaCl 2 (5mM) at room temperature for two 
hours followed by elution in the presence of D-myo inositol (0.5M) and Me-a-D-
mannopyranoside (0.5M). 
Upon elution, once all unbound material was washed off, an increase in both C 6-NBD-Cer 
and C6-NBD-IPC was observed by TLC. Quantification indicates that C 6-NBD-IPC and C 6-
NBD-Cer binds to ConA at a concentration of 0.12J.L.M and 0.25iM per milligram of ConA, 
respectively. This calculation is based on the average of 12.5mg of ConA per lml of resin 
binding 1.51 jiM of C 6-NBD-[PC and 3.13 jiM of C6-NBD-Cer per 1 ml of resin. This was 
observed over a number of experiments. Unfortunately C 6-NBD-Cer, which contains no 
inositol moiety, appears to bind with higher affinity to ConA than C 6-NBD-IPC. This may 
be attributed to the presence of Triton X-100 mixed micelles in the IPC synthase assay. As 
the C6-NBD-Cer concentration remains higher than the turnover to C 6-NBD-IPC, micelles 
will contain a higher concentration of C 6-NBD-Cer. Thus, although C 6-NBD-IPC may bind 
via its inositol moiety to ConA, an increase in C 6-NBD-Cer would also be observed due to 
the presence of both fluorescent molecules in the mixed micelles. As Triton X-100 cannot 
be fully removed because this would cause JPC synthase to precipitate this method is not 
applicable to fluorescent product and substrate separation. 
Initial substrate tolerance and structure activity relationship studies of S. cerevisiae IPC 
synthase and its substrates were conducted to allow for future structure based design of a 
fluorescent substrate that might be utilised in a continuous assay. Preliminary data obtained 
with C8-ceramide 47 as a competitive substrate under the optimised C 6-NBD-Cer assay 
conditions at 40 and 80 minutes indicate that 96.1 ± 6.5jiM of C 8-ceramide is required to 
achieve 50% inhibition of C6-NBD-Cer activity. If it is assumed that C 8-ceramide is a 
competitive inhibitor, this result suggests that C 6-NBD-Cer is 5.5-6 times more active than 
C 8-ceramide. Assuming Michaelis-Menten kinetics apply this would give an apparent km of 
approximately 30j.iM, similar to that estimated for [3H]C2-ceramide [448], or an apparent k m  
of approximately 66jiM if the calculation was modified to incorporate a substrate inhibition 
parameter, as was the case with C 6-NBD-Cer. The reason C 6-NBD-Cer appears to have a 
higher affinity for IPC synthase than C 2-ceramide or C 8-ceramide is probably due to the fact 
that the NBD moiety on C 6-NBD-Cer increases the length of the hydrophobic fatty acyl 
chain making it more like the C18  or C20 moiety of the natural phytoceramide. 
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Both lyso Fl 48 and glycerol- i-phosphate 49 were used in place of P1 at various 
concentrations under optimised C 6-NBD-Cer IPC synthase activity assay conditions. By 
comparing specific activity data obtained with equivalent concentrations of P1, it was 
determined that Lyso P1 has approximately 24% of the activity of P1 and glycerol- I-
phosphate has approximately 0.5% of the activity of P1. This emphasises the importance of 
long hydrocarbon chains on the donor substrate. That Lyso P1 can be a substrate mimic has 
been reported by Aeed et. al. who found that Lyso P1 inhibits IPC synthase via a mixed 
mechanism yielding an apparent k 1 in the 50.tM range [501]. 
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Chapter 4: Recombinant Aurip 
Genetic manipulation of A URI and IPCJ genes has been engineered by the insertion of 
promoters at the N-termini by homologous recombination into the genome at the 
A URJ/IPC1 locus [360, 482]. The galactose inducible promoter, GAL 7, was inserted 
upstream to C. neoformans IPCJ [360] and S. cerevisiae Aurip has previously been 
overexpressed in yeast in a pYES plasmid under the control of the galactose inducible 
promoter GAL] [81]. The protein was not isolated and the success of the expression was 
based on the growth of cells in the presence of AbA. At this time the connection that A UR] 
encodes at least an essential subunit of [PC synthase had not been made and [PC synthase 
activity was not determined [81]. S. pombe Aurip has also been up-regulated under the 
control of the thiamine inducible promoter, nmtl, by construction of a pREP 1 plasniid and 
insertion into the S. pombe genome [82]. Mutated S. cerevisiae A UR] has also been utilised 
as an AbA resistance selection marker in transformation systems for industrial yeast strains 
(section 1.7.4.1, [4564601). 
Levine et. al. have inserted three HA epitopes and protein A at the C-terminus of S. 
cerevisiae Aurip [86]. To demonstrate that Aurip and Csglp/Cshlp co-localise to the Golgi 
Lisman et. al. inserted three HA epitopes on the C-terminus of S. cerevisiae Aurip. They 
used anti-HA antibodies attached to magnetic beads to immuno-isolate Aurip containing 
membranes yielding isolation of almost 20% of membranes that contained Aurlp [97]. 
However, as yet there have been no reports of overexpression of Aurip for the purpose of 
purification and characterisation. 
In order to obtain an increased quantity of enzyme for biochemical and structural studies and 
further assay development Syngenta made available an A URI clone from B. cinerea, which 
contains a full length cDNA of B. cinerea AUR] and a 90 base pair untranslated region. 
Workers at Syngenta inserted the cDNA into pBS BK+ plasmid at the restriction sites EcoRI 
and XhoI, followed by PCR amplification. The PCR product was cut with BamHI and 
ligated into pET21a to yield the plasmid, pLZ30. Expression of pLZ30 AUR] (pET21a) was 
attempted in E. coli in both BL2I(DE3) and Stratagene BL21(DE3) Codon plus strains at 
37°C and 28°C. Induction with IPTG concentrations between 100 and 400p.M was also 
investigated. Their analysis of the cell lysate by Coomassie stained gels showed no 
overexpression of AURI under any of these conditions. At this point the B. cinerea AUR] 
construct, pLZ30 A URJ/Bc, was made available for this project. 
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4.1 Recombinant B. cinerea Aurl p Expression in E. coil 
4.1.1 Sequencing pLZ30 AURIIBc 
pLZ30 AUR 1/Bc was transformed into Top 10 One ShotTm Competent Cells (Novagen) and 
sequenced using four primers. Initially, the commercially available T7 (forward) and T7 
term (reverse) primers were used. However, after approximately 550bp the quality of 
sequencing deteriorated and thus, two internal primers, pLZ30 primer intl and pLZ30 primer 
int2, which bound to regions starting at 498bp and 969bp, respectively, were specifically 
synthesised. Analysis has shown that the sequence obtained was identical to that supplied by 
Syngenta. B. cinerea AURJ is 1469 bp in length and contains a large number of intrinsic 
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Figure 4.1: Schematic Representation of B. cinerea AURJ 
The endonuclease restriction sites present in the cloning regions ofpRL385 and pPICZ plasmids are 
highlighted 
4.1.2 Cloning of B. cinerea AURI in E. coil Constructs 
As Syngenta had previously tried recombinant B. cinerea Aurip expression in E. coli to no 
avail, it was decided to investigate this further by developing new constructs. In order to 
reduce the number of purification steps required and increase yields (refer to section 3.1) 
fusion tagging was investigated since this would enable affinity chromatography 
purification. Consequently, histidine (His 6) tagging was investigated and expression of the 
construct should lead to one step purification with immobilised metal affinity 
chromatography. 
His6 tags could be expressed as N-terminal fusions if B. cinerea Aurlp is expressed as part 
of a pETl6b or pET28a construct. As the endonuclease restriction sites NdeI and BamHI are 
present in the cloning regions of both vectors but not in B. cinerea AURI, both sites could be 
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utilised in the cloning procedure. The vector pET 16b has a built in Factor Xa protease 
cleavage site between the His 6 tag and the cloning region and pET28a has a thrombin 
protease cleavage site. Both cleavage sites are upstream of the NdeI site, which after IMAC 
purification and cleavage B. cinerea Aurip would be left with one histidine residue and three 
residues, GlySerllis, attached to the N-terminus of Aurl p, respectively. 
B. cinerea Aurl p does not contain an intrinsic Factor Xa protease cleavage site; however, it 
does contain one Pro-Arg pairing, which has been recognised as a thrombin protease 
cleavage site by PeptideCutter software [624]. There is no consensus target sequence for 
thrombin cleavage but it frequently occurs after the above pairing when it's 30  structure is 
properly exposed [625]. These residues (P353-R354) reside at the start of the predicted 
hydrophilic cytoplasmic tail of B. cinerea Aurip (section 2.4) making correct exposure 
possible. However, biotinylated thrombin and restriction grade thrombin from Novagen are 
functionally tested for specific cleavage at the target sequence LeuValProArgGlySer in 
recombinant fusions, a sequence which does not occur in B. cinerea Aurip. Thus, it was 
decided to attempt cloning in both vectors to maximise the potential for successful 
expression. 
To facilitate cloning a recognition site for the restriction endonuclease NdeI was inserted at 
the 5'end of B. cinerea AURJ and BamHl and Sail recognition sites were inserted at the 
3'end. Primers were designed to incorporate these recognition sites and the pLZ30 AURJ 
insert was amplified with the forward primer, pLZ30 NdeI, and the reverse primer, pLZ30 
rev BamHl Sail. The 3' deoxyadenosine (A) overhang at each end of the PCR product, 
present due to the terminal transferase activity of Taq polymerase, was exploited by TOPO 
TA cloning, which uses a linearised vector (pCR2.l®-TOPO, Invitrogen) that contains a 
single 3' deoxythymidine (T) overhang at position 295. Incorporation of a PCR product into 
position 295 of pCR2.l0-TOPO vector disrupts the ORF of Lac Za and positive 
transformants can be identified by blue/white screening when grown in the presence of X-
gal. When Top 10 cells were transformed with pCR2.1 AURJ/Bc (NdeVSalJlBamI-II) (Figure 






Rachel Breen 	 Chapter 4: Recombinant Aurip 	 Page 113 







Ampicillin 	 Kanamycin 
resistance resistance 
B 	 T7 promoter 
Co1EI on 
/ 





I 	 Co1E1 on 







pCR2.1 AURJ/Bc Forward 	 pCR2.1 AUR1/Bc Reverse 
Figure 4.2: Plasmid maps of pCR2.18-TOPO Vector (Invitrogen) (A) and Forward (B) 
and Reverse (C) pCR2.1 AURJ/Bc (NdeI/SaIIIBamHI) 
As the PCR products could insert into the vector in either direction, positive constructs were 
analysed by digestion with various restriction endonucleases. Analysis determined that both 
forward (Figure 4.213) and reverse (Figure 4.2C) directed constructs had been obtained for 
the NdeJISa!llBamHl/ inserts. The fact that Sail had poor digestion efficiency compared to 
BamHI resulted in all future manipulations being carried out with NdeI and BamHI. 
Large-scale endonuclease restriction digest of the pCR2. 1 A URJ/Bc NdellSalI/BamHI 
construct, to obtain the insert gene, and the expression plasmids pET I 6b and pET28a were 
successfully carried out with NdeI and BamI-II. A number of ligated transformants were 
obtained for both the pET 16b and pET28a constructs. However, no plasmid DNA was 
observed by agarose gel electrophoresis. Antibiotic selection was employed and colonies 
will only grow when an antibiotic resistant plasmid is present inside the cells. Plasmid 
pET 16b contains an ampicillin resistance gene and pET 28a has a kanamycin resistance 
gene. The whole process from digestion to analysis was repeated with fresh materials to no 
avail. A notable difference observed when purifying the DNA, was that far less genomic 
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DNA precipitated than when plasmid DNA is recovered, suggesting a poor growth rate. 
This would be expected since the host cell cannot grow in antibiotic rich media when 
antibiotic resistance is lost. It is possible that the ligated constructs are toxic to E. coli 
causing the cells to degrade the vectors. 
Consequently, it was decided to investigate expression of a GST-Aurlp fusion, which should 
lead to one step purification with glutathione sepharose affinity chromatography. Moreover, 
it was conjectured that the addition of Schistosomajaponicum Glutathione S-transferase 
(GST), which is an exceptionally soluble protein, might increase the solubility of Aurip. An 
N-terminal GST fusion was constructed using the pRL385 plasmid (Figure 4.3). Again both 
NdeI and BamHI or Sall could be utilised in the cloning procedure. Unfortunately the 
protease cleavage site is a thrombin target sequence; however, due to the reasons discussed 
above, cloning was commenced. 
Large scale restriction digest of pRL385 and the pCR2.1 AURI/Bc NdeL'SalJIBarnHI 
construct, to obtain the insert gene, was successfully carried out with NdeI and Barn/lI. A 
single transformant colony was obtained when Top 10 cells were transformed with the 
pRL385 and B. cinerea AURJ ligation product (Figure 4.3). Endonuclease restriction digest 
analysis and sequencing showed B. cinerea AURI to be present. 
promoter 
Thrombin 	IPTG induction 
lacil 	 cleavage site 
Nde site 
pRL3 85-A URI/Bc 
6320 bp 
AURI/& GST (26kDa ) Aurlp/Bc (5OkDa) 
Plasmid _-
replication 
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4.1.3 Expression and Purification of B. cinerea Aurlp as an N-
Terminal GST Fusion in E. coil 
Protein expression using the pRL385 plasmid is under the control of the tac promoter. The 
vector also contains a lad' gene, whose product, the lac repressor, can repress basal 
expression of the target protein. Since both the tac promoter and the lad" gene are present 
on the pRL385 plasmid, a DE3 sequence on the host's genome is not required and it is 
possible to overexpress protein in Top I OTm cells. A typical 3h induction period did not 
yield any overexpression visible by SDS-PAGE compared to the control. However, 
heterologous overexpression of the GST-Aur 1 p/Bc fusion was achieved in inclusion bodies 
in E. co/i Top lOTht  cells with 100mM IPTG induction at 37°C over 18h (Figure 4.4). Cell 
lysis during expression as well as a lack of expression by SDS-PAGE proved to be a 
problem when expressing the GST-A URJ/Bc construct, probably due to the toxic nature of 
the protein to E. coli. Presumably when the protein was expressed in inclusion bodies the 
cells survived because the inclusion bodies protected the cell from the toxic effect of the 
protein. Those which did grow and express successfully had a very distinctive smell. 
Expression was also attempted in the 131-2 I (DE3) strain, however, no hyperexpression was 
observed by SDS-PAGE. This is parallel to observations by Syngenta workers when using 
BL21 strains. 
kDa M Control Induced 
Figure 4.4: SDS-PAGE gel of GST-Aurl p/Bc expression in Top 1OTM  Cells 
Induction conditions are 100mM IPTG, 18h, 37°C, 250rpm; Control conditions are as induced but 
without the addition of IPTG. In order to determine approximate molecular weights a low molecular 
weight standard, M, was used. The expected mass for GST-Aurlp/Bc is 7591413a 
Expression in inclusion bodies can have the advantage that an increased quantity, greater 
than 25%, of expressed protein can be achieved compared to the soluble form [626]. 
Furthermore, the proteins which exist in inclusion bodies generally have far higher purity 
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than cytoplasmic counterparts requiring less purification upon solubilisation. However, this 
does require that effective methods for solubilismg the proteins are available. Solubilisation 
of GST-Aur 1 p/Bc from the inclusion bodies was attempted with a number of detergents, 
including Triton X-100, Octyl glucoside and DDM at various concentrations. Success was 
eventually achieved with 20mM DDM. Recovery appeared to be proportional to the 
incubation time of the inclusion bodies with detergent. Increasing the solubilisation time 
increased the solubilised protein yield. For example, from a similar cell pellet mass, 72h 
solubilisation yielded 0.6mg of GST-affinity purified protein but 24h solubilisation yielded 
0.3mg of purified protein. It should be noted that the GST-Aurlp solubilisation problem 
here is not the same as the solubilisation of wild type IPC synthase since DDM did not 
solubilise wild type B. cinerea IPC synthase activity. Clearly the attachment of the GST 
fusion aids Aurip solubilisation. 
Once solubilised the GST-Aurlp/Bc fusion was subjected to glutathione sepharose affinity 
chromatography and bound protein was eluted using reduced glutathione (Figure 4.5A). As 
can be seen from Table 4.1 only 15% IPC synthase activity was recovered in the elution. 
The SDS-PAGE of the elution is presented in Figure 4.5B and it shows that approximately 
90% of the eluted protein appears to be free GST. GST-Aurlp/Bc did express as a fusion, 
because if miss translation occurred and only GST was expressed it would be soluble, 
expressed in the cytoplasm and present in the cell free extract. However, the free GST was 
solubilised from inclusion bodies, indicating that it has been expressed as a fusion with 
Aur ip. This suggests the fusion was cleaved under the solubilisation conditions utilised. 
This cleavage was observed in all the expression and solubilisation conditions tried. This 
appears to be a 'catch 22' situation as although degradation of the fusion is observed upon 
inclusion body solubilisation, obtaining expression without the GST tag as a non-fused form 
was toxic to E. co/i cells. 
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Figure 4.5: Purification of Solubilised GST-Aurlp/Bc Fusion 
Elution Profile of glutathione sepharose affinity chromatography (A). The red line under the x-axis 
represents eluted IPC synthase activity. 
SDS-PAGE of the purified GST-Aurlp/Bc fusion concentrated 5-fold after elution off the GST 
column (B). Protein (12.tg) was treated with thrombin for 18h at 4°C. 1 unit (U) of thrombin cleaves 
1mg of fusion protein when incubated at 20°C for 16h. When at 4°C, twice as much thrombin is 
required [625]. In order to determine approximate molecular weights a low molecular weight 
standard, M, was used. 
Protein 




Activity Activity (fold) 
Activity 
(nMlrnm) (nM/minlmg) (%) 
20mM DDM extract 41 570 14 1 100 
GST affinity column 0.6 84 140 10 15 
bound 
GST affinity column 40 440 11 0.8 77 
unbound 
Table 4.1: Purification of GST-Aurlp/Bc Fusion 
Starting with 7.35g of E. coil Top 1OTM  cell pellet. 
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There are two possible mechanisms by which this cleavage could occur, by proteolytic or 
chemical cleavage. Inclusion bodies generally do not contain proteolytic proteases. 
However, an E. coli outer membrane aspartyl endoprotease, OmpT [627] has been found to 
associate with inclusion bodies [628] cleaving recombinant fusions that have been expressed 
in inclusion bodies upon solubilisation [629], even under urea denaturing conditions [630]. 
OmpT predominantly cleaves between two consecutive basic amino acid residues, although 
there have been reports of cleavage when only one amino acid was basic [631]. Human 
interferon-y contains ten putative cleavage sites but only two have been shown to be cleaved 
by OmpT [632]. This suggests that the 3° structure of the protein substrate plays a role in 
cleavage by allowing access to the amino acid residues or alternatively, that the enzyme 
interacts differently depending on the residues flanking the cleavage site. 
B. cinerea Aurl p contains a cluster of basic residues (RRMRRRLR, depicted by a yellow 
box in Figure 2.3, section 2.2) at positions 33-40 in a predicted N-terminal hydrophilic loop 
(Figure 2.8, section 2.4). Cleavage here would disconnect GST from B. cinerea Aurip while 
still retaining IPC synthase activity based on the observation that N-terminal truncated 
mutants expressed in P. pastoris are still active (discussed in section 4.2). This would result 
in a GST fraction that has an expected mass of 30kDa and a B. cinerea Aurip fraction of 
45kDa. There is one further potential cleavage site in B. cinerea Aurip, two consecutive 
histidines, which are thought to be part of the active site (Chapter 2). The results do not 
indicate cleavage here as IPC synthase activity would have been lost in the cleaved fraction. 
Moreover, the mass of the major band of the GST affinity column elution runs just below the 
30kDa marker by SDS-PAGE (Figure 4.513), which suggests cleavage occurs near the fusion 
point of the two expressed proteins. GST also contains three possible cleavage sites, K44-
K45 and Kl80-K181-R182; however, as discussed above the major band in Figure 4.5B 
appears to contain full length GST, which has an expected mass of 26kDa. Alternatively, it 
is possible that the cleavage is chemical as doubling the concentration of protease inhibitors 
had no discernable effect on decreasing the cleavage of the GST-Aurlp/Bc fusion. Chemical 
cleavage near the fusion point would yield the mass of the major observed band as it does 
appear to run slightly below the mass expected from OmpT cleavage (30kDa). 
Thrombin cleavage of the GST-Aurlp/Bc fusion was studied under a number of thrombin 
concentrations for various time periods at room temperature and 4°C. At room temperature 
the fusion appeared to degrade rapidly without the appearance of a band corresponding to 
cleaved B. cinerea Aurip. However, at 4°C after l8h with 0.1 and 1 units of thrombin 
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incubation the appearance of an extra band below that of the fusion was observed by SDS-
PAGE (Figure 4.5B). This band could be attributed to either miscleavage of B. cinerea 
Aurip at residues P353-R354, which would yield an expected mass of 66kDa or correct 
cleavage of the fusion, which would yield an expected mass of 50kDa (B. cinerea Aur ip) 
and 26kDa (GST). The band corresponding to the GST fraction in Figure 4.5B does appear 
to thicken slightly with an increased shadow running below the major band. This could 
tentatively be attributed to thrombin cleaved GST (26kDa). The presence of the shadow 
does suggest that the thrombin cleaved GST is of lower mass than the cleavage that occurs 
upon solubilisation indicating that the two cleavages do not occur in the same place, the first 
cleavage occurring further down stream in the B. cinerea Aurip sequence. 
The GST-Aurlp/Bc fusion band purified by GST affinity chromatography was subjected to 
MALDI-ToF mass spectrometry. Although some peaks did correspond to the fusion both 
the coverage and intensity of the peaks were poor, requiring an increased quantity of protein 
for successful analysis. Unfortunately on the scale these studies were conducted not enough 
recombinant fusion was generated to enable further characterisation. 
As the GST affinity column unbound fraction appears to have IPC synthase activity (77% 
activity yield, Table 4.1) the cleaved B. cinerea Aurip must still be functional. It was 
decided to attempt purification of the cleaved protein. The isoelectric point of free B. 
cinerea Aurip is 6.83, with a charge of -0.45 at pH 7.0. Based on the poor binding observed 
with wild type S. cerevisiae IPC synthase on anion exchange columns (section 3.1.1) in 
conjunction with the fact that S. cerevisiae Aur Ip has a much lower isoelectric point of 5.66, 
-6.51 at pH 7.0, it was decided to attempt purification at lower pH and utilise cation 
exchange chromatography. The pH was reduced to 6.00 by dialysis against Bis-Tris-CI 
(50mM, pH 6.0) and glycerol (10%). As DDM was present at 2mM, and its CMC is 0.1-
0.6mM with the micelles having an average molecular weight of 50kDa, it was anticipated 
that the detergent would not be removed by this procedure. Although wild type B. cinerea 
IPC synthase was not solubilised by DDM it appears that the detergent micelles stabilised 
the cleaved recombinant B. cinerea Aurip preventing precipitation. 
The results presented in Table 4.2 indicate that at pH 6.0 cleaved B. cinerea Aurip does bind 
to Resource S, a strong cation exchanger. IPC synthase activity eluted over 0.33-0.42M 
NaCl (Figure 4.6A) giving an activity yield of 81% for the step and an overall activity yield 
of 62% from inclusion body solubilisation. These results agree with the train of thought 
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discussed in section 3. 1.1 in that low S. cerevisiae IPC syrithase yields were obtained due to 
the presence of Triton X-100 micelles, which masked the protein and prevented binding to 
the resin. Although, DDM was present above its CMC there was less (2mM, 0.1%) 
compared to the levels of Triton X- 100 present in S. cerevisiae samples prior to ion 
exchange separation. 
The major band eluted from the Resource S resin (Figure 4.6B) could be cleaved B. cinerea 
Aurip running anomalously higher on SDS-PAGE than the expected mass of 45kDa. The 
highly organised hydrophobic 2° structure of Aurlp could still be retained even in the 
presence of the SDS denaturant causing the protein to run slowly during SDS-PAGE [633]. 
The sample in Figure 4.6B is 2.5-fold more dilute than those in Figure 4.5B. This, in 
conjunction with the fact that only 3-fold purification is obtained, suggests it is possible that 
B. cinerea Aurip is one of the weaker bands in the elution fraction in Figure 4.6B. The high 
activity yield for the Resource S column suggests that TPC synthase activity is not degrading. 
However, further concentration and purification by gel filtration resulted in the loss of IPC 
synthase activity, mainly due to precipitation of protein upon concentration. 
An additional point of concern is that the specific activity of the recombinantly expressed B. 
cinerea Aurlp is less than wild type B. cinerea IPC synthase. E. coil does lack eukaryotic 
activators, and these may be required for optimum activity. Furthermore, E. coii does not 
carry out eukaryotic post translational modifications. As demonstrated in section 3.2, S. 
cerevisiae IPC synthase is glycosylated when natively expressed. This appears to play a role 
in stabilising the activity of S. cerevisiae [PC synthase. Thus, it is logical to suggest that an 
increase in B. cinerea [PC synthase activity may be obtained when it is expressed in a 
eukaryotic host. For this purpose recombinant activity in P. pastoris was investigated 
(section 4.2). 
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Figure 4.6: Resource S Purification of Recombinant B. cinerea Aurip Cleaved from the 
GST-Aurl p/Bc Fusion 
Elution Profile (A) and SDS-PAGE (B) of Resource S chromatography. In order to determine 
approximate molecular weights a low molecular weight standard, M, was used. The input to the 
column is the unbound fraction of the glutathione sepharose affinity column. The unbound sample in 
B is the unbound fraction of the Resource S column. The red line under the x-axis (A) represents 
eluted IPC synthase activity and the eluted protein content is presented in the bound fraction on B. 
	
Protein 	Total 	Specific 	Purification 	Recovered Purification Step 	(mg) 
Activity Activity 
(fold) Activity (%) 
(nMlmin) 	(nMlmin/mg) 
Resource S input 20 220 11 1 100 
Resource S bound 5.5 180 32 3 81 
Resource S unbound 11 33 3 0.3 15 
Table 4.2: Resource S Purification of Recombinant B. cinerea Aurip Cleaved from the 
GST-Aurlp/Bc Fusion 
Half of the GST affinity column unbound fraction was used as input to the Resource S column. 
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4.2 Recombinant Expression in P. pastoris7 
Because of the problems experienced in trying to overexpress full length functional B. 
cinerea Aurl p in E. coli it was decided to attempt expression in a eukaryotic system. There 
are several reasons for choosing the eukaryotic expression system of Pichia pastoris. P. 
pastoris has the benefits of E. coli (high expression level, easy-scale up, inexpensive 
growth) but also has the advantages of eukaryotic systems (protein processing, folding and 
post translational modifications). P. pastoris is unicellular budding yeast like S. cerevisiae 
and there have been a number of reports in which IPC synthase has been expressed in yeast 
[79, 86, 97, 442, 500, 611]. However, P. pastoris contains stacked Golgi cistemae unlike S. 
cerevisiae, which has dispersed Golgi. Thus, the environment for recombinant expression of 
B. cinerea Aurip may be more similar to its native environment if expressed in P. pastoris 
rather than S. cerevisiae. Furthermore, enzymes in the sphmgolipid pathway have been 
functionally recombinantly expressed in P. pastoris [137]. 
If the putative N-Glycosylation site in B. cinerea Aurip is glycosylated, it should be 
modified during expression in the P. pastoris host. Both S. cerevisiae and P. pastoris 
contain N-linked glycosylated proteins with high mannose content. However, P. pastoris, 
which typically contains glycoproteins with 8-14 mannose side chain residues, are less likely 
to hyper-glycosylate recombinantly expressed proteins compared to those expressed in S. 
cerevisiae, which typically has 50-150 mannose side chains residues on glycosylated 
proteins [635, 636]. Moreover, S. cerevisiae glycans contain terminal al,3 glycan linkages, 
whereas P. pastoris generated glycoprotein is thought to resemble the glycan structure of 
higher eukaryotes [637]. This also suggests that expression in P. pastoris may be more 
beneficial to B. cinerea Aurip than heterologous expression in S. cerevisiae. 
P. pastoris is methyltropic as it can metabolise methanol as its sole carbon source. Hence, 
methanol inducible expression vectors, pPICZ vectors, are available, which enable 
expression of the target protein with His 6 and c-myc epitope tags at the C-terminus. The 
His6 tag could be utilised for IMAC purification and commercially available anti-c-myc 
epitope antibodies could be utilised for detection of recombinantly expressed protein. This 
method should be successful as Levine et. al. have previously expressed S. cerevisiae Aurip 
in a diploid yeast strain with a C-terminal c-myc epitope tag [86]. Recombinant expression 
of S. cerevisiae Aurip in P. pastoris was also investigated for comparison. 
see [634] for background information on recombinant expression in P.pastoris 
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Heterologous proteins in P. pastoris can either be secreted or expressed intracellularly. As 
very little native protein is secreted by P. pastoris, using the secretion method would act as 
the initial purification step [638]. In order for secretion to occur a signal sequence, which 
targets the secretary pathway is required. Variable success has been achieved with a variety 
of signal sequences, including those native to the heterologous protein. By far the greatest 
success has been achieved with the a-factor prepro peptide from S. cerevisiae [637, 639]. 
As such, P. pastoris pPICZ vectors are available, which contain the cc-factor signal 
sequence. 
The presence of both the native heterologous protein signal sequence and the a-factor signal 
sequence could cause confusion during the processing of the recombinant protein. This 
could be alleviated by the removal of the native sequence when expressed as a pPICZaA 
construct. Analysis of Aurip sequences with respect to signal sequence prediction indicates 
that yeast and fungal Aurl proteins contain at least one peptide anchor that is thought to 
target retention of the protein to the medial Golgi membrane by either passive or active 
means (section 2.3). Aurip contains multi TMHs and removal of the signal anchor(s) would 
require expression without one or two of the TMFIs. This could be problematic as the 
topology of the TMHs could be altered causing a loss of IPC synthase activity through 
misfolding. In addition, due to the presence of numerous TMHs there is also the possibility 
that Aurip would be retained in the membrane and not secreted. Both these factors suggest 
that intracellular expression maybe more applicable to Aurip. However, in order to conduct 
a comprehensive study on the expression of Aurl p in P. pastoris it was decided to 
investigate both intracellular and secreted expression. 
Although there is a lack of conservation in the C-terminal Aurip amino acid sequences 
(section 2.1) it has been proven to be essential for S. cerevisiae and S. pombe IPC synthase 
activity and as such is thought to be species specific [79, 82, 83]. There have not been any 
reports of similar investigations into the role of the N-terminus. As discussed above and in 
section 2.3, Aurip does not appear to contain a classical signal sequence. However, removal 
of the positively charged N-terminal region (n-region, section 2.3) could affect the behaviour 
of the putative signal anchor and reduce the possibility of complications upon expression 
with the a-factor secretion signal sequence. Expression without the N-terminus could also 
determine its effect on IPC synthase activity and/or stability. In order to study this and to 
prevent the topology of Aurip TMBs from being disrupted, the AURJ gene was truncated 
upstream of the first predicted TMH corresponding to Ser75 and A1a4 I for B. cinerea and S. 
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cerevisiae Aurip, respectively (denoted by V in Figure 2. 1, section 2.1). Consequently, 
pPICZaA (secretion) and pPICZ XhoI mut (intracellular) constructs of full length A URI and 
truncated A URI were prepared for both B. cinerea AURI and S. cerevisiae AURI. 
4.2.1 Cloning of B. cinerea and S. cerevisiae AURI in P. pastoris 
Constructs 
Of the ten endonuclease recognition sites available in the cloning region of pPICZaA, four 
were present in B. cinerea A URI (Figure 4.1) and one was present in S. cerevisiae A URJ 
(Figure 4.7). Based on the remaining available restriction sites and the degree of base pair 
overhang upon endonuclease digestion A7oI, XbaI and Nod were selected for cloning. All 
three have an overhang of four base pairs upon digestion that should facilitate ligation. 
Barn/-Il (155) 	EcoRI (424) 	NcoI (608) 	 Pstl (1042) 
- I 	 I 
A URJ/Sc 
1206 bp 
Figure 4.7: Schematic Representation of S. cerevLsiae AURJ 
The endonuclease restriction sites present in the cloning regions of pRL385 and pPICZ plasmids are 
highlighted 
Constructs were made both with and without the cc-factor secretion signal sequence. Upon 
secretion of the target protein to the media the signal sequence is cleaved at both Kex2 and 
Ste 13 cleavage sites. For expression as part of the pPICZaA construct and for Aurlp to 
exhibit its native N-terminus upon cleavage of the cc-factor secretion signal sequence, XlzoI 
had to be utilised as the 5' restriction endonuclease (Figure 4.8). PCR was used to rebuild 
the Kex2 and Ste 13 cleavage sites downstream of the first )72o1 target sequence. 
In order for Aurip to be expressed iniracellularly under its native signal sequence the 
presence of a kozak sequence is required at the 5' end of the gene. A kozak sequence is a 
yeast consensus sequence of approximately 5-6 base pairs in length, AJYAA/TAAI, where 
Y is pyrimidine T or C. The sequence must be flush to the start codon and is required for P. 
pastoris mRNA recognition [640]. The sequence utilised successfully was 
XhoI-CAATAATG. The addition of this sequence was not required in the preparation of the 
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gene for expression as part of pPICZaA constructs as the ATG of the a-factor corresponds 
to the initiation sequence of the AOXJ gene. 
There is a second JlioI recognition site present in the cloning region of pPICZaA. However, 
it was decided to utilise a different endonuclease recognition site for the 3' ligation so that 
the direction of the inserted gene could be controlled. Initially the endonuclease recognition 
site for XbaI was utilised at the 3' end of the gene as this would minimise the number of 
additional amino acid residues present between the end of the target protein and the 
beginning of the c-myc epitope tag. However, only one construct (pPICZ(xA-AURJ/Bc) was 
successfully cloned using A72o1 and XbaI. The reasons for this are discussed in further detail 
below. The remaining cloning procedures were conducted using .XhoI and NotI. To allow 
for C-terminal c-myc epitope and polyhistidine tags the Aurip stop codon was removed. In 
addition two extra base pairs were added when XbaI was used at the 3' end of the gene to 
ensure an in phase ORF. These extra base pairs were not required when the NotI recognition 
site was utilised. 
S. cerevisiae A URI and B. cinerea A UR] were amplified by PCR using S. cerevisiae 
genomic DNA and pPRL3 85-A URJ/Bc as templates. Endonuclease recognition sites were 
incorporated at the 5' and 3' end of each gene with additional modifications corresponding 
to the requirements of the expression vectors discussed above. The PCR products were 
ligated into either pCR2. 1 (A URJ/Bc Kex XhoIJXbaI) or pGEM (other PCR products) 
amplification vectors. The pGEM vector is a commercially available linearised vector based 
on the same principals as pCR2. I. The truncated genes were initially prepared by PCR 
without the incorporation of the 5' restriction site and additional modifications. They were 
ligated into pGEM vectors for use as templates in a second PCR. A second amplification 
was conducted to incorporate the required restriction sites and the modifications required for 
expression as part of a P. pastoris construct. 
The amplification vectors were digested with XhoI and either XbaI or Nod restriction 
endonucleases and ligated into the P. pastoris expression vectors, pPICZaA or pPICZ XhoI 
mut (Figure 4.8, Figure 4.9 and Table 4.3) depending on whether secretion or intracellular 
expression was intended. This initial cloning was carried out in E. co/i cells as the P. 
pastoris expression vectors are shuttle vectors, which contain the pUC origin sequence. 
Selection was based on the antibiotic zeocin, under low salt concentration [634]. 
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The pPICZ XhoI mut construct required for intracellular expression of the target protein was 
prepared from pPICZaA. The SfuI recognition site upstream of the 5' end of the ct-factor 
secretion signal sequence was mutated to an )7oI recognition site using site directed 
mutagenesis. Quick Change Mutagenesis (Stratagene) was utilised in which overlapping 
primers containing the two base pair mutations were used to amplify the vector by PCR. The 
methylated template was digested with the restriction endonuclease DpnI. Top 10 cells were 
transformed with the undigested mutated vector, pPICZ XhoJ mut. Preparative digestion of 
the mutated vector with XhoI and NotI restriction endonuc leases successfully removed the cc-
signal sequence ORF. A control pPICZ XhoI mut vector was prepared by an X7zoI 
endonuclease restriction digest to remove the a-factor signal sequence. 
5' AOXJ promoter 
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Figure 4.8: Plasmid map of pPICZaA and pPICZ XhoI mut (no a) 
The expanded region of pP!CZctA (A) highlights the cloning region of the vector. The endonuclease 
restriction sites utilised in the cloning and transformation procedures are highlighted by an asterisk. 
The SfuI site was mutated to an Xhol site to yield pPICZ )t7iol mut. Digestion of the Xhol mutant with 
XhoI removes the a-factor to yield pP!CZXhoI mut(no a) (B). AOXI TT corresponds to the AOXI 
transcription termination region. The pUC ori allows cloning to be carried out in E. coli and is located 
on the opposite strand to the other features highlighted. 
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Figure 4.9: Plasmid map of pPICZaA A URJ and pPICZ XhoI mut A URJ 
A URI corresponds to both full length and truncated A URI from both B. cinerea and S. cerevisiae. 
The endonuclease restriction sites utilised in the cloning and transformation procedures are 
highlighted. pPICZctA AURI/Bc used XhoI and XbaI; the remaining clones used XhoI and NotI. 







used in Cloning 
Amplification 
Vector 
pPICZaA A URI/Bc Bc Full length Secretion XhoI/Xbal pCR2. I 
pPICZaA A URI/Bc Trunc Bc Truncated Secretion .XholJNotI pGEM 
pPICZaA A URI/Sc Sc Full length Secretion XhoL/NotI pGEM 
pPICZaA AURJ/Sc Trunc Sc Truncated Secretion XhoIINotI pGEM 
pPICZaA - - Secretion - - 
pPICZ Xhol mut A URI/Bc Bc Full length Intracellular XhoL'NotI pGEM 
pPICZ XhoI mut A UR 1/Bc Bc Truncated Intracellular XhoL/NotI pGEM 
Trunc 
pPICZ XhoI mut A URI/Sc Sc Full length Intracellular XhoIlNotI pGEM 
pPICZ XhoI mut AURI/Sc Sc Truncated Intracellular )7zoIINotI pGEM 
Tnmc 
pPICZ Xhol mut (no a) - - Intracellular Xhol - 
Table 4.3: Constructs Prepared for Aurip Expression in P. pastoris 
Abbreviations Bc, B. cinerea; Sc, S. cerevisiae 
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B. cinerea A URJ was successfully amplified by PCR with XhoI and XbaI recognition sites 
incorporated at the 5' and 3' end of the gene, respectively. The 3' end of the a-factor 
sequence containing the Kex2 and Ste 13 cleavage sites were added between the XhoI 
recognition site and the start of AUR], and the stop codon was removed to yield the PCR 
product, A URI/Bc Kex XhoL1XbaI. The agarose gel electrophoresis purified PCR product 
was successfully cloned into the amplification vector, pCR2. I yielding 3 positive 
transformants. Ligation of the X7zoI and XbaI digested gene and pPICZaA yielded 11 
positive iransformants, termed pPICZaA-AURJ/Bc (Figure 4.9). 
When this was repeated with the 5' Kozak primer, AURJBc XholKozak F, for B. cinerea 
AUR] and both the Kex, AURJSc XholKex F, and Kozak, AURISc XholKozak F, primers 
for S. cerevisiae A UR] in conjunction with XbaI reverse primers, anomalous results were 
obtained. Sequencing of the obtained pCR2. I vectors showed that the plasmids had 
rearranged and the ampicillin resistance gene had inserted into the cloning region in place of 
AUR1. To combat this, primers were designed which incorporated the necessary restriction 
sites and extended the length of the PCR product to optimise endonuclease restriction digest 
efficiency and make an amplification vector unnecessary. The PCR products (extended 
A URJ/Bc Kozak Xho!JXbaI, extended A URJ/Sc Kex A7IoL/)thal and extended A URI/Sc 
Kozak XhoL'XbaI) were then purified by phenol/chloroform extraction and ethanol 
precipitation before digestion with J72oI and XbaI. 
Sequencing of pPICZaA-AURJ/Sc purified from both of the obtained transformants revealed 
that the two )7zoI recognition sites in the pPICZaA cloning region had been digested and 
then re-ligated, removing the 3' end of the a-factor and the cleavage sites but not digesting 
the XbaI target sequence. Using pPICZaA-A URJ/Bc as the pPICZaA source in preparative 
restriction digest did yield successful digestion but no transformants upon ligation. This may 
be due to poor digestion of the A URI gene in the extended PCR products. Problems with 
ligations using XbaI as one of the restriction endonuc leases have also been reported in our 
laboratory (Andy Herbet, private communication). Thus, in the remaining cloning 
procedures I utilised Notl in place of XbaI at the 3' end of the gene. As an additional 
measure pGEM vectors were used to amplify the PCR products prior to digestion. 
Due to the presence of additional NotI restriction sites in the pGEM vector close to the 
inserted PCR products, simultaneous )UoI and NotI digestion ofAURJ proved difficult. The 
solution was to digest the vectors sequentially by initially incubating with A7zoI prior to the 
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addition of Noll. This sequential method of digestion was also employed for removal of the 
cc-factor in pPICZ dk7zoI mut constructs and the digestion of pPICZaA when XhoI and Noll 
were utilised as the restriction endonucleases. As the second ..k7zoI site and the Notl site are 
close together, the pPICZ plasmids were initially incubated with Nod, followed by )7zoI. 
This approach proved successful for cloning the remaining constructs. 
Rapid T4 DNA ligase (Roche) was routinely used in the final ligations of the cloning 
procedure. However, only a few transformants were obtained each time with a maximum of 
20 colonies for the full length S. cerevisiae AURJ constructs. Ligation of the truncated genes 
into pPICZaA to yield pPICZaA-AURJ/Bc Trunc and pPICZaA-AURJ/Sc Trunc as well as 
preparation of the pPICZ XhoI mut construct without the cc-factor, for use as a control 
(digestion with XlzoI only) proved difficult to achieve under the conditions described above, 
using Rapid ligase (Roche, 5U/pJ) and normal T4 ligase (New England Biolabs, 400U/p.l). 
However, when concentrated T4 ligase (2000U/tl) was utilised in an 18h incubation at room 
temperature, over a hundred transformant colonies for each construct were obtained. 
Restriction digest analysis of pPICZ )ThoI mut AURJ/Bc revealed that an additional EcoR! 
endonuclease restriction site had been incorporated into the construct. This is due to the Notl 
site at the 3' end of the gene being adjacent to an EcoRI site and another Notl site after 
insertion into the pGEM vector. When digested with )7ioI and Notl the second Notl site was 
cleaved. Insertion of the extra sites (EcoRI and Not!) did not affect the ORF allowing C-
terminal expression of the c-myc epitope and polyhistidine tag. Even though the amino acid 
spacer between the end of Aurlp and the tags would be increased from 6 to 15, with an 
increase in mass from 52.5kDa to 53.4kDa, it should have very little if any affect on the 
expression of the construct. 
Sequencing of full length and truncated B. cinerea and S. cerevisiae AURI pPICZ constructs 
showed the genes had inserted correctly, with the exception of additional residues present in 
pPICZ XhoI mut AURJ/Bc, as discussed above. Unfortunately, sequencing using the internal 
primers also indicated that seven single base pair mutations had occurred during PCR 
amplification of B. cinerea AURI. Two of these did not alter the translated amino acid; 
however, five did cause amino acid mutations: E145V, L179R, Y220H, 5404T and P412T, 
where the residue number corresponds to the position of the amino acid in full length B. 
cinerea AURI. The first mutation, E145V, occurs at the beginning of the conserved central 
section. This is not involved in a putative post translational modification pattern (Figure 2.3) 
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but the acidic property of the amino acid (E or D) is conserved in fungal and S. cerevisiae 
Aurip (Figure 2.1). Leu179 and Tyr220 are conserved in yeast and fungal Aurip and reside 
upstream of Dl and between Dl and D2 within the predicted ABC transporter domain of C. 
neoformans Aur Ip (Figure 2.1, section 2.1.1). As such both residues could potentially be 
involved in substrate binding. Ser404 is conserved in flmgal Aurip sequences and Pro412 is 
conserved in the majority of Aurip sequences analysed (Figure 2.1). Pro412 lies within a 
putative Casein Kinase II phosphorylation motif but it is not a consensus residue for this type 
of sequence (Figure 2.3, section 2.2.2). However, it was decided to use the constructs for 
studying B. cinerea Aur I  recombinant expression. If successful expression was achieved 
then the required clone could be reconstructed by re-mutation or using pLZ30 as the 
template and higher affinity polymerase. 
4.2.2 Transformation into P. pastoris and Clone Selection 
Two different P. pastoris strains were transformed by electroporation with the P. pastoris 
AUR] constructs shown in Table 4.3. Additional strains were also transformed with 
pPICZaA and pPICZ XhoI mut (no a) as controls. Three endonuclease recognition sites, 
Sad, PmeI and BstXI, are available on the pPICZ vectors for generation of linear plasmids. 
As B. cinerea A URI contains a BstXI recognition site, Sacl or PmeI were used to linearise 
the constructs prior to electroporation. In order for complete digestion to occur excess 
endonuclease had to be used and the purified plasmids had to be concentrated to 
approximately 3p.g/j.tl by isopropanol precipitation. Using approximately lOp.g of lineansed 
construct, the target AURI gene and controls were inserted into the P. pastoris genome of 
both X-33(Mut) or KM7IH (MutS)  strains yielding hundreds of positive transformants per 
construct. Selection occurred using the antibiotic zeocin (100tg/ml). For each construct 
sixteen transformants were analysed. 
Linear constructs tend to favour single crossover events at the AOXJ locus [634] and the 
majority of transformed X-33 strains would insert the construct at the 5' end of the AOXJ 
gene, leaving X-33 with a Mut phenotype. However, as the 3 'A OXI sequence is present on 
the plasmids, recombination could disrupt wild type AOXI rendering it MutS.  Confirmation 
of the transformed X-33 phenotype, by growth on both methanol and dextrose based media, 
was required to determine expression conditions. As KM7 111 is already MutS,  it will retain 
this phenotype. Hence, such analysis is not necessary for KM71H strains. Only one of all 
X-33 recombinants analysed, a transformant of the control construct pPICZaA, had become 
MutS .  This strain was not taken further. 
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Multiple recombinants were screened for by observing the growth on plates containing a 
high concentration of zeocin (500p.g) (Figure 4.10). The majority of strains were healthy in 
the presence of high antibiotic dose. Healthy transformants were screened for the 
recombinant AURI gene insert by PCR with 5' and 3' AOXI primers and primers unique to 
B. cinerea and S. cerevisiae A UR] (Figure 4.11). Results were improved when the P. 
pastoris genomic DNA was purified prior to amplification. When using AOXI primers on 
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Figure 4.10: Example of Results Obtained with P. pastoris Transformants in the 
Presence of High Antibiotic Dose 
The growth of two streaked P. pastoris transformants after 2 days at 30°C on an '{PDS plate 
containing 500p.gIml zeocin is presented. The left-hand strain is a multi recombinant strain whereas 
the right-hand strain is a possible single recombinant. 



















Figure 4.11: 1% Agarose Gel of the PCR Screen of P. pastoris Genomic DNA 
Transformed with pPICZaA AURJ/Sc Trunc 
Both 5' and 3' AOX primers (A) and A URI primers (A URI/Sc Kex Trunc )31o1 F and A URJ/Sc Not! 
R) (B) were used. The results from two P. pastoris X-33 transforrnants (lanes 1 and 2) and two P. 
pastoris KM7 1H transformants (lanes 3 and 4) are presented. The pPICZaA A URI/Sc Trunc plasmid 
was used as a control (lane 5). Hyperladder I TM  standard was used to determine approximate number 
of base pairs. The expected number of base pairs using 5' and 3' AOXprimers was 1626bp (A) and 
using AURI primers was 1 l3Obp (B). The additional bands at 2200bp for X-33 (Mutt) strains when 
the AOXprimers were used is due to amplification of the AOXI gene (A). 
Based on the results obtained for the PCR screen of the earlier transformants, pPICZaA-
AURJ/Bc and pPICZaA-AURI/Sc, ten X-33 strains and ten KM71H strains were selected 
and screened by small scale expression (lOml). Both cell pellets and media were analysed 
by SDS PAGE, anti-His (C-term)-HRP antibody western blots and IPC synthase activity 
assays. There was no conclusive evidence to suggest recombinant expression. Thus, the 
pPICZ XhoI mut and truncated A URI constructs were made and two of each strain were 
selected for large scale expression based upon the results of the PCR screen. 
4.2.3 Expression and Purification of Recombinant B. cinerea and 
S. cerevisiae Aurip in P. pastoris 
AOXJ is tightly regulated at the transcription level and expression is a two step process of 
repression/depression and induction mechanisms, similar to GAL] in S. cerevisiae [6411. 
Glucose represses transcription even in the presence of methanol induction. Thus, P. 
past oris cells were grown on de-repressor glycerol based media [634]. 
The selected strains were initially grown in glycerol based media (X-33, Sml; KM7IH, 
I Omi) under zeocin selection (1 OOp.gIml) for 18h at 30°C, 250rpm. The cultures were then 
used to inoculate larger volumes of glycerol based media (X-33, 300m1; KM71H I.2L) for a 
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further 18h. After the initial growth, the cell density was high enough to omit zeocin in the 
larger batches. Both these steps were utilised to generate cell mass. In the absence of 
methanol both phenotypes, Mut and Muts,  had an equivalent growth rate with a doubling 
time of two hours. However, in the presence of methanol Muts  growth is much slower with 
a doubling time of 18h compared to Mut of 4-6h. After harvesting by centrifugation, 
treatments of the two phenotypes bifurcate. The X-33 (Mut') strains were resuspended to an 
ODl .5 in methanol (0.5%v/v) based media and grown in the log phase for 4 days 
(250rpm, 30°C, 600m1, 2x300ml in 2xlL flask). In contrast, KM71H (MutS)  strains were 
resuspended to a much higher cell density with an 0D 60020-40 in methanol (0.5%v/v) based 
media and grown for 6 days (250rpm, 30°C, 300mL in ixiL flask). Methanol was added to 
both phenotypes to a final concentration of 1 .0%v/v every 24h to compensate for metabolism 
and evaporation. As additional controls, untransformed X-33 and KM7IH strains were also 
grown in both glycerol and methanol based media without the presence of zeocin. All cells 
grown in methanol based media had a light green colouration. This is due to the presence of 
induced alcohol oxidase, which forms a homo-octamer that binds flavin adenine 
dinucleotide. When present in high concentration, as is experienced in the presence of 
methanol, the enzyme forms a crystalloid with a green chromophore [642]. 
The cell pellets, and media in the case of the secretion constructs containing the a-factor, 
were analysed by SDS-PAGE, westerns blots and IPC Synthase activity assays. As no 
positive results were obtained for the small scale expression ofpPICZaA-AUR]/Bc and 
pPICZaA-AURJ/Sc constructs using anti-His (C-term)-HRP antibody, possibly due to the 
conjugation of HRP to the anti-His antibody, it was decided to use anti c-myc antibodies for 
detection of the large scale expressions. Failure of detection using anti-His antibodies has 
previously been experienced in our laboratory (Andy Herbert, private communication). 
Thus, it was decided to use separate antibodies (1 0, anti c-myc antibody (mouse); 2°, anti 
mouse-HRP) for the detection of recombinantly expressed protein. Due to the large quantity 
of native protein present, many bands were observed by both SDS-PAGE and western blots. 
Little information could be gleaned from either, as the AURI transformants appeared to be 
very similar to the controls. Cell based [PC synthase activity assays were conducted under 
optimum conditions using a similar method to that described by Levine et. al. [86] (section 
5.18.3.8). The results are represented graphically in Figure 4.12. 
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Figure 4.12: IPC synthase Activity of P. pastoris Cell Pellets: A, Specific Activity; B, 
Total Activity 
The controls represented by methanol or glycerol media have not been transformed with any 
constructs. The pPICZ XhoI mut construct does not contain the a-factor secretion signal sequence. 
The horizontal dashed lines represent the threshold of native P. pastoris IPC synthase specific activity 
for the X-33 strain (Mut,_ - -) and the KM7IH strain (MutS,_ - ). IPC synthase activity above 
the threshold is attributable to recombinant Aurip. Two of each strain were subjected to large scale 
expression, however, only those chosen to be purified are presented here. 
As the P. pastoris strains utilised are not A UR] deletion strains and that P. pastoris is a 
yeast, one would expect P. pastoris to contain native Aurlp and IPC synthase activity. This 
is reflected in the measured IPC synthase activity obtained in the controls (Figure 4.12). 
With the exception of the pPICZctA-AURJ/Bc construct, the X-33 strains appear to exhibit 
higher IPC synthase specific activity than the KM7 I H strains for both the controls and those 
containing recombinantly expressed Aurlp. In the presence of methanol, X-33 is in the 
exponential phase and would grow in a way that is comparable to the wild type conditions 
for native Aurip expression. It is also possible that due to faster growth rate X-33 contains 
Aur I  activators not present in KM  1 H. 
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Strains exhibiting IPC synthase activity above the threshold indicate recombinant Aurip 
expression. The pPICZ )c7iol mut constructs, which facilitate intracellular expression, appear 
to successfully express recombinant Aurip from B. cinerea and S. cerevisiae. The strains 
containing truncated A URJ in the secreted constructs also appear to express Aurip, but to a 
lesser extent. One X-33 strain and one KM71H strain were selected for each construct based 
on the cell based IPC synthase activity assay and the PCR screen for enzyme isolation and 
purification. 
The C-terminal polyhistidine tag attached to recombinantly expressed Aurip was utilised for 
purification using IMAC. The aim of this was to determine which constructs best express 
Aurlp. At this stage it was not yet known how recombinant Aurip would behave, and to 
minimise the number of Ni2l  columns required, the selected pellets were lysed and 
solubilised in buffer containing 1% Triton X- 100 (20m1). Wild type IPC synthase isolation 
typically employs Tris-CI (50mM, pH 7.0) buffer for lysis and Bis-Tris-CI (50mM, pH 6.0) 
buffer for solubilisation (section 3. 1.1 and 5.16.1). However, as Tns based buffers can elute 
weakly bound proteins from the Ni" Sepharose resin, it was decided to use K-Phos (20mM, 
pH 7.4) in the presence of 0.5M NaCl, which is recommended for this type of 
chromatography. EDTA, usually present in the lysis buffer, was omitted to prevent nickel 
ions from being stripped from the resin. The divalent metal ions (Mg 2 and Mn2 ) known to 
stimulate solubilised JPC synthase activity [611] were also omitted in case they bound to the 
polyhistidine tag and reduced binding to the resin. 
Cell pellets were lysed using a bead beater in buffer containing Triton X-100 (1%) and 
stirred slowly for 2h at 4°C to ensure solubilisation of Aur ip. Insoluble material was 
removed by centrifugation (1 00,000g, 4°C, 45mm) and the supernatant was passed through a 
Ni2l column (0.25m1 column volume). To ensure unbound proteins were removed the 
column was washed with 20 volumes of buffer containing 0.05% Triton X-100 and 5mM 
imidazole (5mL, 20 column volumes). Elution of bound protein was achieved with buffer 
containing 0.05% Triton X-100 and 0.5M imidazole (1.25mL, 5 column volumes). The 
media samples were dialysed against the equilibration buffer prior to loading onto the 
column to remove any secreted amino acids, especially histidine, which could reduce or 
prevent binding. The purified samples were analysed by SDS-PAGE, western blot (1°, anti 
c-myc antibody (mouse); 2°, anti mouse-HRP) and IPC synthase activity assay. Media 
samples were also concentrated by TCA precipitation prior to SDS-PAGE and western blot. 
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Very little useful information was obtained from the cell pellets of strains containing the Ct-
factor secretion sequence. Analysis of the media of strains containing the pPICZxA 
constructs also gave poor results. Although the media samples appeared to exhibit IPC 
synthase activity prior to IMAC treatment, so did the media of the control strains. Assay 
controls which utilised boiled media samples were used to determine the background 
fluorescence and it was found that something present in the media degraded C 6-NBD-Cer 
yielding an increase in background fluorescence at the equivalent R f to C6-NBD-IPC. When 
the protein in the media samples were TCA precipitated and subjected to SDS-PAGE and 
western blots positive bands were observed. However, upon MAC purification only one 
protein band was observed for the pPICZaA AURJ/Bc X-33 strain at a mass of 
approximately 33kDa. The KM71H strains containing the truncated AURJ constructs 
appeared to have a small amount of activity above the background but even after TCA 
precipitation of the eluted samples no further bands, except the one at 3 3kDa for the 
pPICZaA AURJ/Bc X-33 strain, were observed by SDS-PAGE or western blot. 
The data obtained from the intracellular expression was much more promising. Proteins 
eluted from Ni" chromatography gave bands on SDS-PAGE corresponding to AURJ, which 
gave a positive response in western blotting using anti c-myc antibody and HRP detection 
(Figure 4.13). There are also bands present in the control elution of equal intensity by SDS-
PAGE that do not give a positive western. This indicates that the antibody is selective for a 
c-myc epitope. As all columns were washed with twenty column volumes the protein 
present from the control construct should not be due to non-specific binding, suggesting that 
there are proteins present in the cell lysate of the controls that can bind to Ni . This is 
discussed below. 
Two bands (Figure 4.13), which appear just above the 64kDa marker in extracts of strains 
encoding full length B. cinerea and S. cerevisiae Aur I  are unique to these strains and are 
not present in the strains containing truncated Aurip. This suggests they are due to full 
length recombinant Aurip. The second band in full length constructs just below the 64kDa 
marker is also present in the intracellular truncated Aurl p purified samples and is unique to 
these four strains. It is highly probable that this band is due to Aurlp truncated upstream of 
the first predicted TMH. As this region would be exposed in its 30  structure it is possible 
that full length Aurlp would be subject to proteolysis giving rise to a band of similar mass to 
the intentionally truncated Aurip's. It is also possible that the presence of recombinant 
Aurip may cause up-regulation of other genes but the western blotting results indicate that 
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the majority of the purified bands are due to recombinant protein. This suggests that 
recombinant Aurip is being degraded. 
Little is known about proteolysis in P. pastoris and as such prediction of proteolytic sites in 
the Aurip sequences is difficult. However, it is probable that cleavage occurs between the 
predicted TMHs due to exposure of the 3° structure in hydrophilic loops. As the TMIHs are 
thought to reside at similar positions in the B. cinerea and S. cerevisiae Aurl p sequences 
(see section 2.4) cleavage at the TMH extremities would give rise to similar sized B. cinerea 
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and 48kDa for S. cerevisiae) 
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Figure 4.13: SDS-PAGE (A) and Western Blot (B) of pPICZ XhoI mut AURJ 
Constructs Expressed in P. pastoris after Solubilisation with Triton X-100 and IMAC 
The constructs contained full length B. cinerea AURI (lane 1), full length S. cerevisiae AURI (lane 2), 
truncated B. cinerea A URJ (lane 3), truncated S. cerevisiae A URI (lane 4) and the pPICZ xhol mut 
(No (x) control (lane 5). All constructs containing AURJ (lanes 14) were expressed in KM7IH 
(Muts) but the control was expressed in X-33 (lane 5). No bands were observed by SDS-PAGE or 
western blot for the corresponding X-33 strains for AURI constructs or the for KM7IH strain for the 
control. In order to determine approximate molecular weights a SeeBlue® Plus2 Pre-Stained 
Standard, M, was used. Western blotting used Anti c-myc (mouse) and anti mouse-HRP (sheep) 
antibodies. 
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The expected mass of full length Aurip and truncated Aurip species is 53, 48 and 44kDa for 
B. cinerea Aur ip, S. cerevisiae Aur 1 p  and both B. cinerea and S. cerevisiae truncated 
Aurip. However, as can be seen in Figure 4.13 the bands giving rise to positive western 
blots exhibit much higher mass. This suggests that the protein is modified in some way. 
Preliminary investigations (Figure 4.14) reveal that IMAC purified recombinant Aurip is not 
complexed to a co-factor(s) as boiling the samples or treatment with 6M guanidine does not 
alter the position of the bands on SDS-PAGE. Incubation with ConA resin has tentatively 
indicated glycosylation of recombinant B. cinerea and S. cerevisiae Aurip. Although after 
incubation the supernatant does still contain the same bands by SDS-PAGE the intensity of 
the bands was reduced greatly and these cannot be observed for the truncated S. cerevisiae 
Aur 1 p  preparation, indicating binding to the ConA resin. The results suggest that all bands 
are glycosylated as all of them disappear or are equivalently reduced in intensity. 
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Figure 4.14: SOS-PAGE of IMAC Purified Full Length and Truncated S. cerevisiae 
AURJ pPICZ XhoI mut Constructs Expressed in P. pastoris KM71H and Subjected to 
Various Treatments 
The constructs containing full length S. cerevisiae A URI are in the odd numbered lanes (lanes 
1,3,5,7). The constructs containing truncated S. cerevisiae A URI are in the even numbered lanes 
(lanes 2,4,6,8). The proteins were treated for 10 minutes at 100°C (lanes 1 and 2), for 45 minutes at 
100°C (lanes 3 and 4), with 6M guanidine (lanes 5 and 6) and by incubation with ConA resin (lanes 7 
and 8). Prior to loading all samples were suspended in SDS buffer containing (3-mercaptoethanol and 
held at 100°C for 10 minutes, unless otherwise stated. The corresponding B. cinerea A URJ constructs 
were subjected to equivalent treatment and gave rise to very similar results by SDS-PAGE. In order 
to determine approximate molecular weights a SeeBlue® Plus2 Pre-Stained Standard, M, was used. 
Treatment of wild type S. cerevisiae solubilised microsomes with ConA has shown wild type 
S. cerevisiae IPC synthase to be glycosylated (section 3.2). However, not all of the protein 
bound leaving 11% of recovered 1PC synthase activity in the unbound fraction. The 
conserved N-glycosylation motif lies downstream of the first two predicted TM}Is (see 
section 2.4) and so both B. cinerea and S. cerevisiae Aurl p sequences could be glycosylated 
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when truncated. In addition to the conserved N-glycosylation site, S. cerevisiae and B. 
cinerea Aurip contain two or three more N-glycosylation motifs (Figure 2.3, section 2.2.1). 
Hence, it is possible that not all bands are glycosylated to the same extent and that 
glycosylation possibly occurs after cellular proteolysis. Due to a lack of available material 
this could not be investigated further. The numerous putative phosphorylation patterns on B. 
cinerea and S. cerevisiae Aurip (Figure 2.3, section 2.2.2) as well as the potential for 
palmitoylation (section 2.2.3) could lead to other modifications on the Aurip sequences, 
which would also cause the proteins to run more slowly by SDS-PAGE than expected. 
With the exception of the pPICZ XhoI mut (no a) control, no bands were observed by SDS-
PAGE or western blot for the IMAC purified pPICZ XhoI mut A URJ constructs expressed in 
the X-33 strain. Neither were bands observed for the KM71H control. The protein 
concentration of eluted samples was 0.02mg/ml (0.03mg) for the X-33 strains containing 
AURJ and 0.05mg/ml (0.06mg) for the KM71H control (Table 4.4). Even though cell pellet 
mass was lower for X-33 strains than KM7 I H strains the ratio of purified protein to cell 
pellet is much lower for X-33 indicating that recombinant Aur 1 p  under the control of the 
AOXpromoter is optimally expressed in KM7IH strains that exhibit a MutS  phenotype and 
are induced with methanol at high cell density. 
The pPICZ A71o1 mut A UR] constructs in X-33 strains after purification obtained an 
expression level of 0.05mg/L whereas in KM71H strains 0.70mgfL was achieved for full 
length Aurip from both B. cinerea and S. cerevisiae, and 1 .7mg/L was achieved for 
truncated Aurip from both B. cinerea and S. cerevisiae (Table 4.4). These quantities are in 
line with previously reported expression levels for membrane proteins in P. pastoris [643, 
644]. 
The activity of the purified pPICZ )aiol mut containing constructs is presented in Table 4.4 
and graphically in Figure 4.15. For both KM7IH and X-33 strains, [PC synthase specific 
activity increased after the IMAC step, indicative of enzyme purification (Figure 4.1 5A,B). 
As predicted from the SDS-PAGE and western blotting results, the total activity of the eluted 
samples was 2-4 fold higher for KM71H strains containing recombinant Aurlp than the 
corresponding X-33 strains (Figure 4.15D). The difference in the total activities was smaller 
prior to MAC purification (Figure 4.1 5C). These results suggest that a high percentage of 
the [PC synthase activity in the X-33 strain is due to native P. pastoris [PC synthase rather 
than recombinant Aurip resulting in lower activity yields upon MAC purification. 
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Figure 4.15: IPC synthase Activity Exhibited by pPICZ XhoI mut AURI Constructs 
Expressed in P. pastoris after IMAC 
The specific activity exhibited in both the [MAC input and elution is shown for protein expressed in 
X-33 (A) and KM7IH (B). The total activity exhibited by protein expressed in X-33 and KM71H is 
shown for the IMAC input (C) and elution (D). The IMAC input is cell free extract lysed in the 
presence of 1% Triton X-100. The pPICZ XhoI mut control contains no a-factor. 
IMAC Input IMAC Elution Purified 
Cell 
Strain Pellet Protein 
Specific Total Protein 
Specific Total Recovered Expression 
(g) Activity Activity Activity Activity Activity 
Level 
(mg) (nMlmin/mg) (nM/mm) (nM/minfmg) (nM/rmn) (%) (mg/L) 
X-33 
AURI/Bc 6.27 1 2420 2420 0.03 5800 170 7 0.05 
AURI/Sc 6.51 0.8 2700 2160 0.03 6240 190 9 0.05 
A URI/Bc 
6.25 0.4 1830 730 0.03 3360 100 14 0.05 Trunc 
A URI/Sc 
4.13 1 1820 1820 0.03 6240 190 10 0.05 
Trunc 
Control 5.83 17 110 1870 0.4 243 100 5 0.7 
KM71 H 
AUR//Bc 8.32 7 530 3710 0.2 2480 500 13 0.7 
AURI/Sc 10.24 5 650 3250 0.2 2810 560 17 0.7 
A URI/Bc 9.99 8 290 2320 0.5 720 500 22 1.7 
Trunc 
A URI/Sc 18.56 13 270 3510 0.5 770 390 11 1.7 
Trunc 
Control 18.23 11 57 630 0.06 300 18 3 0.2 
Table 4.4: IMAC Purification of pPICZ XhoI mut AURJ Constructs Expressed in P. 
pastoris X-33 (Mut 4) and KM71H (MutS) 
The control is pPICZ XlzoI mut (no (x). 
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Unfortunately low activity yields upon IMAC purification were obtained for both X-33 and 
KM7 I H strains. As the calculations are based on total activity it is not surprising that 
slightly higher recovered activities were obtained for Aurip in KM71H compared to those in 
X-33 (Table 4.4). The low yields are probably due to a combination of factors. The 
presence of detergent micelles may partially or fully mask the polyhistidine tag and as such 
reduce binding to Ni 2 . Some of the activity in the input will be affiliated to unpurified 
native P. pastoris IPC synthase. As discussed previously, there are a number of bands by 
SDS-PAGE and western blot that could be attributed to degraded Aurip. With the exception 
of truncated S. cerevisiae Aurl p expressed in X-33, it does appear that truncated Aur ip is 
less active than its full length counterpart. This may be attributed to reduced stabilisation 
upon solubilisation due to the loss of a hydrophilic loop and/or loss of activation sites as a 
number of post translational modification motifs are present in the N-terminal region (Figure 
2.3, section 2.2). This suggests that further degradation would reduce activity and if cellular 
proteolysis could be prevented an increase in activity yield might be observed. 
In contrast to the total activities obtained, both the input and eluted samples originating from 
the X-33 (Mut) strains have higher specific activity compared to equivalent constructs in 
KM71H (Muts)  strains. As native IPC synthase activity is maximally expressed in the mid 
to late exponential phase [442], it is possible that Aurip expressed in X-33 cells, which 
experience increased growth rate in methanol based media compared to KM7 1 H, facilitates 
Aurip cell cycle regulated modification that is required to increase IPC synthase activity. 
The IPC synthase activity exhibited by strains containing B. cinerea A UR] appears to be 
very similar to that exhibited by strains containing S. cerevisiae A URI. This suggests that 
the mutations in the B. cinerea Aurip sequence, discussed in section 4.2.1, do not affect its 
activity nor do they appear to affect stability as degradation seems to occur in a similar 
manner for both recombinant B. cinerea and S. cerevisiae Aurlp. 
Surprisingly the control elutions also exhibited IPC synthase activity suggesting that native 
P. pastoris IPC synthase can bind to Ni 2 . However, the specific activities, total activities 
and yields are lower for native IPC synthase than recombinant polyhistidine tagged Aurip, 
consistent with weaker binding of the wild type enzyme. The presence of activity in the 
control elution corresponds to the bands observed by SDS-PAGE. Although not in exactly 
the same position as the recombinant Aurip, enriched bands are present in the control at 
similar masses and could be due to native P. pastoris Aurip and its degradation products. 
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Although native IPC synthase does not possess a polyhistidine tag, the Aur ip sequences 
analysed in Chapter 2 contain two conserved adjacent histidines central to the putative D4 
thought to be present in the active site, of which one of the conserved histidines is predicted 
to be part of the catalytic triad (Scheme 22, Chapter 2). The consensus 2° structure 
prediction model presented in Figure 2. 10, section 2.4, reveals the two adjacent histidines 
could be exposed to the Ni 2 ion. There have been a number of reports that demonstrate two 
adjacent histidine residues present in a loop can complex metal ions such as Cu(ll), Ni(H) 
and Co(II) [645, 646]. In fact a high Cu(H) affinity peptide that contained only one histidine 
residue has been identified. Its high copper affinity was attributed to the presence of several 
nearby hydrophobic residues [646]. Moreover, Battistoni et. al. report of pathogenic 
bacterial proteins containing clusters of 24 histidines and negatively charged residues, 
which can bind Ni, Zn or other transition metals [647]. Burns et. al. have proposed the 
interactions shown in Figure 4.16 can occur between a Ni-NTA chelate and two adjacent 
histidine residues [648]. 
0 V DI 
HN 
Figure 4.16: Structure of NTA-Nickel- Polyhistidine Ternary Complex Proposed by 
Burns et. al.16481 
In Aurip sequences the two adjacent histidine residues are flanked by the polar residues 
serine or threonine upstream and negatively charged tyrosine downstream. These four 
conserved residues act as a loop between two hydrophobic TMHs ( ... L(S/T)HHY(F/A)V..., 
see Chapter 2). 
In order to determine if this was a plausible purification tool for native Aurip, wild type 
Triton X-100 solubilised samples were subjected to IMAC. Both B. cinerea and the P. 
pastoris strains X-33 and KM7IH were examined. Protein fractions which bound to the 
columns showed higher specific activities than the unbound fractions (Figure 4.18). [MAC 
chromatography led to a 3-5 fold increase in specific activity. Fractions from the P. pastoris 
strains grown in glycerol based media gave rise to the highest specific activity. This might 
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be due to a reduction in degradation of Aurl p due to the absence of methanol. However, 
very little protein is present by SDS-PAGE (Figure 4.17). This suggests that the protein 
concentration determination may contain a high level of error leading to possible inaccuracy 
in both specific and total activity calculations (Figure 4.18, Table 4.5). 
kDa 	kDa 
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64 qb 64 qM 
51 51 
39 39 1 28 28 19 4b 
14 ft 19 
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Figure 4.17: SDS-PAGE of Wild Type Yeast and Fungi Triton X-100 Solubilised 
Microsomes after IMAC 
S. cerevisiae (lane 1), B. cinerea (lane 2), P. pastoris X-33 grown in glycerol based media (lane 3), P. 
pastoris KM71H grown in glycerol based media (lane 4), P. pastoris X-33 grown in methanol based 
media (lane 5) and P. pastoris KM7 1 H grown in methanol based media (lane 6). In order to determine 
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Figure 4.18: LPC synthase Specific Activity Exhibited by Wild Type Yeast and Fungi 
Solubilised Microsomes after IMAC 
The specific activity is presented for wild type S. cerevisiae (wt Sc), wild type B. cinerea (wt Bc), P. 
pastoris X-33 grown in glycerol based media (X-33 Gly), P. pastoris KM7 1 H grown in glycerol 
based media (KM71H Gly), P. pastoris X-33 grown in methanol based media (X-33 MeOH) and P. 
pastoris KM71H grown in methanol based media (KM7IH MeOH). All cells were grown in baffled 
flasks except wild type S. cerevisiae, which was fermented. The input to the Ni 2 column was 
solubilised using Triton X- 100. 
Caution: Due to the error in determination of low protein concentration, the specific activity 
calculations may not be reliable. 
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MAC Input flvic Elution Cell Purification Reco')'ered 
Species Pellet Protein Specific Total Protein Specific Total (fold) Acity 
(g) (mg) Activity Activity Activity Activity (nM/mm/mg) (nMimin) (nM/mm/mg) (nMlmin) 
wt Sc 20.0 40 320 13000 5 130 700 0.4 4 
wtBc 61.5 6 70 400 0.4 260 100 4 25 
X-33 
Gly 8.33 2 350 700 0.02 1000 20 3 3  
KM71H 
Gly 9.96 5 150 800 0.03 800 20 5 3 
X-33 
MeOH 7.62 1 170 200 0.02 500 10 3 5 
KM71H 
MeOH 7.67 13 100 1300 0.7 290 200 3 15 
Table 4.5: Summary of IMAC Purification of Wild Type Yeast and Fungi Solubilised 
Microsomes 
Refer to Figure 4.18 for an explanation of the species abbreviations. Caution: Due to the error in 
determination of low protein concentration both the specific and total activity calculations may not be 
reliable. 
Unfortunately, it appears that S. cerevisiae IPC synthase specific activity is reduced upon 
IMAC treatment. It is possible that the conserved histidine residues in P. pastoris and B. 
cinerea Aurip are more exposed and as such S. cerevisiae Aurip may have to unfold slightly 
in order to bind to the Ni" ions, reducing the activity of Aurip in the elution. 
With wild type B. cinerea Aurlp I achieved an activity yield of 25% but the yields for the 
other species were much lower (Table 4.5). Triton X-100 could mask the histidine residues, 
predicted to lie at the membrane surface, preventing or reducing binding to the nickel 
column. Wild type Aurip could also be subjected to degradation as observed with the 
recombinant protein. Disruption of protein and/or lipid complexes that stabilise and/or 
activate IPC synthase as well as the reduction in Triton X-100 upon elution could all 
contribute to a lower specific activity and thus, lower total activity and yield. 
In conclusion, both B. cinerea and S. cerevisiae Aurip have been successfully expressed 
heterologously in P. pastoris using the intracellular expression construct pPICZ AlzoI mut. 
Expression was achieved with both full length and truncated forms; however, increased 
activity was observed with the full length protein. This could be attributed to the increased 
stability upon solubilisation and/or the requirement of the N-terminus for enzyme activation. 
Although expressed intracellularly, all four constructs retained the putative signal anchor and 
so should be directed to the Golgi and retained in the medial Golgi cisternae. Hence, the 
proteins should be processed as if expressed natively. The B. cinerea constructs are far more 
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active when expressed in P. pastoris rather than E. coli. This could be attributed to the 
correct processing and post translational modifications occurring in the eukaryotic system. 
This study has also demonstrated that P. pastoris does contain native IPC synthase activity, 
which has not been previously reported. Furthermore, a possible isolation method using 
native P. pastoris and B. cinerea Aurip has been identified. The main problems to be 
tackled are the heterogeneity of the activity, the native background [PC synthase activity in 
recombinant expression and the low yields obtained by MAC purification. 
4.3 Possibilities for Future Studies 
The purified protein samples obtained from recombinant Aurip expression in P. pastoris 
were subjected to LC-MS, however, as previously observed with native S. cerevisiae JPC 
synthase and recombinant B. cinerea Aurip expressed as a GST fusion, no useable data was 
obtained from the intact proteins. Investigation of the fragment peaks of full length 
recombinant B. cinerea and S. cerevisiae Aurip obtained using trypsin digest and MALDI-
ToF spectrometry is being conducted by Beverley Cameron. 
It is worth noting that due to the number of constructs and strains handled the recombinant 
proteins expressed in P. pastoris were isolated by cell lysis in the presence of detergent. 
Subsequent isolation would involve a more rigorous process, in which the in vivo 
localisation of the recombinant protein would be determined, facilitating organelle 
fractionation prior to solubilisation. This should reduce the amount of proteases in contact 
with Aurip and thus, reduce degradation. Resuspension of insoluble Aurip in fresh 
solubilisation buffer would allow for EDTA to be present in the lysis buffer minimising 
potential degradation upon cell lysis. Furthermore, again due to the number of constructs 
and strains handled, KM71H strains were grown in the presence of methanol for six days. 
The optimum expression time needs to be determined to achieve maximum expression and 
minimum degradation. 
If these approaches do not minimise proteolysis then temperature regulation of the 
expression culture could be employed. Expression at low temperature has previously been 
shown to drastically reduce proteolysis of recombinant proteins expressed in P. pastoris 
[649]. Alternatively, protease deficient P. pastoris strains, SMD, are available from 
Invitrogen and have been successful in the expression of proteolytic sensitive proteins [642]. 
Unfortunately, these strains have a Muf phenotype and may not be applicable to 
recombinant Aurip expression. By screening hundreds of recombinant clones for 
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MutfMutS phenotypes it may be possible to identify a strain that has become Muts  following 
electroporation with a pPICZ A URJ construct. Alternatively, a single endonuclease 
restriction site not present in the rest of the vector could be introduced to the AOXJ IT 
region. This site could be used to linearise the plasmid, which upon electroporation should 
promote integration at the 3' end of the AOXJ gene in the P. pastoris genome rendering it 
MutS. A more complex alternative would be to modify the SMD genome in a similar manner 
to KM7IH by homologous recombination forming aoxl::ARG4 prior to transformation with 
the pPICZ A URJ construct. 
An additional problem to the proteolysis of Aurip is the native expression of P. pastoris IPC 
synthase. Using an A UR] null strain as the expression host would prevent native expression 
and enable complementation studies to be conducted. As A URJ is an essential gene, a 
heterozygous diploid A UR1 knockout strain would be required prior to complementation by 
recombinant Aurip. Pichia diploids are extremely unstable and spontaneously undergo 
sporulation [642]. This would make generation of a P. pastoris AUR] knockout 
heterozygous diploid very difficult. However, as sporulation of S. cerevisiae diploids 
requires induction, generation of an A UR] knockout diploid would be possible in S. 
cerevisiae. In fact, S. cerevisiae heterozygous A UR] knockout diploid strains are 
commercially available from Open Biosystems. 
Expression of B. cinerea Aurip under the control of the GAL] promoter in pYES constructs 
should be successful as expression has been achieved in P. pastoris. Furthermore, S. 
cerevisiae Aurlp and C. neoformans Ipclp have both been previously expressed under GAL! 
and GAL 7 promoters, respectively [81, 360]. S. cerevisiae A UR], generated by homologous 
recombination, is commercially available with a C-terminal TAP tag or as a green 
fluorescent protein fusion for expression in S. cerevisiae (Open Biosystems). This particular 
tandem affinity protein (TAP) tag consists of a calmodulin binding peptide, a TEV cleavage 
site and 2IgG binding domains of protein A. TAP can be utilised for the isolation of protein 
complexes and determination of protein-protein interactions. 
From the work carried out in this study using the c-myc epitope and the polyhistidine tag it 
appears that purified recombinant Aurip is not in a complex with a co-factor as guanidine 
treatment and boiling did not alter the appearance of the protein bands by SD S-PAGE. If the 
yield for the IMAC purification could be increased and/or is conducted on a much larger 
scale then the two adjacent internal histidines could be utilised in pull down experiments. 
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This would help to determine if native Aurlp does exist in a protein complex or solely 
encodes IPC synthase. If the Triton X-100 micelles are masking the polyhistidine tag and 
the two adjacent internal histidines reducing binding to Ni 2 , the Triton X- 100 concentration 
could be reduced by dilution prior to loading onto the Ni 2 -sepharose column or incubation 
with Ni2  beads. If yields are increased, this method would be applicable for wild type B. 
cinerea and P. pastoris IPC synthase isolation and purification. The cumulative affect of a 
reduction in degradation, removal or suppression of native IPC synthase activity and 
optimisation of incubation and elution conditions for [MAC should increase activity yields 
upon purification of recombinant Aurip. 
Reduced activity was observed for recombinant B. cinerea Aurip when expressed in E. coli 
compared to P. pastoris. However, if cleavage of the GST-Aurlp fusion was prevented, E. 
coli may be a suitable system for obtaining protein for structural studies. One avenue for 
investigation would be to reduce the quantity of the outer membrane protease, OmpT, in the 
E. coli cells. Although expression of the GST-AurlpIBc fusion was not observed in 
BL21(DE3) cells under the conditions tried, the 13-type strains (13834, 131-2 1, Origami, 
Rosetta, Turner) could be investigated further as they are deficient in OmpT as well as ion 
proteases. Rosetta strains, which enhance expression of eukaryotic proteins by containing 
codons rarely used by E. coil, could be a plausible host for expression of the fusion. Even 
though truncation of the N-terminus of B. cinerea Aurip does cause a reduction in IPC 
synthase activity when expressed recombinantly in P. pastoris the mutant does remain 
active. A similar truncation of AURJ could be utilised in a GST fusion, thus removing the 
putative OmpT cleavage site. 
Although further optimisation is required, this study has demonstrated that both B. cinerea 
and S. cerevisiae Aurlp can be recombinantly expressed and purified using affinity tags. 
This should facilitate generation of purified active material for future assay development, 
inhibitor, biochemical and structural studies. 
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Chapter 5: Materials and Methods 
5.1 General Reagents 
Chemicals and solvents were of the appropriate quality and were purchased from Amersham 
Biosciences, Amicon, Biorad, Gibco BRL, Invitrogen, New England Biolabs, Oxoid, 
Pharmacia, Promega, Roche, Sigma or Waters Millipore unless otherwise stated. 
5.2 Equipment 
PCR reactions were carried out in a Perkin Elmer DNA thermal cycler. Electrophoresis was 
carried out using a Biorad Protean H minigel system (protein) or for pre-cast protein gels an 
Invitrogen XCe11 SureLockm  Mini-Cell system was used. Electrophoresis of DNA was 
carried out using a Gibco BRL H5 system. Denley BR401, Sorvall ® RC-5B, DuPont 
Micrcospin 12 and Sorvall ® Discovery lOOSE centrifuges were used for centrifugation. A 
Savant Speed Vac® Plus SC  IOA gyrovap was used for drying DNA and protein 
precipitates. A Pharmacia FPLC system and various columns were used for 
chromatographic separations of proteins. UV/Vis scans were conducted using an ATI 
Unicam LTV/Vis spectrometer (UV4). 
5.3 Sterilisation 
Flame sterilisation was employed when sterile conditions were required. Equipment and 
broth were sterilised using the autoclave, unless stated otherwise. All inoculations were 
carried out under sterile conditions. 
5.4 Solutions and Buffers 
5.4.1 General 
AE - Sodium acetate (50mM, pH 5.3), EDTA (100mM). 
Ampidillin - A stock solution (lOOmg/ml) was sterilised by filtration (0.2j.tm) and used at a 
final concentration of lOOp.g/ml. The solution was stored at 4 °C. 
Bis-Tris-CI - Bis-Tris adjusted to the required pH with hydrochloric acid. 
Ethidium bromide - A stock solution (1 OmgIml) was made and used at a final concentration 
of 5p.g/ml. The solution was stored at 4°C in a dark bottle. 
IPTG - A stock solution of isopropyl40,D-thiogalactopyranoside (100mM) was sterilised by 
filtration (0.2.tm filter) and stored at 4°C. 
20mM K-Phos - Potassium phosphate dibasic (16.67mM), Potassium phosphate monobasic 
(3.33mM), adjusted to pH 7.5 with orthophosphoric acid. 
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lx NuPAGE® MOPS SDS running buffer - 20x NUPAGE® MOPS SDS running buffer 
(50m1, Invitrogen) was diluted with distilled water (950m1). 
lx NuFAGE® Transfer buffer - 20x NuPAGE® Transfer buffer (50ml, Invitrogen) was 
diluted with methanol (1 OOml) and distilled water (850m1). 
PBS - Phosphate Buffered Saline tablets (pH 7.4, Oxoid) were dissolved in distilled water (1 
tabletllOOml) and sterilised by autoclaving. 
PBST -Tween-20 was added to PBS to a final concentration of 0.05%v/v. 
PBSTM -Dried skimmed milk (Marvel) was added to PBST to a final concentration of 
5%w/v. 
SDS running buffer - Tris-CI (25mM, pH 8.3), glycine (192mM), SDS (1 %w/v) 
SDS sample buffer - Tris-Cl (1.5 M, pH 6.8, l.Oml), glycerol (2.0ml), SDS (10 0/ow/v, 1.6 
ml), 2-3-mercaptoethanol (0.4 ml), bromophenol blue (0.05%w/v, 2.Oml) 
Tris-CI - Tris adjusted to the required pH with hydrochloric acid. 
TAE - Tns-Cl (40mM, pH 8.3), acetic acid (20mM), EDTA (1mM). 
TE - Tris-CI (10mM, pH 8.0), EDTA (1mM). 
ZeocinTM - Zeocin was stored at a concentration of I OOmg/ml at -20 °C and used at a final 
concentration of 25 j.tg/ml (E. co/i) and 100ig/m1 (P. pastoris). 
5.4.2 IPC Synthase Buffers 
All in one buffer -K-phos (20mM, pH 7.4), glycerol (10%v/v), NaCl (0.5M), sucrose 
(03M), -mercaptoethano1 (5mM), Triton X-100 (l%v/v) and complete EDTA free 
protease inhibitor cocktail tablet (1 tablet' 50m1 buffer, Roche). 
Anion exchange chromatography buffer -Bis-Tris-CI (50mM , pH 6.0), glycerol 
(10%v/v), M902  (5mM), MnCl2 (1mM), 3-mercaptoethanol (5mM), PMSF (1mM), 
benzamidine (0.1mM), leupeptin (0.5p.g/ml) and Triton X- 100 (0.05%v/v). 
lx Assay buffer -Bis-Tris-CI (50mM, pH 6.5), M9C1 2 (5mM), MnCl2 (1mM) and Triton X-
100 (5mM). 
Concanavalin A buffer 1 - Bis-Tris-CI (50mM, pH 6.5), NaCl (100mM), MgCl 2(5mM), 
MnC12 (5mM) and CaC12 (5mM). 
Concanavalin A buffer 2 -Bis-Tris-Ci (50mM, pH 5.8), glycerol (10%v/v), 3-
mercaptoethanol (5mM), M902  (5mM), MnC12 (5mM), CaC12 (5mM) and Triton X-100 
(0.05%v/v). 
Concanavalin A buffer 3 - Tris-CI (50mM, pH 7.0), glycerol (10%v/v), 3-mercaptoethanol 
(5mM), M902  (5mM), MnCl2 (5mM), CaCl 2 (5mM) and Triton X-100 (0.05%v/v). 
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Dialysis buffer 1 - K-phos (20mM, pH 7.4), glycerol (10%v/v), NaCl (0.5M), I-
mercaptoethanol (5mM) and Triton X-100 (0.05%v/v). 
Dialysis buffer 2 - Bis-Tris-CI (50mM, pH 5.8), glycerol (10%v/v), 13-mercaptoethanol 
(5mM), MnC12 (1mM), and Triton X-100 (0.05%vlv). 
GST binding buffer - lx PBS (pH 7.4), glycerol (10%v/v), -mercaptoethanol (5mM) and 
DDM (2mM). 
GST cation exchange elution buffer - Bis-Tris-Ci (50mM, pH 6.0), glycerol (10%v/v), 
NaCl (1M), MnC1 2 (1mM), -mercaptoethanol (5mM) and Triton X-100 (0.05%v/v). 
GST dialysis buffer - Bis-Tris-Cl (25mM, pH 6.0), glycerol (10%v/v) and Triton X-I00 
(0.05%v/v). 
GST elution buffer - Tris-Cl (50mM, pH 8.0), glycerol (lO%v/v), 3-mercaptoethanol 
(5mM), DDM (2mM) and reduced glutathione (10mM). 
GST gel filtration buffer - Bis-Tris-Ci (50mM, pH 6.5), glycerol (I0%v/v), NaCl 
(100mM), MgCl2  (5mM), MnC12 (1mM), 3-mercaptoethanol (5mM) and Triton X- 100 
(0.05%v/v). 
Hydrophobic chromatography buffer - Tris-Cl (50mM, pH 7.0), glycerol (10%v/v), 
MgCl2 (5mM), MnC12 (lmM), 3-mercaptoethanol (5mM), PMSF (1mM), benzamidine 
(0.1mM), leupeptin (0.5tg/ml) and NaCl (1.5M). 
IMAC buffer - K-phos (20mM, pH 7.4), glycerol (10%v/v), NaCl (0.5M), f3-
mercaptoethanol (5mM), Triton X-100 (0.05%v/v) and imidazole (5mM). 
Inclusion body solubifisation buffer - Bis-Tns-Cl (50mM, pH 6.0), 20% glycerol, NaCl 
(100mM), 3-mercaptoethanol (5mM), DDM (20mM) and complete protease inhibitor 
cocktail tablet with EDTA (2 tablets! 20m1 buffer, Roche). 
Lysis buffer - Tris-Ci (50mM, pH 7.0), sucrose (03M), 3-mercaptoethanol (10mM), sodium 
EDTA (1mM) and Complete EDTA-free protease inhibitor cocktail tablet (1 tablet! 50m1 
buffer, Roche). 
Microsomal storage buffer - Tris-CI (50mM, pH 7.0), glycerol (10%v/v), 3-
mercaptoethanol (5mM), and complete mini-EDTA free protease inhibitor cocktail tablet (1 
tablet' 20ml buffer, Roche). 
Solubilisation buffer - Bis-Tris-CI (50mM, pH 6.0), glycerol (10%v!v), J3-mercaptoethanol 
(5mM), MnCl2 (1mM), Triton X- 100 (l%v/v) and complete mini-EDTA free protease 
inhibitor cocktail tablet (1 tablet! 20m] buffer, Roche). 
Rachel Breen 	 Chapter 5: Materials and methods 	 Page 151 
5.4.3 P. pastoris Stock Solutions 
500x Biotin (500xB) - A 500x Biotin stock solution (0.02%w/v, 20mg/lOOml) was sterilised 
by filtration (0.2jtm filter) and stored at 4°C. 
1 O Dextrose (lOxD) - A lOx Glucose stock solution (20%w/v, 200g/IL) was sterilised by 
autoclaving and stored at room temperature. 
1 O Glycerol (1OxGY) - A lOx Glycerol stock solution (l0%v/v, lOOmIJlL) was sterilised 
by autoclaving and stored at room temperature. 
lOx Methanol (lOxM) - A lOx Methanol stock solution (5%v/v, 5m1/lOOml) was sterilised 
by filtration (0.2j.im filter) and stored at 4°C. 
lOx Yeast Nitrogen base (1OxYNB) - A lOx stock solution of either YNB with ammonium 
sulphate and without amino acids (13 .4%w/v, I 34gfL) or YNB without both ammonium 
sulphate and amino acids (34gfL) and ammonium sulphate (1 OOg/L) was sterilised by 
filtration (0.2gm filter) and stored at 4°C. 
IM K-phos - Potassium phosphate dibasic (132mM), Potassium phosphate monobasic 
(868mM). Adjusted to pH 6.0 with orthophosphoric acid, sterilised by autoclaving and stored 
at 4°C. 
5.5 Media 
5.5.1 E. coil Media 
Agar plates - bacto-agar (1 5g/L) was added to specified media to prepare agar plates. 
Luria Bertani (LB) - bacto - tryptone (lOg), bacto - yeast extract (5g), NaCl (lOg) were 
dissolved in distilled water (IL) and then adjusted to pH 7.5 with sodium hydroxide. 
Low salt Luria Bertani (Low salt LB) - As described above in LB preparation except a 
lower NaCl concentration was used (5g/L). 
Nutrient broth - Distilled water (I L) was added to Nutrient broth (13g, pH 7.4, Oxoid) The 
pre-made nutrient broth contains lab-lemco beef extract (lg/L), bacto - tryptone (5gfL), 
bacto - yeast extract (2g/L), NaCl (5g(L). 
XGalTMILB Agar plates— Distilled water (500m1) was added to a single packet of X-
Gal/LB Agar blend (Sigma). 
Soc growth - Bacto - tryptone (20g), bacto - yeast extract (5g), NaCl (0.5g), magnesium 
sulphate (5g), glucose (3.2g) were dissolved in distilled water (1 L) and then adjusted to pH 
7.5 with sodium hydroxide. 
2YT - Bacto - tryptone (16 g), bacto - yeast extract (lOg), NaCl (5g) were dissolved in 
distilled water (1 L) and then adjusted to pH 7.5 with sodium hydroxide. 
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5.5.2 S. cerevisiae Fermentation Media 
Buffered Minimal Dextrose Medium (BMID) - K-phos (IM, pH 6.0, lOOmI), IOxYNB 
(100m1), D-Glucose (2g in lOmi distilled water, filter sterilised (0.2im)) and 500xB (2m1) 
were added to autoclaved distilled water (790m1). 
Fermentation Basal Salt medium (FBSM) —phosphoric acid (85%v/v, 66.75m1), calcium 
sulfate (2.33g), potassium sulfate (45.50g), magnesium sulfate.71-1 20 (37.25g), potassium 
hydroxide (10.33g), D-glucose (5g) and NaCI (1.5g) was made up to 2.5L with distilled 
water. The solution was sterilised in situ in the fermentor. 
25%w/v D-Glucose solution (Feed 1) - Glucose (250g) was dissolved in distilled water 
(1 L) and sterilised by autoclaving. 
28%w/v Ammonium hydroxide solution (Feed 2) - Purchased lOOmI solution from Sigma 
Aldrich. 
Trace Salt Solution - Cupric sulfate.51-1 20 (300mg), sodium iodide (4mg), manganese 
sulfate.H20 (150mg), sodium molybdate.2H 20 (10mg), Boric acid (ling), cobalt chloride 
(25mg), zinc chloride (ig), ferrous sulfate.711 20 (3.25g), sulfuric acid (0.25m1), biotin 
(10mg) was made up to 50ml with distilled water and sterilised by filtration (0.2tm). 
Vitamin solution - Calcium pantothenate (0.6g), inositol (3g), pyridoxine HC1 (0.6g) and 
thiamine HCl (0.6g) were dissolved in distilled water (1 Sml) using sonication and sterilised 
by filtration (0.2p.m). 
5.5.3 B. cinerea Media 
Tryptone (4g), D-glucose (4g), yeast extract (0.5 g), potassium phosphate monobasic 
(1.75g), magnesium sulfate.711 20 (0.75g), citric acid (1.92g), CaC1 2 .21120 (0.0132g) myo-
inositol (5mM, 0.901g) and Tween 20 (0.02%v/v, 200.il) were made up to 1L with distilled 
water, adjusted to pH 4.5 and sterilised by autoclaving. 
5.5.4 P. pastoris Media 
Agar plates - bacto-agar (20g/L) was added to specified media to prepare agar plates. 
Buffered Minimal Glycerol Medium (BMG) - K-phos (1M, pH 6.0, lOOmI), 1OxYNB 
(lOOml), 1OxGY (lOOml) and 500xB (2m1) were added to autoclaved distilled water (700m1). 
Yeast Extract Peptone Dextrose Medium (YPD) - Tryptone (20g), yeast extract (10 g) and 
D-glucose (20g) were dissolved in distilled water (IL). 
Yeast Extract Peptone Dextrose Sorbitol Medium (YPDS) - Tryptone (20g), yeast extract 
(10 g), D-glucose (20g) and sorbitol (182.2g) were dissolved in distilled water (1L). 
Minimal Dextrose Medium (MD) - 1OxYNB (I 00m]), lOxi) (lOOmI) and 500xB (2ml) 
were added to autoclaved distilled water (800m1). 
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Minimal Glycerol Medium (MGY) - 1 OxYNB (1 OOml), 1 OxGY (1 OOml) and 500xB (2m1) 
were added to autoclaved distilled water (800m1). 
Minimal Methanol Medium (MM) - 1OxYNB (lOOml), lOxM (lOOmI) and 500xB (2m1) 
were added to autoclaved distilled water (800m1). 
5.6 Cell Lines 
JM 101 and TOP I 0' cell lines were used for the storage of genes and also for the initial 
transformation of ligation products. In the case of GST fusion TOP 1OTM  were also used for 
protein hyperproduction. P. pastoris cell lines, X-33 and KM71H, were used for over 
expression of A UR]. 
Species 	Cell Line 	Genotype 	 Phenotype 	 Usage 
(P.pastoris only) 
E. co/i 	JM1O1 	F' traD36 laclq A(lacZ) M15 proA 4B7 supE 	Storage of 
thi z(1ac-proAB) 	 plasmid DNA 
F'mcrA D(mrr-hsdRMS-mcrBC) 	Storage, transfonning 
E. co/i 	Top 1 ° 	801acZAM 15 AlacX74 deoR recA 1 araD 139 ligations and expression host 
(ara-leu)7697 galJU gaL'K rpsL endA 1 nupG 	for GST fusion. 
P. pastoris 	X-33 	Wild type 	 Mut 
Insertion of target gene 
into the genome and 
P. pastoris 	KM71H 	Arg4 aoxl::ARG4 	Muts, 	 expression host. 
Table 5.1: Cell Line Information 
5.7 DNA Vectors and Plasmids 
The E. coli plasmid used for the cloning and over expression of AURJ/Bc was pRL385 (N-
terminal GST fusion A URJ/Bc). The P. pastoris plasmids used for the cloning and over 
expression of A UR] were pPICZaA and pPICZA .X71o1 mut (A URIIBc, A URJ/Sc, Truncated 
AURI/Bc and Truncated AURI/Sc. All were C-terminal 10 amino acid c-myc epitope and 
His6 tagged). Control plasmids pPICZaA and pPICZA .X7ioI mut (no (x) were also inserted 
into the P. pastoris genome as controls. 
5.8 Oligonucleotide Primers 
The following oligonucleotide primers were used. Endonuclease restriction sites are in bold. 
5.8.1 Sequencing Primers 
pLZ30 primer intl 	5 '-ATTAGCAACATITCTCTCGGCA-3' 
pLZ30 primer int2 	5'-TATCTATCTCACCATITACGCC-3' 
pCR2.1 For 	 5'-GTAAAACGACGGCCAG-3' 
pCR2.1 Rev 	 5'-CAGGAAACAGCTATGAC-3' 
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pET For 	 5 '-CCCCTATAGTGAGTCGTATTA-3' 
pET Rev 	 5'-GGATATAGTFCCTCC1TTCAGC-3' 
pGEM For 	 5'-TAATACGACTCACTATAGGG-3' 
pGEM Rev 	 5'-AmAGGTGACAcTATAGA-3' 
pGEX For 	 5'-GGGCTGGCAAGCCACGmGGTG-3' 
pGEX Rev 	 5 '-CGGGAGCTGCATGTGTCAGAGG-3' 
5'AOX seq 	 5'-GACTGGTTCCAATFGACAAGC-3' 
3'AOX seq 	 5'-GCAAATGGCA1TCTGACATCC-3' 
The pLZ30 primer intl and pLZ30 primer int2 were used as internal primers for sequencing 
AURI/Bc starting at 498bp (inti) and 969bp (int2) into the gene. The pCR2.l, pET, pGEM, 
pGEX and AOX primers were used to sequence pCR2.1, pET, pGEM, pRL385 and pPICZ 
plasmids, respectively. 
5.8.2 Primers used for Cloning B. cinerea AURI into E. coil 
Expression Vectors 
pLZ30 NdeI 	 5 '-CGCTCATAACTFCATATGCCGGAAAC-3' 
pLZ30 rev BamNI Sail 5'-GAGTGGGATCCTATFGTCGACGTAAAAAGAT 
CA-3' 
pLZ30 NdeI introduced a NdeI site to the 5' end of the A URJ gene. pLZ30 rev BamHl Sail 
introduced BamHl and Sall sites to the 3' end of the AUR] gene. 
5.8.3 Primers used for Cloning AURI into P. pastoris Expression 
Vectors 
The Kex and Kozak sequences are underlined. 
5.8.3.1 B. cinerea AUR1 Forward Primers 
A URJBc XhoI Kex F 	5 '-CTCGAGAAAAGAGAGQCTGAAGCTATGCCGGA 
AACAAATFATFATrC-3' 
AURJBc XlzolKozak F 5'-CTCGAGCAATAATGCCGGAAACAAATFAT-3' 
AURJBc Kozakk7loI ex 5'-GCCGCTCGAGCAATAATGCCGGAAAC-3' 
5.8.3.2 Truncated B. cinerea AUR1 Forward Primers 
AURJBc Trunk F 	 5'-ATGTCCGTVFATGATGGTCAATAmG-3' 
AURJBc Kex Trunk XhoIF 	5'-CTCGAGAAAAGAGAGQCTGAAGCTATGTCCGT 
TFATGATGGTCAATA1TrG-3' 
AURJBc Kozak Trunk XholF 5'-CTCGAGCAATAATGTCCGlTFATGATGGTC 
AATAT-3' 
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5.8.3.3 S. cerevisiae A UR1 Forward Primers 
AURJScXhoIKex F 
AURISc KexA7wJex 
AURJSc KexA7iolex 2 
AURlScXhoIKozak F 




5 '-CCCGCCGCTCGAGAAAAGAGAGGCTGAAGC -3' 
5 '-CTCGAGCAATAATGGCAAACCCTYFTTCGAG -3' 
5 '-GCCGCTCGAGCAATAATGGCAAACCC -3' 
5.8.3.4 S. cerevisiae Truncated A URJ Forward Primers 
AURISc Trunk F 	 5'-ATGGCTITAAGCGACTGGGTGCATFAC-3' 
AURJSc Kex TrunLk7zolF 5'-CTCGAGAAAAGAGAGGCTGAAGCTATGGCYrT 
AAGCGACTGGGTGCATFAC-3' 
AURISc Kozak Trunk ,ThoJF 5'-CTCGAGCAATAATGGClTTAAGCGACTGGGTGC 
AT-3' 
All of the forward primers used to facilitate cloning of A URI into P. pastoris expression 
vectors, except AURJBc Trunk F and AURISc Trunk F, insert an )7zo1 site to the 5' end of 
the gene. When the AURI gene was cloned into the pPICZaA vector Kex2 and Ste 13 
cleavage sites had to be rebuilt by PCR. The primers containing the Kex notation in their 
name contain this sequence, denoted by underlining. When the AURJ gene was cloned into 
pPICZ X7oI mut (No a) a P. pastoris RNA recognition site, known as a kozak sequence 
(CAATAAATG) and is denoted by underlining, had to be built be PCR. 
AURIBc Trunk F and AURJSc Trunk F truncate AUR1 just before the putative first TMH at 
303 and 121 bp corresponding to Ser75 and A1a4 1 for B. cinerea A URJ and S. cerevisiae 
AUR], respectively. The primers insert a methionine codon at the 5'end of the truncated 
gene. The Kex trunk XhoI F and Kozak trunk )i7wI F primers insert an Xhol site followed by 
the kex or kozak sequence at the 5' end of the truncated gene. 
5.8.3.5 B. cinerea AUR1 Reverse Primers 
A URIBc XbaI R 	5'-TCTAGACCCCTAACAATGACCTCACTAAGCTC-3' 
A UR1Bc XbaI R ex 5'-GCTCTAGACCCCTAACAATGACCTCAC-3' 
A URIBc NotI R 	5'-GCGGCCGCCCTAACAATGACCTCACTAAGCTCAC-3' 
5.8.3.6 S. cerevisiaeAURl Reverse Primers 
AURISc XbaIR 	5'-TCTAGACCAGCCCTC1TTACACCTAGTGACG-3' 
A URJSc XbaJ R ex 5 '-GCTCTAGACCAGCCCTCTITACACC-3' 
A URJSc NotI R 	5 '-GCAGATAAAATGCGGCCGCAGCCCTCTYTACACCTAG 
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TG-3' 
AURISc NouIR ex 	5'-TGCTVVFCCTVfGCGGCCGCAGCCCTC-3' 
The reverse primers insert either an XbaI or Nod site at the 3 'end of the A UR] gene. The 
primers also remove the stop codon to allow for expression of the C-terminal c-myc and His6 
tags. No additional base pairs are required for the NoiI primers, however, an extra two base 
pairs (CC) are required for the XbaI primers to allow for an in frame ORF with the C-
terminal peptide. Extended primers, denoted by ex, were utilised when there were problems 
with cloning into the amplification vector, pCR2. 1. The extended sequence was present to 
facilitate an increased efficiency in the endonuclease restriction digest, reducing the need for 
an amplification vector. 
5.8.4 Primers used for Mutating the P. pastoris Expression Vector 
pPICZaA 
pPICZ XhoI For 	5 '-CAACTAATFACTCGAGACGATGAGATVI'C-3' 
pPICZ XhoI Rev 	5'-GAAATCTCATCGTCTCGAGTAATTAGTTG-3' 
The two above primers were designed for use with the Quick Change Mutagenisis kit 
(Stratagene, section 5.13.1.1) to mutate an SfuI site to an )thol site at the 5' end of the a-
secretion signal sequence on the pPICZaA plasmid, resulting in pPICZaA )7wI mut. 
Digestion of pPICZcLA X7zoI mut with J7zoI in the cloning steps removes the a-secretion 
signal sequence to yield pPICZA ,ThoI mut (no a). 
5.9 Storage of Bacterial Stocks 
Colonies of bacteria were stored on inverted sealed agar plates at 4°C for up to four weeks. 
For long term storage strains were frozen (-80°C) in 2YT medium containing glycerol 
(1 0%v/v). Protein was stored for short periods of time at either 4°C or -20°C and for long 
term storage at -80°C. 
5.10 Storage of Yeast and Fungal Stocks 
Colonies of yeast and fungi were stored on inverted sealed agar plates at 4°C for up to two 
months. For long term storage strains were frozen (-80°C) in YPD medium containing 
glycerol (1 0%v/v). Protein was stored for short periods of time at either 4°C or -80°C and 
for long term storage at -80°C. 
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5.11 Analysis by Electrophoresis 
5.11.1 Electrophoresis of DNA 
TAE buffer (100m1) was added to Agarose (1.0g) and heated to boiling in a microwave 
(2mm) until it dissolved. The solution was allowed to cool to 55°C and ethidium bromide 
was added to a final concentration of 0.5 jig/n-il. The gel was then poured into the casting 
mould and allowed to set at room temperature. Blue/Orange 6x Loading Dye (Promega) was 
added to the DNA and loaded onto the gel, which was immersed in 1xTAE buffer and 
subjected to electrophoresis at bOy (lh). 
5.11.2 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
5.11.2.1 SDS-PAGE (15% Acrylamide, running gel) 
Acrylamide (30%w/v, 5.0ml), distilled water (2.185m1), Tris-CI (1.5M, pH 8.8, 2.5ml), SDS 
(10%w/v, iOOj.d), TEMED (15j.tI), APS (100mg/mi, 200p1) were added to a universal tube 
and agitated briefly. This solution was immediately added to the glass plates to 
approximately 1.5cm from the top. This was then filled with 80% isopropanol (aq) and the gel 
allowed to set at RT. 
5.11.2.2 SDS-PAGE (4% Acrylamide, stacking gel) 
Acrylamide (30%w/v, 1.35m1), distilled water (5.8m1), Tris-CI (0.5M, pH 6.8, 2.5m1), SDS 
(l0%w/v, lOOp.l), TEMED (15p.l), APS (100mg/mi, 200j.xl) were added to a universal tube 
and agitated briefly. The isopropanol was run off the set running gel and the solution 
immediately added to the glass plates. The loading teeth were inserted and the gel was 
allowed to set at RT. The protein was denatured by adding SDS sample buffer and boiling 
(1 0mm) prior to loading onto the gel and subjecting it to electrophoresis at 200V (45mm). 
5.11.2.3 PRE-CAST SDS-PAGE (NuPAGE ®  Novex 4-12% Bis-Tris, 
Invitrogen) 
Samples were prepared as above. Pre-cast gels were ran using the XCeII SurelockTM Mini-
Cell system (lnvitrogen) with lx NUPAGE®  MOPS buffer at 200V for 50 minutes. 
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5.12 Analysis by Western Blot 
5.12.1 	Protein Transfer onto Nitrocellulose 
Pre cast NUPAGEr  Novex 4-12% Bis-Tris gels (Invitrogen) were used for the protein gel 
electrophoresis (section 5.11.2.3). The protein was transferred onto Hybondm-ECLTM 
Nitrocellulose membrane (Amersham Biosciences) using a Transblot® SD semi-dry transfer 
cell system (BioRad) with lx NuPAGE® Transfer buffer (Invitrogen) at 180mA (I h). See 
Blue Plus2 marker (Invitrogen) was used to view the transfer. 
5.12.2 Antibody Incubation 
All blocking, washes and incubations were carried out with gentle agitation. 
The membrane was blocked in PBSTM (20m1, 4°C, 18h). Fresh PBSTM (20ml) was used to 
block the membrane for a further lh at RT. The membrane was washed with PBST (3x 
20m1, RT, 3x 5mm) and then incubated in PBST containing the primary antibody; 
Monoclonal Anti-c-myc (mouse IgGI isotype, clone 9E10, Sigma, 1:5000 dilution, 4p.l in 
20m1, RT, 2h). The membrane was washed again with PBST (3x 20m1, RT, 3x 5mm), 
followed by incubation in PBST containing the secondary antibody; ECLTM Anti-mouse IgG, 
peroxidase-linked species specific whole antibody from sheep (Amersham Biosciences, 
1:5000 dilution, 4fl in 20m1, RT, lh). Excess antibody was removed by washing the 
membrane with PBST (3x 20m1, RT, 3x 5mm). 
5.12.3 Detection 
The membrane was dried using filter paper and the anti-mouse HRP was detected using 
ECL' Western Blotting Detection Reagents (Amersham Biosciences; solution 1, imI; 
solution 2, imI; RT, 1mm). A photograph was taken using HyperfilmTM (Amersham 
Biosciences) with 1, 5, 10 and 20 minute exposures. The film was developed using a Konica 
SRX-101A. 
5.12.4 Variation: Using Anti -H is(C-term) -H RP Antibody 
The electrophoresis, transfer of protein to the nitrocellulose membrane and detection was as 
described in section 5.12.1 and 5.12.3. However, only one antibody incubation occurs. As 
in section 5.12.2, blocking, washing and incubation were all carried out with gentle agitation. 
The membrane was blocked in PBSTM (20m1, RT, lh) and incubated in PBSTM containing 
Monoclonal Anti-His(C-term)-HRP antibody (mouse IgG, Invitrogen, 1:5000 dilution, 4p.l 
in 20ml, RT, 2h). Excess antibody was removed by washing the membrane with PBST (3x 
20mi, 3x 5mm, RT). 
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5.13 DNA Manipulation and Purification 
5.13.1 Polymerase Chain Reaction (PCR) 
The template (51il), primer I (forward, 5p.l) and primer 2 (reverse, 5p.l) were added to a PCR 
tube (0.5m1) containing Ready To Go PCR beads (x2, Pharmacia Biotech). This was diluted 
to 50p.l with distilled water and nujol oil (2 drops) was overlayed. The PCR reaction was 
carried out with thirty temperature cycles of 94°C (60s), 54°C (30s) and 72°C (90s) followed 
by a final extension of 72°C (1 0mm). The PCR product (lower layer) was extracted, 
Blue/Orange 6x Loading Dye (lOp.l, Promega) was added and the resulting solution was 
subjected to electrophoresis on agarose. 
5.13.1.1 Quick Change Mutagenesis Kit (Stratagene) 
The template pPICZaA (5j.xl), primer 1 (forward, pPICZ )ilzol FOR, 1 p.1), primer 2 (reverse, 
pPICZ XhoI REV, 1 p.1), 1 Ox reaction buffer (5 p.1), dNTP (1 p.1), sterile water (36p.l) and pfii 
turbo DNA polymerase (1p.l) were added to a PCR tube (O. 5m1) and nujol oil (2 drops) was 
overlayed. The PCR reaction was carried out with an initial step of 95°C (30s) followed by 
sixteen temperature cycles of 95°C (30s), 55°C (1mm) and 68°C (6mm). The PCR product 
(lower layer) was cooled on ice for 2 minutes, incubated with the restriction endonuclease, 
DpnI (lp.1) at 37°C (90mm) and transformed (2p.l) into Top 10 One ShotTm Competent Cells 
(50p.l, Novagen, see section 5.13.3.1). Colonies were grown on Low salt LB/zeocin 
(25p.g!ml) plates. At each stage, after the PCR reaction and DpnI incubation, 5p.1 was 
removed and analysed by electrophoresis on agarose. 
5.13.1.2 PCR Screen of P pasloris Genomic DNA 
Stock solutions were prepared which contained primer 1 (forward, 1 p.1), primer 2 (reverse, 
1 p.1) and distilled water (3 p.1) per reaction and Ready To Go PCR beads (x2/5 reactions, 
Pharmacia Biotech). Purified P. pastoris genomic DNA (5 p.1, section 5.13.5.4) and the stock 
solution (5p.l) were added to a PCR tube (0.5m1) and nujol oil (2 drops) was overlayed. The 
PCR reaction was carried out with an initial step of 94°C (5mm) followed by thirty 
temperature cycles of 94°C (60s), 54°C (30s) and 72°C (90s) with a final extension of 72°C 
(1 0mm). The PCR product (lower layer) was extracted, Blue/Orange 6x Loading Dye (2 p.1, 
Promega) was added and the resulting solution was subjected to electrophoresis on agarose. 
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5.13.2 Cloning into Amplification Vectors 
5.13.2.1 pCR2.1 
Topo cloning was carried out using TOPO TA Cloning® Kit (Invitrogen). 
The purified PCR Product (2j.iI) was cloned into pCR® 2.1-TOPO Vector (1.tl), in the 
presence of salt solution (1.2M NaCl, 0.06M MgCl 2, 1 j.tl) and sterile water (1 p.1) by 
incubation at RT (30mm). The resulting plasmid (2p.l) was transformed into Top 10 One 
ShotTm Competent Cells (25p.l, Novagen, see section 5.13.3.1), and colonies were grown on 
X-GaP/LB/ampicillin plates. 
5.13.2.2 pGEM 
Topo cloning was carried out using pGEM®-T Easy Vector System (Promega). 
The purified PCR Product (3p.l) was cloned into pGEM ®-T Easy Vector (1p.l), in the 
presence of T4 DNA ligase (3U/pi, 1p.l) and 2x rapid ligation buffer (5j.tl) by incubation at 
4°C (18h). The resulting plasmid (2p.l) was transformed into Top 10 One ShotTm Competent 
Cells (25p.1, Novagen, see section 5.13.3.1), and colonies were grown on X-
Gaf'/LB/ampicillin plates. 
5.13.3 Transformation into E. coil Cells 
Plasmid stocks (1p.l) were added to Top 10 One Shot' Competent Cells (12.5 j.tl, Novagen), 
mixed gently and incubated on ice ( 30mm), heat shocked at 42°C (30s), followed by re-
incubation on ice (2mm). SOC growth medium (250p.l) was added and agitated at 37°C 
(250rpm, lh). The resulting medium was spread (50 p.1) to dryness on selected plates and 
incubated at 37°C (1 8h). 
5.13.3.1 Ligation or Topo Cloning Transformations 
Trahsformation of Ligation or Topo cloning mixtures required 2p.l to be added to Top 10 
One ShotTM Competent Cells (2541) and all the SOC growth medium (250p.l) was spread on 
the plates. 
5.13.4 Transformation into the P. pastoris Genome 
Each plasmid was transformed into both X-33 (Mu() and KM7 1 H (MutS) P. pastoris strains. 
5.13.4.1 Plasmid Preparation 
The plasmids were purified by Maxi Prep (see section 5.13.5.2) and the DNA concentration 
was determined (section 5.18.1). The plasmids were then precipitated using isopropanol 
(section 5.13.6.1) and resuspended in sterile water (0.2p.m filtered, 90p.l). The plasmids 
(approximately 1004g) were linearised (section 5.13.7.4), phenol/chloroform extracted 
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(section 5.13.5.5) and then precipitated using ethanol (section 5.13.6.2). The DNA 
precipitate was resuspended in sterile water (0.2tm filtered, 11 tl) and the concentration 
determined using ipi (section 5.18.1). The remaining sample (lOul) was used in the 
electroporation (section 5.13.4.3). 
5.13.4.2 Cell Preparation 
A single P. postoris colony (X-33 or KM7111) was used to inoculate YPD broth (lOmi) and 
grown at 30°C with shaking (250rpm, 18h). Fresh YPD medium (200ml) was inoculated 
with the overnight culture (20-200j.il) and grown at 30°C with shaking (250rpm,18h) to an 
OD600 1.3-1.5. The cells were harvested by centrifugation (1500g. 3000rpm, 4°C, 5mm) and 
resuspended in ice cold (0°C) sterile water (200ml). The centrifugation and resuspension 
was repeated with sterile water (1 OOml), sorbitol (1 M, 8ml) and finally sorbitol (1 M, 400 j.tl). 
Both the water and sorbitol were ice cold (0°C). The cells were kept on ice in sorbitol (IM, 
40041) until used in electroporation (up to lh). 
5.13.4.3 Electroporation 
The linearised plasmid (1 Opi, approximately I Op.g, see section 5.13.4.1) was transferred to 
halfway down the side of an ice cold (0°C) 0.2cm electroporation cuvette. The plasmid was 
overlaid by the P. pastoris cells (X-33 or KM71H, 80pi, see section 5.13.4.2). The plasmid 
and cells were mixed by flicking the side of the cuvette and incubated on ice (5mm). The 
cells were pulsed (1.5kv, 25F, 2000, 3 seconds) using a Gene Pulser II (Bi0RAD). Ice 
cold (0°C) sorbitol (1M, 1 ml) was added immediately. The contents of the cuvette were 
transferred to a 1 5ml falcon tube and incubated at 30°C (2-3h) without shaking. The 
resulting medium was spread (1 0-200pJ) to dryness on YPDS plates, containing zeocin 
(1 00g/ml) and incubated at 30°C (72h). 
5.13.5 DNA Purification 
5.13.5.1 Plasmid DNA Purification from E. coli (Mini Prep) 
Cultures were grown by inoculating 2YT broth (lOmi), containing the appropriate antibiotic, 
ampicillin (lOOp.g/ml) or zeocin (25p.g/ml), in sterile conditions, with a single transformant 
colony and agitating at 37°C (250rpm, 18h). The cells were harvested by centrifugation 
(1500g, 3000rpm, 15mm, 4°C) and the supernatant discarded. The plasmid DNA was 
extracted and purified using QlAprep® Spin Mini-Prep Kit (Qiagen), eluting the purified 
plasmid DNA into Tris-CI (10mM, pH 8.5, lOOpi). 
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5.13.5.2 Plasmid DNA Purification from E. coli (Maxi Prep) 
Cultures were grown by inoculating 2YT broth (150m1), containing zeocin (25.1g/ml), in 
sterile conditions, with a single transformant colony and agitating at 37°C (250rpm, 18h). 
The cells were harvested by centrifugation (1500g, 3000rpm, 4°C, 10mm) and the 
supernatant discarded. The plasmid DNA was extracted and purified using GenEl uteTM }.fl) 
Plasmid Maxi-Prep Kit (Sigma). The purified plasmid DNA was eluted into distilled water 
(3m1) and concentrated (see section 5.13.6.1). 
5.13.5.3 DNA Purification from Agarose 
The DNA band was excised and purified using QlAquick® Gel Extraction Kit (Qiagen), 
eluting the purified DNA into Tris-CI (10mM, pH 8.5, 2041). 
5.13.5.4 R pastoris Genomic DNA Purification 
Cultures were grown by inoculating BMG broth (l0ml), containing zeocin (lOOp.g/ml), in 
sterile conditions, with a single P. pastoris transformant colony from a YPDS/zeocin 
(1 00Wml) plate and agitating at 30°C (250rpm, 18h). The cells were harvested by 
centrifugation (1500g. 3000rpm, 10mm, 4°C) and the supernatant discarded. The cell wall 
was lysed by resuspending the cells in sorbitol (1 M), EDTA (100mM), 13-mercaptoethanol 
(14mM) and lyticase (200U, 600p.l) and incubating at 30°C (lh). The spheroplasts were 
harvested by centrifugation (1000rpm, RT, 10mm). The genomic DNA was extracted from 
the spheroplasts and purified using DNeasy ® Tissue Kit (Qiagen), eluting the purified 
genomic DNA into AE buffer (200pJ). 
5.13.5.5 Phenol/Chloroform Extraction 
DNA (PCR digest or linear plasmid digest, 50pJ) was made up to 1 00tl with sterile TE and 
phenollchloroform/isoamyl alcohol (25:24:1, 100p1) was added, voretexed (15s) and 
centrifuged (13Krpm, RT, 2mm). The upper aqueous layer was removed (approximately 
80tl) and collected in a new eppendorf (1 .5m1). Sterile TE (50p.l) was added to the lower 
layer, vortexed and centrifuged as before. The upper layer (50tl) was pooled with the 
previous fraction and ethanol precipitated (section 5.13.6.2). 
5.13.6 DNA and Protein Precipitation 
5.13.6.1 DNA Precipitation using Isopropanol 
Purified plasmid DNA (3ml, section 5.13.5.2) was concentrated by the addition of 100% 
isopropanol (2.1ml at RT) and sodium acetate (3M, pH 5.2, 300p1) and centrifuged (13k 
rpm, 4°C, 30mm). The supernatant was discarded and the precipitate was washed with ice 
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cold (0°C) 70% ethanol (1.5m1) and centrifuged (13k rpm, 4°C, 10mm). The supernatant 
was discarded and the precipitate was dried in air (1 0mm) and then next to an open flame 
(20mm) or in a gyrovap (42°C, 1 5mm). The precipitate was resuspended in sterile water 
(9Otl). 
5.13.6.2 DNA Precipitation using Ethanol 
100% ethanol (2 volumes, 27041), sodium acetate (3M, pH 5.2, 0.1 volumes, 13.tI) and 
glycogen (20mg/mi, lj.il) were added to the extracted DNA (l3Opi, section 5.13.5.5) and the 
resulting solution was incubated at -80°C (30mm). The DNA precipitate was collected by 
centrifugation (13k rpm, 4°C, 30mm) and the supernatant was discarded. The precipitate 
was washed with ice cold (0°C) 70% ethanol (50.d) and centrifuged (13k rpm, 4°C, 5mm). 
The supernatant was discarded and the precipitate was dried in air (10mm) and then next to 
an open flame (20mm) or in a gyrovap (42°C, 15mm). 
5.13.6.3 Protein Precipitation using Trichioroactetic Acid (TCA) 
TCA precipitation was carried out on P. pastoris pPICZaA strain media samples. 
An equal volume of 20% TCA was added to the protein sample (0.6-1.5m1) and incubated on 
ice (30mm). The precipitate was harvested by centrifugation (13k rpm, 4°C, 15mm) and the 
supernatant was discarded. The precipitate was washed with ice cold (0°C) 100% acetone 
(300 j.il) and centrifuged (13k rpm, 4°C, 5mm). The supernatant was discarded and the 
precipitate was dried in air (1 0mm) and then next to an open flame (20mm) or in a gyrovap 
(42°C, 15mm). The precipitate was resuspended with lx SDS sample buffer (20-100tl), 
boiled (10mm), loaded (20jtl) onto either SDS-PAGE (15%) or Pre-cast SDS-PAGE and 
subjected to electrophoresis (see section 5.11.2). 
5.13.7 Digestion of DNA using Restriction Endonucleases 
5.13.7.1 Analysis 
Plasmid DNA (7.tl) was incubated with the required restriction endonucleases (11 .tl), I Ox 
buffer (1.d) and sterile water (3tl) at 37°C (2-18h). Blue/Orange 6x Loading Dye (lp.l, 
Promega) was added and the DNA fragments were analysed by electrophoresis on agarose. 
5.13.7.2 Preparative (Excluding pGEM AUR1 Trunc, pICZaA and 
pPICZ XhoI mut Plasmids) 
Plasmid DNA (30tl) was incubated with the required restriction endonucleases (lp.l of each 
enzyme), lOx buffer (40) and sterile water (4.tl) at 37°C (2-18h). Blue/Orange 6x Loading 
Dye (7p.l, Promega) was added and the DNA fragments were subjected to electrophoresis on 
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agarose. The required DNA fragment was then excised and extracted as described in section 
5. 13 .5 .3. 










XhoI/HindlTT 2 + BSA 
XhoLfNot! 3 + BSA 
XhoJlXbaI 2+ BSA 
Table 5.2: Buffers Used in which the Restriction Endonucleases were 100% Active 
5.13.7.3 Preparative Digest of pGEM A URJ Trunc and pICZaA and 
pPICZ XhoI mut Vectors 
Plasmid DNA (30il) was incubated sequentially with the required restriction endonuclease, 
lOx buffer 3 (4j.tl), I 00 BSA (0.4j.tl) and sterile water (2tl) at 37°C (enzyme 1, 2t1, 6h; 
enzyme 2, 2p.l, 18h, Table 5.3). Blue/Orange 6x Loading Dye (7p.l, Promega) was added, 
the DNA fragments were subjected to electrophoresis on agarose and the required DNA 
fragment was excised and extracted (see section 5.13.5.3). 
Plasmid 
	 Restriction endonuclease 
6h incubation (Enzyme 1) 	18h incubation (Enzyme 2) 
pGEM AURJ Bc Kex Trunc 	 ,171o1 	 Not! 
pGEM A URI Sc Kex Trunc XhoI Nod 
pGEM AUR) Bc Kozak Trunc 	 XloI 	 Nod 
pGEM AURI Sc Kozak Trunc )O,oI Nod 
pPICZaA 	 NotI 	 )7zoI 
pPICZctA A7ioI mat 	 Nod AlzoI 
Table 5.3: Restriction Endonucleases used in Sequential Preparative Digests 
5.13.7.4 Linearisation of Plasmids for Electroporation 
Plasmid DNA concentrated by isopropanaol precipitation (30.x1, section 5.13.6.1) was 
incubated with either Sac! or PmeI restriction endonucleases (15 p1), 1 Ox buffer (Sac!, buffer 
1; PmeI, buffer 4; 5p.1) and lOOx BSA (0.5p1) at 37°C (18h). The DNA was extracted using 
phenol/chloroform (section 5.13.5.5) and concentrated by ethanol precipitation (section 
5. 13.6.2). 
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5.13.8 DNA Ligation 
5.13.8.1 Normal T4 DNA Ligase (New England Biolabs) 
The gene insert (1 3tl) and vector (3pJ), previously cut with the appropriate restriction 
enzymes, were incubated with T4 DNA Ligase (40OU/tl, 2t1) and 1 Ox Ligase Buffer (2j.tl) 
at RT (18-48h). A control was also carried out, replacing the gene insert with sterile water 
(13pJ). The ligation mixture (2jil) was transformed into Top 10 One ShotTM  Competent cells 
(25tl, see section 5.13.3.1). 
5.13.8.2 Concentrated T4 DNA Ligase (New England Biolabs) 
The procedure was as described above in section 5.13.8.1, however, concentrated T4 DNA 
Ligase (200OU/tl) was used instead of normal T4 DNA Ligase (40OU/.tl). 
5.13.8.3 Rapid DNA Ligation Kit (Roche) 
The gene insert (3-4t1) and vector (1 -2p1) previously cut with the appropriate restriction 
enzymes (concentration 3:1), were incubated with 5x DNA dilution buffer 2 (2tl) and 
diluted to a final volume of l0.tl with sterile water. The solution was mixed well and 2xT4 
DNA Ligase buffer 1 (lOj.il) was added, mixed well again, and followed by the addition of 
T4 DNA Ligase 3 (5U/pi, I tl). The solution was mixed and incubated at room temperature 
(30mm). The ligation mixture (3p.l) was transformed into Top 10 One Shot Tm Competent 
cells (501.il, see section 5.13.3.1). 
5.13.9 DNA Sequencing 
The DNA template (4p1), primer (lp.l), sterile water (1 lj.tl) and ABI prism BigDye 
Terminator V3.0 Cycle Sequencing ready reaction kit mix (4j.il) were added to a PCR tube 
(0.5m1) and nujol oil (2 drops) was overlayed. The temperature cycle: 96°C (30s), 45°C (15s) 
and 60°C (4mm) was repeated thirty times. The PCR product (lower layer) was extracted 
into a clean eppendorf (1 .Sml) before submitting it for sequencing. This was carried out by 
Simon Harding and Anna Montazam using the ABI Prism 377 DNA sequencer. 
5.14 P pastoris Transformant Analysis 
5.14.1 Isolation of Multi-Copy Recombinants 
A single P. pastoris transformant colony was restreaked onto two YPDS plates containing 
zeocin (100 j.tg/ml and 500p.g/ml) and incubated at 30°C (48h). Multi-copy recombinants 
grew in the presence of high zeocin concentration (500 j.iglml). 
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5.14.2 PCR Analysis of P. pastoris Integrants 
A single transformant colony was cultured, the genomic DNA was purified (section 5.13.5.4) 
and the integrant was analysed by PCR using AOX and A URI primers (section 5.13.1.2). 
5.14.3 Mut Phenotype Determination 
A single P. pasroris X-33 transformant colony from a YPDS/zeocin (100tg/m1) plate was 
spotted onto a MM plate followed by a Ml) plate and incubated at 30°C (48h). After 48h the 
colonies were respotted onto fresh MM and MD plates and incubated at 30°C for a further 
48h, this reduced the possibility of misclassification. Approximately ten recombinants were 
spotted per plate in a grid format. Wild type X-33 (Mut) and KM7 1 H (MutS)  colonies were 
used as controls. Both Mut strains grew well on MD plates but MutS  strains showed little or 
no growth on MM plates. KM71H recombinants did not require their Mut phenotype 
determined as they remain M uts 
5.14.4 Wild Type Cell Preparation 
5.14.5 Wild Type S. cerevisiae Fermentation (5L) 
A single colony of Wild type S. cerevisiae was obtained by streaking onto a YPD plate and 
incubating at 30°C (72h). 
5.14.5.1 Batch Phase (500m1) 
BMD (lOmi) was inoculated with a single wild type S. cerevisiae colony and agitated at 
30°C (250rpm, 18h). The resulting medium was then distributed evenly between BMD broth 
(2 x 250ml) and agitated at 30°C (250rpm, 18h). The cells were harvested by centrifligation 
(5k rpm, 10mm, 4°C) and the cell pellet was stored at 4°C until required. 
5.14.5.2 Fermentation Phase (5L) 8 
The fermentor containing FBSM (2.5L) was sterilised and a dissolved oxygen probe was 
attached and allowed to equilibrate (6h). Ammonium hydroxide solution (28%w/v) was 
attached as feed 2 and was added until pH 5 was obtained (automated control). The trace 
salt solution (7.5m1) and vitamin solution (3.75m1) were added to the D-Glucose( aq solution 
(25%w/v, 1.25L) and attached as feed 1. The trace salt solution (4.35m1/lL FBSM, 
10.88m1) and vitamin solution (3mlIlL FBSM, 7.5ml) were also added to the FBSM in the 
fermentor, via a syringe and septum. The batch phase wild type S. cerevisiae cell pellet 
(section 5.14.5.1) was resuspended in BMD (150m1), agitated at 30°C (2h) and then used to 
inoculate the FBSM in the fermentor. Once all the glucose in the FBSM had been used, feed 
I was added in pulses. Feed 1 was kept as a limiting factor to prevent ethanol production. 
8  Dr. Laurie Cooper and Dr. Andy Herbert assisted with the fermentation phase. 
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The fermentation temperature was 30°C and agitation was varied depending on the dissolved 
oxygen concentration. The cells were harvested by centrifugation (5k rpm, 10mm, 4°C) 54h 
after inoculation (final volume, approximately 5L) and the cell pellet (767g) was stored in 
25g aliquots at -80°C until required. 
5.14.6 Wild Type B. cinerea Preparation (51- Batch) 
Conidia was mechanically harvested, under class H conditions, from three plates of wild type 
B. cinerea9 using Tween 20(aq)  (0.02%v/v, lOOmI) and filtered through thin gauze to remove 
solids. The conidia concentration (4x10 6 conidia/ml) was calculated using a Neubaun 
haemocytometer. The B. cinerea media (4L) was inoculated with the conidia solution (final 
concentration lx 10 5 conidialml), under sterile conditions, evenly distributed (8 x 500ml in 8 
x 1L flasks) and agitated at 20°C (120rpm). The cells were harvested after 8 days (8 x 
500m1) by filtration through fine gauze. The cell pellet (146.2g) was stored at 
-80°C until required. 
5.14.7 Wild Type P. pastoris (X-33 and KM7IH) Preparation 
Two wild type P. pasloris colonies of each strain, X-33 and KM71H, were grown as 
described in section 5.15.2.2, except zeocin was omitted from all cultures. The cell pellet 
from the second colony of each strain was resuspended in MGY media (X-33, 600m1, 
2x300m1 in 2xlL flask; KM71H, 300ml in lxlL flask) instead of MM media to determine 
the affect of methanol on wild type P. pastoris IPC synthase expression. 
5.15 Recombinant Protein Expression 
5.15.1 Protein Expression in E. coil Host 
5.15.1.1 Mini Induction 
2YT broth (imi), containing ampicillin (100tgIml), was inoculated with a single colony and 
agitated at 37°C (250rpm) until an 013 0 1 was reached. A control (0.5m1) was taken and the 
remainder was induced with IPTG (1mM) and agitated at 37°C (250rpm, 3h). The cells were 
harvested by centrifugation (13k rpm, RT, 10mm). The supernatant was discarded and the 
cell pellet was resuspended in SDS sample buffer (50p.I) and distilled water (50j.tl), boiled 
(10mm), then loaded (20p.l) onto a SDS-PAGE gel (15%) and subjected to electrophoresis 
(section 5.11.2). 
5.15.1.2 Large Scale Preparation (3L) 
2YT broth (300mi), containing ampicillin (100g/ml), was inoculated with a single colony 
of pRL3851AURJ/Bc (Top 10 cells) and agitated at 37°C (250rpm, 18h). The resulting 
Wild type B. cinerea plates were grown at Syngenta by Anne Stevens. 
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medium was then distributed evenly between 2YT broth (6 x 500m1) containing ampicillin 
(1 00tg/ml) and agitated at 37°C (250rpm) until an 0D 600 1 was reached. A control (0.5m1) 
was taken and the remainder was induced with IPTG (1mM) and agitated at 37°C (250rpm, 
24h). The cells were harvested by centrifugation (5k rpm, 15mm, 4°C). The supernatant was 
discarded and the cell pellet (9.87g) was stored at -20°C until the protein was purified 
according to its requirements. 
5.15.2 Protein Expression in P. pastoris Host 
5.15.2.1 Mini Induction of pPICZaAAURJ BC and pPICZaA 
control P pastoris Strains 
MGY (1 Oml), containing zeocin (1 00tg/m1), was inoculated with a single P. pastoris 
transformant colony from a YPDS/zeocin (1 00tg/ml) plate and agitated at 30°C (250rpm, 
18h). When an OD 0 2-6 was reached, X-33 (Mut) and KM7 1 H (MutS)  strains were treated 
differently. 
5.15.2.1.1 X-33 (Mut) Strains (10 pPICZaAAURJIBC and 4 pPICZ(XA) 
The OD 0 was measured and the volume corresponding to an OD 6W I when resusepended in 
I imi was harvested by centrifugation (1500g. 3k rpm, 4°C, 10mm) under sterile conditions. 
The cell pellets were resuspended in MM media (Ilml, OD 1) and agitated at 30°C 
(250rpm). Fractions (imi) were removed and centrifuged (1500g, 3k rpm, 4°C, 10mm) at 
various time points (Oh, 12h, 24h (1 day), 36h, 48h (2 days), 60h, 72 h (3 days), 84h, 96h (4 
days), 108h, 120h (5 days)). Both the pellets and the supernatants were stored at -80°C until 
analysed. 100% methanol was added every 24h to a final concentration of 0.5%v/v to 
compensate for metabolism and evaporation. 
5.15.2.1.2 KM7IH (MutS)  Strains (10 pPICZaA AURJ/BC and 4 pPICZ(xA) 
The OD 3 was measured and the cells were harvested by centrifugation (1500g. 3k rpm, 
4°C, 1 0mm) under sterile conditions. The cell pellets were resuspended in MM media 
(1.5m1, OD20-40) and agitated at 30°C (250rpm, 144h, 6 days). A lml fraction was 
removed and centrifuged (1500g. 3k rpm, 4°C, 10mm). Both the pellets and supernatants 
was stored at -80°C until analysed. 100% methanol was added every 24h to a final 
concentration of 0.5%v/v to compensate for metabolism and evaporation. 
5.15.2.1.3 	Analysis 
The cell pellets (X-33, 120h; KM71H, 144h) were resuspended in SDS sample buffer (75.tl) 
and distilled water (75p1) and boiled (10mm). The media supernatant (X-33, 120h; KM71H, 
144h) was subjected to TCA precipitation (see section 5.13.6.3). Both the cell pellet and 
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media samples were loaded (20j.tl) onto an SDS-PAGE gel (15%) and subjected to 
electrophoresis (section 5.11.2). Western blolting using Anti-His(C-term)-HRP antibody 
were carried out as described in section 5.12.4. 
5.15.2.2 Large Scale expression 
Two colonies of each strain, X-33 and KM71H strains containing pPICZcx.A and pPICZA 
)i7loI mut (AURJ/Bc, AURJ/Sc, Truncated AURI/Bc, Truncated AURJ/Sc and controls), were 
used for large scale expression. 
MGY (lOmi), containing zeocin (100tg/ml), was inoculated with a single P. pastoris 
transformant colony from a YPDS/zeocin (100p.g/ml) plate and agitated at 30°C (250rpm, 
18h). When an 013600 2-6 was reached, X-33 (Mut) and KM7 I H (MutS)  strains were treated 
differently. 
5.15.2.2.1 	X-33 (Mui') Strains 
A third of the resulting culture was used to inoculate MGY (300m1 in IxiL flask) and the 
cells were grown to an OD 2-6 at 30°C with agitation (250rpm, 18h). The 0136W was 
measured and the volume corresponding to an 013 6w 1.5 when resusepended in 600m1 was 
harvested by centrifugation (1500g. 3k rpm, 4°C, 10mm) under sterile conditions. The cell 
pellet was resuspended in MM media (600m1, 2x 300ml in 2xlL flask, OD WO 1.5) and 
agitated at 30°C (25 0rpm, 96h, 4 days). 100% methanol was added every 24h to a final 
concentration of I .0%v/v to compensate for metabolism and evaporation. Cells were 
harvested by centrifugation (1500g. 3k rpm, 4°C, 10mm) and stored at -80°C until required. 
In the case of pPICZaA strains the media was also stored at -80°C. 
5.15.2.2.2 	KM71H (MutS)  Strains 
The resulting culture was used to inoculate MGY (1200m1, 3x400ml in 3xlL flask) and the 
cells were grown to an OD 2-6 at 30°C with agitation (250rpm, 18h). The OD ® was 
measured and the cells were harvested by centrifugation (1500g, 3k rpm, 4°C, 10mm) under 
sterile conditions. The cell pellet was resuspended in MilvI media (300m1 in lxi L flask. 
OD 20-40) and agitated at 30°C (250rpm, 144h, 6 days). 100% methanol was added every 
24h to a final concentration of 1 .0%v/v to compensate for metabolism and evaporation. 
Cells were harvested by centrifugation (1500g. 3k rpm, 4°C, 10mm) and stored at -80°C until 
required. In the case of pPICZaA strains the media was also stored at -80°C. 
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5.15.2.2.3 	Analysis 
The cell pellets (and media for pPICZctA strains) were analysed by SDS-PAGE (see section 
5.11.2, for TCA precipitation of media prior to SDS-PAGE see section 5.13.6.3), western 
blotting (1° antibody, anti c-myc antibody (mouse); 2° antibody, anti mouse-HRP; see 
section 5.12) and IPC Synthase activity assays (see section 5.18.3.8 for cell pellets and 
sections 5.18.3.1 and 5.18.3.3 for media). One strain of each type was selected, based on 
1PC synthase activity and the quality of the PCR screen (section 5.13.1.2), for enzyme 
isolation and purification (section 5.17.2). 
5.16 Wild Type Enzyme Isolation and Protein Purification 
All steps were carried out at 4°C, except where stated. 
5.16.1 Wild type S. cerevisiae IPC Synthase Isolation 
5.16.1.1 Cell Disruption using a French Press 
The S. cerevisiae cell pellet (approximately 250g) was resuspended in lysis buffer (250m1, I 
volume) and the cells were disrupted using a French Press (4000pSi, Constant Cell 
Disruption Systems). The cell debris was removed by centrifugation (1500g, 5k rpm. 4°C, 
10mm). The cell free extract was centrifuged (27k g, 15k rpm, 4°C, 25mm) to remove the 
mitochondrial fraction and the 27k g supernatant was centrifuged (100k g, 30k rpm, 4°C, 
45mm) to obtain the microsomal fraction. The microsomal fraction (100k g pellet) was 
washed with microsomal storage buffer (20m1) and resupended in the same buffer to a 
concentration of 1 OOmg/ml and stored at -80°C until required. 
5.16.1.2 Cell Disruption using a Bead Beater 
The S. cerevisiae cell pellet (approximately 25g) was resuspended in lysis buffer (25m1, 1 
volume) and the cells were disrupted using a bead beater (Biospec Products). A 43%work 
volume of 400-600p.M acid washed glass beads (Sigma): resuspended cell volume was 
employed. The inner chamber was surrounded by a 50:50 ice cold (0°C) EtOH:H 20 % ice 
bath and the cells were disrupted over three cycles (bead beater on, 30s; rest interval, 30s). 
The supernatant was decanted off the glass beads and the cell debris was removed by 
centrifugation (1500g, 5k rpm, 4°C, 10mm). 
5.16.1.3 Preparation of Solubilised Microsomes 
(Cells Disrupted by a French Press) 
The microsomal membrane fraction (20n -fl, 100mg/mm, section 5.16.1.1) was diluted with 5x 
solubilisation buffer and distilled water to give a final protein concentration of 10mg/mi in 
lx solubilisation buffer. The resulting suspension was slowly agitated at 4°C (90mm) and 
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the insoluble fraction was removed by centrifugation (100k g, 30k rpm, 4°C, 45mm). The 
solubilised crude microsomal fraction (supernatant) was stored at -80°C until required. 
5.16.1.4 Preparation of Solubilised Microsomes 
(Cells Disrupted by a Bead Beater) 
The cell free extract (section 5.16.1.2) was centrifuged (27k g, 15k rpm, 4°C, 25mm) to 
remove the mitochondrial fraction and the 27k g supernatant was centrifuged (100k g, 30k 
rpm, 4°C, 45mm) to obtain the microsomal fraction. The microsomal pellet (100k g pellet) 
was resuspended in solubilisation buffer (20m1) and agitated slowly at 4°C (90mm). The 
insoluble fraction was harvested by centrifugation (100k g, 30k rpm, 4°C, 45mm) and the 
supernatant was stored at -80°C until required. 
5.16.1.5 Purification of Solubilised IPC Synthase 
5.16.1.5.1 	Anion Exchange Chromatography (Q Sepharose) 
The solubilised enzyme solution (200m1, 3.71mg/mi, section 5.16.1.3) was filtered (0.45 j.tm) 
and loaded onto a 26/10 Q-Sepharose column (55m1, Pharmacia, 4°C, flow rate 2 ml/mm) 
equilibrated with anion exchange chromatography buffer. The column was washed (flow rate 
4 nil/min) until an 0D280<0.l was obtained (approximately 10 column volumes). Bound 
protein was eluted with a 0-1M NaCl gradient over twenty column volumes (flow rate 
lmllmin, collection fraction volume 20m1). The fractions were analysed by SDS-PAGE 
(section 5.11.2) and IPC Synthase activity assays (sections 5.18.3.1 and 5.18.3.3). Fractions 
5-17 (0.07-0.3M NaCl) were pooled (260m1) and dialysed against hydrophobic 
Chromatography buffer (3L, 18h, 4°C). 
5.16.1.5.2 	Hydrophobic Chromatography (Resource Phe) 
The dialysed sample (200m1) was filtered (0.45tm) was loaded onto a Resource Phe column 
(I nil, Pharmacia, 4°C, flow rate I ml/min) equilibrated with hydrophobic chromatography 
buffer. The column was washed (flow rate 1 ml/min, I OmI, 10 column volumes), followed 
by washing with buffer containing no NaCl until an 0D 280<0. 1 was obtained (approximately 
10 column volumes). Bound proteins were eluted with a 0-1%v/v Triton X-100 gradient 
(NaCl was omitted) over twenty five column volumes (flow rate lmllmin, collection fraction 
volume 1 ml). The fractions were analysed by SDS-PAGE (section 5.11.2) and IPC Synthase 
activity assays (sections 5.18.3.1 and 5.18.3.3). Fractions 5-14 (0.2-0.6%v/v Triton X-100) 
were pooled (lOmi) and purified further by Anion exchange chromatography (Mono Q). 
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5.16.1.5.3 Anion Exchange Chromatography (Mono Q) 
The Resource Phe purified fractions (lOml) were filtered (0.45im) and loaded onto a Mono 
Q column (I nil, Pharmacia, 4°C, flow rate 1 ml/mm) equilibrated with anion exchange 
chromatography buffer. The column was washed (flow rate 1 ml/min) until an 0D 280< 0.1 
was obtained (approximately 30 column volumes). Bound proteins were eluted with a 0-1M 
NaC1 gradient over twenty column volumes (flow rate lmllmin, collection fraction volume 
imI). The fractions were analysed by SDS-PAGE (section 5.11.2) and IPC Synthase activity 
assays (sections 5.18.3.1 and 5.18.3.3). Fractions 2-4 (0.1-0.2M NaCl, 3ml) and 5-6 (0.2-
0.3M NaCl, 2m1) were pooled, concentrated to 200 jtl using vivaspin concentrators, 10,000 
PES membrane (VivaScience), re-analysed and stored at -80°C. 
5.16.1.6 IMAC 
Wild type S. cerevisiae cell pellet (25g) was disrupted (section 5.17.2.1) and purified by 
IMAC (section 5.17.2.3). The column was washed with 40 column volumes (lOmi) prior to 
elution. The fractions were analysed by SDS-PAGE (section 5.11.2.3) and IPC synthase 
activity assay (sections 5.18.3.1 and 5.18.3.3). 
5.16.2 Wild Type B. cinerea IPC Synthase Isolation 
5.16.2.1 Preparation of Solubilised Microsomes 
The B. cinerea cell pellet (approximately 12g) was resuspended in lysis buffer (60m1, 5 
volumes) and the cells were disrupted using a bead beater (section 5.16.1.2). The 
supernatant was decanted off the glass beads and the microsomes obtained by centrifugation 
(27k g, 15k rpm, 4°C, 25mm). The 27k  pellets were combined (5.95g) and resuspended in 
solubilisation buffer (5m1) containing 1mM P1 and agitated slowly at 4°C (2.5h). The 
insoluble fraction was harvested by centrifugation (27k g, 15k rpm, 4°C, 45mm) and the 
supernatant was stored at -80°C until required. 
5.16.2.2 IMAC 
Wild type B. cinerea solubilsed microsomes (5m1) were dialysed against dialysis buffer 1 
(2L, 4°C, 18h), filtered (0.45p.m) and purified by IMAC (section 5.16.1.6). 
5.16.3 Wild Type P. pastoris IPC Synthase Isolation 
Wild type P. pastoris (X-33 and KM71H) cell pellets were disrupted, solubilised (section 
5.17.2.1) and purified using IMAC (see section 5.16.1.6 for cells grown in MGY and section 
5.17.2.3 for cells grown in MM). 
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5.17 Recombinant Enzyme Isolation and Protein Purification 
All steps were carried out at 4°C, except where stated. 
5.17.1 Recombinant GST-Aurl p/Bc (Expressed in E. coil) 
5.17.1.1 Preparation of Solubilised Inclusion Bodies 
The cell pellet (9.87g, section 5.15.1.2) was resuspended in Bugbuster Tm Protein Extraction 
Reagent (Novagen) (25m1, 2.5m1/g) and agitated slowly at RT (30mm). The lysed cell 
debris and inclusion bodies were harvested by centrifugation (12k rpm, 20mm, 4°C). The 
pellet and inclusion bodies were resuspended in inclusion body solubilisation buffer (20m1) 
and agitated slowly at 4°C (1 8h). The suspension was centrifuged (100k g, 30k rpm, lh, 
4°C) and the supernatant filtered (0.45p.m). 
5.17.1.2 Glutathione Sepharose Affinity Chromatography 
The DDM (20mM) solubilised fraction (0.45p.m filtered) was loaded onto a GST affinity 
column (GSTrap, 5m!, Pharmacia, 4°C, flow rate 0.5 ml/min) equilibrated with GST binding 
buffer. The column was washed with GST binding buffer (50m1, 10 column volumes, flow 
rate 0.5ml/min) and bound proteins were eluted with GST elution buffer (50m1, 10 column 
volumes, flow rate 0.5m1/min, collection fraction volume 5m1). GST-Aurlp/Bc and free GST 
were eluted between 5-15m1, fractions 2 and 3. The fractions were analysed by SDS-PAGE 
(section 5.11.2) and IPC Synthase activity assays (sections 5.18.3.1 and 5.18.3.3). Fractions 
2 and 3 were pooled (lOmi) and concentrated to 200111 using vivaspin concentrators, 10,000 
PES membrane (VivaScience), re-analysed and stored at -80°C. 
5.17.1.3 Thrombin Cleavage of GST-Aurlp/Bc 
Concentrated protein eluted from the GSTrap column (1 2j.tg) was treated with a range of 
thrombin concentrations (0.04-1 unit& °, restriction grade, Novagen), in the presence of lx 
thrombin cleavage and storage buffer, at RT and 4°C for various periods of time (2-36h). 
Treated samples were analysed by SDS-PAGE (see section 5.11.2). 
5.17.1.4 Treatment of the Unbound Glutathione Sepharose Affinity 
Chromatography Fraction 
5.17.1.4.1 	Cation Exchange Chromatography (Resource S) 
The unbound fraction (20m1) was dialysed against GST dialysis buffer (2x 2L, 2x lh), 
filtered (0.45.tm) and loaded onto a Resource S column (6m1, Pharmacia, 4°C, flow rate 
imi/min) equilibrated with GST dialysis buffer. The column was washed (flow rate 2 
101 unit of thrombin cleaves 1mg of fusion protein when incubated at 20°C for 16h. 
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ml/min) until an OD, 80<0. 1 was obtained. Bound proteins were eluted over a 0-1M NaCI 
gradient using GST cation exchange elution buffer (120m1, 20 column volumes, flow rate 2 
ml/min, collection fraction volume 5ml). Fractions were analysed by SDS-PAGE (section 
5.11.2) and IPC Synthase activity assays (sections 5.18.3.1 and 5.18.3.3). Fractions 9-11 (5 
ml) were concentrated separately to 200tl using vivaspin concentrators, 10,000 PES 
membrane (VivaScience), re-analysed and stored at -80°C. 
5.17.1.4.2 	Size Exclusion Chromatography (Superdex 75) 
The concentrated fractions 9 and 10 were pooled (300p.l), filtered (0.451m) and loaded onto 
a Superdex 75 gel filtration column (29m1, Pharmacia, 4°C, flow rate 0.5 ml/min) 
equilibrated with GST gel filtration buffer. The proteins were eluted over one isocratic 
column volume (29m1, flow rate 0.5 ml/min, collection fraction volume lml). Fractions were 
analysed by SDS-PAGE (section 5.11.2) and IPC Synthase activity assays (sections 5.18.3.1 
and 5.18.3.3). Fractions 7-10 were pooled and stored at -80°C. 
5.17.2 Recombinant Aurlp-c-myc-His 6 (Expressed in P. 
pastoris) 
5.17.2.1 Preparation of Solubilised Microsomes 
The cell pellets (4 -1 8.5g) were resuspended in All in one buffer (20ml) and disrupted using 
a bead beater (section 5.16.1.2). The supernatant was decanted off the glass beads and the 
supernatant was agitated slowly at 4°C (2h). The insoluble fraction was removed by 
centrifugation (100k g, 30k rpm, 4°C, 45mm) and the supernatant was stored on ice at 4°C 
until required (up to a maximum of 24h). 
5.17.2.2 Preparation of Media Samples 
Media from the pPICZaA expression system (1 OOml) was agitated slowly at 4°C (2h) in the 
presence of Triton X-100 (1 %v/v). The resulting solution was dialysed against dialysis 
buffer 1 (2L, 3h, 4°C) stored on ice at 4°C until required (up to a maximum of 24h). 
5.17.2.3 IMAC 
Prepared samples (section 5.17.2.1 or 5.17.2.2) were filtered (0.45p.m) and loaded onto Ni 
Sepharose High Performance resin (0.25m1, Amersham Bioscience, 4°C) prepared in a 
polypropylene column (I ml, Qiagen) and equilibrated with [MAC buffer. The column was 
washed (flow rate gravity, 20 column volumes, Sml) and bound proteins were eluted with 
IMAC buffer containing 500mM imidazole (flow rate gravity, 5 column volumes, 1 .25m1). 
The fractions were analysed by SDS-PAGE (section 5.11.2), western blotting (1° antibody, 
anti c-myc antibody (mouse); 2° antibody, anti mouse-HRP (sheep); section 5.12) and IPC 
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synthase activity assays (sections 5.18.3.1 and 5.18.3.3) and stored at -80°C. The media 
elution samples were TCA precipitated (section 5.13.6.3) and re-analysed by SDS-PAGE 
and western blotting. 
5.18 Assays 
5.18.1 DNA Concentration Assays 
DNA (1 .t1) was diluted to 1 00.il with distilled water and the concentration was measured 
using an Eppendorf Biophotometer (0D 260 x SOng/mi x dilution factor = DNA concentration 
(ng/ml), OD260  I = SOng/mi). 
5.18.2 Protein Concentration Assays 
The protein concentration was determined according to Bradford [614] using bovine serum 
albumin as a reference (BioRad Protein Assay, BioRAD). 
5.18.3 IPC Synthase Activity Assay 
5.18.3.1 Incubation 
IPC synthase source (25.t1, up to a maximum of 100ig protein) was incubated at 30°C 
(5mm). The substrate mix (25.t1), containing C 6-NBD-Cer (0.4125p.l, 2mM in DMSO), P1 
(2pi, 50mM in Ix assay buffer), 5x assay buffer (10t1) and distilled water (12.5875i.ii), was 
added and incubated at 30°C (80mm). Final assay concentrations were protein (2mg/mi, 
lOOp.g), C6-NBD-Cer (16.5p.M), P1 (2mM) and lx assay buffer (Bis-Tns-Cl (50mM, pH 
6.5), MgCl2 (5mM), MnCl 2 (1mM) and Triton X-lOO (5mM)). Assays were carried out in at 
least duplicate and controls were taken in which the IPC synthase source was replaced by 
distilled water. 
5.18.3.2 Development of Optimum Assay Conditions 
Wild type S. cerevisiae crude solubilised microsomes (4.2mg/mi, 20m1, section 5.16.1.3) 
were dialysed against solubilisation buffer modified by reduction of Triton X-100 from I to 
0.05% and removal of protease inhibitors (3L, 4°C, 18h). KM values were determined for P1 
and C6-NBD-Cer using Michaelis-Menten kinetics (sections 5.19.1.2 and 5.19.1.1). C6-
NBD-Cer (16.5MM, 3xMichaelis-Menten KM)  and P1 (2mM, SXK M) were incubated with the 
IPC synthase source described above (25 p1 at 4.2mg/mi, 100tg) and the assay was carried 
out as described in section 5.18.3.1. The assay was terminated (section 5.18.3.3) at various 
time points between 0 and 8 hours. An assay time of 80 minutes was selected as this was 
within the linear range of C 6-NBD-Cer turnover to C6-NBD-IPC. 
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5.18.3.3 TLC Detection 
The assay was terminated by the addition of HCl (0. 1M) in methanol (0.35m1). MgC12(aq) 
(1M, 0.5m1) and chloroform (0.5m1) were added, mixed and centrifuged (13k rpm, RT, 
2mm). The upper (aqueous) layer was removed and the lower (choloroform) layer was 
concentrated by evaporation (RT, 18h). The lipid (chloroform) residue was resuspended 
with chloroform (2 drops) and the lipids were separated by analytical TLC on silica 60 plates 
using the solvent system chloroform: methanol: water (65:25:4). The TLC plate was imaged 
using a phosphorimager Typhoon 9400 (Variable mode imager, Arnersham Biosciences, 
excitation Blue2 X 488nm, emission X 520±40rim, 400V, 501xm, normal sensitivity) and 
quantified using Image Quant software. The Rf values for C6-NBD-Cer and C 6-NBD-IPC 
were 0.77 and 0. 13, respectively. 
5.18.3.3.1 NBD-X Identification by TLC 
The C6-NBD-Cer degradation product, NBD-X, was identified by co-migration by TLC 
(section 5.18.3.3) with a standard (NBD-X, Molecular Probes, R f 0.63). C6-NBD-Cer 
(16.5.tM) and the JPC synthase assay reaction mix (section 5.18.3.1) without an IPC 
synthase source were treated with excess H2SO4  (165 j.tM, lOeq. and IM, 60eq.) or excess 
NaOH (165tM, lOeq) at 30°C, 60 °C and 100'C for 10 minutes prior to TLC work-up 
(section 5.18.3.3). Controls at the respective temperatures without excess H 2SO4 or NaOH 
were also carried out. Various IPC synthase sources were boiled (10 minutes) and allowed 
to cool to 30°C prior to initiation of the IPC synthase activity assay (sections 5.18.3.1 and 
5.18.3.3). LC-MS, El-MS with direct infusion and MALDI-ToF were also carried out with 
C6-NBD-Cer, C6-NBD-Cer degradation products, NBD-X and the assay reaction mixture. 
5.18.3.4 HPLC Detection 
The assay was terminated by the addition of 100% acetic acid (5 p1, final concentration 
1 0%v/v) and the pellet was removed by centrifugation (13k rpm, RT, 5mm). The lipids in 
the supernatant were separated by reverse phase HPLC (HP 1100) on a Hewlett Packard 
ZOBAX 5.tm C 18 (250 x 4.6mm) column with a 50-90% acetonitrile gradient over 20 
minutes using an acetonitrile/ water/ acetic acid (0.1 %v/v) solvent system (flow rate 
lmllmin). A 20p1 aliquot was injected using an automatic sample injector. The fluorescent 
lipids were detected using an Agilent 1100 Fluorescence detector (excitation X 480nm, 
emission X 535nm) and quantified by integration of the peaks. Retention times for C 6-NBD-
Cer and C6-NBD-IPC were 13.4 and 5.0 minutes, respectively. 
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5.18.3.5 Fluorescent Plate Reader Detection 
Assays were setup in triplicate as described in section 5.18.3.1 in a microtitre 96 well plate. 
One assay used wild type S. cerevisiae crude solubilised microsomes (25tl at 4.2mg/nil, 
1 00p.g, section 5.16.1.3) as the IPC synthase source, one used wild type S. cerevisiae crude 
solubilised microsomes incubated with AbA (lOOppm, 0.1mg/mi, 91 PM final concentration) 
and the third used distilled water instead of an IPC synthase source. All assays used C 6-
NBD-Cer (40p.M) and were incubated at 30°C (4h). The fluorescence (excitation X 485nm, 
emission X 535nm) was measured every 10 minutes for 4 hours using a SPECTRAF1uor Plus 
plate reader (Tecan, XFLUOR4 V4.03 software). The assays were repeated with reduced 
Triton X-100 in the assay buffer. 
5.18.3.6 Fluorimeter Detection 
100t1 assays were setup as described in section 5.18.3.5. After 4 hours at 30°C the reactions 
were diluted with distilled water to 1 ml and fluorescently scanned using a Hitachi U-30 10 
spectrophotometer. The excitation wavelength was scanned at a fixed emission wavelength 
(535nm) followed by an emission wavelength scan with fixed excitation wavelengths of 290, 
340, 460,475 and 485nm. 
5.18.3.7 Product Separation using Concanavalin A 
Wild type S. cerevisiae crude solubilised microsomes (25 .tl at 4.2mg/mi, section 5.16.1.3) 
were used as the IPC synthase source in a 200 p1 assay (see section 5.18.3.1). Final assay 
concentrations were protein (2mg/mi, 100g), C 6-NBD-Cer (40p.M), P1 (2mM) and lx assay 
buffer. The assay was terminated after 90 minutes by the addition of 100% acetic acid (20p1, 
final concentration I 0%v/v) and the pellet was removed by centrifugation (13k rpm, RT, 
5mm). The supernatant was made up to 300p.l with Concanavalin A buffer 1 and the acetic 
acid was removed using a G25 Sephadex column, NAP 5 (0.5m1, Amersham Biosciences) 
equilibrated with Concanavalin A buffer 1. The lipids (200 jtl column input) were eluted 
isocratically (flow rate gravity, 1 .6m1, collection fraction volume 400p1). The eluted 
fractions at pH 6.5 (fractions 1-2, 0-800p1) were pooled, 400p1 was aliquoted for TLC work-
up (section 5.18.3.3) and the remaining 400p1 was incubated with Concanavalin A sepharose 
resin (I ml, Sigma) equilibrated with Concanavalin A buffer I (RT, 2h). The resin was 
washed (4x 0.5m1) and any bound compounds were eluted by incubation with Concanavalin 
A buffer I (I nil, RT, 2h) containing D-myo inositol (0.5M) and Me-ct-D-mannopyranoside 
(0.5M). The fluorescence of the supernatants from the input incubation, washes and elution 
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were measured using a SPECTRAF1uor Plus plate reader (Tecan) and then subjected to TLC 
work-up (section 5.18.3.3). 
5.18.3.8 Whole Cell Pellet Assay 
Cell pellets resuspended to an OD o 5.6 with BMG media (45p.l) containing P1 (2p1, 50mM 
in lx assay buffer) were incubated on ice (1h). The cells were then incubated at 30°C (5mm) 
and BMG media (5p.l) containing C 6-NBD-Cer (0.4125tl, 2mM in DMSO) was added and 
incubated at 30°C (80mm). Final concentrations were cells (OD 5.0), C 6-NBD-Cer 
(16.5p.M), PT (2mM) and BMG (K-phos (100mM, pH 6.0), yeast nitrogen base (1.34%w/v) 
containing magnesium sulphate (4mM) and manganese sulphate (2.tM), biotin (5x10 5%w/v) 
and glycerol (l%v/v)) in 50i1. The assay was terminated by the addition of chloroform: 
methanol: 1 M HC1(aq) (5:12:4, 0.5n-J). Acid washed glass beads (0.2m1, Sigma) were added 
and the cells disrupted by vortex (5mm). The resulting suspension was centrifuged (13k 
rpm, RT, 5mm), the pellet was discarded and chloroform (0.5m1) was added to the 
supernatant, mixed and centrifuged (13k rpm, RT, 2mm) to obtain two layers. The upper 
(aqueous) layer was removed. The lower (choloroform) layer was concentrated by 
evaporation (RT, 18h) and then subjected to TLC detection (section 5.18.3.3). 
5.19 Characterisation of Wild Type IPC Synthase 
5.19.1 Kinetic Parameter Determination 
5.19.1.1 Kinetic Data for C 6-NBD-Cer 
Two stock solutions, A and B, were prepared (A, P1 (5mM), C 6-NBD-Cer (160p.M) and 2x 
assay buffer; B, P1 (5mM) and 2x assay buffer). Solution B was used to dilute solution A to 
give substrate stock solutions with a final concentration of P1 (5mM), 2x assay buffer and 
C6-NBD-Cer (160, 80, 40, 20, 10, 5p.M). Wild type S. cerevisiae crude solubilised 
microsomes (25 .d at 4.2mglml, section 5.16.1.3) as the IPC synthase source was incubated at 
30°C (5mm). The substrate stock solutions (25p1) were added and incubated at 30°C for 
various time points. The assays were terminated and the fluorescent lipids separated by 
I{PLC (section 5.18.3.4). Final assay concentrations were protein (2mg/mi, IOOp.g), P1 
(2.5mM), lx assay buffer and C 6-NBD-Cer (80, 40, 20, 10, 5, 2.5iM). Time periods were 0, 
2.5, 5, 7.5, 10, 12.5, 15, 30, 60 and 90 minutes. All assays were carried out in duplicate. 
Initial rates were calculated using Origin 7 and SigmaPlot 9.0 was used to calculate the KM 
and VMAX using Michaelis-Menten and Substrate Inhibition kinetics. 
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5.19.1.2 Kinetic Data for P1 
Two stock solutions, A and B, were prepared (A, P1 (2.5mM), C 6-NBD-Cer (40jiM) and 2x 
assay buffer; B, C 6-NBD-Cer (40p.M) and 2x assay buffer). Solution B was used to dilute 
solution A to give substrate stock solutions with a final concentration of C 6-NBD-Cer 
(40j.tM), 2x assay buffer and P1(2.5, 1.875, 1.25, 0.62 and 0.3mM). Wild type S. cerevisiae 
crude solubilised microsomes (25 .tl at 4.2mg/ml, section 5.16.1.3) as the IPC synthase 
source was incubated at 30°C (5mm). The substrate stock solutions (25tl) were added and 
incubated at 30°C for various time points. The assays were terminated and the fluorescent 
lipids separated by FIPLC (section 5.18.3.4). Final assay concentrations were protein 
(2mg/mi, 10099), C6-NBD-Cer (20tM), lx assay buffer and P1(2.5, 1.25, 0.9375, 0.625, 
0.31, 0.15 and 0mM). Time periods were 0, 2.5, 5, 7.5, 10, 12.5, 15, 30, 60 and 90 minutes. 
All assays were carried out in duplicate. Initial rates were calculated using Origin 7 and 
SigrnaPlot 9.0 was used to calculate the KM and VMAJ using Michaelis-Menten and Substrate 
Inhibition kinetics. 
5.19.1.3 Aureobasidin A Concentration Response 
AbA stock solutions in DMSO were prepared by dilution of a 5mg/mi (4.5mM) parent 
solution to give 10 final stock concentrations ranging logarithmically between 5 and 5x 1 0 
mg/mi. Wild type S. cerevisiae crude solubilised microsomes (25p1 at 4.2mg/mi, section 
5.16.1.3) as the IPC synthase source was incubated with AbA stock solution or DMSO for 
the control (ltl) at 30°C (5mm). The substrate mix (24p1), containing C 6-NBD-Cer 
(0.4125.tl, 2mM in DMSO), P1 (2tl, 50mM in lx assay buffer), 5x assay buffer (I 0.d) and 
distilled water (11 .5 875 j.tl) was added and incubated at 30°C (80mm). Final assay 
concentrations were protein (2mg/ml, 10099), C6-NBD-Cer (16.5.iM), P1 (2mM), lx assay 
buffer and AbA (1 mg/nil (910p.M) - 1x10 9 mg/ml (0.91pM) and 0 mg/mi control). All 
assays were carried out in at least duplicate. The assays were terminated and the fluorescent 
lipids separated by TLC (section 5.18.3.3). The AbA 1050 was determined using SigmaPlot 
9.0. 
5.19.2 Structure Activity Relationship of Substrates 
Wild type S. cerevisiae crude solubilised microsomes (5mi, section 5.16.1.3) were dialysed 
against lx assay buffer (2L, 4°C, 2h) to remove low molecular weight inhibitors and 
proteases. 
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5.19.2.1 C8-Ceramide 
C8-ceramide stock solutions in DMSO were prepared by dilution of a 4mM parent solution 
to give 8 final stock concentrations ranging between 4 and 0.0625mM. The dialysed 
solubilised microsomal IPC synthase source (25j.tl at 4.2mg/mi, section 5.16.1.3) was 
incubated at 30°C (5mm). The substrate mix (24p.l), containing C 5-NBD-Cer (0.4125t1, 
2mM in DMSO), P1 (2pi, 50mM in lx assay buffer), 5x assay buffer (lOLil) and distilled 
water (1 1.5875p1), and the C 8-ceramide stock solution or DMSO for the control (1il) was 
added and incubated at 30°C (40 and 80mm). Final assay concentrations were protein 
(2mg/mi, 10099), C6-NBD-Cer (16.5p.M), P1 (2mM), lx assay buffer and C 8-ceramide (80, 
40, 20, 16.5, 10, 5, 2.5, 1.25, 0tM). The assays were terminated and the fluorescent lipids 
separated by TLC (section 5.18.3.3). 
5.19.2.2 LysoPi 
Lyso P1 stock solutions in distilled water were prepared by 2-fold dilutions of a 100mM 
parent solution to give 6 final stock concentrations ranging between 100 and 3.125mM. The 
dialysed solubilised microsomal [PC synthase source (25j.il at 4.2mg/mi, section 5.16.1.3) 
was incubated at 30°C (5mm). The substrate mix (20ja.l), containing C 6-NBD-Cer (0.4125p1, 
2mM in DMSO), 5x assay buffer (lOp.l) and distilled water (9.5875p.l), and the lyso P1 stock 
solution or water for the control (5i1) was added and incubated at 30°C (40 and 80mm). 
Final assay concentrations were protein (2mg/mi, lOOj.ig), C 6-NBD-Cer (16.5pM), lx assay 
buffer and lyso P1(10, 5, 2.5, 1.25, 0.625, 0.3 125, 0mM). The assays were terminated and 
the fluorescent lipids separated by TLC (section 5.18.3.3). The assays were repeated with 
the concentration of Lyso P1 replaced with PT. 
5.19.2.3 Glycerol-i -Phosphate 
Glycerol- 1-phosphate stock solutions in distilled water were prepared by dilution of a 
100mM parent solution to give 4 final stock concentrations ranging between 100 and 10mM. 
The dialysed crude microsomal [PC synthase source (25p.l at 4.2mg/mi, section 5.16.1.3) 
was incubated at 30°C (5mm). The substrate mix (20t1), containing C 6-NBD-Cer (0.4125p1, 
2mM in DMSO), 5x assay buffer (10.tl) and distilled water (9.5875i.tl), and the Glycerol-i-
phosphate stock solution or water for the control (5j.il) was added and incubated at 30°C 
(80mm). Final assay concentrations were protein (2mg/mi, 100.tg), C 6-NBD-Cer (16.5pM), 
lx assay buffer and Glycerol- I -phosphate (10, 5, 2, 1 and 0mM). The assays were 
terminated and the fluorescent lipids separated by TLC (section 5.18.3.3). 
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5.19.3 Glycosylation Determination 
5.19.3.1 Endoglycosidase Treatment 
Endoglycosidases and their buffers were purchased from New England Biolabs. 
Wild type S. cerevisiae crude solubilised microsomes (20m1, section 5.16. 1.4) were dialysed 
against dialysis buffer 2 (3L, 4°C, 18h) to remove low molecular weight inhibitors and 
proteases. The resulting dialysed solubilsed microsomes were either treated with 
glycosidases (Endollf, PNGaseF) or used as controls. Treatment was carried out with the 
proteins either in their native state or denatured prior to treatment. To denature the proteins 
the dialysed samples (2m1, 1.6mg/mi) were incubated with 1 Ox denaturing buffer (200p.I) 
and boiled for 10 minutes. 
EndoH1 (1000U/jil) 
Native IPC Synthase source: Native dialysed wild type S. cerevisiae crude solubilised 
microsomes (2m1, 1.6mg/mI) were incubated with lOx G5 buffer (250p1), EndoHf(30tl) and 
distilled water (220.d) at 37°C (6h). 
Denatured IPC Synthase source: Denatured samples (2.2m1) were incubated with lOx G5 
buffer (250pJ), EndoHf(30.tl) and distilled water (20j.tl) at 37°C (6h). 
Control: Native samples (2ml) were incubated with lOx G5 buffer (250 j.xl) and distilled 
water (250 j.il) at 37°C (6h). 
PNGaseF (500U/p1) 
Native IPC Synthase source: Native samples (2m1, 1.6mg/mi) were incubated with lOx G7 
buffer (280 j.il), 10%NP-40 (280p.l), PNGaseF (10tl) and distilled water (230 j.ii) at 37°C (6h). 
Denatured IPC Synthase source: Denatured samples (2.2m1) were incubated with lOx G7 
buffer (280j.tl), 10%NP-40 ( 280pi), PNGaseF (lOjil) and distilled water (30p.l) at 37°C (6h). 
Control: Native samples (2m1) were incubated with lOx G7 buffer (280il), 10%NP-40 
(280ti), and distilled water (240p,l) at 37°C (6h). 
The native samples were then centrifuged (13k rpm, RT, 1mm) to remove the precipitate. 
The supernatant was analysed by [PC synthase activity assay (sections 5.18.3.1 and 
5.18.3.3). Both the native and denatured samples were analysed by SDS-PAGE. The gels 
were stained with coomniassie blue and a glycosylation staining kit, Glyco Stain (Sigma). 
The samples were also subjected to Concanavalin A sepharose chromatography (section 
5.19.3.2). RNaseB (native and denatured) was used as a control to determine if the 
endoglycosidases were working correctly. 
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5.19.3.2 Concanavalin A Sepharose Chromatography 
The samples were prepared (section 5.19.3.1), filtered (0.45 p.m) and loaded onto 
concanavalin A sepharose resin (1 ml, Sigma, 4°C) prepared in a polypropylene column (1 ml, 
Qiagen) and equilibrated with Concanavalin A buffer 2. The column was washed (flow rate 
gravity, 12 column volumes, 12m1) and bound proteins were eluted with Concanavalin A 
buffer 2 (flow rate gravity, 8 column volumes, 8m1, collection fraction volume Imi) 
containing Me-a-D-mannopyranoside (1M). The fractions were analysed by SDS-PAGE 
(section 5.11.2), stained with coomniassie blue and Glyco Stain and stored at -80°C. The 
native samples were also analysed by IPC Synthase activity assays (sections 5.18.3.1 and 
5.18.3.3). Wild type S. cerevisiae crude solubilised microsomes, native and denatured, not 
incubated at 37°C and untreated with glycosidases were also subjected to concanavalin A 
sepharose chromatography. 
5.20 Characterisation of Recombinant Aurl p 
5.20.1 IPC Synthase Activity Assay 
The activity assays for the cell pellets were carried out as described in section 5.18.3.8. 
The activity assays for the solubilised protein were carried out as described in sections 
5.18.3.1 and 5.18.3.3. 
5.20.2 SDS-PAGE Analysis of IMAC Purified Recombinant Aurip 
All samples were ran using PRE-CAST SDS-PAGE (section 5.11.2.3). 
5.20.2.1 Boiling 
The proteins (50p.l) were denatured by adding 2x SDS sample buffer (50j.tl) and boiling for 
either 10 or 45 minutes. 
5.20.2.2 Guanidine Treatment 
IMAC buffer containing 12M guanidine (75j.tl) was added to proteins in IMAC buffer 
containing SOOmIvI imidazole (75j.tl) and incubated on ice (3h, 6M guanidine). The 
guanidine was removed by buffer exchange into IMAC buffer using a vivaspin concentrator 
30,000 PES membrane (VivaScience). The protein was concentrated by TCA precipitation 
(section 5.13.6.3) and resuspendend in lx SDS sample buffer (150 j.tl) and boiled (10mm). 
5.20.2.3 Concanavalin A Treatment 
Proteins in IMAC buffer (75tl) were exchanged into Concanavalin A buffer 3 without CaC1 2 
using a vivaspin concentrator 30,000 PES membrane (VivaScience). CaC1 2(2 (IM ) was 
added to a final concentration of 5mM and the resulting solution (200p.l) was incubated with 
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concanavalin A sepharose resin (200tl, Sigma, 4°C, 3h, slow rotation using a blood rotator) 
equilibrated with Concanavalm A buffer 3. The supernatant was removed (200t1) and 
unbound protein was concentrated by TCA precipitation (section 5.13.6.3), resuspendend in 
Ix SDS sample buffer (150d) and boiled (10mm). 
5.21 Mass Spectrometry 
5.21.1 Liquid Chromatography-Mass Spectrometry 
Mass spectrometry was performed on a Micromass Platform equipped with an electrospray 
ion source. The spectrometer cone voltage was ramped from 40 to 70 volts and source 
temperature set to 140°C. Protein samples were separated with a Waters HPLC 2690 with 
Phenomenex C 5 reverse phase column directly connected to the spectrometer. The proteins 
were eluted from the column with a 5-95% acetonitrile gradient using an acetonitrile/ water! 
TFA (0.01%v/v) solvent system (flow rate 0.4m1/min). The total ion count in the range 500 
to 2000 m/z was scanned at 0.1 Is intervals. The scans were accumulated, the spectra 
combined and the molecular mass was determined by the MaxEnt and Transform algorithms 
of the Mass Lynx software (MicroMass). 
5.21.2 MALDI-T0F Mass Spectrometry 
SDS-PAGE gels were stained with GelCode Blue (Pierce) and the bands were excised. The 
proteins were digested with Trypsin using a standard In-gel digestion protocol. The resulting 
peptides were desalted and concentrated using C 18  ZipTips (Millipore Corp.). The analyte 
(1 t1) was mixed with the matrix solution (a saturated solution of -cyano-4- 
hydroxycinnamic acid in 50% acetonitrile with 0.1% TFA, 1 j.tl), air dried on a MALDI plate 
and MALDI-MS (Tof-Spec 2E, Micromass, U.K) was carried out with the help of Nick 
Tomczyk. Peptide fingerprinting of the fragment peaks was conducted using the Mascot 
search engine (www.matrixscience.com ). 
5.22 Bioinformatics 
5.22.1 Basic Local Alignment Search Tool (BLAST) 
Similar Aurip sequences were identified using BLASTp [BLAST 1.5.4-Paracel [502, 503] 
accessed via ExPASy/SIB [504] (http:/!ca.expasy.orgJtools/blast/)], against the 
ExPASyIUniprotKB database, the UniprotKB A. thaliana database and the Syngenta plant 
database. S. cerevisiae Aurip (P36107) was used as the query sequence with low 
complexity regions replaced by X and gapped alignment checked on. 
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5.22.2 Sequence Alignments 
The Swiss-Prot database (http://ca.expasy.orgJsprou ) was used to obtain amino acid 
sequences that were aligned with either Align X in the Vector NTI 8 suite or ClustaiW [605] 
(http://www.ebi.ac.uk/clustalwf) . Both programs use a ClustaiW alignment algorithm [605]. 
5.22.3 Vector NTI 8 
Vector NTI 8 suite was used for drawing plasmids, manipulating nucleic acid and protein 
sequences, designing primers, carrying out amino acid sequence alignments and 
phylogenetic tree generation. 
5.22.4 Phylogenetic Tree Generation 
5.22.4.1 Method 1: Vector NT! 8 
A phylogenetic tree was automatically generated upon carrying out a sequence alignment 
with Align X in the Vector NTI 8 suite. The tree was generated using the sequence distance 
method and the Neighbor Joining algorithm [506]. Tree parameters, Kimura's correction 
[507] and ignore positions with gaps, were checked on. 
5.22.4.2 Method 2: Phylip 
An alignment generated with Clustal W was prepared. The N- and C- termini and the 
gapped regions were removed manually. A consensus tree was generated from 100 
bootstrap cycles using Phylip:protidist [508, 509] 
(bioweb.pasteur.fr/seqanal/phylogeny/phylip-uk.html)  Neighbor distance method and the 
UPGMA tree reconstruction algorithm. 
5.22.5 Domain Analysis 
Domain searching was carried out on all Aurip sequences analysed using both InterProScan 
[510-512](hiip://www.ebi.ac.uk/InteLProScan/)  and the NCBI CD server [513] 
(http://www.ncbi .nlm.nih.gov/Structure/cddlwrpsb.cgi).  
5.22.6 Post Translational Modification Prediction 
Post translational modification analysis of Aurip and Iptip sequences was carried out by 
searching for post translational modification patterns using ScanProsite [533-535] 
(http://www.expasy.org/tools/scanprosite/)  and the NetAcet 1.0 server [538] 
(http://www.cbs.dtu.dk/services/NetAcetf . The PredictProtein server [537] 
(http://www.predictprotein.org/)  was also used to analyse S. cerevisiae and B. cinerea Aurip 
sequences, using the default submission form. 
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5.22.7 Targeting Sequence Prediction 
Aur lp sequences were analysed for signal peptides and signal anchors using SignalP 3.0 
[548-550] (http://www.cbs.dtu.dk/services/SignalPI) . All sequences, except B. 
thetaiotaomicron Aur ip, were trained on eukaryotic models; whereas B. thetaiotaomicron 
Aurip was trained on gram negative bacterial models. Sequences were analysed with both a 
70 and 125 amino cut input cut off threshold. 
PeptideCutter [624] (http://www.expasy.org/tools/peptidecutterf)  was used to identify 
putative protease cleavage sites in B. cinerea and S. cerevisiae Aurip sequences and in their 
recombinant constructs. Aur 1 p  and Ipt 1 p  sequences were analysed for PEST sequences 
using PESTfind [103, 547] (http://www.at.embnet.org/embnetitools/bio/PESTfmd/) . 
ProtParam [624] (http://www.expasy.org/tools/protparam.html)  was also used for further 
analysis of protein stability of S. cerevisiae and B. cinerea Aurip sequences. 
S. cerevisiae and B. cinerea Aur 1 p  sequences were also analysed for Coiled coil regions 
using the PredictProtein server [650], COILS [651] 
(http://www.ch.embnet.org/software/COILSform.htmfl,  multicoil [652] 
(hltp:Hmulticoil.Ics.mit.edu/cizi-bin/multicoil) and paircoil [653] 
(http://paircoil.lcs.mit.edulcgi-binlpaircoil ) programs, and for disulfide bond connectivity 
using the PredictProtein server trained on DISULFIND [561-5631. 
5.22.8 Structure Analysis 
Structure analysis of Aurip sequences was carried out using TMHMM versions one and two 
[584, 5851 (http://www.cbs.dtu.dk/services/TrvIHMM-2.0/) . S. cerevisiae and B. cinerea 
Aurip sequences were analysed in more detail using TopPred [587, 588] 
(http://bioweb.pasteur.fr/seqanallinterfaces/toppred.html),  TMpred [589] 
(httt://www.ch.embnet.org/software/TMPRED  form.html), SOSUI [590-593] 
(httt://sosui.proteome.bio.tuat.ac.jp/sosuiframeO.html),  MEMSTAT2 [594, 595] 
(http:/fbioinf.cs.ucl.ac.uk/psipredlpsiform.html),  PHDhtm [596-598] and PSIPRED [599] 
(http://bioinf.cs.ucl.ac.uklpsipredlpsiform.html ) programs in addition to TMHMM. PHDhtm 
was accessed via both the PredictProtein server [537] and the Network Protein Sequence 
Analysis server [604] (http://npsa-pbil.ibcp.fr/cgi-
binlnpsaautomat.pl?page=/NPSAlnpsahtm.htmj).  
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Appendix: Publication 11 
The mechanism of 7,8-diaminopelargonate synthase; the role of S- 
adenosylmethionine as the amino donor 
Rachel S. Breen, Dominic J. Campopiano, Scott Webster, 
Mhairi Brunton, Rory Watt and Robert L. Baxter 
Organic and Biomolecular Chemistry, 2003, 1(20), 3498-3499 
During the course of my PhD studies I have researched and published [654] work on 
7,8-diaminopelargonate synthase (DAPA synthase). DAPA synthase, encoded by BioA, 
catalyses the stereo specific transamination of (7S) 8-amino-7-oxononanoate to yield (7S,8R) 
7,8-diaminononanoate (7,8-diaminopelargonate) by a PLP mediated mechanism in the biotin 
(vitamin H) biosynthetic pathway. The enzyme is unique in that it utilises 
S-adenosyl-L-methionine (SAM) as an amino donor. A radioactive ([14C-methyl]SAM) 
HPLC assay was developed and conditions were established which captured the unstable 
keto product, S-adenosyl-2-oxo-4-methyl-thiobutyric acid (oxy-SAM), in its reduced form as 
S-adenosyl-2-hydroxy-4-methyl-thiobutyric acid (SAM-OH). This study provides evidence 
that in the first step of the DAPA catalysed reaction the amino group of SAM is transferred 
to PLP generating the corresponding oxy-SAM. 
11 [654] is attached at the end of this thesis. 
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ie product of the first transamination step in the reaction 
talysed by diaminopelargonate (DAPA) synthase has 
en shown to be 4-(S-adenosyl)-2-oxobutanoate, which 
s been trapped as the corresponding alcohol. 
e biosynthesis of biotin (vitamin H), the cofactor in most 
)logical carboxylation and transcarboxylation reactions, has 
.racted considerable interest over the past decade. This is due 
I only to the novelty of the enzyme reactions involved, and 
plicitly their suitability as potential targets for selective 
tibiotics and herbicides, but also to the long term aim of 
Dducing the vitamin by fermentation.-' Diaminopelargonate 
APA) synthase is a pyridoxal 5'-phosphate (PLP) dependent 
zyme, obligate in biotin biosynthesis, which catalyses the 
ond committed step in the four step pathway, the stereo-
ecific amination of (7S) 8-amino-7-oxononanoate 1 to give 
S',8R) 7,8-diaminononanoate (7,8-diaminopelargonate) 2. 
us aminotransferase, first described by Eisenberg in 1970, is 
ique in that it uses S-adenosylmethionine (SAM) as an 
ino donor. The usual roles that SAM performs in metabolic 
sctions are as a methyl donor in methyl transferases 4 and as a 
te radical initiator in Fe—S cluster enzymes such as biotin 
nthase. 5 The crystal structure of DAPA synthase has been 
termined 6 and its kinetics and its inhibition by the antibiotic 
ruiclenomycin have been studied . 7 ' 8 Despite the fact that it uses 
unique amino donor, the reaction mechanism, shown in 
heme I, is similar to that of other PLP-dependent amino-
snsferases. 9 However the identity of the SAM transamination 
oduct, produced in the first step, is based on indirect evidence 
m early studies which reported the isolation of 2-oxobutenoic 
:id, which could result from non-enzymatic elimination of 
-methylthioadenosine from the oxo-acid 3•3  However this 
itative product has never been isolated and, since SAM itself 
relatively unstable, it is conceivable that 2S-aminobutenoate, 
rmed by elimination of 5'-methylthioadenosine, could be the 
tual amino donor. Here we describe studies which show that 
is indeed the enzymatic product. 
(±) 8-Amino-7-oxononanoate I was synthesised from 
2-acetyl-1 ,3-dithiolane' ° by the route shown in Scheme 2 and 
the DAPA synthase gene was cloned from E. coil JMI01 
genomic DNA by PCR and inserted in a pETl6 derived vector. 
The protein was over-expressed in E. coil BL2I (DE3) cells. 
Purification by chromatography gave the essentially pure 
holo-enzyme which showed ping-pong kinetic behaviour." The 
first half-reaction - the reaction of the PLP form of the enzyme 
with SAM to form the pyridoxamine phosphate (PMP) bound 
form and the putative transamination product 3— was followed 
by UV-vis spectrophotometry which shows the rapid appear-
ance of a transient peak at 487 rim (Fig. I). 
This peak can be ascribed to the intermediate quinonoid 
form (Enz.Q) formed from SAM and the cofactor. The first 
part of the half-reaction, transimination of the bound PLP 
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Fig. I Time course of the half-reaction of DAPA synthase (20 sM) 
with SAM (1 mM) at 25°C in potassium phosphate buffer (20 mM, pH 
75). Spectra were recorded on a HP8453 single beam diode-array 
spectrophotometer at 60 s intervals. 
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Scheme 1 The diasninopelargonate synthase reaction. 
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theme 2 Reagents and conditions: (I) LDA, THF, (ii) ethyl 6-
dohexanoate, HMPA. (iii) TICL, Et 3N, (Me3Si)2NH, (iv) NaCNBH,, 
CM, (v) NBS, MeCN-H 20 (4-I), (vi) sq. HCI (6 M). 
rm the quinonoid is rapid but the subsequent hydrolysis to 
ie bound PMP form is very slow and this appears to be the 
tte determining step in the overall catalytic reaction. 
Under the conditions used in the enzyme experiments we 
)und that SAM degrades slowly affording 5-methylthio-
denosine (z, 	20 h at 37 °C and pH 75)•hI  Under steady state 
onditions' 2 (both substrates at Ca 5 x KM) disappearance of 
AM was accompanied by the appearance of an HPLC peak 
orresponding to a new product. On standing this compound 
ecomposed to give 5'-methylthioadenosine much more rapidly 
ian SAM suggesting that the oxo-acid 3 was indeed being 
)rmed and subsequently disproportionated. Since we were 
nable to find HPLC conditions' 3 which gave satisfactory 
paration of this product from SAM, a series of incubations 
as carried out under non-optimum catalytic conditions with 
t)-1 (6 LLM, 5 x KM) in excess but where the SAM concen-
ration (200-300 AM, 1.3-2.0 X KM) was limited so that it was 
Imost completely depleted from the incubation mixture within 
fteen minutes, thus minimising the contamination of the 
roduct by SAM. HPLC-MS of the reaction mixtures showed 
hat the unstable product had a M peak at 400 amu. However 
his is very close to the molecular weight of the SAM cation 
:self (399 amu). So, to determine unambiguously whether the 
ompound formed in the enzymatic reaction was indeed the 
utative oxo-acid, we elected to reduce the product in situ to 
.fford the more stable hydroxy-acid 4. Accordingly, authentic 4 
vas synthesised directly from SAM by partial diazotisation 
ssentially as described by Zappia.' 4 ' 5 
The enzyme was incubated under the above conditions with 
he addition of [14C-methyl]SAM ( 2 nmoles, 0.024 M Bq), the 
nixture was spin-filtered to remove the protein, and treated 
tith NaBH4 (5 mM, 5 mm, on ice) to convert 3 to 4. 
Under conditions where virtually all of the SAM was turned 
ver 88% of the radioactivity co-purified with 4 and 8% with 
'-methylthioadenosine. This provides compelling evidence that  
the first step in the reaction, the transfer of the amino group of 
SAM to PLP, generates the corresponding oxo-acid 3 as shown 
in Scheme I. 
This study was funded by BBSRC. RSB & MB thank 
Syngenta Ltd. for support through CASE awards. 
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